Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:aldehydo-D-glucose
go back to main search page
Accession:CHEBI:42758 term browser browse the term
Definition:The open chain form of D-glucose.
Synonyms:exact_synonym: aldehydo-D-gluco-hexose
 related_synonym: (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal;   D-GLUCOSE IN LINEAR FORM;   D-glucose;   Dextrose;   Formula=C6H12O6;   Glucose;   InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1;   InChIKey=GZCGUPFRVQAUEE-SLPGGIOYSA-N;   SMILES=[H]C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO;   WURCS=2.0/1,1,0/[o2122h]/1/
 alt_id: CHEBI:37625;   CHEBI:42756
 xref: Beilstein:1724615;   CAS:50-99-7;   DrugBank:DB01914;   GlyGen:G59743JO;   GlyTouCan:G59743JO;   Gmelin:306224
 xref_mesh: MESH:D005947
 xref: PDBeChem:GLO;   Wikipedia:Glucose
 cyclic_relationship: is_enantiomer_of CHEBI:37626



show annotations for term's descendants           Sort by:
aldehydo-D-glucose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA CTD PMID:37567420 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of ABCA1 mRNA; Glucose results in decreased expression of ABCA1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 protein]
CTD PMID:34485530 NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression ISO Glucose results in decreased expression of ABCB1 protein CTD PMID:22363694 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ABCB4 mRNA CTD PMID:37567420 NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
JBrowse link
G Abcb7 ATP binding cassette subfamily B member 7 decreases expression ISO Glucose results in decreased expression of ABCB7 mRNA CTD PMID:17178593 NCBI chr  X:69,295,598...69,436,775
Ensembl chr  X:69,295,552...69,436,858
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]]; Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] CTD PMID:10856430 NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP [Benzbromarone results in decreased activity of ABCC2 protein] inhibits the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [Furosemide results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [sulfanitran results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione] CTD PMID:19782883 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ABCD2 mRNA CTD PMID:37567420 NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of ABCG1 mRNA; Glucose results in decreased expression of ABCG1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 protein]
CTD PMID:34485530 NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions
decreases expression
increases expression
decreases phosphorylation
ISO
EXP
[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA; [Pyruvic Acid co-treated with Glucose] results in increased phosphorylation of ACACA protein; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA]
Glucose results in decreased expression of ACACA protein modified form
Glucose results in increased expression of ACACA mRNA
CTD PMID:15066988 PMID:18482975 PMID:19071085 PMID:19724016 PMID:24349266 More... NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
JBrowse link
G Acacb acetyl-CoA carboxylase beta multiple interactions
decreases phosphorylation
ISO 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]]; ACACB protein affects the reaction [Glucose results in decreased expression of NPHS1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SLC2A4 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of IRS1 protein]
Glucose results in decreased phosphorylation of ACACB protein
CTD PMID:33957017 NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain multiple interactions ISO 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA] CTD PMID:32613381 NCBI chr 1:186,188,939...186,227,796
Ensembl chr 1:186,188,987...186,230,379
JBrowse link
G Ace angiotensin I converting enzyme increases expression
multiple interactions
decreases expression
ISO
EXP
Glucose results in increased expression of ACE protein
Enalaprilat inhibits the reaction [Glucose results in increased expression of ACE protein]
Glucose results in decreased expression of ACE mRNA
CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]
Glucose results in increased expression of ACE mRNA
NFE2L2 protein affects the reaction [Glucose results in increased expression of ACE mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]]; trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]
CTD PMID:16452552 PMID:29211853 PMID:29266779 PMID:31655124 NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions
decreases expression
EXP
ISO
NFE2L2 protein affects the reaction [Glucose results in decreased expression of ACE2 mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter]; Valsartan inhibits the reaction [Glucose results in decreased expression of ACE2 protein]
CTD PMID:29211853 PMID:29266779 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:30,293,589...30,340,977
JBrowse link
G Ache acetylcholinesterase multiple interactions
decreases activity
ISO Ascorbic Acid inhibits the reaction [Glucose results in decreased activity of ACHE protein] CTD PMID:26163454 NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
JBrowse link
G Acly ATP citrate lyase increases expression EXP
ISO
Glucose results in increased expression of ACLY mRNA
Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein
CTD PMID:24349266 PMID:26811028 NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
JBrowse link
G Aco1 aconitase 1 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein] CTD PMID:16135072 NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
JBrowse link
G Aco2 aconitase 2 multiple interactions EXP [Glucose co-treated with Oxygen] affects the activity of ACO2 protein; Glucose results in decreased expression of and results in decreased activity of ACO2 protein; LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein]]; manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein] CTD PMID:11520895 PMID:31639451 NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression
multiple interactions
ISO Glucose results in increased expression of ACOT1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ACOT1 mRNA
CTD PMID:17178593 PMID:37567420 NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression ISO Glucose results in increased expression of ACOX1 mRNA CTD PMID:36156098 NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression ISO Glucose results in decreased expression of ACOX2 mRNA CTD PMID:17178593 NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ACSBG1 mRNA CTD PMID:37567420 NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391
JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 increases expression ISO Glucose results in increased expression of ACSM2 mRNA CTD PMID:31525975 NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ACSM3 mRNA CTD PMID:37567420 NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 increases expression ISO Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression
multiple interactions
decreases expression
EXP
ISO
Glucose results in increased expression of ACTA1 mRNA
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ACTA1 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ACTA1 mRNA]
CTD PMID:24810525 PMID:33448797 PMID:37567420 NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
increases expression
ISO
EXP
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of ACTA2 protein]
Glucose results in increased expression of ACTA2 mRNA; Glucose results in increased expression of ACTA2 protein
cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein]
CTD PMID:20060012 PMID:21829520 PMID:26045780 PMID:29163160 PMID:35961541 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
JBrowse link
G Actb actin, beta decreases expression ISO Glucose deficiency results in decreased expression of ACTB protein CTD PMID:22314686 NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
JBrowse link
G Actg1 actin, gamma 1 multiple interactions EXP ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
Ensembl chr 3:105,619,737...105,624,232
JBrowse link
G Actr2 actin related protein 2 multiple interactions
decreases expression
ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of ACTR2 protein] CTD PMID:31483951 NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
JBrowse link
G Adam17 ADAM metallopeptidase domain 17 decreases expression ISO Glucose results in decreased expression of ADAM17 mRNA CTD PMID:31655124 NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
JBrowse link
G Adam19 ADAM metallopeptidase domain 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ADAM19 mRNA CTD PMID:37567420 NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
JBrowse link
G Adam32 ADAM metallopeptidase domain 32 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADAM32 mRNA CTD PMID:37567420 NCBI chr16:67,102,384...67,212,163
Ensembl chr16:67,102,320...67,212,161
JBrowse link
G Adam7 ADAM metallopeptidase domain 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ADAM7 mRNA CTD PMID:37567420 NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201
JBrowse link
G Adam8 ADAM metallopeptidase domain 8 increases expression
multiple interactions
ISO Glucose results in increased expression of ADAM8 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADAM8 mRNA
CTD PMID:17178593 PMID:37567420 NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Glucose results in increased expression of ADAMTS1 mRNA CTD PMID:17178593 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
JBrowse link
G Adcy7 adenylate cyclase 7 decreases methylation
multiple interactions
increases expression
ISO Glucose results in decreased methylation of ADCY7 gene
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of ADCY7 gene]; fucoxanthin inhibits the reaction [Glucose results in increased expression of ADCY7 mRNA]
CTD PMID:33448797 NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
JBrowse link
G Adgra1 adhesion G protein-coupled receptor A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRA1 mRNA CTD PMID:37567420 NCBI chr 1:194,629,744...194,673,254
Ensembl chr 1:194,629,726...194,672,550
JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA CTD PMID:37567420 NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRE4 mRNA CTD PMID:37567420 NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
JBrowse link
G Adgrf4 adhesion G protein-coupled receptor F4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ADGRF4 mRNA CTD PMID:37567420 NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
JBrowse link
G Adgrg4 adhesion G protein-coupled receptor G4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADGRG4 mRNA CTD PMID:37567420 NCBI chr  X:134,734,610...134,864,449
Ensembl chr  X:134,854,736...134,864,449
JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression ISO Glucose results in decreased expression of ADHFE1 mRNA CTD PMID:17178593 NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
increases expression
multiple interactions
increases secretion
EXP
ISO
Glucose results in decreased expression of ADIPOQ protein
Glucose results in increased expression of ADIPOQ protein
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
Glucose deficiency results in increased secretion of ADIPOQ protein
ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein]; argan oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]; Corn Oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]
CTD PMID:21912612 PMID:24802182 PMID:29165388 PMID:32407875 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions
decreases expression
EXP FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]
Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein
CTD PMID:24413998 NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241
JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions
decreases expression
EXP ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] CTD PMID:21912612 NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
JBrowse link
G Adra1a adrenoceptor alpha 1A multiple interactions EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; [cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased transport of Glucose; Prazosin inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose] CTD PMID:15550506 NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
JBrowse link
G Adrb2 adrenoceptor beta 2 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose; [Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose; ICI 118551 inhibits the reaction [[BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose]; ICI 118551 inhibits the reaction [[Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose] CTD PMID:18552870 NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
JBrowse link
G Adrb3 adrenoceptor beta 3 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in decreased abundance of Glucose; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADRB3 mRNA CTD PMID:20930473 PMID:37567420 NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
JBrowse link
G Afp alpha-fetoprotein increases expression ISO Glucose results in increased expression of AFP mRNA CTD PMID:17178593 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
JBrowse link
G Agbl4 AGBL carboxypeptidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AGBL4 mRNA CTD PMID:37567420 NCBI chr 5:125,254,963...126,534,367
Ensembl chr 5:125,254,956...126,534,367
JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
increases expression
ISO
EXP
GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; Glucose promotes the reaction [RELA protein binds to AGER promoter]; Luteolin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; RELA promotes the reaction [Glucose results in increased expression of AGER mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER protein]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER protein]
[Ribose co-treated with Glucose] results in increased expression of AGER protein; AGER protein affects the reaction [Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]]
Glucose results in increased expression of AGER mRNA; Glucose results in increased expression of AGER protein
AGER protein results in increased susceptibility to [Azoxymethane co-treated with Glucose co-treated with Linoleic Acid]; Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]; Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Losartan inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Losartan inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]
CTD PMID:19557821 PMID:19759273 PMID:19833897 PMID:22467055 PMID:30101366 NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
JBrowse link
G Agl amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase increases uptake ISO AGL protein results in increased uptake of Glucose CTD PMID:24700805 NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
JBrowse link
G Agt angiotensinogen multiple interactions
increases expression
affects metabolic processing
ISO
EXP
(3,4-dihydroxyphenylamino)-2-imidazoline inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; acetovanillone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of AGT protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]; Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]; Rotenone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT mRNA]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT protein]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT mRNA]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT mRNA]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT protein]; NFE2L2 protein affects the reaction [Glucose results in increased expression of AGT mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT protein]; Taurine inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Taurine inhibits the reaction [Glucose results in increased expression of AGT protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT protein]; trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Valsartan promotes the reaction [Glucose results in increased expression of AGT protein]
AGT protein affects the metabolism of Glucose
Glucose results in increased expression of AGT mRNA; Glucose results in increased expression of AGT protein
CTD PMID:11115780 PMID:12130563 PMID:15677497 PMID:16452552 PMID:19225232 More... NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression
multiple interactions
ISO Glucose results in increased expression of AGTR1 mRNA; Glucose results in increased expression of AGTR1 protein
Enalaprilat inhibits the reaction [Glucose results in increased expression of AGTR1 protein]
CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]
CTD PMID:16452552 PMID:29266779 PMID:31655124 PMID:34464088 NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions
increases expression
ISO CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein] CTD PMID:29266779 NCBI chr  X:112,119,876...112,124,060
Ensembl chr  X:112,120,228...112,124,057
JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
increases response to substance
ISO 4,7-phenanthroline inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]
AHR protein promotes the reaction [Tetrachlorodibenzodioxin affects the susceptibility to Glucose]
AHR results in increased susceptibility to Glucose
CTD PMID:8738555 PMID:19623578 PMID:21849270 NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of AIF1 mRNA CTD PMID:37567420 NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 affects localization
multiple interactions
EXP Glucose affects the localization of AIFM1 protein
Quercetin affects the reaction [Glucose affects the localization of AIFM1 protein]; sesamin affects the reaction [Glucose affects the localization of AIFM1 protein]
CTD PMID:19146853 PMID:22524206 NCBI chr  X:127,650,223...127,689,356
Ensembl chr  X:127,650,226...127,689,256
JBrowse link
G Ak8 adenylate kinase 8 increases expression
multiple interactions
ISO Glucose results in increased expression of AK8 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA]
CTD PMID:33448797 NCBI chr 3:12,028,895...12,144,468
Ensembl chr 3:12,028,954...12,144,465
JBrowse link
G Akap5 A-kinase anchoring protein 5 increases expression ISO Glucose results in increased expression of AKAP5 mRNA CTD PMID:31525975 NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions
decreases expression
ISO fidarestat inhibits the reaction [Glucose results in decreased expression of AKR1A1 mRNA] CTD PMID:16805838 NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions
increases expression
ISO AKR1B1 protein promotes the reaction [Glucose results in increased abundance of Sorbitol]
Glucose results in increased expression of AKR1B1 mRNA; Glucose results in increased expression of AKR1B1 protein
CTD PMID:16805838 PMID:25451566 NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of AKR1C6 mRNA CTD PMID:37567420 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA CTD PMID:37567420 NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
increases response to substance
decreases expression
decreases phosphorylation
ISO
EXP
Glucose results in increased phosphorylation of AKT1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [Glucose affects the susceptibility to INS protein] which affects the phosphorylation of AKT1 protein; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Fluorometholone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]
AKT1 protein mutant form results in increased susceptibility to Glucose deficiency
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein; [Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; AKT1 protein modified form inhibits the reaction [arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; Bezafibrate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; Glucose affects the phosphorylation of and affects the activity of AKT1 protein; methyl pyruvate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]
Glucose results in decreased expression of AKT1 protein modified form
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; [3,4-Dihydroxyphenylacetic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Catechin co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Simvastatin inhibits the reaction [Glucose results in decreased expression of AKT1 protein modified form]
CTD PMID:15806154 PMID:16385087 PMID:17520061 PMID:18004065 PMID:20370652 More... NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Akt2 AKT serine/threonine kinase 2 affects response to substance ISO AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
JBrowse link
G Alb albumin multiple interactions
increases metabolic processing
decreases uptake
ISO
EXP
[Fructose co-treated with Glucose] results in increased glycation of ALB protein; [Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein; Phlorhizin inhibits the reaction [Glucose results in decreased uptake of ALB protein]; pimagedine inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]; pimagedine inhibits the reaction [[Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein]; ursonic acid inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]
Glucose results in increased metabolism of ALB protein
[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA
ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:8536680 PMID:12196478 PMID:12434198 PMID:16313995 PMID:27415824 More... NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
JBrowse link
G Alcam activated leukocyte cell adhesion molecule multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 increases expression ISO Glucose deficiency results in increased expression of ALDH1B1 protein CTD PMID:22314686 NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ALDH1L2 mRNA CTD PMID:37567420 NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member decreases expression
multiple interactions
EXP Glucose results in decreased expression of ALDH2 protein
N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ALDH2 protein]
CTD PMID:29128638 NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALDH3B3 mRNA CTD PMID:37567420 NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Glucose results in decreased expression of ALDH6A1 mRNA CTD PMID:17178593 NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
JBrowse link
G Aldoc aldolase, fructose-bisphosphate C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ALDOA mRNA CTD PMID:37567420 NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase decreases expression ISO Glucose results in decreased expression of ALG12 mRNA CTD PMID:17178593 NCBI chr 7:119,895,112...119,909,488
Ensembl chr 7:119,895,120...119,909,458
JBrowse link
G Alk ALK receptor tyrosine kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ALK mRNA CTD PMID:37567420 NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type increases expression ISO Glucose results in increased expression of ALOX12 mRNA CTD PMID:32942007 NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
increases expression
EXP
ISO
[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein; caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]
Glucose results in increased expression of ALOX5 mRNA
CTD PMID:18951527 PMID:31655124 NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
JBrowse link
G Alpk3 alpha-kinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALPK3 mRNA CTD PMID:37567420 NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated decreases expression
multiple interactions
ISO
EXP
Glucose results in decreased expression of ALPL mRNA
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]
morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]
CTD PMID:32643284 PMID:33450223 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
JBrowse link
G Amer2 APC membrane recruitment protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AMER2 mRNA CTD PMID:37567420 NCBI chr15:34,525,352...34,535,660
Ensembl chr15:34,524,542...34,528,455
JBrowse link
G Amot angiomotin decreases expression ISO Glucose results in decreased expression of AMOT mRNA CTD PMID:17178593 NCBI chr  X:108,982,399...109,041,265
Ensembl chr  X:108,984,022...109,041,272
JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO Glucose results in increased expression of ANGPTL4 mRNA CTD PMID:16805838 NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
JBrowse link
G Ankrd61 ankyrin repeat domain 61 decreases expression
multiple interactions
ISO Glucose results in decreased expression of ANKRD61 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ANKRD61 mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr12:10,718,908...10,723,267
Ensembl chr12:10,718,908...10,723,265
JBrowse link
G Anks1b ankyrin repeat and sterile alpha motif domain containing 1B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ANKS1B mRNA CTD PMID:37567420 NCBI chr 7:24,313,339...25,479,307
Ensembl chr 7:24,312,843...25,477,693
JBrowse link
G Anxa5 annexin A5 decreases expression ISO Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
JBrowse link
G Aoc1 amine oxidase, copper containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of AOC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AOC1 mRNA CTD PMID:37567420 NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA] CTD PMID:33962019 NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression EXP Glucose results in decreased expression of APC mRNA CTD PMID:21818840 NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
JBrowse link
G Apcs amyloid P component, serum multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of APCS mRNA CTD PMID:37567420 NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
JBrowse link
G Apoa1 apolipoprotein A1 increases expression
decreases expression
EXP Glucose results in increased expression of APOA1 mRNA; Glucose results in increased expression of APOA1 protein
Glucose results in decreased expression of APOA1 mRNA
CTD PMID:9322794 PMID:9668074 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
JBrowse link
G Apob apolipoprotein B multiple interactions ISO Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
JBrowse link
G Apoe apolipoprotein E affects secretion
multiple interactions
decreases expression
ISO Glucose deficiency affects the secretion of APOE protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of APOE mRNA; morroniside inhibits the reaction [Glucose results in decreased expression of APOE mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of APOE protein]
Glucose results in decreased expression of APOE mRNA; Glucose results in decreased expression of APOE protein
CTD PMID:24802182 PMID:34485530 PMID:37567420 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
JBrowse link
G Apol9a apolipoprotein L 9a multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of APOL9A mRNA CTD PMID:37567420 NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
JBrowse link
G Aqp1 aquaporin 1 increases expression
multiple interactions
EXP Glucose results in increased expression of AQP1 mRNA
benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]
CTD PMID:11510275 NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression
ISO Glucose promotes the reaction [AQP3 protein results in increased transport of Glycerol]
Glucose results in increased expression of AQP3 mRNA; Glucose results in increased expression of AQP3 protein
CTD PMID:12234316 NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
JBrowse link
G Aqp4 aquaporin 4 multiple interactions
increases expression
EXP benazepril inhibits the reaction [Glucose results in increased expression of AQP4 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP4 mRNA] CTD PMID:11510275 NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
JBrowse link
G Aqp5 aquaporin 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of AQP5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AQP5 mRNA CTD PMID:37567420 NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
JBrowse link
G Aqp8 aquaporin 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AQP8 mRNA CTD PMID:37567420 NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
JBrowse link
G Areg amphiregulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AREG mRNA CTD PMID:37567420 NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
JBrowse link
G Arg2 arginase 2 increases expression ISO Glucose results in increased expression of ARG2 mRNA CTD PMID:17178593 NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
JBrowse link
G Arhgap6 Rho GTPase activating protein 6 increases expression ISO Glucose results in increased expression of ARHGAP6 mRNA CTD PMID:31525975 NCBI chr  X:24,953,464...25,490,003
Ensembl chr  X:24,953,464...25,488,663
JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta decreases expression
multiple interactions
ISO Glucose results in decreased expression of ARHGDIB mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]
CTD PMID:33448797 NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
JBrowse link
G Arl4d ADP-ribosylation factor like GTPase 4D multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ARL4D mRNA; ARL4D protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
JBrowse link
G Arl5b ADP-ribosylation factor like GTPase 5B increases expression ISO Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 NCBI chr17:77,955,864...77,979,895
Ensembl chr17:77,955,818...77,979,854
JBrowse link
G Arl5c ADP-ribosylation factor like GTPase 5C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ARL5C mRNA CTD PMID:37567420 NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002
JBrowse link
G Armcx6 armadillo repeat containing, X-linked 6 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ARMCX6 mRNA] CTD PMID:33448797 NCBI chr  X:97,929,032...97,932,031
Ensembl chr  X:97,929,041...97,931,977
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions
increases activity
ISO [Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA; Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA]
[Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]
Glucose results in increased activity of ARNT protein
CTD PMID:15767253 PMID:18227068 PMID:33962019 NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
JBrowse link
G Arsj arylsulfatase family, member J multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of ARSJ mRNA CTD PMID:37567420 NCBI chr 2:214,774,631...214,854,614
Ensembl chr 2:214,774,654...214,854,612
JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ASCL1 mRNA CTD PMID:37567420 NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) affects expression ISO Glucose affects the expression of ASNS mRNA CTD PMID:17409444 NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
JBrowse link
G Aspg asparaginase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ASPG mRNA CTD PMID:37567420 NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
JBrowse link
G Aspn asporin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ASPN mRNA CTD PMID:37567420 NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
JBrowse link
G Atad1 ATPase family, AAA domain containing 1 multiple interactions EXP ATAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:230,544,227...230,610,524
Ensembl chr 1:230,544,047...230,596,548
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ATF3 mRNA CTD PMID:37567420 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
JBrowse link
G Atf4 activating transcription factor 4 increases expression
increases response to substance
multiple interactions
ISO
EXP
Glucose deficiency results in increased expression of ATF4 mRNA
ATF4 protein results in increased susceptibility to Glucose
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF4 protein]
Glucose deficiency results in increased expression of ATF4 protein
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]; [Galactose co-treated with Glucose deficiency] promotes the reaction [Leflunomide results in increased expression of ATF4 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]]
CTD PMID:27226639 PMID:27278863 PMID:29427785 PMID:31022492 PMID:34801538 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions
ISO
EXP
Glucose deficiency results in increased expression of ATF6 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]
CTD PMID:31022492 PMID:34801538 NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
JBrowse link
G Atg10 autophagy related 10 increases expression
multiple interactions
ISO Glucose results in increased expression of ATG10 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ATG10 mRNA]
CTD PMID:33448797 NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
JBrowse link
G Atg5 autophagy related 5 multiple interactions
decreases expression
EXP 3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; ULK1 protein affects the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]] CTD PMID:29128638 NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
JBrowse link
G Atg7 autophagy related 7 multiple interactions
decreases expression
EXP Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein] CTD PMID:35243728 NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
JBrowse link
G Atl1 atlastin GTPase 1 multiple interactions EXP ATL1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204
JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression ISO Glucose results in increased expression of ATOX1 mRNA CTD PMID:32942007 NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions ISO
EXP
Glucose results in decreased expression of and results in decreased activity of ATP1A1 protein; INS protein inhibits the reaction [Glucose results in decreased expression of ATP1A1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein]
CTD PMID:22162761 PMID:29702141 NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of ATP2A1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ATP2A1 mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
JBrowse link
G Atp5f1d ATP synthase F1 subunit delta multiple interactions EXP 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] CTD PMID:25305180 NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 increases expression
multiple interactions
EXP Glucose results in increased expression of ATP6AP2 mRNA; Glucose results in increased expression of ATP6AP2 protein
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein]
CTD PMID:19861503 NCBI chr  X:10,183,983...10,210,948
Ensembl chr  X:10,183,068...10,210,918
JBrowse link
G Aurka aurora kinase A increases expression ISO Glucose results in increased expression of AURKA mRNA CTD PMID:17178593 NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding affects secretion ISO Glucose deficiency affects the secretion of AZGP1 protein CTD PMID:24802182 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
JBrowse link
G B2m beta-2 microglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of B2M mRNA CTD PMID:37567420 NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
JBrowse link
G B3gat3 beta-1,3-glucuronyltransferase 3 increases expression
multiple interactions
EXP Glucose results in increased expression of B3GAT3 mRNA
[XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]
CTD PMID:11801247 NCBI chr 1:205,817,374...205,823,928
Ensembl chr 1:205,817,378...205,837,807
JBrowse link
G B3gnt6 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B3GNT6 mRNA CTD PMID:37567420 NCBI chr 1:152,484,572...152,496,226
Ensembl chr 1:152,486,343...152,492,150
JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B4GALNT4 mRNA CTD PMID:37567420 NCBI chr 1:196,171,394...196,182,294
Ensembl chr 1:196,171,394...196,182,294
JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions ISO [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]; Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein CTD PMID:20370652 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions EXP
ISO
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA]
CTD PMID:29122578 PMID:33962019 NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
JBrowse link
G Bambi BMP and activin membrane-bound inhibitor multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of BAMBI mRNA] CTD PMID:33448797 NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
JBrowse link
G Barx2 BARX homeobox 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BARX2 mRNA CTD PMID:37567420 NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
JBrowse link
G Batf2 basic leucine zipper ATF-like transcription factor 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BATF2 mRNA CTD PMID:37567420 NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
affects expression
ISO
EXP
Glucose results in increased expression of BAX mRNA; Glucose results in increased expression of BAX protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased expression of BAX mRNA]; [Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of BAX protein; asiatic acid inhibits the reaction [Glucose results in increased expression of BAX mRNA]; Carnosine inhibits the reaction [Glucose results in increased expression of BAX mRNA]; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of BAX protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX protein]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of BAX protein]; NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; salvianolic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in increased expression of BAX protein]; [Glucose co-treated with Bupivacaine] results in increased expression of BAX protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein modified form; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Valsartan inhibits the reaction [Glucose results in increased expression of BAX protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of BAX protein]; [Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of BAX protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; cinnamic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of BAX protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; Metformin inhibits the reaction [Glucose results in increased expression of BAX protein]; morroniside inhibits the reaction [Glucose results in increased expression of BAX protein]; naringenin inhibits the reaction [Glucose results in increased expression of BAX mRNA]; naringenin inhibits the reaction [Glucose results in increased expression of BAX protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein]; Quercetin affects the reaction [Glucose affects the expression of BAX protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; sesamin affects the reaction [Glucose affects the expression of BAX protein]; STIM1 protein affects the reaction [Glucose results in increased expression of BAX protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]
CTD PMID:21803128 PMID:22524206 PMID:23192364 PMID:23451161 PMID:24218232 More... NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]
CTD PMID:24451382 PMID:28675767 PMID:33962019 NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
JBrowse link
G Bche butyrylcholinesterase multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of BCHE mRNA] CTD PMID:33448797 NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
JBrowse link
G Bcl11a BCL11 transcription factor A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
affects expression
multiple interactions
ISO
EXP
Glucose results in decreased expression of BCL2 mRNA; Glucose results in decreased expression of BCL2 protein
Glucose affects the expression of BCL2 mRNA; Glucose affects the expression of BCL2 protein
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; cinnamic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Diosgenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; Metformin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; morroniside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]; Quercetin affects the reaction [Glucose affects the expression of BCL2 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; sesamin affects the reaction [Glucose affects the expression of BCL2 protein]; STIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein; [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein; asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Berberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; Carnosine promotes the reaction [asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; diallyl trisulfide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in increased degradation of and results in decreased expression of BCL2 protein; Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein]; MitoTEMPO inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein]; [Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
CTD PMID:18088078 PMID:19557821 PMID:21413024 PMID:21803128 PMID:21818840 More... NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743
JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions EXP BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions
increases expression
EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
JBrowse link
G Bcl2l15 Bcl2-like 15 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA] CTD PMID:33962019 NCBI chr 2:191,338,959...191,344,078
Ensembl chr 2:191,338,959...191,344,078
JBrowse link
G Bco1 beta-carotene oxygenase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BCO1 mRNA CTD PMID:37567420 NCBI chr19:45,149,250...45,186,102
Ensembl chr19:45,149,265...45,186,101
JBrowse link
G Bdkrb1 bradykinin receptor B1 increases expression
multiple interactions
EXP Glucose results in increased expression of BDKRB1 protein
argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]
CTD PMID:29165388 NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
JBrowse link
G Becn1 beclin 1 multiple interactions
decreases expression
increases expression
EXP
ISO
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]; [Resveratrol co-treated with Glucose] results in increased expression of BECN1 protein; Inositol inhibits the reaction [Glucose results in decreased expression of BECN1 protein]
Glucose results in increased expression of BECN1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; HU 308 inhibits the reaction [Glucose results in decreased expression of BECN1 protein]
CTD PMID:25997894 PMID:28713934 PMID:30459625 PMID:33450223 PMID:35243728 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
JBrowse link
G Begain brain-enriched guanylate kinase-associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of BEGAIN mRNA CTD PMID:37567420 NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841
JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions
decreases expression
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]
morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP protein]
Glucose results in decreased expression of BGLAP mRNA; Glucose results in decreased expression of BGLAP protein
CTD PMID:32643284 PMID:33450223 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BHMT mRNA CTD PMID:37567420 NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA] CTD PMID:33962019 NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
JBrowse link
G Bmp2 bone morphogenetic protein 2 decreases expression
multiple interactions
ISO
EXP
Glucose results in decreased expression of BMP2 mRNA
cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA]; tin mesoporphyrin promotes the reaction [Glucose results in decreased expression of BMP2 mRNA]
morroniside inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA]
CTD PMID:19924377 PMID:32643284 NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
JBrowse link
G Bmper BMP-binding endothelial regulator multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BMPER mRNA CTD PMID:37567420 NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA] CTD PMID:33962019 NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
JBrowse link
G Bnip3l BCL2 interacting protein 3 like multiple interactions
decreases expression
ISO
EXP
[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA]
Glucose results in decreased expression of BNIP3L protein
Inositol inhibits the reaction [Glucose results in decreased expression of BNIP3L protein]
CTD PMID:33962019 PMID:35243728 NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
JBrowse link
G Bst2 bone marrow stromal cell antigen 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BST2 mRNA CTD PMID:37567420 NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
JBrowse link
G Btbd17 BTB domain containing 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BTBD17 mRNA CTD PMID:37567420 NCBI chr10:99,826,132...99,832,624
Ensembl chr10:99,826,132...99,832,624
JBrowse link
G C1qtnf3 C1q and TNF related 3 decreases expression ISO Glucose results in decreased expression of C1QTNF3 mRNA CTD PMID:31525975 NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
JBrowse link
G C1r complement C1r decreases secretion ISO Glucose deficiency results in decreased secretion of C1R protein CTD PMID:24802182 NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
JBrowse link
G C1s complement C1s affects secretion ISO Glucose deficiency affects the secretion of C1S protein CTD PMID:24802182 NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
JBrowse link
G C3 complement C3 increases expression
multiple interactions
ISO Glucose results in increased expression of C3 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of C3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of C3 mRNA
CTD PMID:17178593 PMID:23199288 PMID:37567420 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
JBrowse link
G C4b complement C4B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of C4B mRNA CTD PMID:37567420 NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
JBrowse link
G C5 complement C5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HC mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HC mRNA CTD PMID:37567420 NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
JBrowse link
G C5ar1 complement C5a receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C5AR1 mRNA CTD PMID:37567420 NCBI chr 1:76,948,622...76,959,826 JBrowse link
G Cabp4 calcium binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA CTD PMID:37567420 NCBI chr 1:201,428,671...201,442,950
Ensembl chr 1:201,428,672...201,433,172
JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CACNA1S mRNA CTD PMID:37567420 NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318
JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression
multiple interactions
ISO Glucose results in increased expression of CALCA mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CALCA mRNA
CTD PMID:31655124 PMID:37567420 NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
JBrowse link
G Calm2 calmodulin 2 multiple interactions EXP CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
Ensembl chr15:7,091,567...7,104,287
JBrowse link
G Calr calreticulin decreases expression ISO Glucose results in decreased expression of CALR mRNA CTD PMID:17178593 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Calu calumenin decreases secretion ISO Glucose deficiency results in decreased secretion of CALU protein CTD PMID:24802182 NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
JBrowse link
G Caly calcyon neuron-specific vesicular protein multiple interactions EXP CALY protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551
JBrowse link
G Canx calnexin decreases expression
multiple interactions
increases expression
ISO
EXP
Glucose results in decreased expression of CANX mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CANX protein]
CTD PMID:17178593 PMID:34801538 NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
JBrowse link
G Capn1 calpain 1 multiple interactions
increases expression
EXP
ISO
2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein]; [Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein
Glucose results in increased expression of CAPN1 protein
Furans analog inhibits the reaction [Glucose results in increased expression of CAPN1 protein]
CTD PMID:24726522 PMID:28911973 NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
JBrowse link
G Car3 carbonic anhydrase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CAR3 mRNA CTD PMID:37567420 NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
JBrowse link
G Casp1 caspase 1 multiple interactions
increases activity
increases expression
increases cleavage
ISO
EXP
Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; Glucose results in increased cleavage of and results in increased activity of CASP1 protein; Glucose results in increased expression of and results in increased cleavage of CASP1 protein
Glucose results in increased activity of CASP1 mRNA; Glucose results in increased activity of CASP1 protein
Glucose results in increased expression of CASP1 mRNA; Glucose results in increased expression of CASP1 protein
[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of CASP1 protein]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Suramin inhibits the reaction [Glucose results in increased activity of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
CTD PMID:20370652 PMID:21832250 PMID:23647015 PMID:27783111 PMID:29031534 More... NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
JBrowse link
G Casp12 caspase 12 multiple interactions
increases expression
increases cleavage
ISO
EXP
TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP12 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]
Glucose results in increased expression of CASP12 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CASP12 protein]
CTD PMID:30076216 PMID:34801538 NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity
increases expression
increases cleavage
decreases expression
ISO
EXP
[Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased activity of CASP3 protein]; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form; [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP3 protein; [Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein; asiatic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Carnosine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; diallyl trisulfide inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Gliclazide inhibits the reaction [Glucose results in increased expression of CASP3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CASP3 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein]; MitoTEMPO inhibits the reaction [Glucose results in increased activity of CASP3 protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Rosiglitazone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; rutecarpine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]
[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Glucose results in increased cleavage of and results in increased activity of CASP3 protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; INO 1001 inhibits the reaction [Glucose results in increased activity of CASP3 protein]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR322 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [[Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein]
Glucose results in increased activity of CASP3; Glucose results in increased activity of CASP3 protein
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of and affects the activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP3]; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cinnamic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; Glucose results in increased expression of and results in increased activity of CASP3 protein; Glucose results in increased expression of and results in increased cleavage of CASP3 protein; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; Metformin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; morroniside inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]; plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; sesamin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Simvastatin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STIM1 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]
Glucose results in increased expression of CASP3 mRNA; Glucose results in increased expression of CASP3 protein; Glucose results in increased expression of CASP3 protein modified form
Glucose results in decreased expression of CASP3 mRNA
CTD PMID:15322300 PMID:16135072 PMID:17065336 PMID:17309078 PMID:17928392 More... NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp8 caspase 8 increases activity
multiple interactions
ISO
EXP
Glucose results in increased activity of CASP8 protein
[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA]
Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8]
CTD PMID:18791325 PMID:18973755 PMID:33962019 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G Casp9 caspase 9 multiple interactions
increases cleavage
increases expression
increases activity
ISO
EXP
[Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]
Glucose results in increased expression of CASP9 mRNA
[Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9]; Glucose results in increased expression of and results in increased cleavage of CASP9 protein; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA]
CTD PMID:17309078 PMID:18791325 PMID:23192364 PMID:25997894 PMID:30431688 More... NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Casz1 castor zinc finger 1 increases expression
multiple interactions
ISO Glucose results in increased expression of CASZ1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of CASZ1 mRNA]
CTD PMID:33448797 NCBI chr 5:159,243,965...159,393,935
Ensembl chr 5:159,243,995...159,393,400
JBrowse link
G Cat catalase multiple interactions
decreases expression
increases expression
decreases activity
increases activity
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]]; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased cleavage of PARP1 protein; CAT inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]; CAT inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; Furans analog inhibits the reaction [Glucose results in decreased activity of CAT protein]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CAT protein]; solanesol inhibits the reaction [Glucose results in decreased activity of CAT protein]; spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]
Glucose results in decreased expression of CAT mRNA
[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB1 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein]; naringenin inhibits the reaction [Glucose results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Glucose results in decreased activity of CAT protein]
Glucose deficiency results in increased expression of CAT protein; Glucose results in increased expression of CAT protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein; cyclopamine inhibits the reaction [polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; cyclopamine promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]
CTD PMID:12130563 PMID:17309078 PMID:20691780 PMID:21818840 PMID:23192364 More... NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Cav1 caveolin 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of CAV1 mRNA; Glucose results in decreased expression of CAV1 protein
EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]
CTD PMID:19816600 PMID:31655124 NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO Glucose results in increased expression of CBR3 mRNA CTD PMID:17178593 NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
JBrowse link
G Cbs cystathionine beta synthase increases expression
decreases expression
ISO
EXP
Glucose results in increased expression of CBS mRNA
Glucose deficiency results in decreased expression of CBS mRNA
CTD PMID:17178593 PMID:35577173 NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
JBrowse link
G Ccdc116 coiled-coil domain containing 116 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CCDC116 mRNA] CTD PMID:33448797 NCBI chr11:83,842,707...83,850,607
Ensembl chr11:83,845,557...83,850,607
JBrowse link
G Ccdc169 coiled-coil domain containing 169 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCDC169 mRNA CTD PMID:37567420 NCBI chr 2:139,321,644...139,351,161
Ensembl chr 2:139,321,670...139,351,161
JBrowse link
G Ccdc190 coiled-coil domain containing 190 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CCDC190 mRNA CTD PMID:37567420 NCBI chr13:82,147,161...82,154,863
Ensembl chr13:82,147,176...82,154,863
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
multiple interactions
increases secretion
ISO
EXP
Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Glucose co-treated with fatostatin] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; HTS 466284 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; isoangustone A inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; picolinic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of MCP1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]
Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein; Glucose results in increased expression of MCP1 mRNA
duanbanhuain A inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; duanbanhuain B inhibits the reaction [Glucose results in increased secretion of CCL2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL2 mRNA; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 mRNA]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]]
CTD PMID:16143069 PMID:16600694 PMID:17178593 PMID:17607302 PMID:17655880 More... NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCL28 mRNA CTD PMID:37567420 NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
multiple interactions
decreases expression
ISO Glucose results in increased expression of CCL5 mRNA
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA
Glucose results in decreased expression of CCL5 mRNA
CTD PMID:17178593 PMID:31655124 PMID:32613381 PMID:32942007 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL7 mRNA CTD PMID:37567420 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Glucose results in increased expression of CCN1 mRNA CTD PMID:17178593 NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions
increases expression
ISO
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCN2 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; Cadmium inhibits the reaction [Glucose results in increased expression of CCN2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCN2 protein]; Zinc inhibits the reaction [Glucose results in increased expression of CCN2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]
Aspirin inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; CCN2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; fatostatin inhibits the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]]
Glucose results in increased expression of CCN2 mRNA; Glucose results in increased expression of CCN2 protein
CTD PMID:10026205 PMID:14586741 PMID:19369054 PMID:21124846 PMID:21367880 More... NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCNB1 mRNA CTD PMID:37567420 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of CCND1; Glucose results in increased expression of CCND1 mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]
resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 protein]
[Glucose co-treated with resveratrol] results in decreased expression of CCND1 mRNA; resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 mRNA]
CTD PMID:23690508 PMID:24064760 PMID:24971582 PMID:27049278 PMID:27481074 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
JBrowse link
G Ccnd2 cyclin D2 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA] CTD PMID:27481074 NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
JBrowse link
G Ccne1 cyclin E1 increases expression
multiple interactions
EXP Glucose results in increased expression of CCNE1 protein
resveratrol inhibits the reaction [Glucose results in increased expression of CCNE1 protein]
CTD PMID:24971582 NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
JBrowse link
G Ccnl1 cyclin L1 increases expression ISO Glucose results in increased expression of CCNL1 mRNA CTD PMID:17178593 NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
JBrowse link
G Ccr10 C-C motif chemokine receptor 10 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CCR10 mRNA] CTD PMID:33448797 NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
JBrowse link
G Ccr6 C-C motif chemokine receptor 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CCR6 mRNA CTD PMID:37567420 NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCR7 mRNA CTD PMID:37567420 NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
JBrowse link
G Cd14 CD14 molecule multiple interactions ISO CD14 protein affects the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]; Curcumin inhibits the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein]]; Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein] CTD PMID:18180316 NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
JBrowse link
G Cd151 CD151 molecule (Raph blood group) multiple interactions EXP CD151 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753
JBrowse link
G Cd160 CD160 molecule decreases expression ISO Glucose results in decreased expression of CD160 mRNA CTD PMID:31525975 NCBI chr 2:184,340,820...184,383,421
Ensembl chr 2:184,340,599...184,375,834
JBrowse link
G Cd163 CD163 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD163 mRNA CTD PMID:37567420 NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
JBrowse link
G Cd19 CD19 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CD19 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD19 mRNA CTD PMID:37567420 NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
JBrowse link
G Cd1d1 CD1d1 molecule multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CD1D1 mRNA] CTD PMID:33448797 NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
JBrowse link
G Cd226 CD226 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD226 mRNA CTD PMID:37567420 NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
JBrowse link
G Cd247 Cd247 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD247 mRNA CTD PMID:37567420 NCBI chr13:78,043,302...78,118,437
Ensembl chr13:78,043,307...78,122,263
JBrowse link
G Cd300a Cd300a molecule increases expression
multiple interactions
ISO Glucose results in increased expression of CD300A mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD300A mRNA
CTD PMID:31525975 PMID:37567420 NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674
JBrowse link
G Cd300lb CD300 molecule-like family member b multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD300LB mRNA CTD PMID:37567420 NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
JBrowse link
G Cd36 CD36 molecule multiple interactions
increases expression
ISO (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]
Glucose results in increased expression of CD36 mRNA
CTD PMID:32613381 PMID:36156098 NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD3E mRNA CTD PMID:37567420 NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
JBrowse link
G Cd40lg CD40 ligand multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD40LG mRNA CTD PMID:37567420 NCBI chr  X:135,127,052...135,138,768
Ensembl chr  X:135,126,969...135,138,306
JBrowse link
G Cd44 CD44 molecule increases expression
multiple interactions
ISO Glucose results in increased expression of CD44 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD44 mRNA
CTD PMID:17178593 PMID:37567420 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
JBrowse link
G Cd48 Cd48 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD48 mRNA CTD PMID:37567420 NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
JBrowse link
G Cd5 Cd5 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD5 mRNA CTD PMID:37567420 NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
JBrowse link
G Cd52 CD52 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD52 mRNA CTD PMID:37567420 NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
JBrowse link
G Cd6 Cd6 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD6 mRNA CTD PMID:37567420 NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634
JBrowse link
G Cd74 CD74 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD74 mRNA CTD PMID:37567420 NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
JBrowse link
G Cd8b CD8 subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD8B1 mRNA CTD PMID:37567420 NCBI chr 4:103,312,596...103,328,523
Ensembl chr 4:103,312,578...103,328,553
JBrowse link
G Cd96 CD96 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD96 mRNA CTD PMID:37567420 NCBI chr11:54,702,290...54,776,618
Ensembl chr11:54,702,290...54,776,621
JBrowse link
G Cdc42 cell division cycle 42 increases expression
multiple interactions
ISO Glucose results in increased expression of CDC42 mRNA; Glucose results in increased expression of CDC42 protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of CDC42 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 protein]
CTD PMID:24659233 PMID:31483951 NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression
ISO 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; [Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of CDH1 protein]
Glucose results in decreased expression of CDH1 mRNA; Glucose results in decreased expression of CDH1 protein
CTD PMID:21829520 PMID:26045780 PMID:29163160 PMID:33992720 PMID:35445903 More... NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
JBrowse link
G Cdh5 cadherin 5 decreases expression ISO Glucose results in decreased expression of CDH5 mRNA CTD PMID:31655124 NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CDK1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CDK1 mRNA CTD PMID:37567420 NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
JBrowse link
G Cdk9 cyclin-dependent kinase 9 increases phosphorylation
multiple interactions
ISO Glucose results in increased phosphorylation of CDK9 protein
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of CDK9 protein]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL6 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of NOS2 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TNF mRNA]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of IL6 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of TNF protein]
CTD PMID:33631230 NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of CDKN1A mRNA
Glucose results in decreased expression of CDKN1A protein
Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]; NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]]; TGFB1 protein promotes the reaction [Glucose results in increased expression of CDKN1A mRNA]
Glucose results in increased expression of CDKN1A mRNA; Glucose results in increased expression of CDKN1A protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA; Fluorometholone inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA]; Melatonin inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; TAS1R1 protein affects the reaction [Glucose results in decreased expression of CDKN1A protein]
CTD PMID:17178593 PMID:22561310 PMID:24451382 PMID:27049278 PMID:27652271 More... NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of CDKN1B protein
[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA]
NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]
CTD PMID:22561310 PMID:33962019 PMID:33992720 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression
multiple interactions
ISO Glucose results in increased expression of CDKN2A protein alternative form
SIRT3 protein inhibits the reaction [Glucose results in increased expression of CDKN2A protein alternative form]
CTD PMID:23494737 NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 multiple interactions
decreases expression
decreases secretion
ISO cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CEACAM3 mRNA
CTD PMID:19924377 PMID:37567420 NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
JBrowse link
G Ceacam19 CEA cell adhesion molecule 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CEACAM19 mRNA CTD PMID:37567420 NCBI chr 1:79,542,107...79,550,927
Ensembl chr 1:79,542,107...79,550,927
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPA protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression
ISO CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPB protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of MAS1 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter]
Glucose results in decreased expression of CEBPB protein
CTD PMID:24376792 PMID:28482072 PMID:29266779 NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPD protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein] CTD PMID:24376792 NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
JBrowse link
G Celf3 CUGBP, Elav-like family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CELF3 mRNA CTD PMID:37567420 NCBI chr 2:182,116,034...182,130,163
Ensembl chr 2:182,116,073...182,130,163
JBrowse link
G Celf4 CUGBP, Elav-like family member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELF4 mRNA CTD PMID:37567420 NCBI chr18:16,786,578...17,065,045
Ensembl chr18:16,786,867...17,064,786
JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CELSR1 mRNA] CTD PMID:33448797 NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164
JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CELSR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELSR3 mRNA CTD PMID:37567420 NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
JBrowse link
G Cemip cell migration inducing hyaluronidase 1 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA] CTD PMID:33448797 NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
JBrowse link
G Cenpf centromere protein F multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CENPF mRNA CTD PMID:37567420 NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
JBrowse link
G Cert1 ceramide transporter 1 multiple interactions
increases expression
EXP rhodioloside inhibits the reaction [Glucose results in increased expression of CERT1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of CERT1 mRNA] CTD PMID:29031534 NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074
JBrowse link
G Ces2f carboxylesterase 2F increases expression ISO Glucose results in increased expression of CES2F mRNA CTD PMID:31525975 NCBI chr19:7,527...14,898
Ensembl chr19:7,527...14,898
JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CES2H mRNA CTD PMID:37567420 NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
JBrowse link
G Cfap45 cilia and flagella associated protein 45 increases expression ISO Glucose results in increased expression of CFAP45 mRNA CTD PMID:31525975 NCBI chr13:84,989,474...85,012,880
Ensembl chr13:84,981,728...85,012,878
JBrowse link
G Cfap74 cilia and flagella associated protein 74 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CFAP74 mRNA CTD PMID:37567420 NCBI chr 5:165,970,611...166,046,068
Ensembl chr 5:165,979,805...166,046,071
JBrowse link
G Cfap97d1 CFAP97 domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CFAP97D1 mRNA CTD PMID:37567420 NCBI chr10:86,933,585...86,944,566
Ensembl chr10:86,933,808...86,938,244
JBrowse link
G Cfd complement factor D decreases expression
multiple interactions
EXP
ISO
Glucose results in decreased expression of CFD mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CFD mRNA
CTD PMID:3299706 PMID:37567420 NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
JBrowse link
G Cfl1 cofilin 1 increases secretion ISO Glucose deficiency results in increased secretion of CFL1 protein CTD PMID:24802182 NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
JBrowse link
G Cfp complement factor properdin decreases expression
multiple interactions
ISO Glucose results in decreased expression of CFP mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CFP mRNA]
CTD PMID:33448797 NCBI chr  X:1,162,014...1,167,576
Ensembl chr  X:1,161,979...1,167,573
JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 multiple interactions EXP CHAC1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] CTD PMID:29042441 NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
JBrowse link
G Chgb chromogranin B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHGB mRNA CTD PMID:37567420 NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
JBrowse link
G Chkb choline kinase beta multiple interactions EXP CHKB protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 7:120,500,960...120,504,359
Ensembl chr 7:120,500,984...120,504,461
JBrowse link
G Chrdl2 chordin-like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA CTD PMID:37567420 NCBI chr 1:154,343,201...154,370,651
Ensembl chr 1:154,343,201...154,370,640
JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 increases expression EXP Glucose results in increased expression of CHRM2 mRNA CTD PMID:18715473 NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHRNA2 mRNA CTD PMID:37567420 NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
JBrowse link
G Cimap1c ciliary microtubule associated protein 1C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA CTD PMID:37567420 NCBI chr 8:57,248,746...57,281,084
Ensembl chr 8:57,248,746...57,281,004
JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
JBrowse link
G Ckb creatine kinase B multiple interactions
increases activity
ISO Glucose inhibits the reaction [daidzein results in increased activity of CKB protein]; Glucose inhibits the reaction [Dihydrotestosterone results in increased activity of CKB protein]; Glucose inhibits the reaction [Estradiol results in increased activity of CKB protein]; Glucose inhibits the reaction [Genistein results in increased activity of CKB protein]
Glucose results in increased activity of CKB protein
CTD PMID:16621514 NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression ISO Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 NCBI chr17:13,570,611...13,575,770 JBrowse link
G Clec4a C-type lectin domain family 4, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA CTD PMID:37567420 NCBI chr 4:156,340,439...156,434,212
Ensembl chr 4:156,414,688...156,432,402
JBrowse link
G Clec4e C-type lectin domain family 4, member E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLEC4E mRNA CTD PMID:37567420 NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
JBrowse link
G Clhc1 clathrin heavy chain linker domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CLHC1 mRNA CTD PMID:37567420 NCBI chr14:103,288,116...103,328,725
Ensembl chr14:103,288,134...103,328,715
JBrowse link
G Clic6 chloride intracellular channel 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLIC6 mRNA CTD PMID:37567420 NCBI chr11:31,737,813...31,780,360
Ensembl chr11:31,737,813...31,780,061
JBrowse link
G Clspn claspin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLSPN mRNA CTD PMID:37567420 NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
JBrowse link
G Clstn3 calsyntenin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLSTN3 mRNA CTD PMID:37567420 NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
JBrowse link
G Cma1 chymase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CMA1 mRNA CTD PMID:37567420 NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
JBrowse link
G Cnih2 cornichon family AMPA receptor auxiliary protein 2 increases expression ISO Glucose results in increased expression of CNIH2 mRNA CTD PMID:17178593 NCBI chr 1:202,399,416...202,405,110
Ensembl chr 1:202,399,419...202,405,089
JBrowse link
G Cnn1 calponin 1 increases methylation
decreases expression
multiple interactions
ISO Glucose results in increased methylation of CNN1 gene
Glucose results in decreased expression of CNN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CNN1 mRNA]
CTD PMID:33448797 NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
JBrowse link
G Cnr1 cannabinoid receptor 1 decreases expression
multiple interactions
increases expression
EXP Glucose results in decreased expression of CNR1 mRNA
MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 mRNA]; MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 protein]
Glucose results in increased expression of CNR1 mRNA; Glucose results in increased expression of CNR1 protein
CTD PMID:19501110 PMID:30642005 NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
JBrowse link
G Cntn4 contactin 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CNTN4 mRNA CTD PMID:37567420 NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090
JBrowse link
G Cntnap2 contactin associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CNTNAP2 mRNA CTD PMID:37567420 NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
JBrowse link
G Cntnap5b contactin associated protein family member 5B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA CTD PMID:37567420 NCBI chr13:17,863,367...18,766,983
Ensembl chr13:18,093,420...18,761,014
JBrowse link
G Col19a1 collagen type XIX alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL19A1 mRNA CTD PMID:37567420 NCBI chr 9:26,673,916...27,022,139
Ensembl chr 9:26,675,391...27,022,106
JBrowse link
G Col1a1 collagen type I alpha 1 chain affects secretion
decreases expression
increases expression
multiple interactions
ISO
EXP
Glucose deficiency affects the secretion of COL1A1 protein
Glucose results in decreased expression of COL1A1 mRNA
Glucose results in increased expression of COL1A1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]
Curcumin analog inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]
CTD PMID:24802182 PMID:28700904 PMID:29163160 PMID:38000455 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions
increases secretion
increases expression
ISO troglitazone inhibits the reaction [Glucose results in increased expression of COL1A2 mRNA]
Glucose deficiency results in increased secretion of COL1A2 protein
CTD PMID:17199790 PMID:24802182 NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of COL27A1 mRNA CTD PMID:37567420 NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174
JBrowse link
G Col3a1 collagen type III alpha 1 chain affects secretion
increases expression
multiple interactions
ISO Glucose deficiency affects the secretion of COL3A1 protein
Glucose results in increased expression of COL3A1 protein
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein]
CTD PMID:24802182 PMID:29266779 NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions
increases expression
EXP
ISO
[eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin analog inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]
CTD PMID:18682491 PMID:28700904 PMID:33270355 NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
JBrowse link
G Col4a2 collagen type IV alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
JBrowse link
G Col4a4 collagen type IV alpha 4 chain increases expression
multiple interactions
ISO Glucose results in increased expression of COL4A4 mRNA
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]
CTD PMID:33631230 NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876
JBrowse link
G Col5a1 collagen type V alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL5A1 protein CTD PMID:24802182 NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
JBrowse link
G Col5a2 collagen type V alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL5A2 mRNA CTD PMID:37567420 NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
JBrowse link
G Col6a1 collagen type VI alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
JBrowse link
G Col6a2 collagen type VI alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A2 protein CTD PMID:24802182 NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
JBrowse link
G Col6a5 collagen type VI alpha 5 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A5 mRNA CTD PMID:37567420 NCBI chr 8:106,483,806...106,584,114
Ensembl chr 8:106,483,799...106,584,113
JBrowse link
G Col6a6 collagen type VI alpha 6 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A6 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A6 mRNA CTD PMID:37567420 NCBI chr 8:106,318,010...106,473,419
Ensembl chr 8:106,306,422...106,473,472
JBrowse link
G Col7a1 collagen type VII alpha 1 chain multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of COL7A1 mRNA] CTD PMID:33448797 NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
JBrowse link
G Col8a2 collagen type VIII alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA CTD PMID:37567420 NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:138,585,999...138,612,850
JBrowse link
G Commd9 COMM domain containing 9 multiple interactions EXP COMMD9 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:88,175,909...88,190,427
Ensembl chr 3:88,175,987...88,190,439
JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression ISO Glucose deficiency results in increased expression of COX4I1 mRNA CTD PMID:26811028 NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions EXP COX5B protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of COX6A2 mRNA CTD PMID:37567420 NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
JBrowse link
G Cpe carboxypeptidase E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CPE mRNA CTD PMID:37567420 NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
JBrowse link
G Cpq carboxypeptidase Q multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CPQ mRNA] CTD PMID:33448797 NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression
multiple interactions
ISO Glucose results in decreased expression of CPT1A protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]
Glucose results in decreased expression of CPT1A mRNA
CTD PMID:23090186 PMID:32613381 PMID:36156098 NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 affects expression EXP Glucose affects the expression of CPT2 mRNA CTD PMID:24349266 NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases activity
multiple interactions
ISO
EXP
Glucose results in increased activity of CREB1 protein
[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein]
CTD PMID:15767253 PMID:24726522 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CREB3L3 mRNA CTD PMID:37567420 NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
JBrowse link
G Crlf1 cytokine receptor-like factor 1 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CRLF1 mRNA] CTD PMID:33448797 NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997
JBrowse link
G Crmp1 collapsin response mediator protein 1 multiple interactions EXP CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr14:73,509,933...73,556,192
Ensembl chr14:73,509,933...73,556,177
JBrowse link
G Crtac1 cartilage acidic protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRTAC1 mRNA CTD PMID:37567420 NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421
JBrowse link
G Cryaa crystallin, alpha A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CRYAA mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CRYAA mRNA CTD PMID:37567420 NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349
JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRYBG2 mRNA CTD PMID:37567420 NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression ISO Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
JBrowse link
G Cst6 cystatin E/M multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CST6 mRNA CTD PMID:37567420 NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
JBrowse link
G Cth cystathionine gamma-lyase decreases expression EXP Glucose deficiency results in decreased expression of CTH mRNA; Glucose deficiency results in decreased expression of CTH protein CTD PMID:35577173 NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
JBrowse link
G Ctnnb1 catenin beta 1 decreases expression
affects localization
multiple interactions
increases expression
EXP
ISO
Glucose results in decreased expression of CTNNB1 mRNA; Glucose results in decreased expression of CTNNB1 protein
Glucose affects the localization of CTNNB1 protein
[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein; [ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein]
Glucose results in increased expression of CTNNB1 mRNA; Glucose results in increased expression of CTNNB1 protein
Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein]
CTD PMID:18004065 PMID:21818840 PMID:29163160 PMID:35385194 NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
JBrowse link
G Ctsb cathepsin B multiple interactions
increases expression
ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein; Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein]
Glucose results in increased expression of CTSB mRNA
CTD PMID:17178593 PMID:21392095 NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
JBrowse link
G Ctsl cathepsin L increases secretion ISO Glucose deficiency results in increased secretion of CTSL protein CTD PMID:24802182 NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
JBrowse link
G Ctsw cathepsin W multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CTSW mRNA CTD PMID:37567420 NCBI chr 1:202,772,395...202,777,021
Ensembl chr 1:202,772,572...202,775,964
JBrowse link
G Cttn cortactin decreases expression
multiple interactions
ISO Glucose results in decreased expression of CTTN protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of CTTN protein]
CTD PMID:31483951 NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
increases expression
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]
Glucose results in increased expression of CX3CL1 mRNA; Glucose results in increased expression of CX3CL1 protein
CTD PMID:19132243 PMID:31655124 NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions
ISO Glucose results in increased expression of CXCL10 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL10 mRNA
CTD PMID:17178593 PMID:37567420 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO Glucose results in increased expression of CXCL2 mRNA CTD PMID:17178593 NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression
multiple interactions
ISO Glucose results in increased expression of CXCL1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CXCL1 mRNA
CTD PMID:17178593 PMID:37567420 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions ISO [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 mRNA; [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 protein CTD PMID:18227068 NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression
decreases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of CYBA protein
Glucose results in decreased expression of CYBA mRNA
Glucose results in increased expression of CYBA mRNA; Glucose results in increased expression of CYBA protein
[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species; CYBA protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of CYBA protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA protein]
dorsomorphin inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CYBA protein]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein]
CTD PMID:17916771 PMID:18088078 PMID:22245600 PMID:31838053 PMID:32942007 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions
increases expression
increases localization
ISO
EXP
acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; Glucose results in increased expression of and results in increased activity of CYBB protein; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased expression of CYBB mRNA; Glucose results in increased expression of CYBB protein
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased localization of CYBB protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]
CTD PMID:19878672 PMID:21925195 PMID:22253932 PMID:26054749 PMID:31494106 More... NCBI chr  X:13,358,101...13,392,570
Ensembl chr  X:13,359,430...13,392,586
JBrowse link
G Cycs cytochrome c, somatic affects localization
multiple interactions
increases expression
EXP
ISO
Glucose affects the localization of CYCS protein
naringenin inhibits the reaction [Glucose affects the localization of CYCS protein]
Glucose results in increased expression of CYCS mRNA; Glucose results in increased expression of CYCS protein
[Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of CYCS protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of CYCS protein]
CTD PMID:23192364 PMID:31115753 PMID:33962019 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
Ensembl chr18:79,651,378...79,654,054
JBrowse link
G Cygb cytoglobin decreases expression ISO Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 decreases expression EXP Glucose results in decreased expression of CYP11B2 mRNA CTD PMID:15017115 NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
ISO Polyphenols promotes the reaction [Glucose results in increased expression of CYP1A1 mRNA]
CYP1A1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:21682256 PMID:31776611 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein CTD PMID:28400208 NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:37567420 NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP27B1 mRNA CTD PMID:37567420 NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CYP2E1 mRNA] CTD PMID:33448797 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CYP7B1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP7B1 mRNA CTD PMID:37567420 NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
JBrowse link
G Cysrt1 cysteine rich tail 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CYSRT1 mRNA CTD PMID:37567420 NCBI chr 3:8,054,195...8,057,846
Ensembl chr 3:8,053,482...8,059,721
JBrowse link
G Daxx death-domain associated protein multiple interactions
affects localization
ISO Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]
Glucose deficiency affects the localization of DAXX protein
CTD PMID:14505347 NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
JBrowse link
G Dbi diazepam binding inhibitor increases expression ISO Glucose results in increased expression of DBI mRNA CTD PMID:17178593 NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
JBrowse link
G Dbn1 drebrin 1 decreases expression
multiple interactions
EXP Glucose results in decreased expression of DBN1 mRNA; Glucose results in decreased expression of DBN1 protein
Curcumin inhibits the reaction [Glucose results in decreased expression of DBN1 mRNA]
CTD PMID:23333261 NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DBP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DBP mRNA CTD PMID:37567420 NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
JBrowse link
G Dcx doublecortin increases expression ISO Glucose results in increased expression of DCX protein CTD PMID:23776576 NCBI chr  X:107,430,767...107,573,612
Ensembl chr  X:107,430,767...107,507,476
JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DDIAS mRNA CTD PMID:37567420 NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression
multiple interactions
increases expression
ISO
EXP
Glucose results in decreased expression of DDIT3 mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
[Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of DDIT3 protein]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; DDIT3 affects the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; Gadolinium inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Glucose inhibits the reaction [DDIT3 protein binds to PPARGC1A promoter]; TRPM7 protein affects the reaction [Glucose results in increased expression of DDIT3 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
Glucose deficiency results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 protein
Glucose deficiency results in increased expression of DDIT3 protein; Glucose results in increased expression of DDIT3 protein
CTD PMID:17178593 PMID:21337367 PMID:24349266 PMID:27226639 PMID:28482072 More... NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked increases degradation ISO Glucose deficiency results in increased degradation of DDX3X protein CTD PMID:30821613 NCBI chr  X:9,479,532...9,493,169
Ensembl chr  X:9,479,532...9,493,168
JBrowse link
G Defb24 defensin beta 24 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DEFB19 mRNA CTD PMID:37567420 NCBI chr 3:141,046,571...141,052,706
Ensembl chr 3:141,046,564...141,052,753
JBrowse link
G Dek DEK proto-oncogene multiple interactions ISO DEK protein affects the chemical synthesis of and affects the uptake of Glucose CTD PMID:28558019 NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
JBrowse link
G Depp1 DEPP autophagy regulator 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DEPP1 mRNA CTD PMID:37567420 NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
JBrowse link
G Derl3 derlin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DERL3 mRNA CTD PMID:37567420 NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
JBrowse link
G Deup1 deuterosome assembly protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of DEUP1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DEUP1 mRNA CTD PMID:37567420 NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199
JBrowse link
G Dgkd diacylglycerol kinase, delta multiple interactions
affects localization
ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [Glucose affects the localization of DGKD protein alternative form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of DGKD protein alternative form] CTD PMID:22974639 NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
JBrowse link
G Dhh desert hedgehog signaling molecule increases expression ISO Glucose results in increased expression of DHH mRNA CTD PMID:31525975 NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
JBrowse link
G Dhps deoxyhypusine synthase multiple interactions EXP DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr19:23,082,454...23,086,544
Ensembl chr19:23,082,448...23,086,881
JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
JBrowse link
G Dhx58 DEXH-box helicase 58 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DHX58 mRNA CTD PMID:37567420 NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions
increases expression
ISO [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA]
Glucose results in increased expression of DIABLO mRNA
CTD PMID:33962019 NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DIAPH3 mRNA CTD PMID:37567420 NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
JBrowse link
G Diras2 DIRAS family GTPase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA CTD PMID:37567420 NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,725,149...12,761,663
JBrowse link
G Disc1 DISC1 scaffold protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DISC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DISC1 mRNA CTD PMID:37567420 NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778
JBrowse link
G Disp2 dispatched RND transporter family member 2 increases expression
multiple interactions
ISO Glucose results in increased expression of DISP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of DISP2 mRNA]
CTD PMID:33448797 NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800
JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions ISO DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of LEF1 mRNA] CTD PMID:29163160 NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DLK1 mRNA CTD PMID:37567420 NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
JBrowse link
G Dmtn dematin actin binding protein increases methylation
multiple interactions
decreases expression
ISO Glucose results in increased methylation of DMTN gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DMTN mRNA]
CTD PMID:33448797 NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601
JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 decreases expression ISO Glucose results in decreased expression of DNAJB11 mRNA CTD PMID:17178593 NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 decreases expression ISO Glucose results in decreased expression of DNAJC3 mRNA CTD PMID:17178593 NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
JBrowse link
G Dnase1l3 deoxyribonuclease 1-like 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DNASE1L3 mRNA CTD PMID:37567420 NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
JBrowse link
G Dnm1l dynamin 1-like increases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of DNM1L protein
[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA]
cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein]
CTD PMID:27684054 PMID:30144576 PMID:31115753 PMID:33962019 NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Glucose results in increased expression of DNMT1 mRNA CTD PMID:29854080 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
JBrowse link
G Dok7 docking protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DOK7 mRNA CTD PMID:37567420 NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386
JBrowse link
G Dpep2 dipeptidase 2 increases expression ISO Glucose results in increased expression of DPEP2 mRNA CTD PMID:31525975 NCBI chr19:33,883,557...33,896,487
Ensembl chr19:33,885,478...33,891,954
JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DPP6 mRNA CTD PMID:37567420 NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532
JBrowse link
G Dscaml1 DS cell adhesion molecule-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA CTD PMID:37567420 NCBI chr 8:45,740,298...46,057,322
Ensembl chr 8:45,740,298...46,057,320
JBrowse link
G Duox1 dual oxidase 1 decreases expression ISO Glucose results in decreased expression of DUOX1 mRNA CTD PMID:32942007 NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
JBrowse link
G Duox2 dual oxidase 2 decreases expression ISO Glucose results in decreased expression of DUOX2 mRNA CTD PMID:32942007 NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Glucose results in increased expression of DUSP1 mRNA CTD PMID:17178593 PMID:32942007 NCBI chr10:16,680,478...16,683,275 JBrowse link
G Dusp13b dual specificity phosphatase 13B decreases expression
multiple interactions
ISO Glucose results in decreased expression of DUSP13B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DUSP13B mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr15:2,567,432...2,575,105
Ensembl chr15:2,533,547...2,575,539
JBrowse link
G Dusp2 dual specificity phosphatase 2 increases expression ISO Glucose results in increased expression of DUSP2 mRNA CTD PMID:17178593 NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of DUSP5 mRNA CTD PMID:37567420 NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO Glucose results in increased expression of DUSP6 mRNA CTD PMID:17178593 NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
JBrowse link
G Ebln1 endogenous Bornavirus like nucleoprotein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGKV8-24 mRNA CTD PMID:37567420 NCBI chr10:78,938,645...78,940,651 JBrowse link
G Edaradd EDAR associated via death domain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EDARADD mRNA CTD PMID:37567420 NCBI chr17:85,866,629...85,910,612
Ensembl chr17:85,656,905...85,910,447
JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 decreases expression ISO Glucose results in decreased expression of EDEM1 mRNA CTD PMID:17178593 NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression
decreases expression
ISO
EXP
carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; U 0126 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]
Glucose affects the reaction [EDN1 protein affects the abundance of and affects the localization of Calcium]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of EDN1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]]
Glucose results in increased expression of EDN1 mRNA; Glucose results in increased expression of EDN1 protein
Glucose results in decreased expression of EDN1 mRNA
CTD PMID:12821678 PMID:16428915 PMID:20691780 PMID:20960276 PMID:24376792 More... NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
JBrowse link
G Edn3 endothelin 3 multiple interactions EXP EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] CTD PMID:15127950 NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
JBrowse link
G Ednra endothelin receptor type A increases expression ISO Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions EXP EEF1A1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
JBrowse link
G Eef2 eukaryotic translation elongation factor 2 multiple interactions
decreases phosphorylation
ISO resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of EEF2 protein] CTD PMID:19765649 NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase multiple interactions
increases phosphorylation
ISO resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EEF2K protein] CTD PMID:19765649 NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
JBrowse link
G Efhc1 EF-hand domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of EFHC1 mRNA CTD PMID:37567420 NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
JBrowse link
G Egf epidermal growth factor multiple interactions ISO EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; EGF protein promotes the reaction [Glucose results in increased expression of TGFA mRNA]; Glucose promotes the reaction [EGF protein results in increased expression of TGFA mRNA] CTD PMID:8638660 PMID:19816600 NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
JBrowse link
G Egr1 early growth response 1 multiple interactions
increases expression
ISO Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]
Glucose results in increased expression of EGR1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA
CTD PMID:17178593 PMID:19225232 PMID:37567420 NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EGR2 mRNA CTD PMID:37567420 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
JBrowse link
G Ehd3 EH-domain containing 3 multiple interactions EXP EHD3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236
JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EHHADH mRNA CTD PMID:37567420 NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation
ISO acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK2 protein]; Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation
ISO
EXP
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2AK3 protein]
Glucose results in increased phosphorylation of EIF2AK3 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]
CTD PMID:31022492 PMID:34801538 NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases phosphorylation
ISO
EXP
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]]
CTD PMID:18973755 PMID:31022492 PMID:34801538 NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases degradation ISO Glucose deficiency results in increased degradation of EIF4A1 protein CTD PMID:30821613 NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
JBrowse link
G Eif4e eukaryotic translation initiation factor 4E increases phosphorylation
multiple interactions
ISO Glucose results in increased phosphorylation of EIF4E protein
Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4E protein]
CTD PMID:19765649 NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions EXP
ISO
resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4EBP1 protein]
[AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein
CTD PMID:15806154 PMID:20332614 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 multiple interactions ISO Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
JBrowse link
G Eif4h eukaryotic translation initiation factor 4H increases degradation ISO Glucose deficiency results in increased degradation of EIF4H protein CTD PMID:30821613 NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 increases expression
multiple interactions
ISO Glucose results in increased expression of ELAPOR1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ELAPOR1 mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression ISO Glucose results in increased expression of ELK3 mRNA CTD PMID:17178593 NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of ELOVL6 mRNA
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]
CTD PMID:15066988 PMID:16790840 PMID:32613381 NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
JBrowse link
G Emc1 ER membrane protein complex subunit 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of EMC1 mRNA CTD PMID:37567420 NCBI chr 5:151,608,557...151,633,888
Ensembl chr 5:151,608,568...151,633,888
JBrowse link
G Endog endonuclease G multiple interactions
affects localization
ISO
EXP
[Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] affects the localization of ENDOG protein
Glucose affects the localization of ENDOG protein
CTD PMID:17309078 PMID:23192364 NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
JBrowse link
G Enkur enkurin, TRPC channel interacting protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENKUR mRNA CTD PMID:37567420 NCBI chr17:83,690,105...83,714,756
Ensembl chr17:83,690,797...83,714,408
JBrowse link
G Eno1 enolase 1 decreases secretion ISO Glucose deficiency results in decreased secretion of ENO1 protein CTD PMID:24802182 NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
JBrowse link
G Eno2 enolase 2 increases secretion ISO Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
JBrowse link
G Entpd1 ectonucleoside triphosphate diphosphohydrolase 1 increases expression ISO Glucose results in increased expression of ENTPD1 mRNA CTD PMID:31525975 NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENTPD4 mRNA CTD PMID:37567420 NCBI chr15:44,630,878...44,658,654
Ensembl chr15:44,630,873...44,658,706
JBrowse link
G Ep300 E1A binding protein p300 multiple interactions
increases expression
ISO [cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]] CTD PMID:22228707 PMID:25192544 PMID:26045780 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088
JBrowse link
G Ephx4 epoxide hydrolase 4 decreases expression ISO Glucose results in decreased expression of EPHX4 mRNA CTD PMID:31525975 NCBI chr14:2,343,376...2,372,680
Ensembl chr14:2,340,248...2,373,022
JBrowse link
G Epo erythropoietin multiple interactions ISO [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 protein; [EPO protein co-treated with Glucose] results in increased expression of SP7 mRNA; [EPO protein co-treated with Glucose] results in increased expression of SP7 protein CTD PMID:30894315 NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
JBrowse link
G Epop elongin BC and polycomb repressive complex 2 associated protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPOP mRNA CTD PMID:37567420 NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912
JBrowse link
G Eppk1 epiplakin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EPPK1 mRNA CTD PMID:37567420 NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
JBrowse link
G Epsti1 epithelial stromal interaction 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of EPSTI1 mRNA CTD PMID:37567420 NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [Glucose deficiency co-treated with Quercetin] results in increased ubiquitination of ERBB2 protein; Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose CTD PMID:14711829 NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions
increases expression
ISO 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 protein]
Glucose results in increased expression of ERCC1 mRNA; Glucose results in increased expression of ERCC1 protein
CTD PMID:22228707 NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit increases expression
multiple interactions
ISO Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]
CTD PMID:22228707 NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation
multiple interactions
ISO
EXP
Glucose deficiency results in increased phosphorylation of ERN1 protein
Glucose results in increased phosphorylation of ERN1 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of ERN1 protein]; [Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein]
CTD PMID:31022492 PMID:34801538 PMID:35961541 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
JBrowse link
G Ern2 endoplasmic reticulum to nucleus signaling 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ERN2 mRNA CTD PMID:37567420 NCBI chr 1:176,726,454...176,743,289
Ensembl chr 1:176,726,454...176,743,289
JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha decreases expression
increases expression
multiple interactions
ISO
EXP
Glucose results in decreased expression of ERO1A mRNA
Glucose results in increased expression of ERO1A protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ERO1A protein]; Metformin inhibits the reaction [Glucose results in increased expression of ERO1A protein]
CTD PMID:17178593 PMID:34801538 NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
JBrowse link
G Esr1 estrogen receptor 1 increases expression
decreases expression
multiple interactions
increases phosphorylation
increases abundance
ISO
EXP
Glucose results in increased expression of ESR1 mRNA
Glucose results in decreased expression of ESR1 mRNA
ESR1 protein promotes the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]
Glucose results in increased phosphorylation of ESR1 protein
ESR1 protein results in increased abundance of Glucose
Endosulfan promotes the reaction [ESR1 protein results in increased abundance of Glucose]
CTD PMID:16621514 PMID:18426865 PMID:23690508 PMID:31520823 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
JBrowse link
G Esr2 estrogen receptor 2 increases expression
decreases expression
ISO Glucose results in increased expression of ESR2 mRNA
Glucose results in decreased expression of ESR2 mRNA
CTD PMID:16621514 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression
multiple interactions
ISO Glucose results in increased expression of ESRP1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ESRP1 mRNA]
CTD PMID:33448797 NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
JBrowse link
G Esrra estrogen related receptor, alpha decreases expression
multiple interactions
ISO Glucose results in decreased expression of ESRRA protein
resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein]
CTD PMID:23090186 NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
JBrowse link
G Ezr ezrin multiple interactions
decreases expression
ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of EZR protein] CTD PMID:31483951 NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
JBrowse link
G F13a1 coagulation factor XIII A1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of F13A1 mRNA CTD PMID:37567420 NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Glucose results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions
increases expression
ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 protein]
Glucose results in increased expression of F3 mRNA; Glucose results in increased expression of F3 protein
CTD PMID:35264022 NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
JBrowse link
G F7 coagulation factor VII multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of F7 mRNA CTD PMID:37567420 NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
JBrowse link
G Fabp1 fatty acid binding protein 1 increases expression ISO Glucose results in increased expression of FABP1 mRNA CTD PMID:36156098 NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
increases expression
ISO
EXP
[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
Glucose results in increased expression of FABP4 mRNA
CTD PMID:3299706 PMID:8536680 PMID:32407875 NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
JBrowse link
G Fam163a family with sequence similarity 163, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FAM163A mRNA CTD PMID:37567420 NCBI chr13:68,262,867...68,341,323
Ensembl chr13:68,262,872...68,341,049
JBrowse link
G Fam163b family with sequence similarity 163, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM163B mRNA CTD PMID:37567420 NCBI chr 3:10,437,383...10,466,458
Ensembl chr 3:10,437,383...10,466,458
JBrowse link
G Fam167a family with sequence similarity 167, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM167A mRNA CTD PMID:37567420 NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469
JBrowse link
G Fam178b family with sequence similarity 178, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FAM178B mRNA CTD PMID:37567420 NCBI chr 9:38,805,864...38,913,681
Ensembl chr 9:38,805,864...38,913,672
JBrowse link
G Fam78b family with sequence similarity 78, member B decreases expression
multiple interactions
ISO Glucose results in decreased expression of FAM78B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM78B mRNA]
CTD PMID:33448797 NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500
JBrowse link
G Fam83c family with sequence similarity 83, member C multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of FAM83C mRNA] CTD PMID:33448797 NCBI chr 3:144,333,736...144,339,758
Ensembl chr 3:144,332,982...144,339,802
JBrowse link
G Fam98c family with sequence similarity 98, member C decreases expression
multiple interactions
ISO Glucose results in decreased expression of FAM98C mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA]
CTD PMID:33448797 NCBI chr 1:84,452,806...84,456,414
Ensembl chr 1:84,452,814...84,456,385
JBrowse link
G Fas Fas cell surface death receptor increases expression
decreases expression
multiple interactions
ISO Glucose results in increased expression of FAS mRNA; Glucose results in increased expression of FAS protein
Glucose results in decreased expression of FAS mRNA
dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]; STO 609 inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]
CTD PMID:23319015 PMID:31655124 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
JBrowse link
G Faslg Fas ligand increases expression
multiple interactions
ISO Glucose results in increased expression of FASLG mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA
CTD PMID:31655124 PMID:37567420 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
JBrowse link
G Fasn fatty acid synthase increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of FASN mRNA
Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; Glucose promotes the reaction [SREBF1 protein binds to FASN promoter]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]
[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides; [INS protein co-treated with Glucose] results in increased expression of FASN mRNA; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA]
CTD PMID:15066988 PMID:18482975 PMID:19724016 PMID:22031849 PMID:23647015 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
JBrowse link
G Fat3 FAT atypical cadherin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FAT3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAT3 mRNA CTD PMID:37567420 NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135
JBrowse link
G Faxc failed axon connections homolog, metaxin like GST domain containing multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAXC mRNA CTD PMID:37567420 NCBI chr 5:35,480,137...35,539,741
Ensembl chr 5:35,480,402...35,544,446
JBrowse link
G Fbp2 fructose-bisphosphatase 2 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FBP2 mRNA] CTD PMID:33448797 NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
JBrowse link
G Fbxl13 F-box and leucine-rich repeat protein 13 increases expression ISO Glucose results in increased expression of FBXL13 mRNA CTD PMID:31525975 NCBI chr 4:13,414,880...13,607,079
Ensembl chr 4:13,414,926...13,641,494
JBrowse link
G Fbxo32 F-box protein 32 multiple interactions
increases expression
ISO FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein]
Glucose results in increased expression of FBXO32 protein
CTD PMID:30635400 NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
JBrowse link
G Fbxo47 F-box protein 47 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO47 mRNA CTD PMID:37567420 NCBI chr10:82,849,514...82,880,337
Ensembl chr10:82,849,730...82,879,538
JBrowse link
G Fbxo48 F-box protein 48 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FBXO48 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO48 mRNA CTD PMID:37567420 NCBI chr14:91,380,857...91,382,314
Ensembl chr14:91,380,857...91,382,314
JBrowse link
G Fbxw12 F-box and WD repeat domain containing 12 increases expression ISO Glucose results in increased expression of FBXW12 CTD PMID:36073553 NCBI chr 8:109,782,315...109,802,086
Ensembl chr 8:109,786,815...109,801,813
JBrowse link
G Fcer1g Fc epsilon receptor Ig decreases expression ISO Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
JBrowse link
G Fcgr3a Fc gamma receptor 3A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA CTD PMID:37567420 NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
JBrowse link
G Fcho1 FCH and mu domain containing endocytic adaptor 1 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FCHO1 mRNA] CTD PMID:33448797 NCBI chr16:18,413,452...18,430,795
Ensembl chr16:18,413,363...18,435,104
JBrowse link
G Fcrlb Fc receptor-like B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FCRLB mRNA CTD PMID:37567420 NCBI chr13:83,148,685...83,157,157
Ensembl chr13:83,149,751...83,155,957
JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of FEN1 mRNA CTD PMID:37567420 NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
JBrowse link
G Fendrr FOXF1 adjacent non-coding developmental regulatory RNA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FENDRR mRNA CTD PMID:37567420 NCBI chr19:49,127,225...49,152,780
Ensembl chr19:49,121,214...49,153,240
JBrowse link
G Ffar1 free fatty acid receptor 1 decreases expression
multiple interactions
EXP
ISO
Glucose results in decreased expression of FFAR1 mRNA
[FFAR1 protein affects the susceptibility to Dietary Fats] affects the reaction [Glucose results in increased secretion of INS1 protein]; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:24349266 PMID:37217659 NCBI chr 1:86,111,368...86,112,272
Ensembl chr 1:86,111,368...86,112,272
JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FFAR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FFAR3 mRNA CTD PMID:37567420 NCBI chr 1:86,105,388...86,106,728
Ensembl chr 1:86,104,920...86,106,849
JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression
multiple interactions
decreases expression
ISO Glucose results in increased expression of FGF1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FGF1 mRNA]
CTD PMID:31655124 PMID:33448797 NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
JBrowse link
G Fgf2 fibroblast growth factor 2 increases expression
multiple interactions
decreases expression
EXP
ISO
Glucose results in increased expression of FGF2 mRNA; Glucose results in increased expression of FGF2 protein
Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA]
Glucose results in decreased expression of FGF2 mRNA
CTD PMID:1518840 PMID:19759273 PMID:31655124 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
JBrowse link
G Fgf21 fibroblast growth factor 21 affects uptake
increases secretion
multiple interactions
increases expression
ISO FGF21 protein affects the uptake of Glucose
Glucose results in increased secretion of FGF21 protein
indolo(3,2-b)carbazole inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]
indolo(3,2-b)carbazole inhibits the reaction [Glucose results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased expression of FGF21 mRNA]
CTD PMID:15902306 PMID:27226639 PMID:28123933 NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
JBrowse link
G Fgf7 fibroblast growth factor 7 affects transport ISO FGF7 protein affects the transport of Glucose CTD PMID:12757114 NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FGG mRNA CTD PMID:37567420 NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
JBrowse link
G Fgl2 fibrinogen-like 2 increases expression
multiple interactions
ISO Glucose results in increased expression of FGL2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA]
CTD PMID:33448797 NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
JBrowse link
G Fhad1 forkhead associated phosphopeptide binding domain 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FHAD1 mRNA CTD PMID:37567420 NCBI chr 5:154,191,593...154,310,442
Ensembl chr 5:154,191,745...154,310,354
JBrowse link
G Fis1 fission, mitochondrial 1 increases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of FIS1 protein
[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA]
cinnamic acid inhibits the reaction [Glucose results in increased expression of FIS1 protein]; Metformin inhibits the reaction [Glucose results in increased expression of FIS1 protein]
CTD PMID:27684054 PMID:30144576 PMID:33962019 NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
JBrowse link
G Flg filaggrin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FLG mRNA CTD PMID:37567420 NCBI chr 2:178,884,793...178,912,986 JBrowse link
G Flg2 filaggrin 2 decreases methylation
decreases expression
ISO Glucose results in decreased methylation of FLG2 promoter
Glucose results in decreased expression of FLG2 mRNA
CTD PMID:31525975 NCBI chr 2:178,789,792...178,802,232 JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of FLT1 mRNA; Glucose results in decreased expression of FLT1 protein
[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of FLT1 protein]
CTD PMID:31655124 PMID:35385194 NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FMO3 mRNA CTD PMID:37567420 NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
JBrowse link
G Fn1 fibronectin 1 increases expression
increases secretion
multiple interactions
decreases expression
decreases secretion
ISO
EXP
Glucose results in increased expression of FN1 mRNA; Glucose results in increased expression of FN1 protein
Glucose results in increased secretion of FN1 protein
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased secretion of FN1 protein]; [Glucose results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased secretion of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 protein]; BQ 788 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; calphostin C inhibits the reaction [Glucose results in increased secretion of FN1 protein]; chelerythrine inhibits the reaction [Glucose results in increased expression of FN1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of FN1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; gingerol inhibits the reaction [Glucose results in increased secretion of FN1 protein]; Glucose results in increased expression of and results in increased secretion of FN1 protein; Indomethacin inhibits the reaction [Glucose results in increased secretion of FN1 protein]; MAPK14 protein promotes the reaction [Glucose results in increased secretion of FN1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; Rotenone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; sitaxsentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased expression of FN1 mRNA]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; NFE2L2 protein affects the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; TXNIP promotes the reaction [Glucose results in increased expression of FN1 mRNA]
Glucose results in decreased expression of FN1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; [[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [Glucose results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased expression of FN1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of FN1 protein]; cinnamaldehyde inhibits the reaction [Glucose results in increased expression of FN1 protein]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; manumycin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased expression of FN1 protein]; NCF1 protein promotes the reaction [Glucose results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SB 203580 inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SPHK1 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; SPHK1 protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; Superoxides affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 protein]; Y 27632 inhibits the reaction [Glucose results in increased expression of FN1 protein]
Glucose deficiency results in decreased secretion of FN1 protein
Glucose results in decreased expression of FN1 mRNA
CTD PMID:9225831 PMID:12388107 PMID:14520012 PMID:15086456 PMID:16320596 More... NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
JBrowse link
G Folr1 folate receptor alpha decreases expression ISO Glucose results in decreased expression of FOLR1 mRNA CTD PMID:19616087 NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of FOS mRNA
[Glucose co-treated with Lipopolysaccharides] results in increased expression of FOS protein
Dactinomycin inhibits the reaction [Glucose results in increased expression of FOS mRNA]; Glucose affects the reaction [Adenosine Triphosphate results in increased expression of FOS mRNA]
CTD PMID:10723097 PMID:11123204 PMID:11557636 PMID:17178593 PMID:18180316 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions
ISO Glucose results in increased expression of FOSL1 mRNA
Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]
CTD PMID:17178593 PMID:19225232 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit increases expression ISO Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
JBrowse link
G Foxa2 forkhead box A2 multiple interactions ISO [Metformin co-treated with Glucose] affects the localization of FOXA2 protein CTD PMID:16489446 NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
JBrowse link
G Foxa3 forkhead box A3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FOXA3 mRNA CTD PMID:37567420 NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
JBrowse link
G Foxf2 forkhead box F2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FOXF2 mRNA CTD PMID:37567420 NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176
JBrowse link
G Foxm1 forkhead box M1 increases expression ISO Glucose results in increased expression of FOXM1 mRNA CTD PMID:32942007 NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
JBrowse link
G Foxo1 forkhead box O1 increases abundance
multiple interactions
decreases response to substance
EXP
ISO
FOXO1 protein mutant form results in increased abundance of Glucose; FOXO1 protein results in increased abundance of Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]]; Acetylcysteine inhibits the reaction [Glucose affects the localization of FOXO1 protein]; Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein
FOXO1 protein results in decreased susceptibility to Glucose
Glucose results in increased acetylation of and results in decreased activity of FOXO1 protein; SIRT3 protein inhibits the reaction [Glucose results in increased acetylation of FOXO1 protein]
FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein; INS1 protein inhibits the reaction [FOXO1 protein results in increased abundance of Glucose]; INS1 protein promotes the reaction [FOXO1 protein mutant form results in increased abundance of Glucose]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein]; resveratrol promotes the reaction [FOXO1 protein results in increased abundance of Glucose]
CTD PMID:15788402 PMID:23494737 PMID:24413998 PMID:33450223 NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
JBrowse link
G Foxo3 forkhead box O3 multiple interactions
decreases expression
increases phosphorylation
increases localization
ISO
EXP
[[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; Glucose affects the phosphorylation of and affects the activity of FOXO3 protein; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]
polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of FOXO3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein; Glucose results in increased phosphorylation of and affects the localization of FOXO3 protein; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]
Glucose results in increased localization of FOXO3 protein
CTD PMID:20370652 PMID:23090186 PMID:23159718 PMID:25471227 PMID:37417536 NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
JBrowse link
G Foxp1 forkhead box P1 multiple interactions
decreases expression
ISO AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of NOX4 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
Glucose results in decreased expression of FOXP1 mRNA; Glucose results in decreased expression of FOXP1 protein
CTD PMID:31494106 NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
JBrowse link
G Frk fyn-related Src family tyrosine kinase multiple interactions ISO FRK protein inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:17179392 NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
JBrowse link
G Frmd3 FERM domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA CTD PMID:37567420 NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:87,764,604...88,031,091
JBrowse link
G Frmpd3 FERM and PDZ domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FRMPD3 mRNA CTD PMID:37567420 NCBI chr  X:103,964,168...104,113,864
Ensembl chr  X:104,043,194...104,111,968
JBrowse link
G Fsbp fibrinogen silencer binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FSBP mRNA CTD PMID:37567420 NCBI chr 5:25,058,003...25,064,276
Ensembl chr 5:25,032,066...25,104,616
JBrowse link
G Fsip1 fibrous sheath interacting protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FSIP1 mRNA CTD PMID:37567420 NCBI chr 3:105,074,584...105,217,180
Ensembl chr 3:105,068,543...105,217,167
JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions ISO
EXP
FTH1 protein inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein]
CTD PMID:16135072 PMID:18931039 NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions EXP [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein] CTD PMID:16135072 NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725
JBrowse link
G Fut1 fucosyltransferase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FUT1 mRNA CTD PMID:37567420 NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
JBrowse link
G Fut2 fucosyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FUT2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FUT2 mRNA CTD PMID:37567420 NCBI chr 1:96,119,549...96,139,567
Ensembl chr 1:96,119,371...96,140,360
JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 increases expression ISO Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 multiple interactions
increases uptake
ISO Deoxyglucose inhibits the reaction [G3BP1 protein results in increased uptake of Glucose]; YWHAZ protein affects the reaction [G3BP1 protein results in increased uptake of Glucose] CTD PMID:35945655 NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions
decreases expression
increases activity
increases expression
ISO
EXP
Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Glucose results in increased stability of and results in increased expression of G6PC1 mRNA
Glucose results in decreased expression of G6PC1 mRNA
Glucose results in increased activity of G6PC1 protein
Glucose results in increased expression of G6PC1 mRNA
Metformin inhibits the reaction [Glucose results in increased expression of G6PC1 mRNA]; tungstate inhibits the reaction [Glucose results in increased activity of G6PC1 protein]; Vanadates inhibits the reaction [Glucose results in increased activity of G6PC1 protein]
[Glucose co-treated with S 4048] results in increased expression of G6PC1 mRNA
CTD PMID:14988444 PMID:15767253 PMID:16920846 PMID:19576170 PMID:31974165 More... NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABBR2 mRNA CTD PMID:37567420 NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GABRP mRNA CTD PMID:37567420 NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516
JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABRQ mRNA CTD PMID:37567420 NCBI chr  X:150,696,161...150,712,948
Ensembl chr  X:150,696,427...150,709,919
JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions EXP GAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:25966616 NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases expression ISO Glucose results in increased expression of GADD45G mRNA CTD PMID:17178593 NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GALNT16 mRNA CTD PMID:37567420 NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GALNT2 mRNA CTD PMID:37567420 NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GALNT6 mRNA CTD PMID:37567420 NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase multiple interactions
increases expression
increases ADP-ribosylation
ISO
EXP
SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
Glucose results in increased expression of GAPDH mRNA
[chloroacetaldehyde results in decreased activity of GAPDH protein] which results in decreased chemical synthesis of Glucose; UCP1 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
Glucose results in increased ADP-ribosylation of GAPDH protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GAPDH mRNA; PARP1 protein affects the reaction [Glucose results in increased ADP-ribosylation of GAPDH protein]
CTD PMID:7826318 PMID:11050244 PMID:14523042 PMID:19733226 PMID:37567420 NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
JBrowse link
G Gask1b golgi associated kinase 1B decreases expression
multiple interactions
ISO Glucose results in decreased expression of GASK1B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GASK1B mRNA]
CTD PMID:33448797 NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
JBrowse link
G Gast gastrin increases secretion EXP Glucose results in increased secretion of GAST protein CTD PMID:19208342 NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
JBrowse link
G Gata4 GATA binding protein 4 increases metabolic processing ISO GATA4 protein results in increased metabolism of Glucose CTD PMID:34087332 NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP2 mRNA CTD PMID:37567420 NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
JBrowse link
G Gbp4 guanylate binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP4 mRNA CTD PMID:37567420 NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
JBrowse link
G Gbp7 guanylate binding protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP7 mRNA CTD PMID:37567420 NCBI chr 2:231,275,521...231,297,289
Ensembl chr 2:231,275,640...231,297,278
JBrowse link
G Gc GC, vitamin D binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GC mRNA CTD PMID:37567420 NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
JBrowse link
G Gcg glucagon multiple interactions
increases secretion
increases abundance
decreases secretion
ISO
EXP
Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GCG protein]
[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; isosteviol inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]
GCG results in increased abundance of Glucose
9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; [GCG protein co-treated with Glucose] results in increased secretion of INS1 protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; Metformin inhibits the reaction [GCG results in increased abundance of Glucose]; Troglitazone inhibits the reaction [Glucose results in decreased secretion of GCG protein]; Zinc inhibits the reaction [Glucose results in increased secretion of GCG protein]
CTD PMID:838844 PMID:12914525 PMID:15919803 PMID:18669601 PMID:19002567 More... NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
JBrowse link
G Gck glucokinase multiple interactions
increases expression
decreases expression
ISO
EXP
[ebselen co-treated with Glucose] results in increased activity of GCK protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of GCK mRNA; Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]
Glucose results in increased expression of GCK mRNA
Glucose results in decreased expression of and affects the localization of GCK protein; Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA]
CTD PMID:12137914 PMID:23795780 PMID:24349266 PMID:31974165 PMID:37567420 NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
JBrowse link
G Gcsam germinal center-associated, signaling and motility multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GCSAM mRNA CTD PMID:37567420 NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992
JBrowse link
G Gdap1l1 ganglioside-induced differentiation-associated protein 1-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA CTD PMID:37567420 NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711
JBrowse link
G Gdf7 growth differentiation factor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GDF7 mRNA CTD PMID:37567420 NCBI chr 6:31,171,495...31,182,484
Ensembl chr 6:31,178,119...31,182,447
JBrowse link
G Gem GTP binding protein overexpressed in skeletal muscle increases expression ISO Glucose results in increased expression of GEM mRNA CTD PMID:17178593 NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein]; Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GH1 protein] CTD PMID:838844 PMID:21559284 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
JBrowse link
G Ghrhr growth hormone releasing hormone receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GHRHR mRNA CTD PMID:37567420 NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions ISO [homoeriodictyol co-treated with Glucose] results in increased secretion of GHRL protein CTD PMID:28834253 NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression
increases degradation
multiple interactions
increases expression
ISO
EXP
Glucose results in decreased expression of GJA1 protein
Glucose results in increased degradation of GJA1 protein
resveratrol inhibits the reaction [Glucose results in increased degradation of GJA1 protein]
Glucose results in increased expression of GJA1 mRNA
Glucose results in increased expression of GJA1 protein
Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of GJA1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]
CTD PMID:17178593 PMID:20578705 PMID:28713934 NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
JBrowse link
G Gla galactosidase, alpha increases expression ISO Glucose results in increased expression of GLA mRNA CTD PMID:17178593 NCBI chr  X:97,769,227...97,780,646
Ensembl chr  X:97,768,996...97,780,664
JBrowse link
G Glb1 galactosidase, beta 1 increases expression
increases activity
multiple interactions
ISO
EXP
Glucose results in increased expression of GLB1 protein
Glucose results in increased activity of GLB1 protein
NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]]; Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]; Melatonin inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein]
CTD PMID:17075048 PMID:22561310 PMID:23494737 PMID:35264022 PMID:38000455 NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions
increases expression
ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]
Glucose results in increased expression of GLI1 protein
CTD PMID:27481074 PMID:33992720 NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
JBrowse link
G Gli2 GLI family zinc finger 2 affects localization
multiple interactions
ISO Glucose affects the localization of GLI2 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GLI2 mRNA
CTD PMID:33992720 PMID:37567420 NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA CTD PMID:37567420 NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
JBrowse link
G Glo1 glyoxalase 1 multiple interactions
decreases expression
ISO
EXP
GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A12 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; SOD2 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; UCP1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]
morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein]
CTD PMID:19833897 PMID:32643284 NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions ISO
EXP
[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]
[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with Oleic Acid] results in decreased expression of GLP1R protein; exenatide inhibits the reaction [[Glucose co-treated with Oleic Acid] results in decreased expression of GLP1R protein]
CTD PMID:18669601 PMID:22925809 NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
JBrowse link
G Glrx glutaredoxin multiple interactions ISO GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein] CTD PMID:24451382 NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
JBrowse link
G Glt8d2 glycosyltransferase 8 domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GLT8D2 mRNA CTD PMID:37567420 NCBI chr 7:21,029,534...21,081,081
Ensembl chr 7:21,029,525...21,081,080
JBrowse link
G Glud1 glutamate dehydrogenase 1 affects expression EXP Glucose affects the expression of GLUD1 mRNA CTD PMID:24349266 NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
JBrowse link
G Glul glutamate-ammonia ligase multiple interactions
decreases expression
EXP Glucose results in decreased expression of and results in decreased activity of GLUL protein; Resveratrol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of GLUL protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of GLUL mRNA] CTD PMID:26677078 NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
JBrowse link
G Gna11 G protein subunit alpha 11 multiple interactions
increases expression
EXP acetovanillone inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein] CTD PMID:20691780 NCBI chr 7:8,163,520...8,177,863
Ensembl chr 7:8,162,750...8,179,812
JBrowse link
G Gna15 G protein subunit alpha 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GNA15 mRNA CTD PMID:37567420 NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
JBrowse link
G Gnai1 G protein subunit alpha i1 decreases expression ISO Glucose results in decreased expression of GNAI1 mRNA CTD PMID:17178593 NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
JBrowse link
G Gnai2 G protein subunit alpha i2 multiple interactions
decreases expression
ISO
EXP
GNAI2 gene mutant form inhibits the reaction [[Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein]; GNAI2 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
Glucose results in decreased expression of GNAI2 protein
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; Uric Acid inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]
CTD PMID:18441196 PMID:25205820 NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
JBrowse link
G Gnai3 G protein subunit alpha i3 multiple interactions
decreases expression
EXP Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; Uric Acid inhibits the reaction [Glucose results in decreased expression of GNAI3 protein] CTD PMID:18441196 NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
JBrowse link
G Gnaq G protein subunit alpha q multiple interactions
increases expression
EXP
ISO
acetovanillone inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]
GNAQ protein affects the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:20691780 PMID:37217659 NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
JBrowse link
G Gnat2 G protein subunit alpha transducin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GNAT2 mRNA CTD PMID:37567420 NCBI chr 2:195,726,371...195,735,866
Ensembl chr 2:195,726,762...195,735,866
JBrowse link
G Gng2 G protein subunit gamma 2 increases expression
multiple interactions
ISO Glucose results in increased expression of GNG2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of GNG2 mRNA]
CTD PMID:33448797 NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183
JBrowse link
G Gng8 G protein subunit gamma 8 decreases expression ISO Glucose results in decreased expression of GNG8 mRNA CTD PMID:31525975 NCBI chr 1:77,564,512...77,568,371
Ensembl chr 1:77,564,515...77,568,371
JBrowse link
G Golt1a golgi transport 1A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GOLT1A mRNA CTD PMID:37567420 NCBI chr13:44,760,356...44,773,123
Ensembl chr13:44,760,380...44,773,122
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression ISO Glucose deficiency results in increased expression of GOT1 mRNA CTD PMID:26811028 NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
JBrowse link
G Gp5 glycoprotein V (platelet) multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GP5 mRNA CTD PMID:37567420 NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
JBrowse link
G Gp6 glycoprotein VI multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GP6 mRNA CTD PMID:37567420 NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
JBrowse link
G Gp9 glycoprotein IX (platelet) multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GP9 mRNA CTD PMID:37567420 NCBI chr 4:120,235,500...120,237,110
Ensembl chr 4:120,235,421...120,237,110
JBrowse link
G Gpc5 glypican 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of GPC5 mRNA CTD PMID:37567420 NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP Glucose results in increased expression of GPD1 mRNA CTD PMID:3299706 NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 multiple interactions ISO [Glucose co-treated with S 4048] results in increased expression of GPD2 mRNA; [GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GPD2 protein inhibits the reaction [Glucose results in increased abundance of alpha-glycerophosphoric acid]; GPD2 protein inhibits the reaction [Glucose results in increased abundance of Glucose-6-Phosphate]; GPD2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA] CTD PMID:10199125 PMID:10464266 PMID:31974165 NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
JBrowse link
G Gpha2 glycoprotein hormone subunit alpha 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of GPHA2 mRNA CTD PMID:37567420 NCBI chr 1:203,525,952...203,527,271
Ensembl chr 1:203,526,122...203,527,270
JBrowse link
G Gpm6b glycoprotein m6b decreases expression
multiple interactions
ISO Glucose results in decreased expression of GPM6B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GPM6B mRNA]
CTD PMID:33448797 NCBI chr  X:28,057,788...28,204,409
Ensembl chr  X:28,059,450...28,204,211
JBrowse link
G Gpnmb glycoprotein nmb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GPNMB mRNA CTD PMID:37567420 NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
JBrowse link
G Gpr151 G protein-coupled receptor 151 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GPR151 mRNA CTD PMID:37567420 NCBI chr18:34,568,907...34,570,301
Ensembl chr18:34,568,907...34,570,301
JBrowse link
G Gpr171 G protein-coupled receptor 171 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GPR171 mRNA CTD PMID:37567420 NCBI chr 2:143,360,402...143,365,494
Ensembl chr 2:143,359,564...143,366,698
JBrowse link
G Gpr85 G protein-coupled receptor 85 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR85 mRNA CTD PMID:37567420 NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566
JBrowse link
G Gpr87 G protein-coupled receptor 87 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GPR87 mRNA CTD PMID:37567420 NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
JBrowse link
G Gprin1 G protein-regulated inducer of neurite outgrowth 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GPRIN1 mRNA CTD PMID:37567420 NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases secretion
EXP
ISO
Glucose inhibits the reaction [(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid results in increased activity of GPT protein]
Glucose results in increased secretion of GPT protein
solanesol inhibits the reaction [Glucose results in increased secretion of GPT protein]
CTD PMID:29479035 PMID:37586544 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
JBrowse link
G Gpx1 glutathione peroxidase 1 decreases expression
multiple interactions
EXP
ISO
Glucose results in decreased expression of GPX1 mRNA
naringenin inhibits the reaction [Glucose results in decreased expression of GPX1 mRNA]
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
CTD PMID:21818840 PMID:23192364 PMID:23795780 PMID:32942007 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of GPX2 mRNA
Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein]
CTD PMID:28027979 PMID:32942007 NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
JBrowse link
G Gpx4 glutathione peroxidase 4 multiple interactions
increases expression
ISO 4-Nitroquinoline-1-oxide promotes the reaction [Glucose results in increased expression of GPX4 protein] CTD PMID:32942007 NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
JBrowse link
G Grap2 GRB2-related adaptor protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GRAP2 mRNA CTD PMID:37567420 NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877
JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression
multiple interactions
ISO Glucose results in increased expression of GREM1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GREM1 mRNA
CTD PMID:10026205 PMID:10744662 PMID:37567420 NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
JBrowse link
G Grem2 gremlin 2, DAN family BMP antagonist multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of GREM2 mRNA CTD PMID:37567420 NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein; Genistein inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein] CTD PMID:27238724 NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of GRIN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of GRIN1 mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
JBrowse link
G Gsdmd gasdermin D multiple interactions
increases expression
increases cleavage
ISO Glucose results in increased expression of and results in increased cleavage of GSDMD protein; GSDMD protein affects the reaction [Glucose results in increased secretion of IL18 protein]; GSDMD protein affects the reaction [Glucose results in increased secretion of IL1B protein]; Hirudins inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]
Glucose results in increased expression of GSDMD mRNA; Glucose results in increased expression of GSDMD protein
loganin inhibits the reaction [Glucose results in increased expression of GSDMD mRNA]; loganin inhibits the reaction [Glucose results in increased expression of GSDMD protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]]
CTD PMID:34212273 PMID:35607288 PMID:37473909 NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
increases expression
decreases phosphorylation
increases phosphorylation
ISO
EXP
[[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose; [Glucose co-treated with ICG 001] results in decreased phosphorylation of GSK3B protein; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased phosphorylation of GSK3B protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]; Panax notoginseng extract inhibits the reaction [Glucose results in increased expression of GSK3B protein]
Glucose results in increased phosphorylation of GSK3B protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein; Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein]; Simvastatin inhibits the reaction [Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein]
[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose; dorsomorphin inhibits the reaction [[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]; Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein promotes the reaction [Glucose results in increased expression of GSK3B protein]
CTD PMID:18004065 PMID:21031461 PMID:22062806 PMID:22180358 PMID:23690508 More... NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
JBrowse link
G Gsn gelsolin decreases secretion ISO Glucose deficiency results in decreased secretion of GSN protein CTD PMID:24802182 NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases activity
decreases expression
ISO
EXP
[Ascorbic Acid co-treated with GSR protein] affects the metabolism of Glucose; [Doxorubicin co-treated with GSR protein] affects the metabolism of Glucose; [Nitrofurantoin co-treated with GSR protein] affects the metabolism of Glucose; Furans analog inhibits the reaction [Glucose results in decreased activity of GSR protein]
naringenin inhibits the reaction [Glucose results in decreased expression of GSR mRNA]
CTD PMID:1901343 PMID:23192364 PMID:28911973 NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
JBrowse link
G Gtf2i general transcription factor II I increases expression ISO Glucose results in increased expression of GTF2I mRNA CTD PMID:32942007 NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
JBrowse link
G Gucy2d guanylate cyclase 2D, retinal multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GUCY2E mRNA CTD PMID:37567420 NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067
JBrowse link
G Gypc glycophorin C increases expression
multiple interactions
ISO Glucose results in increased expression of GYPC mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of GYPC mRNA]
CTD PMID:33448797 NCBI chr18:24,160,738...24,193,408
Ensembl chr18:24,160,739...24,193,204
JBrowse link
G Gys1 glycogen synthase 1 increases phosphorylation
multiple interactions
EXP Glucose results in increased phosphorylation of GYS1 protein
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein]
CTD PMID:29981789 NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
JBrowse link
G Gzmb granzyme B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GZMB mRNA CTD PMID:37567420 NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO Glucose results in increased expression of H1F2 mRNA CTD PMID:17178593 NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression
ISO Glucose promotes the reaction [Bupivacaine results in increased expression of H2AX protein]
Glucose results in increased expression of H2AX protein
CTD PMID:31672611 NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
JBrowse link
G H2bc18 H2B clustered histone 18 decreases expression ISO Glucose results in decreased expression of H2BC18 mRNA CTD PMID:31525975 NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
JBrowse link
G H3f4 H3.4 histone, cluster member multiple interactions EXP Glucose promotes the reaction [H3F4 protein modified form binds to PKLR promoter] CTD PMID:16644726 NCBI chr10:43,740,702...43,741,262 JBrowse link
G H4f16 H4 histone 16 multiple interactions EXP Glucose promotes the reaction [H4C16 protein modified form binds to PKLR promoter] CTD PMID:16644726
G Hamp hepcidin antimicrobial peptide multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAMP mRNA CTD PMID:37567420 NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAPLN1 mRNA CTD PMID:37567420 NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HAVCR1 mRNA CTD PMID:37567420 NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 increases glycation ISO Glucose results in increased glycation of HBA1 protein CTD PMID:26163454 NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
JBrowse link
G Hbb hemoglobin subunit beta multiple interactions
affects binding
ISO
EXP
Furans analog inhibits the reaction [Glucose binds to HBB protein]
Fructose promotes the reaction [Glucose binds to HBB protein]; geraniol inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]]; Pioglitazone inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]]
CTD PMID:25679220 PMID:28911973 NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO Glucose results in increased expression of HBEGF mRNA CTD PMID:17178593 NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
JBrowse link
G Hcrt hypocretin neuropeptide precursor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HCRT mRNA CTD PMID:37567420 NCBI chr10:85,689,979...85,691,214
Ensembl chr10:85,689,465...85,691,210
JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions ISO Glucose promotes the reaction [HDAC1 protein binds to TUG1 promoter] CTD PMID:32467232 NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
JBrowse link
G Hdc histidine decarboxylase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HDC mRNA CTD PMID:37567420 NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 decreases expression ISO Glucose results in decreased expression of HERPUD1 mRNA CTD PMID:17178593 NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
JBrowse link
G Hhat hedgehog acyltransferase decreases expression
multiple interactions
ISO Glucose results in decreased expression of HHAT mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of HHAT mRNA]
CTD PMID:33448797 NCBI chr13:104,024,507...104,283,580
Ensembl chr13:104,010,916...104,282,893
JBrowse link
G Hhipl1 HHIP-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HHIPL1 mRNA CTD PMID:37567420 NCBI chr 6:127,219,616...127,243,839
Ensembl chr 6:127,220,014...127,242,564
JBrowse link
G Hibch 3-hydroxyisobutyryl-CoA hydrolase decreases secretion ISO Glucose deficiency results in decreased secretion of HIBCH protein CTD PMID:24802182 NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions
increases expression
decreases expression
ISO
EXP
2-Methoxyestradiol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in increased expression of HIF1A protein]; [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in decreased activity of HIF1A protein] results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]; [Glucose co-treated with Oxygen deficiency] promotes the reaction [Pyruvaldehyde binds to and results in decreased activity of HIF1A protein]; [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein]
Glucose results in increased expression of HIF1A mRNA
Glucose results in decreased expression of HIF1A mRNA
Glucose results in increased expression of HIF1A mRNA; Glucose results in increased expression of HIF1A protein
[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; [cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein; [Glucose co-treated with Deferoxamine] results in increased expression of HIF1A mRNA; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]; epoxomicin inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Glucose affects the reaction [Fusaric Acid affects the expression of HIF1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of HIF1A mRNA]; MG 262 inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Particulate Matter inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose co-treated with Cycloheximide] results in decreased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein]; scutellarin promotes the reaction [Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; Vehicle Emissions inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]
[[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] which results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of TGFB1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of VEGFA protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]]
CTD PMID:18227068 PMID:19228841 PMID:19429140 PMID:21293012 PMID:21617913 More... NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
JBrowse link
G Hipk4 homeodomain interacting protein kinase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HIPK4 mRNA CTD PMID:37567420 NCBI chr 1:82,810,708...82,821,080
Ensembl chr 1:82,810,708...82,821,077
JBrowse link
G Hist1h2bc histone cluster 1, H2bc increases expression ISO Glucose results in increased expression of H2BC4 mRNA CTD PMID:17178593 NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
JBrowse link
G Hk1 hexokinase 1 increases expression ISO Glucose results in increased expression of HK1 mRNA CTD PMID:17178593 NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
JBrowse link
G Hk3 hexokinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of HK3 mRNA CTD PMID:37567420 NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
JBrowse link
G Hmga2 high mobility group AT-hook 2 increases expression ISO Glucose results in increased expression of HMGA2 mRNA CTD PMID:17178593 NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions
increases expression
increases secretion
ISO GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]; Glucose results in increased expression of and results in increased secretion of HMGB1 protein; JUN promotes the reaction [Glucose results in increased expression of HMGB1 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]
NLRP3 protein promotes the reaction [Glucose results in increased secretion of HMGB1 protein]
CTD PMID:19833897 PMID:27783111 NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565
JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of HMMR mRNA CTD PMID:37567420 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
decreases activity
decreases expression
increases expression
affects expression
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; 4-Nitroquinoline-1-oxide inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; [4-Nitroquinoline-1-oxide results in increased susceptibility to Glucose] which results in increased expression of HMOX1 protein; [Oxygen co-treated with Glucose] promotes the reaction [Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Berberine promotes the reaction [Glucose results in increased expression of HMOX1 protein]; Glucose inhibits the reaction [4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein]; Glucose promotes the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 mRNA]; Glucose promotes the reaction [tin mesoporphyrin results in increased expression of HMOX1 mRNA]; Particulate Matter promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]
Glucose results in decreased activity of HMOX1 promoter
Glucose results in decreased expression of HMOX1 mRNA; Glucose results in decreased expression of HMOX1 protein
Glucose deficiency results in increased expression of HMOX1 mRNA; Glucose results in increased expression of HMOX1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; Antioxidants inhibits the reaction [Glucose results in increased expression of HMOX1 mRNA]; Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]; Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]]; SMARCA4A protein promotes the reaction [Glucose results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]]
Glucose results in increased expression of HMOX1 mRNA; Glucose results in increased expression of HMOX1 protein
Glucose affects the expression of HMOX1 mRNA
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[diallyl trisulfide co-treated with Glucose] results in increased expression of HMOX1 protein]; [cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in decreased susceptibility to Glucose; [diallyl trisulfide co-treated with Glucose] results in increased expression of HMOX1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Acetylcysteine affects the reaction [Glucose affects the expression of HMOX1 mRNA]; Antioxidants inhibits the reaction [Glucose results in increased expression of HMOX1]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; Glucose results in decreased activity of and results in increased expression of HMOX1 protein; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of HMOX1 mRNA]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]; Quercetin inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]; Quercetin inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]]
Glucose affects the expression of HMOX1 protein
CTD PMID:14766238 PMID:16464909 PMID:17928392 PMID:19489000 PMID:19924377 More... NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G Hnf1a HNF1 homeobox A affects response to substance ISO HNF1A gene mutant form affects the susceptibility to Glucose CTD PMID:15787664 NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
JBrowse link
G Hnf1b HNF1 homeobox B multiple interactions ISO HNF1B protein inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]] CTD PMID:32623698 NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888
JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha multiple interactions
decreases expression
increases expression
ISO Cerulenin inhibits the reaction [Glucose results in decreased expression of HNF4A mRNA]; Glucose affects the reaction [HNF4A protein binds to SHBG promoter]
Glucose results in increased expression of HNF4A mRNA
CTD PMID:17992261 PMID:31525975 NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K decreases expression EXP Glucose results in decreased expression of HNRNPK mRNA; Glucose results in decreased expression of HNRNPK protein CTD PMID:16837467 NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
JBrowse link
G Hoxa2 homeobox A2 increases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of HOXA2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA
CTD PMID:21818840 PMID:37567420 NCBI chr 4:81,262,668...81,266,970
Ensembl chr 4:81,262,768...81,265,044
JBrowse link
G Hp haptoglobin affects secretion
multiple interactions
ISO Glucose deficiency affects the secretion of HP protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HP mRNA
CTD PMID:24802182 PMID:37567420 NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
JBrowse link
G Hpgds hematopoietic prostaglandin D synthase increases expression ISO Glucose results in increased expression of HPGDS mRNA CTD PMID:31525975 NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 decreases expression ISO Glucose results in decreased expression of HPRT1 mRNA CTD PMID:31655124 NCBI chr  X:132,736,175...132,768,149
Ensembl chr  X:132,736,096...132,768,154
JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions
increases activity
EXP manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] CTD PMID:16572112 NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
JBrowse link
G Hrg histidine-rich glycoprotein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HRG mRNA CTD PMID:37567420 NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
JBrowse link
G Hs6st2 heparan sulfate 6-O-sulfotransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HS6ST2 mRNA CTD PMID:37567420 NCBI chr  X:130,966,547...131,261,629
Ensembl chr  X:130,968,385...131,261,492
JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression EXP Glucose results in decreased expression of HSD11B2 mRNA CTD PMID:15017115 NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression ISO Glucose results in increased expression of HSD3B1 mRNA CTD PMID:31525975 NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
JBrowse link
G Hsf1 heat shock transcription factor 1 decreases activity ISO Glucose results in decreased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
JBrowse link
G Hsf2bp heat shock transcription factor 2 binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HSF2BP mRNA CTD PMID:37567420 NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242
JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions ISO Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 decreases expression
increases secretion
ISO Glucose results in decreased expression of HSP90B1 mRNA
Glucose deficiency results in increased secretion of HSP90B1 protein
CTD PMID:17178593 PMID:24802182 NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
JBrowse link
G Hspa12a heat shock protein family A (Hsp70) member 12A decreases expression
multiple interactions
EXP Glucose results in decreased expression of HSPA12A protein
KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]
CTD PMID:22413817 NCBI chr 1:257,935,642...258,096,602
Ensembl chr 1:257,935,644...258,096,846
JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 decreases expression ISO Glucose results in decreased expression of HSPA13 mRNA CTD PMID:17178593 NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
JBrowse link
G Hspa1l heat shock protein family A (Hsp70) member 1 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HSPA1L mRNA CTD PMID:37567420 NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression
decreases expression
multiple interactions
ISO
EXP
Glucose deficiency results in increased expression of HSPA5 mRNA; Glucose deficiency results in increased expression of HSPA5 protein; Glucose results in increased expression of HSPA5 mRNA; Glucose results in increased expression of HSPA5 protein
Glucose results in decreased expression of HSPA5 mRNA
Glucose deficiency results in increased expression of HSPA5 protein; Glucose results in increased expression of HSPA5 protein
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA]; 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein]; glucogallin inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Gadolinium inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Glucose affects the reaction [bisphenol A results in decreased expression of HSPA5 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of HSPA5 protein]; Metformin inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
CTD PMID:12147617 PMID:16380481 PMID:17178593 PMID:21337367 PMID:21705745 More... NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 increases expression
decreases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of HSPA9 protein
Glucose results in decreased expression of HSPA9 protein
KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein]
resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein]
CTD PMID:22413817 PMID:24218232 NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
JBrowse link
G Hspb1 heat shock protein family B (small) member 1 multiple interactions
increases phosphorylation
increases secretion
EXP
ISO
[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA]; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein]
Glucose results in increased phosphorylation of HSPB1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of HSPB1 protein]; U 0126 inhibits the reaction [Glucose results in increased phosphorylation of HSPB1 protein]
Glucose deficiency results in increased secretion of HSPB1 protein
CTD PMID:23421680 PMID:24802182 PMID:25373458 NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 decreases expression
multiple interactions
ISO Glucose deficiency results in decreased expression of HSPD1 protein
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of HSPD1 protein]
CTD PMID:17855661 NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
JBrowse link
G Htra3 HtrA serine peptidase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HTRA3 mRNA CTD PMID:37567420 NCBI chr14:75,068,917...75,097,315
Ensembl chr14:75,068,917...75,097,315
JBrowse link
G Hunk hormonally upregulated Neu-associated kinase multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] CTD PMID:33448797 NCBI chr11:29,641,122...29,758,392
Ensembl chr11:29,640,775...29,757,526
JBrowse link
G Hyal4 hyaluronidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA CTD PMID:37567420 NCBI chr 4:53,256,179...53,274,819
Ensembl chr 4:53,256,179...53,274,819
JBrowse link
G Hydin Hydin, axonemal central pair apparatus protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HYDIN mRNA CTD PMID:37567420 NCBI chr19:38,236,996...38,583,271
Ensembl chr19:38,236,464...38,583,264
JBrowse link
G Hyou1 hypoxia up-regulated 1 decreases expression ISO Glucose results in decreased expression of HYOU1 mRNA CTD PMID:17178593 NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
JBrowse link
G Iapp islet amyloid polypeptide multiple interactions
increases expression
ISO
EXP
IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]; Rosiglitazone inhibits the reaction [IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]]
Diazoxide inhibits the reaction [Glucose results in increased expression of IAPP mRNA]; Mannoheptulose inhibits the reaction [Glucose results in increased expression of IAPP mRNA]; Verapamil inhibits the reaction [Glucose results in increased expression of IAPP mRNA]
CTD PMID:9142872 PMID:16204373 NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920
JBrowse link
G Ica1l islet cell autoantigen 1-like multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICA1L mRNA] CTD PMID:33448797 NCBI chr 9:61,410,959...61,469,884
Ensembl chr 9:61,412,091...61,470,134
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression
multiple interactions
increases secretion
ISO
EXP
Glucose results in increased expression of ICAM1; Glucose results in increased expression of ICAM1 mRNA; Glucose results in increased expression of ICAM1 protein
Curcumin analog inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Y 27632 inhibits the reaction [Glucose results in increased expression of ICAM1 protein]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Glucose results in increased expression of ICAM1]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; aspalathin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Hesperidin inhibits the reaction [Glucose results in increased expression of ICAM1]; HTS 466284 inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; isoangustone A inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; manganese chloride inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Mannitol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of ICAM1 protein]; naringin inhibits the reaction [Glucose results in increased expression of ICAM1]; nothofagin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1]; Rimonabant inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; sarpogrelate inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of ICAM1 protein]
CTD PMID:15304054 PMID:16285992 PMID:21367880 PMID:21373835 PMID:21682256 More... NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Icam5 intercellular adhesion molecule 5 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA] CTD PMID:33448797 NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression ISO Glucose results in increased expression of ID1 mRNA CTD PMID:17178593 NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Glucose results in increased expression of ID3 mRNA CTD PMID:17178593 NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
JBrowse link
G Ide insulin degrading enzyme decreases expression ISO Glucose results in decreased expression of IDE mRNA CTD PMID:17178593 NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IDI1 mRNA CTD PMID:37567420 NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
JBrowse link
G Ifi27l2b interferon, alpha-inducible protein 27 like 2B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFI27L2A mRNA CTD PMID:37567420 NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
JBrowse link
G Ifi44 interferon-induced protein 44 increases expression
multiple interactions
ISO Glucose results in increased expression of IFI44 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of IFI44 mRNA]
CTD PMID:33448797 NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
JBrowse link
G Ifit2 interferon-induced protein with tetratricopeptide repeats 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT2 mRNA CTD PMID:37567420 NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT3 mRNA CTD PMID:37567420 NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
JBrowse link
G Ifng interferon gamma multiple interactions ISO
EXP
[IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]
[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
[TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:10967106 PMID:19071154 PMID:23138875 PMID:31776611 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G Igf1 insulin-like growth factor 1 increases uptake ISO IGF1 protein results in increased uptake of Glucose CTD PMID:29330302 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression
multiple interactions
increases expression
ISO Glucose results in decreased expression of IGF1R protein
Berberine inhibits the reaction [Glucose results in decreased expression of IGF1R protein]
Glucose results in increased expression of IGF1R mRNA
CTD PMID:7826318 PMID:23954465 NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IGF2BP1 mRNA CTD PMID:37567420 NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Glucose co-treated with IGF2R protein modified form] results in decreased expression of IL6 protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein modified form; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NOS2 protein; [Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose co-treated with IGF2R protein modified form] results in increased expression of TNF protein; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein] CTD PMID:36462176 NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 decreases expression ISO Glucose results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
JBrowse link
G Igfn1 immunoglobulin-like and fibronectin type III domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGFN1 mRNA CTD PMID:37567420 NCBI chr13:47,395,618...47,427,506
Ensembl chr13:47,395,595...47,437,879
JBrowse link
G Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA CTD PMID:37567420 NCBI chr 4:96,968,574...96,969,477 JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions EXP
ISO
IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IKBKB affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]
IKBKB protein affects the reaction [Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:22558381 PMID:31095431 NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
JBrowse link
G Il12b interleukin 12B multiple interactions
increases expression
ISO 2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL12B mRNA]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IL12B mRNA CTD PMID:21988173 PMID:37567420 NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
JBrowse link
G Il12rb2 interleukin 12 receptor subunit beta 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL12RB2 mRNA CTD PMID:37567420 NCBI chr 4:96,426,396...96,515,251
Ensembl chr 4:96,426,842...96,515,289
JBrowse link
G Il17a interleukin 17A multiple interactions
increases secretion
increases expression
ISO Cycloheximide inhibits the reaction [Glucose results in increased secretion of IL17A protein]; Dactinomycin inhibits the reaction [Glucose results in increased secretion of IL17A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL17A mRNA]; Resveratrol inhibits the reaction [Glucose results in increased secretion of IL17A protein] CTD PMID:18310510 NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
JBrowse link
G Il17ra interleukin 17 receptor A increases expression ISO Glucose results in increased expression of IL17RA mRNA CTD PMID:18310510 NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
JBrowse link
G Il18 interleukin 18 increases expression
multiple interactions
increases secretion
ISO
EXP
Glucose results in increased expression of IL18 mRNA
GSDMD protein affects the reaction [Glucose results in increased secretion of IL18 protein]; Hirudins inhibits the reaction [Glucose results in increased secretion of IL18 protein]
Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL18 protein]; loganin inhibits the reaction [Glucose results in increased expression of IL18 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL18 protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of IL18 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein]
Glucose results in increased expression of IL18 mRNA; Glucose results in increased expression of IL18 protein
CTD PMID:34212273 PMID:35191607 PMID:35607288 PMID:36066211 PMID:37473909 NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
JBrowse link
G Il18rap interleukin 18 receptor accessory protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IL18RAP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL18RAP mRNA CTD PMID:37567420 NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
increases secretion
ISO
EXP
2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; [cobaltiprotoporphyrin co-treated with IL1B protein] affects the susceptibility to Glucose; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein; [IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of IL1B protein]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of JUN protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of PTK2 protein]; GSDMD protein affects the reaction [Glucose results in increased secretion of IL1B protein]; Hirudins inhibits the reaction [Glucose results in increased secretion of IL1B protein]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; IL1B protein inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL1B protein]
Glucose results in increased expression of IL1B mRNA; Glucose results in increased expression of IL1B protein
[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Allopurinol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; farrerol inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of IL1B protein]; IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IL1B protein inhibits the reaction [Glucose results in increased abundance of Proteoglycans]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; morroniside inhibits the reaction [Glucose results in increased secretion of IL1B protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of IL1B protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased secretion of IL1B protein]; [Glucose co-treated with Lipopolysaccharides] results in decreased expression of IL1B protein; [Glucose co-treated with Pam(3)CSK(4) peptide] results in decreased expression of IL1B protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Allopurinol inhibits the reaction [Glucose results in increased expression of IL1B protein]; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Carnosine inhibits the reaction [Glucose results in increased secretion of IL1B protein]; Catechin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of IL1B protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of IL1B protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL1B protein]; loganin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Luteolin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of IL1B protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Phytic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of IL1B protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]]; swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]
CTD PMID:10967106 PMID:11801247 PMID:15194409 PMID:19071154 PMID:19557821 More... NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions EXP
ISO
IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of IL1RN mRNA
CTD PMID:19861503 PMID:37567420 NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
JBrowse link
G Il23r interleukin 23 receptor decreases expression
multiple interactions
ISO Glucose results in decreased expression of IL23R mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of IL23R mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
JBrowse link
G Il24 interleukin 24 increases expression
decreases expression
multiple interactions
ISO Glucose results in increased expression of IL24 mRNA
Glucose results in decreased expression of IL24 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of IL24 mRNA]
CTD PMID:17178593 PMID:33448797 NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
JBrowse link
G Il27 interleukin 27 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IL27 mRNA CTD PMID:37567420 NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
JBrowse link
G Il31ra interleukin 31 receptor A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IL31RA mRNA CTD PMID:37567420 NCBI chr 2:44,118,748...44,189,943
Ensembl chr 2:44,122,624...44,183,767
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
increases secretion
ISO
EXP
[Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Carnosine inhibits the reaction [Glucose results in increased secretion of IL6 protein]; chromic chloride inhibits the reaction [Glucose results in increased secretion of IL6 protein]; chromic chloride promotes the reaction [Estradiol inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Estradiol inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Glucose results in increased secretion of and results in increased expression of IL6 protein; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL6 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of IL6 protein]; picolinic acid inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Polyphenols inhibits the reaction [Glucose results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]
Glucose results in increased expression of IL6 mRNA; Glucose results in increased expression of IL6 protein
2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased secretion of IL6 protein]; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL6 protein; CDK9 protein affects the reaction [Glucose results in increased expression of IL6 mRNA]; CDK9 protein affects the reaction [Glucose results in increased secretion of IL6 protein]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of IL6 protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of and results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein; Artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Curcumin analog inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; duanbanhuain A inhibits the reaction [Glucose results in increased secretion of IL6 protein]; duanbanhuain B inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL6 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of IL6 protein]; farrerol inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of IL6 protein]; morroniside inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Oxygen promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 mRNA]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of IL6 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of IL6 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased secretion of IL6 protein]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of IL6 protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein]
CTD PMID:11108930 PMID:15304054 PMID:15528032 PMID:17665966 PMID:20578705 More... NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Il6r interleukin 6 receptor multiple interactions ISO [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in increased oxidation of IL6RA protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] CTD PMID:21940958 NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
JBrowse link
G Il6st interleukin 6 cytokine family signal transducer multiple interactions ISO [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in increased oxidation of IL6ST protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] CTD PMID:21940958 NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
JBrowse link
G Ins1 insulin 1 increases transport
increases secretion
increases import
multiple interactions
increases uptake
decreases secretion
increases metabolic processing
decreases abundance
decreases expression
affects expression
decreases chemical synthesis
affects secretion
increases expression
EXP
ISO
INS1 protein results in increased transport of Glucose
Glucose results in increased secretion of INS1 protein
INS1 protein results in increased import of Glucose
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[4-(3-3,4-p-menthadien-(1,8)-yl)olivetol co-treated with Glucose] results in increased secretion of INS1 protein]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[O-1602 compound co-treated with Glucose] results in increased secretion of INS1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BLX 1002 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [INS1 protein results in increased uptake of Glucose]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [methylarsonite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]; 7-Ala-angiotensin (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Arsenic Trioxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; [4-(3-3,4-p-menthadien-(1,8)-yl)olivetol co-treated with Glucose] results in increased secretion of INS1 protein; [arachidonyl-2-chloroethylamide co-treated with Glucose] results in increased secretion of INS1 protein; [Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Carbachol co-treated with Glucose] results in increased secretion of INS1 protein; [Chromium co-treated with Vanadates] promotes the reaction [INS1 protein results in increased uptake of Glucose]; [Chromium Compounds co-treated with Vanadates] promotes the reaction [INS1 protein results in increased uptake of Glucose]; [Dietary Fats affects the susceptibility to INS1 protein] which affects the oxidation of Glucose; [Dietary Fats affects the susceptibility to INS1 protein] which affects the uptake of Glucose; [FFAR1 protein affects the susceptibility to Dietary Fats] affects the reaction [Glucose results in increased secretion of INS1 protein]; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein; [Glucose co-treated with Dichlorodiphenyl Dichloroethylene] results in increased secretion of INS1 protein; [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA; [Glucose co-treated with INS1 protein] affects the expression of KDM1B mRNA; [Glucose co-treated with INS1 protein] affects the expression of KDM4B mRNA; [Glucose co-treated with INS1 protein] affects the localization of PDX1 protein; [GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [LDLR gene mutant form results in increased susceptibility to Pravastatin] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [lead nitrate results in increased abundance of Lead] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Mercuric Chloride results in increased abundance of Mercury] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [MME protein results in increased cleavage of angiotensin I (1-7)] affects the reaction [Glucose results in increased secretion of INS1 protein]; [molybdenum trioxide results in increased abundance of Molybdenum] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [O-1602 compound co-treated with Glucose] results in increased secretion of INS1 protein; [Pertussis Toxin co-treated with FR900359] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Pertussis Toxin co-treated with Glucose] results in increased secretion of INS1 protein; [Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; [Tetradecanoylphorbol Acetate co-treated with Glucose] results in increased secretion of INS1 protein; [Tolbutamide co-treated with FR900359] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Adenosine Triphosphate inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Akt-I-1,2 compound inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Akt-I-1,2 compound inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]; Arecoline inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Arsenic Trioxide inhibits the reaction [Estradiol promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Arsenic Trioxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Arsenic Trioxide promotes the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; arsenite inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Benzamides promotes the reaction [INS1 protein results in increased uptake of Glucose]; bisphenol A inhibits the reaction [Glucose results in increased secretion of INS1 protein]; bisphenol A inhibits the reaction [INS1 protein results in increased metabolism of Glucose]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS1 protein]; bisphenol S inhibits the reaction [Glucose results in increased secretion of INS1 protein]; BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]; BLX 1002 promotes the reaction [Glucose results in increased secretion of INS1 protein]; Bumetanide inhibits the reaction [SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein]]; celastrol affects the reaction [[Dietary Fats affects the susceptibility to INS1 protein] which affects the oxidation of Glucose]; celastrol affects the reaction [[Dietary Fats affects the susceptibility to INS1 protein] which affects the uptake of Glucose]; Chromium Compounds promotes the reaction [INS1 protein results in increased uptake of Glucose]; Chromium promotes the reaction [INS1 protein results in increased uptake of Glucose]; cis-9, trans-11-conjugated linoleic acid promotes the reaction [INS1 protein affects the transport of Glucose]; cobaltiprotoporphyrin inhibits the reaction [Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]; copper bis(3,5-diisopropylsalicylate) inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; CYP1A1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Cytochalasin B inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Cytochalasin B inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diethylhexyl Phthalate inhibits the reaction [Glucose results in increased secretion of INS1 protein]; dimethylarsine analog inhibits the reaction [INS1 protein results in increased uptake of Glucose]; dimethylarsinous acid inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; DX600 peptide inhibits the reaction [angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]]; DX600 peptide promotes the reaction [Glucose results in increased secretion of INS1 protein]; ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein]; Estradiol inhibits the reaction [Arsenic Trioxide promotes the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Estradiol inhibits the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Estradiol inhibits the reaction [INS1 protein results in increased transport of Glucose]; Estradiol promotes the reaction [Glucose results in increased secretion of INS1 protein]; Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Exenatide inhibits the reaction [FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Exenatide promotes the reaction [Glucose results in increased secretion of INS1 protein]; ferrostatin-1 inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FR900359 inhibits the reaction [Exenatide promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; FR900359 inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FR900359 inhibits the reaction [TUG-469 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; FRK protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Fulvestrant inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Glyburide inhibits the reaction [Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; GNAI2 gene mutant form inhibits the reaction [[Glucose co-treated with Amino Acids] results in increased secretion of INS1 protein]; GNAI2 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Glucose results in increased secretion of INS1 protein]; GNAQ protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; IKBKB protein affects the reaction [Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]]; isosteviol inhibits the reaction [Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; kaempferol promotes the reaction [INS1 protein results in increased uptake of Glucose]; mercaptosteroid 4 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; mercaptosteroid 6 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; methylarsine oxide inhibits the reaction [INS1 protein results in increased uptake of Glucose]; methylarsonite inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; methylarsonite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Methylprednisolone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MME protein affects the reaction [angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]]; mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]; monomethylarsonic acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]; naringin inhibits the reaction [Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; naringin promotes the reaction [Glucose results in increased secretion of INS1 protein]; Ozone promotes the reaction [INS1 protein results in decreased abundance of Glucose]; Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; Particulate Matter promotes the reaction [Glucose results in increased secretion of INS1 protein]; perfluorooctane sulfonic acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Pioglitazone promotes the reaction [INS1 protein results in increased uptake of Glucose]; platyconic acid promotes the reaction [INS1 protein results in increased uptake of Glucose]; POMC inhibits the reaction [INS1 results in increased uptake of Glucose]; Potassium Chloride inhibits the reaction [FR900359 inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Potassium Chloride promotes the reaction [Glucose results in increased secretion of INS1 protein]; Progesterone inhibits the reaction [INS1 protein results in increased transport of Glucose]; Quercetin promotes the reaction [INS1 protein results in increased uptake of Glucose]; Resveratrol inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Ro 32-0432 inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Rosiglitazone inhibits the reaction [Acrolein inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; rutamarin promotes the reaction [INS1 protein results in increased uptake of Glucose]; Sildenafil Citrate promotes the reaction [INS1 protein results in increased import of Glucose]; SIRT3 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein]; SLC30A3 results in increased susceptibility to [Glucose co-treated with INS1 protein]; SLC30A8 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SOD2 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]; sodium arsenite promotes the reaction [INS1 protein results in decreased chemical synthesis of Glucose]; Sodium Selenite inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Streptozocin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Testosterone inhibits the reaction [INS1 protein results in increased transport of Glucose]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Tolbutamide inhibits the reaction [arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tolbutamide inhibits the reaction [dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tolbutamide inhibits the reaction [methylarsonite inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tolbutamide promotes the reaction [Glucose results in increased secretion of INS1 protein]; tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]; TUG-469 promotes the reaction [Glucose results in increased secretion of INS1 protein]; UGT1A6A protein affects the reaction [Glucose results in increased secretion of INS1 protein]; Vanadates promotes the reaction [INS1 protein results in increased uptake of Glucose]; Wortmannin inhibits the reaction [BLX 1002 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Wortmannin inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Wortmannin inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; YM-254890 inhibits the reaction [Glucose results in increased secretion of INS1 protein]; YM-254890 inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Zinc promotes the reaction [INS1 protein results in increased uptake of Glucose]
Glucose results in decreased secretion of INS1 protein
(+)-JQ1 compound promotes the reaction [Glucose results in increased secretion of INS1 protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Glucose results in increased secretion of INS1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 3-(4-((2',6'-dimethylbiphenyl-3-yl)methoxy)-2-fluorophenyl)propanoic acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; 3-(4-((2,6-dichloropyridin-4-yl)ethynyl)phenyl)propanoic acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene inhibits the reaction [Glucose results in increased secretion of INS1 protein]; 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; 7-nitroindazole inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased transport of Zinc]; 9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; 9-phenanthrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [4-methylcatechol co-treated with Glucose] results in increased secretion of INS1 protein; [[Glucose co-treated with INS1 protein] results in increased abundance of Adenosine Triphosphate] which results in increased secretion of LEP protein; [[valyl-histidyl-threonyl-aspartamide binds to Zinc] results in increased activity of [INS1 protein binds to INS1 protein binds to INS1 protein binds to INS1 protein binds to INS1 protein binds to INS1 protein]] which results in decreased abundance of Glucose; [Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [GCG protein co-treated with Glucose] results in increased secretion of INS1 protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; [Glucose co-treated with 3,4-dihydroxyphenylethanol] results in increased secretion of INS1 protein; [Glucose co-treated with dihydroxyethyldithiocarbamate] results in decreased expression of INS1; [Glucose co-treated with INS1 protein] results in increased abundance of Adenosine Triphosphate; [Glucose co-treated with INS1 protein] results in increased secretion of LEP protein; [Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein; [Glucose co-treated with Plant Extracts] results in increased secretion of INS1 protein; [IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein; [INS1 protein co-treated with Glucose] results in increased transport of Zinc; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]; alpha-methylbenzylaminobenzotriazole inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]; arachidonyltrifluoromethane inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; argan oil inhibits the reaction [Glucose results in increased expression of INS1 protein]; Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]; benazepril inhibits the reaction [Glucose results in increased secretion of INS1 protein]; benazepril promotes the reaction [INS1 protein results in increased metabolism of Glucose]; bisphenol A affects the reaction [Glucose results in increased secretion of INS1 protein]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS1 protein]; BL 11282 analog promotes the reaction [Glucose results in increased secretion of INS1 protein]; BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]; Budesonide inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Budesonide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Bumetanide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Calcium deficiency inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Cannabidiol promotes the reaction [Glucose results in increased secretion of INS1 protein]; Capsaicin promotes the reaction [Glucose results in increased secretion of INS1 protein]; Chlorpyrifos inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Colchicine inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]; cordycepin promotes the reaction [Glucose results in increased secretion of INS1 protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of INS1 protein]; Cycloheximide inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Dexamethasone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diazoxide inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Dietary Fats affects the reaction [INS1 protein results in increased uptake of Glucose]; Dietary Fats inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diethylhexyl Phthalate inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Diethylhexyl Phthalate inhibits the reaction [INS1 protein results in increased metabolism of Glucose]; Dithiothreitol inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Exenatide inhibits the reaction [Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Fluticasone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Fluticasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Fulvestrant inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Glucosamine inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Glucose inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Glucose inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Homocysteine inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Hydrocortisone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; INS1 protein inhibits the reaction [Dichlorvos results in increased abundance of Glucose]; INS1 protein inhibits the reaction [FOXO1 protein results in increased abundance of Glucose]; INS1 protein promotes the reaction [FOXO1 protein mutant form results in increased abundance of Glucose]; INS1 protein promotes the reaction [Glucose results in increased expression of LEP mRNA]; INS1 protein promotes the reaction [Glucose results in increased secretion of LEP protein]; INS1 protein results in increased transport of and results in increased oxidation of Glucose; KMUP 1 inhibits the reaction [Glucose results in decreased secretion of INS1 protein]; Lenalidomide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; LEP promotes the reaction [Glucose results in increased secretion of INS1 protein]; Manganese deficiency inhibits the reaction [INS1 protein results in increased oxidation of Glucose]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of INS1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the secretion of INS1 protein]; Melatonin inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; Metformin inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; N-(-4-(N-(biphenyl-2-ylmethyl)-N-2-methylpropylamino)- 1-(2-(2,4-difluorobenzoyl)benzoyl)pyrrolidin- 2-yl)methyl-3-(4-(2,4-dioxothiazolidin-5-ylidenemethyl) phenyl)acrylamide inhibits the reaction [BL 11282 promotes the reaction [Glucose results in increased secretion of INS1 protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; NFE2L2 protein affects the reaction [Exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Niacinamide inhibits the reaction [Glucose results in increased expression of INS1 protein]; nickel chloride inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; nymphayol promotes the reaction [INS1 protein results in increased uptake of Glucose]; Oleic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of Glucose]; oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Palmitic Acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]; pimobendan promotes the reaction [Glucose results in increased secretion of INS1 protein]; PPARA protein promotes the reaction [Glucose results in increased secretion of INS1 protein]; PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Quercetin inhibits the reaction [INS1 protein results in increased transport of and results in increased oxidation of Glucose]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Resveratrol inhibits the reaction [Dietary Fats inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Resveratrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Ro 31-8220 inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Ro 32-0432 inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Sirolimus inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SIRT1 protein promotes the reaction [[Glucose results in increased abundance of Adenosine Triphosphate] which results in increased expression of INS1 protein]; SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]; SLC30A8 protein affects the reaction [Glucose results in increased secretion of INS1 protein]; SOD1 protein inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein]; sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS1 protein]; sodium arsenite promotes the reaction [Glucose results in increased secretion of INS1 protein]; Sorbitol promotes the reaction [Glucose results in increased secretion of INS1 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Taurine inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Tetradecanoylphorbol Acetate promotes the reaction [Glucose results in increased secretion of INS1 protein]; TRIB3 protein affects the reaction [INS1 protein results in increased uptake of Glucose]; tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]; trichostatin A inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]; tubacin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; tubacin promotes the reaction [Glucose results in increased secretion of INS1 protein]; UCP2 protein inhibits the reaction [SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; Wortmannin inhibits the reaction [apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Zinc inhibits the reaction [Glucose results in increased secretion of INS1 protein]
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; bisphenol A inhibits the reaction [INS1 protein results in increased uptake of Glucose]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; pyrazolanthrone inhibits the reaction [bisphenol A inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
Glucose results in decreased expression of INS1 mRNA
INS1 protein results in increased uptake of Glucose; INS1 results in increased uptake of Glucose
CTD PMID:222008 PMID:1324726 PMID:2185640 PMID:2204694 PMID:2262933 More... NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
JBrowse link
G Ins2 insulin 2 multiple interactions
affects response to substance
increases uptake
increases expression
increases secretion
decreases expression
decreases secretion
decreases chemical synthesis
increases activity
ISO
EXP
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 1-Methyl-3-isobutylxanthine promotes the reaction [Glucose results in increased secretion of INS protein]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Fatty Acids, Nonesterified inhibits the reaction [INS protein results in increased secretion of Glucose]]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in increased expression of INS mRNA]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in increased expression of INS protein]; 3-aminobenzamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of INS mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of INS protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]]; [6alpha-ethyl-23(S)-methylcholic acid co-treated with Glucose] results in increased secretion of INS protein; [Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Glucose results in increased secretion of INS protein]; [chromic chloride results in increased activity of INS protein modified form] which results in increased import of Glucose; [Glucose affects the susceptibility to INS protein] which affects the phosphorylation of AKT1 protein; [Glucose affects the susceptibility to INS protein] which affects the uptake of Glucose; [Glucose co-treated with INS protein] affects the localization of PDX1 protein; [Glucose co-treated with sodium arsenite] results in increased secretion of INS protein; [Glyburide co-treated with Glucose] results in increased expression of INS protein; [INS protein co-treated with Glucose] results in decreased chemical synthesis of Nitric Oxide; [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein; [INS protein co-treated with Glucose] results in increased expression of ACACA mRNA; [INS protein co-treated with Glucose] results in increased expression of FASN mRNA; [INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA; [Lithocholic Acid co-treated with Glucose] results in increased secretion of INS protein; [manganese chloride results in increased abundance of Manganese] inhibits the reaction [Glucose results in increased secretion of INS protein]; [Oleanolic Acid co-treated with Glucose] results in increased secretion of INS protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [SB 203580 co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; [sodium arsenite results in increased abundance of arsenite] inhibits the reaction [Glucose results in increased secretion of INS protein]; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; [Wortmannin co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of INS protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]; alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol promotes the reaction [Glucose results in increased secretion of INS protein]; Arachidonic Acid promotes the reaction [Glucose results in increased secretion of INS protein]; arachidonyltrifluoromethane inhibits the reaction [Glucose results in increased secretion of INS protein]; baicalein promotes the reaction [Glucose results in increased secretion of INS protein]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]; Cadmium Chloride promotes the reaction [Glucose results in increased secretion of INS protein]; Chlorpropamide inhibits the reaction [Glucose results in decreased secretion of INS protein]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]; Dexamethasone inhibits the reaction [INS protein results in increased uptake of Glucose]; Diazoxide inhibits the reaction [Glucose results in increased secretion of INS protein]; Dichlorodiphenyl Dichloroethylene promotes the reaction [Glucose results in increased secretion of INS protein]; Diethylhexyl Phthalate affects the reaction [Glucose results in increased secretion of INS protein]; Enalaprilat inhibits the reaction [Glucose results in decreased secretion of INS protein]; Exenatide inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]]; Fatty Acids, Nonesterified inhibits the reaction [INS protein results in increased secretion of Glucose]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]; Fulvestrant inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]; fumosorinone promotes the reaction [INS protein results in increased uptake of Glucose]; Glucose inhibits the reaction [INS protein results in increased chemical synthesis of Glycogen]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]; Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]; Glyburide inhibits the reaction [Glucose results in decreased secretion of INS protein]; GW8510 promotes the reaction [Glucose results in increased secretion of INS protein]; HNF1B protein inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]; IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]; INS protein inhibits the reaction [Glucose results in decreased expression of ATP1A1 protein]; INS protein mutant form results in decreased uptake of and results in decreased oxidation of Glucose; IRS1 protein polymorphism inhibits the reaction [Glucose results in increased secretion of INS protein]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased chemical synthesis of Nitric Oxide]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; mercaptosteroid 6 inhibits the reaction [Glucose results in increased secretion of INS protein]; Metformin inhibits the reaction [[Glucose affects the susceptibility to INS protein] which affects the uptake of Glucose]; Metformin promotes the reaction [Glucose results in increased secretion of INS protein]; methylarsine oxide inhibits the reaction [Glucose results in increased secretion of INS protein]; Methylcholanthrene promotes the reaction [Glucose results in increased secretion of INS protein alternative form]; MIR133A1 affects the reaction [Glucose results in decreased chemical synthesis of INS protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Glucose results in increased secretion of INS protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; Niacinamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; Niacinamide inhibits the reaction [Glucose results in increased expression of INS mRNA]; Niacinamide inhibits the reaction [Glucose results in increased expression of INS protein]; NKX6-1 protein promotes the reaction [Glucose results in increased secretion of INS protein]; palmitoyl trifluoromethyl ketone inhibits the reaction [Glucose results in increased secretion of INS protein]; PARP1 protein affects the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; perfluorooctane sulfonic acid promotes the reaction [Glucose results in increased secretion of INS protein]; perfluorooctanoic acid inhibits the reaction [Glucose results in increased secretion of INS protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Plant Extracts inhibits the reaction [[Glucose affects the susceptibility to INS protein] which affects the uptake of Glucose]; PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]]; Quercetin inhibits the reaction [Glucose results in increased expression of INS protein]; Resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]; Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]; Ro 32-0432 inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified inhibits the reaction [INS protein results in increased secretion of Glucose]]; Rosiglitazone inhibits the reaction [IAPP protein inhibits the reaction [Glucose results in increased secretion of INS protein]]; Rosiglitazone promotes the reaction [INS protein results in increased uptake of Glucose]; Saquinavir inhibits the reaction [INS protein results in increased import of Glucose]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]]; SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]; SLC30A8 protein promotes the reaction [Glucose results in increased secretion of INS protein]; sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]; sodium arsenite inhibits the reaction [INS protein results in increased uptake of Glucose]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Thapsigargin inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Thioctic Acid inhibits the reaction [Glucose results in increased expression of INS protein]; TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]; TPH1 protein affects the reaction [Glucose results in increased secretion of INS protein]; TPH1 protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]; TPH1 protein affects the reaction [UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]]; tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]; triphenyl phosphate promotes the reaction [Glucose results in increased secretion of INS protein]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]]; UCP3 protein promotes the reaction [Glucose results in increased secretion of INS protein]; UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]
Acetylcysteine inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]]; Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]; IKBKB affects the reaction [IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IKBKB affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Glucose]; Quercetin inhibits the reaction [INS protein results in increased uptake of Glucose]; sodium bisulfide inhibits the reaction [INS protein results in increased uptake of Glucose]
Glucose results in increased expression of INS mRNA; Glucose results in increased expression of INS2 mRNA alternative form
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [triphenyl phosphate promotes the reaction [INS protein results in increased import of Glucose]]; 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [INS protein results in increased uptake of Glucose]; [IL1B protein co-treated with IFNG protein] promotes the reaction [Glucose results in increased secretion of INS protein]; bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]; Estradiol promotes the reaction [Glucose results in increased secretion of INS2 protein]; IL1B protein inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; MIR338 mRNA affects the reaction [Glucose results in increased secretion of INS protein]; Palmitic Acid inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]; PDX1 protein affects the reaction [bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]]; perfluorooctane sulfonic acid promotes the reaction [INS protein results in increased uptake of Glucose]; Resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [INS protein results in increased uptake of Glucose]]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; triphenyl phosphate promotes the reaction [INS protein results in increased import of Glucose]
Glucose results in increased secretion of INS protein; Glucose results in increased secretion of INS2 protein
Glucose results in decreased expression of INS2 mRNA
Glucose results in increased secretion of INS protein; Glucose results in increased secretion of INS protein alternative form; INS protein results in increased secretion of Glucose
Glucose results in increased activity of INS promoter
CTD PMID:838844 PMID:3511099 PMID:7956951 PMID:8725009 PMID:9032110 More... NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
JBrowse link
G Insr insulin receptor increases phosphorylation
multiple interactions
decreases expression
decreases degradation
increases expression
ISO
EXP
Glucose results in increased phosphorylation of INSR protein
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein]; Catechin inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein]; Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein
Glucose results in decreased expression of INSR protein; Glucose results in decreased expression of INSR protein modified form
Catechin inhibits the reaction [Glucose results in decreased expression of INSR protein modified form]; Catechin inhibits the reaction [Glucose results in decreased expression of INSR protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; PARP1 protein affects the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of INSR protein modified form]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of INSR protein]
Glucose results in decreased degradation of INSR mRNA
Glucose results in increased expression of INSR mRNA
CTD PMID:7826318 PMID:21031461 PMID:24262486 PMID:29981789 NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
JBrowse link
G Insyn2a inhibitory synaptic factor 2A increases expression ISO Glucose results in increased expression of INSYN2A mRNA CTD PMID:31525975 NCBI chr 1:189,697,856...189,753,194
Ensembl chr 1:189,697,878...189,752,922
JBrowse link
G Ip6k3 inositol hexakisphosphate kinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of IP6K3 mRNA CTD PMID:37567420 NCBI chr20:5,223,863...5,245,443
Ensembl chr20:5,224,120...5,245,428
JBrowse link
G Ipcef1 interaction protein for cytohesin exchange factors 1 decreases expression ISO Glucose results in decreased expression of IPCEF1 mRNA CTD PMID:32942007 NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
JBrowse link
G Irag1 inositol 1,4,5-triphosphate receptor associated 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of IRAG1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of IRAG1 mRNA]
CTD PMID:33448797 NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
JBrowse link
G Ireb2 iron responsive element binding protein 2 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein; Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein] CTD PMID:16135072 NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRF1 mRNA CTD PMID:37567420 NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
JBrowse link
G Irf2 interferon regulatory factor 2 increases expression
multiple interactions
ISO Glucose results in increased expression of IRF2 mRNA
Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]
CTD PMID:34212273 NCBI chr16:45,439,215...45,550,054
Ensembl chr16:45,439,225...45,550,024
JBrowse link
G Irf7 interferon regulatory factor 7 increases expression
multiple interactions
ISO Glucose results in increased expression of IRF7 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRF7 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of IRF7 mRNA]
CTD PMID:33448797 PMID:37567420 NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
JBrowse link
G Irgm immunity-related GTPase M multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA CTD PMID:37567420 NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions
decreases phosphorylation
decreases expression
increases phosphorylation
ISO ACACB protein affects the reaction [Glucose results in decreased phosphorylation of IRS1 protein]; Catechin inhibits the reaction [Glucose results in decreased expression of IRS1 protein modified form]; Catechin inhibits the reaction [Glucose results in decreased expression of IRS1 protein]; Glucose promotes the reaction [PIK3R1 protein binds to IRS1 protein]; IRS1 protein polymorphism inhibits the reaction [Glucose results in increased secretion of INS protein]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS1 protein modified form]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS1 protein]
Glucose results in decreased expression of IRS1 protein; Glucose results in decreased expression of IRS1 protein modified form
Glucose results in increased phosphorylation of IRS1 protein
CTD PMID:10430617 PMID:24262486 PMID:33957017 NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
JBrowse link
G Irs2 insulin receptor substrate 2 increases phosphorylation
decreases expression
multiple interactions
increases abundance
ISO Glucose results in increased phosphorylation of IRS2 protein
Glucose results in decreased expression of IRS2 protein; Glucose results in decreased expression of IRS2 protein modified form
Catechin inhibits the reaction [Glucose results in decreased expression of IRS2 protein modified form]; Catechin inhibits the reaction [Glucose results in decreased expression of IRS2 protein]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS2 protein modified form]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of IRS2 protein]
IRS2 gene mutant form results in increased abundance of Glucose
CTD PMID:10430617 PMID:20028942 PMID:24262486 NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
JBrowse link
G Islr2 immunoglobulin superfamily containing leucine-rich repeat 2 increases expression
multiple interactions
ISO Glucose results in increased expression of ISLR2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ISLR2 mRNA
CTD PMID:31525975 PMID:37567420 NCBI chr 8:58,608,165...58,616,246
Ensembl chr 8:58,608,709...58,614,650
JBrowse link
G Ism2 isthmin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ISM2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ISM2 mRNA CTD PMID:37567420 NCBI chr 6:106,921,213...106,944,291
Ensembl chr 6:106,926,175...106,944,514
JBrowse link
G Itga2b integrin subunit alpha 2b multiple interactions ISO Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGA2B protein]] CTD PMID:18413191 NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
JBrowse link
G Itga3 integrin subunit alpha 3 decreases expression
multiple interactions
ISO Glucose results in decreased expression of ITGA3 mRNA; Glucose results in decreased expression of ITGA3 protein
notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGA3 mRNA]; notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGA3 protein]
CTD PMID:25503068 NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
JBrowse link
G Itga5 integrin subunit alpha 5 decreases expression ISO Glucose results in decreased expression of ITGA5 mRNA CTD PMID:31655124 NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
JBrowse link
G Itgav integrin subunit alpha V decreases expression ISO Glucose results in decreased expression of ITGAV mRNA CTD PMID:31655124 NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
JBrowse link
G Itgb1 integrin subunit beta 1 increases expression
decreases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of ITGB1 mRNA; Glucose results in increased expression of ITGB1 protein
Glucose results in decreased expression of ITGB1 mRNA
notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGB1 mRNA]; notoginsenoside R1 inhibits the reaction [Glucose results in decreased expression of ITGB1 protein]
Glucose results in decreased expression of ITGB1 mRNA; Glucose results in decreased expression of ITGB1 protein
rosiglitazone inhibits the reaction [Glucose results in increased expression of ITGB1 mRNA]; rosiglitazone inhibits the reaction [Glucose results in increased expression of ITGB1 protein]
CTD PMID:17441352 PMID:25503068 PMID:31655124 NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
JBrowse link
G Itgb3 integrin subunit beta 3 multiple interactions
decreases expression
ISO Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of ITGB3 protein]]
Glucose results in decreased expression of ITGB3 mRNA
CTD PMID:18413191 PMID:31655124 NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
JBrowse link
G Itih2 inter-alpha-trypsin inhibitor heavy chain 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ITIH2 mRNA CTD PMID:37567420 NCBI chr17:68,375,574...68,411,849
Ensembl chr17:68,375,567...68,411,841
JBrowse link
G Izumo1 izumo sperm-oocyte fusion 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of IZUMO1 mRNA CTD PMID:37567420 NCBI chr 1:96,090,817...96,096,893 JBrowse link
G Jak2 Janus kinase 2 multiple interactions
increases phosphorylation
ISO
EXP
(3,4-dihydroxyphenylamino)-2-imidazoline inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; acetovanillone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]; Rotenone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]
Glucose results in increased phosphorylation of JAK2 protein
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Glucose results in increased phosphorylation of JAK2 protein]
CTD PMID:15677497 PMID:20060012 NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
affects localization
increases phosphorylation
increases expression
ISO
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of JUN protein]; [Glucose co-treated with Lipopolysaccharides] results in increased expression of JUN protein; Aspirin inhibits the reaction [Glucose results in increased expression of JUN protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of JUN protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of JUN protein]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A12 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]; Glucose promotes the reaction [JUN protein binds to MMP9 promoter]; Glucose promotes the reaction [JUN protein binds to S100A12 promoter]; Glucose promotes the reaction [JUN protein binds to S100A8 promoter]; JUN promotes the reaction [Glucose results in increased expression of HMGB1 mRNA]; JUN promotes the reaction [Glucose results in increased expression of S100A12 mRNA]; JUN promotes the reaction [Glucose results in increased expression of S100A8 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; SB 203580 inhibits the reaction [Glucose results in increased phosphorylation of JUN protein]
Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of JUN protein]
Dactinomycin inhibits the reaction [Glucose results in increased expression of JUN mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of JUN protein]; Quercetin inhibits the reaction [Glucose affects the localization of JUN protein]; Superoxides affects the reaction [Glucose results in increased phosphorylation of JUN protein]
CTD PMID:11123204 PMID:11557636 PMID:16572112 PMID:16600694 PMID:17178593 More... NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression ISO Glucose results in increased expression of JUNB mRNA CTD PMID:17178593 NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
JBrowse link
G Kat6b lysine acetyltransferase 6B multiple interactions ISO [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA CTD PMID:22951486 NCBI chr15:2,638,885...2,811,977
Ensembl chr15:2,639,200...2,812,316
JBrowse link
G Kcnd2 potassium voltage-gated channel subfamily D member 2 increases import
multiple interactions
ISO KCND2 protein results in increased import of Glucose
[[FAM66C mRNA binds to and results in decreased expression of MIR23 mRNA] which results in increased expression of KCND2 protein] which results in increased import of Glucose; [[MIR23B mRNA binds to KCND2 3' UTR] which results in decreased expression of KCND2 protein] which results in decreased import of Glucose
CTD PMID:34418280 NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
JBrowse link
G Kcng1 potassium voltage-gated channel modifier subfamily G member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KCNG1 mRNA CTD PMID:37567420 NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:156,973,156...156,992,635
JBrowse link
G Kcng3 potassium voltage-gated channel modifier subfamily G member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of KCNG3 mRNA CTD PMID:37567420 NCBI chr 6:11,051,311...11,099,264
Ensembl chr 6:11,051,134...11,099,264
JBrowse link
G Kcnh1 potassium voltage-gated channel subfamily H member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of KCNH1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KCNH1 mRNA CTD PMID:37567420 NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions
decreases expression
decreases activity
ISO
EXP
[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein; alpha-Tocopherol inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Deoxyglucose inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Deoxyglucose promotes the reaction [Glucose deficiency results in decreased activity of KCNH2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Pyruvic Acid inhibits the reaction [[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein]; Sodium Cyanide inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]
Glucose results in decreased expression of KCNH2 protein
Glucose deficiency results in decreased activity of KCNH2 protein; Glucose results in decreased activity of KCNH2 protein
CTD PMID:12531891 PMID:31729781 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
JBrowse link
G Kcnh6 potassium voltage-gated channel subfamily H member 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KCNH6 mRNA CTD PMID:37567420 NCBI chr10:90,949,240...90,970,746
Ensembl chr10:90,949,846...90,970,701
JBrowse link
G Kcnip2 potassium voltage-gated channel interacting protein 2 decreases expression
multiple interactions
increases methylation
ISO Glucose results in decreased expression of KCNIP2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of KCNIP2 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of KCNIP2 mRNA]; fucoxanthin inhibits the reaction [Glucose results in increased methylation of KCNIP2 gene]
Glucose results in increased methylation of KCNIP2 gene; Glucose results in increased methylation of KCNIP2 promoter
CTD PMID:31525975 PMID:33448797 PMID:37567420 NCBI chr 1:244,641,147...244,664,939
Ensembl chr 1:244,641,150...244,664,874
JBrowse link
G Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15 increases expression ISO Glucose results in increased expression of KCNJ15 mRNA CTD PMID:31525975 NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; NS 1619 inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; Tamoxifen inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tetraethylammonium promotes the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of KCNMA1 mRNA
CTD PMID:21413024 PMID:37567420 NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
JBrowse link
G Kcnmb1 potassium calcium-activated channel subfamily M regulatory beta subunit 1 multiple interactions ISO Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; NS 1619 inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; Tamoxifen inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]]; Tetraethylammonium promotes the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]] CTD PMID:21413024 NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
JBrowse link
G Kcnmb3 potassium calcium-activated channel subfamily M regulatory beta subunit 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KCNMB3 mRNA CTD PMID:37567420 NCBI chr 2:115,255,788...115,270,142
Ensembl chr 2:115,253,761...115,270,142
JBrowse link
G Kcnn2 potassium calcium-activated channel subfamily N member 2 decreases expression
multiple interactions
ISO Glucose results in decreased expression of KCNN2 protein
FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein]
CTD PMID:30635400 NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
JBrowse link
G Kctd8 potassium channel tetramerization domain containing 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KCTD8 mRNA CTD PMID:37567420 NCBI chr14:38,773,274...39,018,182
Ensembl chr14:38,773,634...39,017,554
JBrowse link
G Kdm1a lysine demethylase 1A multiple interactions EXP KDM1A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
JBrowse link
G Kdm1b lysine demethylase 1B multiple interactions ISO [Glucose co-treated with INS1 protein] affects the expression of KDM1B mRNA CTD PMID:22951486 NCBI chr17:17,602,961...17,643,865
Ensembl chr17:17,602,961...17,643,800
JBrowse link
G Kdm4b lysine demethylase 4B multiple interactions ISO [Glucose co-treated with INS1 protein] affects the expression of KDM4B mRNA CTD PMID:22951486 NCBI chr 9:1,158,737...1,237,233
Ensembl chr 9:1,158,752...1,236,543
JBrowse link
G Kdr kinase insert domain receptor multiple interactions
increases expression
decreases expression
ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of KDR protein
Glucose results in increased expression of KDR mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of KDR mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of KDR mRNA]
Glucose results in decreased expression of KDR mRNA
CTD PMID:19228841 PMID:31655124 PMID:33962019 NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 multiple interactions
increases expression
ISO
EXP
[NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose
solanesol inhibits the reaction [Glucose results in increased expression of KEAP1 mRNA]; solanesol inhibits the reaction [Glucose results in increased expression of KEAP1 protein]
Glucose results in increased expression of KEAP1 mRNA; Glucose results in increased expression of KEAP1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]
CTD PMID:23017736 PMID:35191607 PMID:37586544 NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
JBrowse link
G Kif19b kinesin family member 19B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of KIF19B mRNA CTD PMID:37567420 NCBI chr12:14,144,163...14,196,259
Ensembl chr12:14,144,118...14,193,648
JBrowse link
G Kif1a kinesin family member 1A increases expression EXP Glucose results in increased expression of KIF1A protein CTD PMID:23776493 NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480
JBrowse link
G Kif20b kinesin family member 20B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of KIF20B mRNA CTD PMID:37567420 NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
JBrowse link
G Kif27 kinesin family member 27 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KIF27 mRNA CTD PMID:37567420 NCBI chr17:6,299,544...6,375,106
Ensembl chr17:6,299,569...6,369,768
JBrowse link
G Kif4a kinesin family member 4A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KIF4 mRNA CTD PMID:37567420 NCBI chr  X:65,721,746...65,824,277
Ensembl chr  X:65,721,779...65,824,139
JBrowse link
G Kif5b kinesin family member 5B decreases expression EXP Glucose results in decreased expression of KIF5B protein CTD PMID:23776493 NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression ISO Glucose results in decreased expression of KIT mRNA CTD PMID:31655124 NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
JBrowse link
G Klf10 KLF transcription factor 10 multiple interactions
increases expression
ISO Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]]
Glucose results in increased expression of KLF10 mRNA
CTD PMID:17178593 PMID:19225232 NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
JBrowse link
G Klf13 KLF transcription factor 13 multiple interactions EXP [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of KLF13 mRNA CTD PMID:29122578 NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227
JBrowse link
G Klf6 KLF transcription factor 6 increases expression ISO Glucose results in increased expression of KLF6 mRNA CTD PMID:17178593 NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
JBrowse link
G Klf9 KLF transcription factor 9 increases expression ISO Glucose results in increased expression of KLF9 mRNA CTD PMID:17178593 NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
JBrowse link
G Klkb1 kallikrein B1 increases expression ISO Glucose results in increased expression of KLKB1 mRNA CTD PMID:31525975 NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
JBrowse link
G Klrd1 killer cell lectin like receptor D1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KLRD1 mRNA CTD PMID:37567420 NCBI chr 4:163,044,920...163,056,568
Ensembl chr 4:163,045,067...163,056,518
JBrowse link
G Klrg1 killer cell lectin like receptor G1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KLRG1 mRNA CTD PMID:37567420 NCBI chr 4:155,455,465...155,467,301
Ensembl chr 4:155,455,495...155,467,424
JBrowse link
G Knl1 kinetochore scaffold 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
JBrowse link
G Krt17 keratin 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA CTD PMID:37567420 NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
JBrowse link
G Krt20 keratin 20 multiple interactions
decreases expression
ISO [Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 mRNA]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of KRT20 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT20 mRNA
Glucose results in decreased expression of KRT20 mRNA; Glucose results in decreased expression of KRT20 protein
CTD PMID:21829520 PMID:37567420 NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
JBrowse link
G Krt5 keratin 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT5 mRNA CTD PMID:37567420 NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
JBrowse link
G Kynu kynureninase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KYNU mRNA CTD PMID:37567420 NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
JBrowse link
G Lamb1 laminin subunit beta 1 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA] CTD PMID:17178593 NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
JBrowse link
G Lamb2 laminin subunit beta 2 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMB2 mRNA] CTD PMID:17178593 NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
JBrowse link
G Lamb3 laminin subunit beta 3 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMB3 mRNA] CTD PMID:17178593 NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
JBrowse link
G Lamc1 laminin subunit gamma 1 multiple interactions ISO TXNIP promotes the reaction [Glucose results in increased expression of LAMC1 mRNA] CTD PMID:17178593 NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 increases expression EXP Glucose results in increased expression of LAMP1 protein CTD PMID:22253932 NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein CTD PMID:21392095 NCBI chr  X:117,173,097...117,222,090
Ensembl chr  X:117,057,606...117,260,522
JBrowse link
G Lax1 lymphocyte transmembrane adaptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of LAX1 mRNA CTD PMID:37567420 NCBI chr13:45,134,825...45,145,381
Ensembl chr13:45,134,834...45,145,381
JBrowse link
G Lca5l lebercilin LCA5 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LCA5L mRNA CTD PMID:37567420 NCBI chr11:35,460,646...35,495,133
Ensembl chr11:35,461,118...35,495,047
JBrowse link
G Lcn2 lipocalin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LCN2 mRNA CTD PMID:37567420 NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
JBrowse link
G Lct lactase multiple interactions
increases hydrolysis
EXP [Aspirin results in decreased activity of LCT protein] which results in decreased transport of Glucose; [nimesulide results in decreased activity of LCT protein] which results in decreased transport of Glucose
LCT protein results in increased hydrolysis of Glucose
CTD PMID:14701853 PMID:16382204 NCBI chr13:39,781,929...39,824,456
Ensembl chr13:39,781,929...39,824,456
JBrowse link
G Ldha lactate dehydrogenase A multiple interactions
increases activity
increases expression
EXP
ISO
LDHA protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in increased activity of LDHA protein
Glucose affects the reaction [Fusaric Acid results in increased expression of LDHA mRNA]; Panax notoginseng extract inhibits the reaction [Glucose results in increased activity of LDHA protein]
Glucose results in increased expression of LDHA protein
CTD PMID:21124846 PMID:27566995 PMID:31654802 PMID:35385194 NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
JBrowse link
G Ldhb lactate dehydrogenase B affects metabolic processing ISO LDHB protein affects the metabolism of Glucose CTD PMID:23437403 NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
JBrowse link
G Ldhd lactate dehydrogenase D increases expression ISO Glucose results in increased expression of LDHD mRNA CTD PMID:31525975 NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions ISO [LDLR gene mutant form results in increased susceptibility to Pravastatin] inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:26875785 NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 increases expression
multiple interactions
ISO Glucose results in increased expression of LEF1 mRNA
DKK1 protein inhibits the reaction [Glucose results in increased expression of LEF1 mRNA]
CTD PMID:29163160 NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
JBrowse link
G Lep leptin multiple interactions
increases secretion
increases expression
increases response to substance
ISO
EXP
Glucose promotes the reaction [LEP protein results in increased chemical synthesis of Reactive Oxygen Species]; LEP protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LEP mRNA; [LEP gene mutant form results in increased susceptibility to [Methionine co-treated with Choline]] which results in decreased abundance of Glucose
Glucose results in increased secretion of LEP protein
Glucose results in increased expression of LEP mRNA; Glucose results in increased expression of LEP protein
Glucose results in increased susceptibility to LEP protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; [[Glucose co-treated with INS1 protein] results in increased abundance of Adenosine Triphosphate] which results in increased secretion of LEP protein; [Glucose co-treated with INS1 protein] results in increased secretion of LEP protein; argan oil inhibits the reaction [Glucose results in increased expression of LEP protein]; Calcium deficiency inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of LEP protein]; Diazoxide inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; INS1 protein promotes the reaction [Glucose results in increased expression of LEP mRNA]; INS1 protein promotes the reaction [Glucose results in increased secretion of LEP protein]; LEP promotes the reaction [Glucose results in increased secretion of INS1 protein]; naringin inhibits the reaction [Glucose results in increased expression of LEP protein]; nickel chloride inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]
CTD PMID:9751766 PMID:10780946 PMID:11342529 PMID:18627777 PMID:24399619 More... NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
JBrowse link
G Lepr leptin receptor affects abundance
increases expression
multiple interactions
decreases response to substance
ISO
EXP
LEPR affects the abundance of Glucose; LEPR protein affects the abundance of Glucose
Glucose results in increased expression of LEPR protein
naringin inhibits the reaction [Glucose results in increased expression of LEPR protein]
Hesperidin affects the reaction [LEPR protein affects the abundance of Glucose]; naringin affects the reaction [LEPR protein affects the abundance of Glucose]
LEPR results in decreased susceptibility to Glucose
CTD PMID:16427799 PMID:20567778 PMID:24399619 NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
JBrowse link
G Lgals3bp galectin 3 binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
JBrowse link
G Lif LIF, interleukin 6 family cytokine multiple interactions
increases expression
ISO [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]
Glucose results in increased expression of LIF mRNA
CTD PMID:17178593 PMID:19225232 NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
JBrowse link
G Lin7b lin-7 homolog B, crumbs cell polarity complex component multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LIN7B mRNA CTD PMID:37567420 NCBI chr 1:95,846,888...95,849,628
Ensembl chr 1:95,846,243...95,849,977
JBrowse link
G Lipg lipase G, endothelial type decreases expression ISO Glucose results in decreased expression of LIPG mRNA CTD PMID:17178593 NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
JBrowse link
G Lipn lipase, family member N increases expression ISO Glucose results in increased expression of LIPN mRNA CTD PMID:31525975 NCBI chr 1:231,584,950...231,603,456
Ensembl chr 1:231,584,956...231,603,468
JBrowse link
G Llcfc1 LLLL and CFNLAS motif containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LLCFC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LLCFC1 mRNA CTD PMID:37567420 NCBI chr 4:70,566,206...70,567,592
Ensembl chr 4:70,566,295...70,567,586
JBrowse link
G Lmod3 leiomodin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of LMOD3 mRNA CTD PMID:37567420 NCBI chr 4:129,843,964...129,858,684
Ensembl chr 4:129,843,970...129,858,244
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial multiple interactions
decreases expression
EXP LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein]]; LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of LONP1 protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of LONP1 protein] CTD PMID:31639451 NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
JBrowse link
G Lpcat1 lysophosphatidylcholine acyltransferase 1 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of LPCAT1 mRNA] CTD PMID:33448797 NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
JBrowse link
G Lpl lipoprotein lipase decreases activity
multiple interactions
ISO Glucose analog results in decreased activity of LPL protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of LPL mRNA
LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose]
CTD PMID:9414485 PMID:20628023 PMID:37567420 NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
JBrowse link
G Lrch4 leucine rich repeats and calponin homology domain containing 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA CTD PMID:37567420 NCBI chr12:19,057,582...19,072,573
Ensembl chr12:19,057,587...19,068,577
JBrowse link
G Lrrc26 leucine rich repeat containing 26 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRC26 mRNA CTD PMID:37567420 NCBI chr 3:8,102,361...8,103,687
Ensembl chr 3:8,102,361...8,103,687
JBrowse link
G Lrrc3b leucine rich repeat containing 3B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRC3B mRNA CTD PMID:37567420 NCBI chr15:9,973,580...10,050,891
Ensembl chr15:9,969,983...10,051,066
JBrowse link
G Lrrc61 leucine rich repeat containing 61 decreases methylation
multiple interactions
increases expression
ISO Glucose results in decreased methylation of LRRC61 gene
fucoxanthin inhibits the reaction [Glucose results in increased expression of LRRC61 mRNA]
CTD PMID:33448797 NCBI chr 4:77,503,882...77,523,909
Ensembl chr 4:77,503,857...77,524,020
JBrowse link
G Lrrn2 leucine rich repeat neuronal 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA CTD PMID:37567420 NCBI chr13:44,321,944...44,382,454
Ensembl chr13:44,321,364...44,382,482
JBrowse link
G LRRTM1 leucine rich repeat transmembrane neuronal 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRRTM1 mRNA CTD PMID:37567420 NCBI chr 4:109,701,815...109,718,924
Ensembl chr 4:109,701,815...109,717,184
JBrowse link
G Lst1 leukocyte specific transcript 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LST1 mRNA CTD PMID:37567420 NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
JBrowse link
G Ltc4s leukotriene C4 synthase multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of LTC4S mRNA] CTD PMID:33448797 NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
JBrowse link
G Ly6a lymphocyte antigen 6 family member A increases expression ISO Glucose results in increased expression of LY6A mRNA CTD PMID:17178593 NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
JBrowse link
G Mafa MAF bZIP transcription factor A multiple interactions
affects expression
increases expression
ISO
EXP
3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; 3-aminobenzamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]; Niacinamide inhibits the reaction [Glucose inhibits the reaction [MAFA protein binds to INS promoter]]
Glucose affects the expression of MAFA mRNA
3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in decreased expression of MAFA mRNA]; 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Glucose results in decreased expression of MAFA protein]; 3-aminobenzamide inhibits the reaction [Glucose results in decreased expression of MAFA mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in decreased expression of MAFA protein]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]
IL1B protein inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; Palmitic Acid inhibits the reaction [Glucose results in increased expression of MAFA mRNA]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]]
CTD PMID:16505238 PMID:22558381 PMID:24349266 NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
JBrowse link
G Maff MAF bZIP transcription factor F increases expression ISO Glucose results in increased expression of MAFF mRNA CTD PMID:17178593 NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
JBrowse link
G Magt1 magnesium transporter 1 decreases expression ISO Glucose results in decreased expression of MAGT1 mRNA CTD PMID:17178593 NCBI chr  X:71,038,489...71,079,704
Ensembl chr  X:71,038,489...71,079,699
JBrowse link
G Mak male germ cell-associated kinase decreases expression
multiple interactions
ISO Glucose results in decreased expression of MAK mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAK mRNA]
CTD PMID:33448797 NCBI chr17:23,683,753...23,731,125
Ensembl chr17:23,693,878...23,730,001
JBrowse link
G Mall mal, T-cell differentiation protein-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MALL mRNA CTD PMID:37567420 NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
JBrowse link
G Mamdc2 MAM domain containing 2 decreases expression
multiple interactions
increases methylation
ISO Glucose results in decreased expression of MAMDC2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]
Glucose results in increased methylation of MAMDC2 gene
CTD PMID:31525975 PMID:33448797 NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
JBrowse link
G Maob monoamine oxidase B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of MAOB mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MAOB mRNA CTD PMID:37567420 NCBI chr  X:5,907,327...6,010,996
Ensembl chr  X:5,907,266...6,011,003
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
decreases lipidation
increases expression
decreases expression
EXP
ISO
3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]; Inositol inhibits the reaction [Glucose results in decreased lipidation of MAP1LC3B protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]; ULK1 protein affects the reaction [Glucose results in decreased expression of MAP1LC3B protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]
Glucose deficiency results in increased expression of MAP1LC3B protein; Glucose deficiency results in increased expression of MAP1LC3B protein modified form
U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form]
CTD PMID:29128638 PMID:34580807 PMID:35243728 NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 multiple interactions ISO [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 increases expression
multiple interactions
ISO Glucose results in increased expression of MAP3K1 mRNA
[MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose
resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA]
CTD PMID:24659233 PMID:27278863 NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
JBrowse link
G Map3k13 mitogen-activated protein kinase kinase kinase 13 increases methylation
multiple interactions
decreases expression
ISO Glucose results in increased methylation of MAP3K13 gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAP3K13 mRNA]
CTD PMID:33448797 NCBI chr11:79,094,087...79,235,181
Ensembl chr11:79,097,247...79,235,181
JBrowse link
G Map3k4 mitogen activated protein kinase kinase kinase 4 increases expression
multiple interactions
ISO Glucose results in increased expression of MAP3K4 mRNA
resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K4 mRNA]
CTD PMID:24659233 NCBI chr 1:48,431,801...48,519,358
Ensembl chr 1:48,431,830...48,519,358
JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions
increases expression
ISO Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein
Glucose results in increased expression of MAP3K5 protein
CTD PMID:14505347 PMID:16731828 PMID:26660634 NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases activity
increases phosphorylation
multiple interactions
affects phosphorylation
increases expression
decreases phosphorylation
ISO
EXP
Glucose deficiency results in increased activity of MAPK1 protein
Glucose results in increased phosphorylation of MAPK1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; EUK-134 inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]]; Glucose deficiency results in increased expression of and results in increased phosphorylation of MAPK1 protein; Glucose promotes the reaction [Bupivacaine results in increased phosphorylation of MAPK1 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Quercetin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]
Glucose affects the phosphorylation of MAPK1 protein
Glucose results in increased expression of MAPK1 protein modified form
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK1 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK1 protein modified form; cinnamaldehyde inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; farrerol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]; MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Quercetin promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Superoxides affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Glucose results in increased expression of MAPK1 protein modified form]; U 0126 inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK1 protein modified form]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK1 protein]; Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]; Silymarin promotes the reaction [Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]
Glucose results in decreased phosphorylation of MAPK1 protein
CTD PMID:14711829 PMID:16572112 PMID:17309078 PMID:18057711 PMID:18310510 More... NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions
decreases phosphorylation
increases activity
ISO CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 mRNA]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of SNAI1 mRNA]; MAPK14 protein promotes the reaction [Glucose results in increased expression of VIM mRNA]; MAPK14 protein promotes the reaction [Glucose results in increased secretion of FN1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]
[resveratrol co-treated with Glucose] results in decreased expression of MAPK14 mRNA; Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein]
Glucose results in decreased phosphorylation of MAPK14 protein
CTD PMID:17309078 PMID:18973755 PMID:20200188 PMID:21829520 PMID:24659233 NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases activity
increases phosphorylation
multiple interactions
increases expression
affects phosphorylation
decreases phosphorylation
ISO
EXP
Glucose deficiency results in increased activity of MAPK3 protein
Glucose results in increased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]; Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; EUK-134 inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]]; Glucose deficiency results in increased expression of and results in increased phosphorylation of MAPK3 protein; Glucose promotes the reaction [Bupivacaine results in increased phosphorylation of MAPK3 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Quercetin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]
Glucose results in increased expression of MAPK3 protein modified form
Glucose affects the phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK3 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK3 protein modified form; cinnamaldehyde inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; diphenyliodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; farrerol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]; MAPK3 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Quercetin promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Superoxides affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Glucose results in increased expression of MAPK3 protein modified form]; U 0126 inhibits the reaction [Quercetin promotes the reaction [Glucose results in increased expression of MAPK3 protein modified form]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK3 protein]; Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]; Silymarin promotes the reaction [Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]
Glucose results in decreased phosphorylation of MAPK3 protein
CTD PMID:14711829 PMID:16572112 PMID:17309078 PMID:18057711 PMID:18310510 More... NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
ISO
EXP
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]]; Glucose deficiency results in increased activity of and results in increased phosphorylation of MAPK8 protein; rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]
[[Paraquat results in increased phosphorylation of MAPK8 protein] which results in decreased abundance of Insulin] which results in increased abundance of Glucose; Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]
CTD PMID:14505347 PMID:19861503 PMID:34801538 PMID:36394833 PMID:36928891 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases phosphorylation EXP Glucose results in increased phosphorylation of MAPK9 protein CTD PMID:19861503 NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
JBrowse link
G Mas1 MAS1 proto-oncogene, G protein-coupled receptor decreases expression
multiple interactions
EXP
ISO
Glucose results in decreased expression of MAS1 mRNA
NFE2L2 protein affects the reaction [Glucose results in decreased expression of MAS1 mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of MAS1 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of MAS1 mRNA]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of MAS1 protein]
CTD PMID:29211853 PMID:29266779 NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
JBrowse link
G Mcub mitochondrial calcium uniporter dominant negative subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA CTD PMID:37567420 NCBI chr 2:218,479,301...218,549,594
Ensembl chr 2:218,479,301...218,549,593
JBrowse link
G Mdh1 malate dehydrogenase 1 increases expression EXP
ISO
Glucose results in increased expression of MDH1 mRNA
Glucose deficiency results in increased expression of MDH1 mRNA
CTD PMID:24349266 PMID:26811028 NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
JBrowse link
G Mdk midkine increases expression ISO Glucose results in increased expression of MDK protein CTD PMID:17607302 NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MEIG1 mRNA CTD PMID:37567420 NCBI chr17:74,810,791...74,828,433
Ensembl chr17:74,814,632...74,828,433
JBrowse link
G Meiob meiosis specific with OB-fold multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MEIOB mRNA CTD PMID:37567420 NCBI chr10:13,833,170...13,865,684
Ensembl chr10:13,833,750...13,865,046
JBrowse link
G Mesp2 mesoderm posterior bHLH transcription factor 2 decreases expression
multiple interactions
ISO Glucose results in decreased expression of MESP2 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MESP2 mRNA
CTD PMID:31525975 PMID:37567420 NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
JBrowse link
G Mfap3 microfibril associated protein 3 multiple interactions EXP MFAP3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:41,696,788...41,711,490
Ensembl chr10:41,696,771...41,710,406
JBrowse link
G Mfap4 microfibril associated protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MFAP4 mRNA CTD PMID:37567420 NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
JBrowse link
G Mfap5 microfibril associated protein 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MFAP5 mRNA CTD PMID:37567420 NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:155,727,925...155,750,458
JBrowse link
G Mff mitochondrial fission factor increases expression
multiple interactions
ISO Glucose results in increased expression of MFF mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of MFF mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of MFF mRNA]
CTD PMID:33962019 NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
JBrowse link
G Mfn1 mitofusin 1 decreases expression EXP
ISO
Glucose results in decreased expression of MFN1 protein
Glucose results in decreased expression of MFN1 mRNA
CTD PMID:27684054 PMID:33962019 NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
JBrowse link
G Mfn2 mitofusin 2 multiple interactions
decreases expression
increases expression
EXP
ISO
cinnamic acid inhibits the reaction [Glucose results in decreased expression of MFN2 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of MFN2 protein]; Oxygen deficiency inhibits the reaction [Glucose results in increased expression of MFN2 protein]; Sevoflurane inhibits the reaction [Oxygen deficiency inhibits the reaction [Glucose results in increased expression of MFN2 protein]]
[Glucose co-treated with Deferoxamine] results in decreased expression of MFN2 mRNA; Melatonin affects the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of MFN2 mRNA]
CTD PMID:27684054 PMID:30144576 PMID:33962019 NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MFSD2A mRNA CTD PMID:37567420 NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
JBrowse link
G Mfsd3 major facilitator superfamily domain containing 3 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of MFSD3 mRNA] CTD PMID:33448797 NCBI chr 7:108,419,644...108,423,469
Ensembl chr 7:108,421,350...108,423,461
JBrowse link
G Mgam maltase-glucoamylase multiple interactions ISO [MGAM protein results in increased metabolism of maltodextrin] which results in increased abundance of Glucose; [MGAM protein results in increased metabolism of Maltose] which results in increased abundance of Glucose CTD PMID:17585022 NCBI chr 4:69,441,626...69,602,068
Ensembl chr 4:69,446,150...69,692,715
JBrowse link
G Miat myocardial infarction associated transcript multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MIAT mRNA CTD PMID:37567420 NCBI chr12:44,414,620...44,429,852 JBrowse link
G Mief2 mitochondrial elongation factor 2 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of MIEF2 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of MIEF2 mRNA] CTD PMID:33962019 NCBI chr10:45,408,055...45,414,144
Ensembl chr10:45,408,082...45,414,144
JBrowse link
G Mir133a1 microRNA 133a-1 increases expression
multiple interactions
ISO Glucose results in increased expression of MIR133A1 mRNA
MIR133A1 affects the reaction [Glucose results in decreased chemical synthesis of INS protein]
CTD PMID:20520763 NCBI chr18:1,885,082...1,885,168 JBrowse link
G Mir135a microRNA 135a multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MIR135A mRNA; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein] CTD PMID:29719095 NCBI chr 7:26,611,990...26,612,089
Ensembl chr 7:26,611,990...26,612,089
JBrowse link
G Mir141 microRNA 141 increases expression ISO Glucose results in increased expression of MIR141 mRNA CTD PMID:26548909 NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
JBrowse link
G Mir144 microRNA 144 multiple interactions ISO [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MIR144 mRNA; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein] CTD PMID:29457851 NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
JBrowse link
G Mir145 microRNA 145 increases expression ISO Glucose results in increased expression of MIR145 mRNA CTD PMID:24223694 NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
JBrowse link
G Mir146a microRNA 146a increases expression
decreases expression
multiple interactions
ISO Glucose results in increased expression of MIR146A mRNA
Glucose results in decreased expression of MIR146 mRNA
Polyphenols inhibits the reaction [Glucose results in increased expression of MIR146A mRNA]
CTD PMID:20520763 PMID:21682256 NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
JBrowse link
G Mir148a microRNA 148a decreases expression ISO Glucose results in decreased expression of MIR148A mRNA CTD PMID:21682256 NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
JBrowse link
G Mir17 microRNA 17 decreases expression
multiple interactions
ISO Glucose results in decreased expression of MIR17 mRNA
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA; [Glucose results in decreased expression of MIR17 mRNA] which results in increased stability of TXNIP protein
CTD PMID:26660634 NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
JBrowse link
G Mir184 microRNA 184 increases expression EXP Glucose results in increased expression of MIR184 mRNA CTD PMID:31729781 NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
JBrowse link
G Mir186 microRNA 186 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of MIR186 mRNA; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] CTD PMID:33759271 NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
JBrowse link
G Mir195 microRNA 195 increases expression EXP Glucose results in increased expression of MIR195 mRNA CTD PMID:31729781 NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
JBrowse link
G Mir200a microRNA 200a decreases expression ISO Glucose results in decreased expression of MIR200A mRNA CTD PMID:23776576 NCBI chr 5:166,648,494...166,648,582 JBrowse link
G Mir200b microRNA 200b decreases expression ISO Glucose results in decreased expression of MIR200B mRNA CTD PMID:23776576 NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
JBrowse link
G Mir200c microRNA 200c increases expression
multiple interactions
ISO Glucose results in increased expression of MIR200C mRNA
MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]; MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]]
CTD PMID:35607288 NCBI chr 4:157,523,679...157,523,747 JBrowse link
G Mir210 microRNA 210 multiple interactions
increases expression
ISO
EXP
MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; MIR210 mRNA results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
Glucose results in increased expression of MIR210 mRNA
CTD PMID:23108914 PMID:31729781 NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
JBrowse link
G Mir217 microRNA 217 multiple interactions
decreases expression
increases expression
EXP
ISO
MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of EDN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of HIF1A protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of TGFB1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of VEGFA protein]
MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL1B protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of IL6 protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of TNF protein]
Glucose results in decreased expression of MIR217 mRNA
Glucose results in increased expression of MIR217 mRNA
CTD PMID:26891083 PMID:33283391 NCBI chr14:102,531,505...102,531,609
Ensembl chr14:102,531,505...102,531,609
JBrowse link
G Mir23b microRNA 23b decreases import
multiple interactions
ISO MIR23B mRNA results in decreased import of Glucose
[[MIR23B mRNA binds to KCND2 3' UTR] which results in decreased expression of KCND2 protein] which results in decreased import of Glucose
CTD PMID:34418280 NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
JBrowse link
G Mir27b microRNA 27b multiple interactions ISO MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]] CTD PMID:36243327 NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
JBrowse link
G Mir29a microRNA 29a multiple interactions EXP MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 mRNA]; MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 protein] CTD PMID:30642005 NCBI chr 4:59,650,608...59,650,695 JBrowse link
G Mir32 microRNA 32 decreases expression EXP Glucose results in decreased expression of MIR32 mRNA CTD PMID:31729781 NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
JBrowse link
G Mir322 microRNA 322 decreases expression
multiple interactions
ISO Glucose results in decreased expression of MIR322
MIR322 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; tempol inhibits the reaction [Glucose results in decreased expression of MIR322]
CTD PMID:25516495 NCBI chr  X:132,806,594...132,806,688
Ensembl chr  X:132,806,594...132,806,688
JBrowse link
G Mir331 microRNA 331 increases expression EXP Glucose results in increased expression of MIR331 mRNA CTD PMID:31729781 NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
JBrowse link
G Mir3588 microRNA 3588 decreases expression EXP Glucose results in decreased expression of MIR3588 mRNA CTD PMID:31729781 NCBI chr11:16,245,611...16,245,716
Ensembl chr11:16,245,611...16,245,716
JBrowse link
G Mir484 microRNA 484 increases expression EXP Glucose results in increased expression of MIR484 mRNA CTD PMID:31729781 NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
JBrowse link
G Mir503 microRNA 503 increases expression EXP Glucose results in increased expression of MIR503 mRNA CTD PMID:31729781 NCBI chr  X:132,806,303...132,806,373
Ensembl chr  X:132,806,303...132,806,373
JBrowse link
G Mir6216 microRNA 6216 increases expression EXP Glucose results in increased expression of MIR6216 mRNA CTD PMID:31729781 NCBI chr 3:44,756,861...44,756,938
Ensembl chr 3:44,756,861...44,756,938
JBrowse link
G Mir99a microRNA 99a multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MIR99A mRNA CTD PMID:37567420 NCBI chr11:16,200,443...16,200,523
Ensembl chr11:16,200,443...16,200,523
JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions ISO [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA
CTD PMID:25192544 PMID:37567420 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
JBrowse link
G Mlx MAX dimerization protein MLX multiple interactions ISO Glucose promotes the reaction [MLX protein binds to TUG1 promoter] CTD PMID:32467232 NCBI chr10:86,019,216...86,024,326
Ensembl chr10:86,019,588...86,032,350
JBrowse link
G Mlxip MLX interacting protein multiple interactions
affects localization
ISO Glucose promotes the reaction [MLXIP protein binds to TUG1 promoter]
Glucose affects the localization of MLXIP protein
pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose affects the localization of MLXIP protein]; RELA protein affects the reaction [Glucose affects the localization of MLXIP protein]; SRI protein inhibits the reaction [Glucose affects the localization of MLXIP protein]
CTD PMID:32467232 PMID:33930463 NCBI chr12:33,128,524...33,192,300
Ensembl chr12:33,128,520...33,192,374
JBrowse link
G Mlxipl MLX interacting protein-like increases expression
multiple interactions
EXP
ISO
Glucose results in increased expression of MLXIPL protein
Glucose results in increased expression of MLXIPL mRNA alternative form
[Glucose co-treated with S 4048] results in increased expression of MLXIPL mRNA; Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter]
CTD PMID:16644726 PMID:16790840 PMID:31974165 PMID:32467232 NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
JBrowse link
G Mme membrane metallo-endopeptidase decreases expression
multiple interactions
ISO Glucose results in decreased expression of MME mRNA
[MME protein results in increased cleavage of angiotensin I (1-7)] affects the reaction [Glucose results in increased secretion of INS1 protein]; MME protein affects the reaction [angiotensin I (1-7) promotes the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:17178593 PMID:28559246 NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions
decreases expression
ISO CD14 protein affects the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]
Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucose inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]
Glucose results in decreased expression of MMP1 mRNA
CTD PMID:18180316 PMID:30098273 PMID:31655124 NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MMP12 mRNA CTD PMID:37567420 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
JBrowse link
G Mmp14 matrix metallopeptidase 14 multiple interactions
decreases expression
ISO isoangustone A inhibits the reaction [Glucose results in decreased expression of MMP14 protein] CTD PMID:21367880 NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
JBrowse link
G Mmp19 matrix metallopeptidase 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MMP19 mRNA CTD PMID:37567420 NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
decreases expression
increases activity
increases expression
ISO
EXP
CEBPB protein inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]; Glucose results in decreased expression of and results in decreased activity of MMP2 protein; Resveratrol inhibits the reaction [Glucose results in increased activity of MMP2 protein]; Valsartan inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]
Glucose results in decreased expression of MMP2 mRNA; Glucose results in decreased expression of MMP2 protein
Glucose promotes the reaction [Air Pollutants results in increased activity of MMP2 protein]; Glucose promotes the reaction [Air Pollutants results in increased expression of MMP2 mRNA]; Glucose promotes the reaction [Particulate Matter results in increased activity of MMP2 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of MMP2 mRNA]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP2 protein]]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP2 protein]]
farrerol inhibits the reaction [Glucose results in decreased expression of MMP2 mRNA]; farrerol inhibits the reaction [Glucose results in decreased expression of MMP2 protein]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of MMP2 mRNA]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of MMP2 protein]
Glucose results in increased expression of MMP2 mRNA; Glucose results in increased expression of MMP2 protein
CTD PMID:18665442 PMID:24659233 PMID:26179980 PMID:29266779 PMID:31838053 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp25 matrix metallopeptidase 25 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MMP25 mRNA CTD PMID:37567420 NCBI chr10:12,661,297...12,676,119
Ensembl chr10:12,661,208...12,675,871
JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MMP7 mRNA CTD PMID:37567420 NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases activity
decreases expression
increases expression
ISO
EXP
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein; [Resveratrol co-treated with Glucose] results in decreased activity of MMP9 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]
Glucose deficiency results in decreased activity of MMP9 protein
Glucose results in decreased expression of MMP9 protein
Glucose results in increased expression of MMP9 mRNA
[Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA; Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]; Glucose promotes the reaction [Air Pollutants results in increased expression of MMP9 mRNA]; Glucose promotes the reaction [JUN protein binds to MMP9 promoter]; Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]; Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]; Glucose promotes the reaction [Particulate Matter results in increased expression of MMP9 mRNA]; Glucose promotes the reaction [RELA protein binds to MMP9 promoter]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of MMP9 mRNA]; PARP1 protein affects the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose results in increased expression of MMP9 mRNA]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]]; SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]]; SIRT1 protein inhibits the reaction [Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]]
[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein]; farrerol inhibits the reaction [Glucose results in decreased expression of MMP9 mRNA]; farrerol inhibits the reaction [Glucose results in decreased expression of MMP9 protein]; Glucose affects the reaction [Azoxymethane affects the expression of MMP9 protein]
CTD PMID:22467055 PMID:24064760 PMID:24659233 PMID:24682241 PMID:26179980 More... NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mnda myeloid cell nuclear differentiation antigen multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFI204 mRNA CTD PMID:37567420 NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
JBrowse link
G Mogat2 monoacylglycerol O-acyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MOGAT2 mRNA CTD PMID:37567420 NCBI chr 1:153,521,813...153,545,756
Ensembl chr 1:153,521,815...153,545,756
JBrowse link
G Morc2 MORC family CW-type zinc finger 2 decreases expression ISO Glucose results in decreased expression of MORC2A mRNA CTD PMID:32467232 NCBI chr14:78,529,603...78,571,375
Ensembl chr14:78,527,009...78,571,343
JBrowse link
G Morf4l2 mortality factor 4 like 2 multiple interactions EXP MORF4L2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr  X:100,082,562...100,093,658
Ensembl chr  X:100,082,404...100,093,728
JBrowse link
G Morn4 MORN repeat containing 4 multiple interactions EXP MORN4 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:240,888,338...240,898,644
Ensembl chr 1:240,888,344...240,898,716
JBrowse link
G Mpo myeloperoxidase multiple interactions
increases expression
EXP
ISO
[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of MPO protein; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of MPO protein]
Glucose results in increased expression of MPO mRNA
CTD PMID:23758074 PMID:32942007 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Mpst mercaptopyruvate sulfurtransferase decreases expression EXP Glucose deficiency results in decreased expression of MPST mRNA CTD PMID:35577173 NCBI chr 7:109,955,581...109,963,155
Ensembl chr 7:109,955,675...109,963,141
JBrowse link
G Mpv17 mitochondrial inner membrane protein MPV17 increases expression ISO Glucose results in increased expression of MPV17 mRNA CTD PMID:32942007 NCBI chr 6:25,221,668...25,236,241
Ensembl chr 6:25,222,896...25,236,244
JBrowse link
G Mpv17l MPV17 mitochondrial inner membrane protein like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MPV17L mRNA CTD PMID:37567420 NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649
JBrowse link
G Mrap melanocortin 2 receptor accessory protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MRAP mRNA CTD PMID:37567420 NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
JBrowse link
G Mras muscle RAS oncogene homolog multiple interactions
increases activity
EXP manumycin inhibits the reaction [Glucose results in increased activity of MRAS protein]; Simvastatin inhibits the reaction [Glucose results in increased activity of MRAS protein] CTD PMID:18569938 NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
JBrowse link
G Mro maestro multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of MRO mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MRO mRNA CTD PMID:37567420 NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
JBrowse link
G Ms4a1 membrane spanning 4-domains A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of MS4A1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MS4A1 mRNA CTD PMID:37567420 NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
JBrowse link
G Ms4a6a membrane spanning 4-domains A6A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA CTD PMID:37567420 NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
JBrowse link
G Msh4 mutS homolog 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MSH4 mRNA CTD PMID:37567420 NCBI chr 2:242,785,392...242,844,609
Ensembl chr 2:242,792,661...242,843,487
JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MSR1 mRNA CTD PMID:37567420 NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676
JBrowse link
G Mt-atp6 mitochondrially encoded ATP synthase membrane subunit 6 affects response to substance EXP ATP6 protein affects the susceptibility to Glucose CTD PMID:18273840 NCBI chr MT:7,919...8,599
NCBI chr MT:7,919...8,599
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of COX1 protein CTD PMID:25997894 NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
JBrowse link
G Mt-co2 mitochondrially encoded cytochrome c oxidase II increases expression ISO Glucose deficiency results in increased expression of COX2 mRNA CTD PMID:26811028 NCBI chr MT:7,006...7,689
NCBI chr MT:7,006...7,689
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
JBrowse link
G Mt-cyb mitochondrially encoded cytochrome b multiple interactions
decreases expression
ISO N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in decreased expression of CYTB mRNA]; PARP1 protein affects the reaction [Glucose results in decreased expression of CYTB mRNA] CTD PMID:28478229 NCBI chr MT:14,136...15,278
NCBI chr MT:14,136...15,278
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
JBrowse link
G Mt1 metallothionein 1 increases expression
multiple interactions
affects expression
EXP Glucose results in increased expression of MT1A mRNA
manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of MT1A mRNA]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of MT1A mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of MT1A mRNA]
CTD PMID:22643931 PMID:23056475 NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
JBrowse link
G Mt2A metallothionein 2A multiple interactions
increases expression
EXP N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of MT2A mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of MT2A mRNA] CTD PMID:23056475 NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
JBrowse link
G Mt3 metallothionein 3 decreases expression ISO Glucose results in decreased expression of MT3 mRNA CTD PMID:32942007 NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of MTHFD2 mRNA CTD PMID:37567420 NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
JBrowse link
G Mtm1 myotubularin 1 decreases expression ISO Glucose results in decreased expression of MTM1 mRNA CTD PMID:17178593 NCBI chr 6:488,923...506,882
Ensembl chr 6:488,969...506,860
JBrowse link
G Mtor mechanistic target of rapamycin kinase increases activity
increases phosphorylation
multiple interactions
decreases uptake
increases expression
ISO
EXP
Glucose results in increased activity of MTOR protein
Glucose results in increased phosphorylation of MTOR protein
Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
[Glucose promotes the reaction [MTOR protein binds to YY1 protein]] which results in increased expression of YY1 protein; FOXP1 protein inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
MTOR gene mutant form results in decreased uptake of Glucose
Glucose results in increased expression of MTOR protein; Glucose results in increased expression of MTOR protein modified form
HU 308 inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]; Resveratrol inhibits the reaction [Glucose results in increased activity of MTOR protein]
CTD PMID:19765649 PMID:22561310 PMID:28713934 PMID:29384525 PMID:30459625 More... NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
JBrowse link
G Mtx1 Metaxin 1 increases expression ISO Glucose results in increased expression of MTX1 mRNA CTD PMID:17178593 NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
JBrowse link
G Muc16 mucin 16, cell surface associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MUC16 mRNA CTD PMID:37567420 NCBI chr 8:16,164,531...16,323,126 JBrowse link
G Muc19 mucin 19, oligomeric multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of MUC19 mRNA CTD PMID:37567420 NCBI chr 7:123,017,896...123,139,053
Ensembl chr 7:123,017,896...123,139,053
JBrowse link
G Mx1 MX dynamin like GTPase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MX1 mRNA CTD PMID:37567420 NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
JBrowse link
G Mxd1 max dimerization protein 1 multiple interactions ISO Glucose promotes the reaction [MXD1 protein binds to TUG1 promoter] CTD PMID:32467232 NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
affects expression
ISO
EXP
MYC protein affects the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]
Glucose results in increased expression of MYC protein
manganese(III)-tetrakis(4-benzoic acid)porphyrin affects the reaction [Glucose affects the expression of MYC mRNA]
Glucose affects the reaction [Dexamethasone results in increased expression of MYC mRNA]; Glucose affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC mRNA]
CTD PMID:2558650 PMID:11990355 PMID:22643931 PMID:33992720 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor increases expression
multiple interactions
EXP Glucose results in increased expression of MYD88 protein
artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein]
CTD PMID:30031708 NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
JBrowse link
G Myh1 myosin heavy chain 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MYH1 mRNA CTD PMID:37567420 NCBI chr10:51,885,913...51,909,699
Ensembl chr10:51,885,913...51,946,295
JBrowse link
G Myh15 myosin, heavy chain 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MYH15 mRNA CTD PMID:37567420 NCBI chr11:51,621,924...51,763,037
Ensembl chr11:51,622,413...51,762,971
JBrowse link
G Myh2 myosin heavy chain 2 multiple interactions ISO MYH2 protein affects the reaction [SLC2A4 protein results in increased uptake of Glucose] CTD PMID:18773891 NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
JBrowse link
G Mylk myosin light chain kinase multiple interactions
increases expression
increases uptake
ISO ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose]; ML 9 inhibits the reaction [MYLK protein results in increased uptake of Glucose]
MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK protein]
Glucose results in increased expression of MYLK mRNA; Glucose results in increased expression of MYLK protein
CTD PMID:18773891 PMID:34464088 NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
JBrowse link
G Myo5a myosin VA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MYO5A mRNA CTD PMID:37567420 NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
JBrowse link
G Myo7b myosin VIIb decreases expression
multiple interactions
ISO Glucose results in decreased expression of MYO7B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of MYO7B mRNA]
CTD PMID:31525975 PMID:33448797 NCBI chr18:23,588,307...23,669,841
Ensembl chr18:23,588,307...23,669,809
JBrowse link
G Myom3 myomesin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of MYOM3 mRNA CTD PMID:37567420 NCBI chr 5:147,992,737...148,043,282
Ensembl chr 5:147,992,737...148,043,274
JBrowse link
G Nalcn sodium leak channel, non-selective multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NALCN mRNA CTD PMID:37567420 NCBI chr15:100,398,583...100,741,243
Ensembl chr15:100,398,615...100,741,001
JBrowse link
G Nampt nicotinamide phosphoribosyltransferase decreases expression
multiple interactions
increases secretion
increases expression
ISO Glucose results in decreased expression of NAMPT mRNA
Diazoxide inhibits the reaction [Glucose results in increased secretion of NAMPT protein]; Nifedipine inhibits the reaction [Glucose results in increased secretion of NAMPT protein]
Glucose results in increased expression of NAMPT mRNA
CTD PMID:20068143 PMID:23536823 NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
JBrowse link
G Nanp N-acetylneuraminic acid phosphatase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NANP mRNA CTD PMID:37567420 NCBI chr 3:139,826,549...139,841,655
Ensembl chr 3:139,826,549...139,841,648
JBrowse link
G Napa NSF attachment protein alpha decreases expression ISO Glucose deficiency results in decreased expression of NAPA protein CTD PMID:22314686 NCBI chr 1:76,787,036...76,805,869
Ensembl chr 1:76,786,932...76,805,869
JBrowse link
G Nat2 N-acetyltransferase 2 increases expression
multiple interactions
increases activity
ISO Glucose results in increased expression of NAT2 mRNA; Glucose results in increased expression of NAT2 protein
[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the activity of NAT2 polymorphism] which affects the chemical synthesis of Glucose; [2-amino-3,4-dimethylimidazo(4,5-f)quinoline affects the activity of NAT2 polymorphism] which affects the chemical synthesis of Glucose; [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline affects the activity of NAT2 polymorphism] which affects the chemical synthesis of Glucose
Glucose results in increased activity of NAT2 protein
CTD PMID:36156098 PMID:37423373 NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
JBrowse link
G Nbea neurobeachin decreases expression ISO Glucose results in decreased expression of NBEA mRNA CTD PMID:17178593 NCBI chr 2:139,780,021...140,338,639
Ensembl chr 2:139,780,021...140,340,584
JBrowse link
G Ncapg non-SMC condensin I complex, subunit G multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NCAPG mRNA CTD PMID:37567420 NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions
increases phosphorylation
increases expression
affects localization
ISO
EXP
acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of NCF1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose affects the localization of NCF1 protein]; Glucose results in increased expression of and results in increased activity of NCF1 protein; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of NCF1 protein]; PRKAA1 protein affects the reaction [rosiglitazone inhibits the reaction [Glucose affects the localization of NCF1 protein]]; rosiglitazone inhibits the reaction [Glucose affects the localization of NCF1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NCF1 mRNA
Glucose results in increased phosphorylation of NCF1 protein
Glucose results in increased expression of NCF1 mRNA; Glucose results in increased expression of NCF1 protein
[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of and results in increased phosphorylation of NCF1 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of NCF1 protein]]; Glucose results in increased expression of and results in increased phosphorylation of NCF1 protein; NCF1 protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; NCF1 protein promotes the reaction [Glucose results in increased expression of FN1 protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of NCF1 protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of NCF1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of NCF1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of NCF1 protein]
CTD PMID:12821678 PMID:17320767 PMID:17916771 PMID:18088078 PMID:19878672 More... NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
JBrowse link
G Ncf2 neutrophil cytosolic factor 2 multiple interactions
increases expression
EXP dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of NCF2 protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of NCF2 protein] CTD PMID:26054749 NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
JBrowse link
G Ncf4 neutrophil cytosolic factor 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA CTD PMID:37567420 NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
JBrowse link
G Nckap5 NCK-associated protein 5 increases expression ISO Glucose results in increased expression of NCKAP5 mRNA CTD PMID:31525975 NCBI chr13:37,369,948...38,283,257
Ensembl chr13:37,370,792...38,283,268
JBrowse link
G Ncor1 nuclear receptor co-repressor 1 multiple interactions ISO Glucose promotes the reaction [NCOR1 protein binds to SRI promoter]; NCOR1 protein affects the reaction [Glucose results in decreased expression of SRI protein] CTD PMID:33930463 NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NCR1 mRNA CTD PMID:37567420 NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
JBrowse link
G Ndel1 nudE neurodevelopment protein 1-like 1 increases expression ISO Glucose results in increased expression of NDEL1 mRNA CTD PMID:17178593 NCBI chr10:53,505,628...53,582,025
Ensembl chr10:53,516,491...53,570,907
JBrowse link
G Ndrg2 NDRG family member 2 multiple interactions EXP
ISO
[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of NDRG2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2 protein; NDRG2 protein affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; TP53 protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2]
NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]
CTD PMID:23451161 NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of NDUFB8 protein CTD PMID:25997894 NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
JBrowse link
G Nedd4l NEDD4 like E3 ubiquitin protein ligase decreases phosphorylation EXP Glucose results in decreased phosphorylation of NEDD4L protein CTD PMID:31729781 NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137
JBrowse link
G Nek2 NIMA-related kinase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NEK2 mRNA CTD PMID:37567420 NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
JBrowse link
G Nfe2 nuclear factor, erythroid 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NFE2 mRNA CTD PMID:37567420 NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
JBrowse link
G Nfe2l1 NFE2 like bZIP transcription factor 1 increases expression
multiple interactions
ISO Glucose results in increased expression of NFE2L1 mRNA; Glucose results in increased expression of NFE2L1 protein
benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L1 protein]; Glucose promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein]
CTD PMID:33838154 NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
increases expression
affects localization
decreases expression
affects response to substance
increases localization
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]]; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]]; Particulate Matter inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; solanesol inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; Vehicle Emissions inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]
Glucose results in increased expression of NFE2L2 mRNA; Glucose results in increased expression of NFE2L2 protein
Glucose affects the localization of NFE2L2 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein; diallyl trisulfide promotes the reaction [Glucose results in increased expression of and affects the localization of NFE2L2 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]; Glucose results in increased expression of and affects the localization of NFE2L2 protein; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; Inositol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; NFE2L2 protein affects the reaction [Exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [Glucose results in decreased expression of ACE2 mRNA]; NFE2L2 protein affects the reaction [Glucose results in decreased expression of MAS1 mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of ACE mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of AGT mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of NQO1 mRNA]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]]; Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA]; Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]; trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]
Glucose results in decreased expression of NFE2L2 mRNA; Glucose results in decreased expression of NFE2L2 protein
NFE2L2 protein affects the susceptibility to Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]]; [NFE2L2 protein binds to TXNIP promoter] inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; [NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose; [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of Glucose; NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]]; NFE2L2 protein affects the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; NFE2L2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]
Glucose deficiency results in increased localization of NFE2L2 protein
Glucose deficiency results in increased expression of NFE2L2 mRNA; Glucose deficiency results in increased expression of NFE2L2 protein; Glucose results in increased expression of NFE2L2; Glucose results in increased expression of NFE2L2 mRNA; Glucose results in increased expression of NFE2L2 protein
CTD PMID:17928392 PMID:20028456 PMID:20086057 PMID:20103708 PMID:21333731 More... NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 increases expression
multiple interactions
ISO Glucose results in increased expression of NFKB1 mRNA; Glucose results in increased expression of NFKB1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NFKB1 protein; Glucose results in increased activity of and affects the localization of NFKB1 protein; INO 1001 inhibits the reaction [Glucose results in increased activity of and affects the localization of NFKB1 protein]; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased activity of NFKB1 protein]
[Glucose results in increased susceptibility to sodium arsenite] which results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; Polyphenols inhibits the reaction [Glucose results in increased expression of NFKB1 mRNA]
CTD PMID:16395278 PMID:17065336 PMID:18180316 PMID:21682256 PMID:28264687 More... NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases phosphorylation
increases expression
decreases expression
ISO
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; Glucose results in increased degradation of and results in decreased expression of NFKBIA protein; Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]; SB 203580 inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in decreased expression of NFKBIA protein]; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein; [Glucose co-treated with IGF2R protein modified form] results in decreased expression of NFKBIA protein modified form; Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein; prolinedithiocarbamate inhibits the reaction [Glucose results in decreased expression of NFKBIA protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NFKBIA protein modified form]; Quercetin inhibits the reaction [Glucose results in increased expression of NFKBIA protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; Sulfasalazine inhibits the reaction [Glucose results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Y 27632 inhibits the reaction [Glucose results in decreased expression of NFKBIA protein]
Glucose results in increased expression of NFKBIA protein; Glucose results in increased expression of NFKBIA protein modified form
Glucose results in increased expression of NFKBIA mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of and results in increased degradation of NFKBIA protein; [Ribose co-treated with Glucose] results in increased phosphorylation of NFKBIA protein; acetovanillone inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; INO 1001 inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased phosphorylation of NFKBIA protein]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein]
CTD PMID:16395278 PMID:17065336 PMID:17178593 PMID:19132243 PMID:19557821 More... NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
JBrowse link
G Nfkbid NFKB inhibitor delta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NFKBID mRNA CTD PMID:37567420 NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
JBrowse link
G Ngf nerve growth factor multiple interactions
decreases activity
decreases expression
ISO
EXP
Berberine inhibits the reaction [Glucose results in decreased expression of NGF protein]
Glucose results in decreased activity of NGF protein
CTD PMID:19501110 PMID:23954465 NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
JBrowse link
G Nkd2 NKD inhibitor of WNT signaling pathway 2 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of NKD2 mRNA] CTD PMID:33448797 NCBI chr 1:29,442,898...29,470,839
Ensembl chr 1:29,441,328...29,470,821
JBrowse link
G Nkg7 natural killer cell granule protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NKG7 mRNA CTD PMID:37567420 NCBI chr 1:93,844,748...93,845,975
Ensembl chr 1:93,844,902...93,845,983
JBrowse link
G Nkpd1 NTPase, KAP family P-loop domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of NKPD1 mRNA CTD PMID:37567420 NCBI chr 1:79,165,642...79,175,126
Ensembl chr 1:79,167,130...79,174,234
JBrowse link
G Nkx6-1 NK6 homeobox 1 multiple interactions ISO NKX6-1 protein promotes the reaction [Glucose results in increased secretion of INS protein] CTD PMID:18347054 NCBI chr14:7,969,756...7,976,689
Ensembl chr14:7,969,756...7,976,681
JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NLRC5 mRNA CTD PMID:37567420 NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions
increases response to substance
increases expression
ISO
EXP
[Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of NLRP3 protein]; loganin inhibits the reaction [Glucose results in increased expression of NLRP3 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; pyrrolidine dithiocarbamic acid promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; swietenine inhibits the reaction [Glucose results in increased expression of NLRP3 protein]
NLRP3 protein results in increased susceptibility to Glucose
NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP2 protein]; NLRP3 protein promotes the reaction [Glucose results in increased secretion of HMGB1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of NLRP3 protein]
Glucose results in increased expression of NLRP3 mRNA; Glucose results in increased expression of NLRP3 protein
CTD PMID:23647015 PMID:27783111 PMID:29031534 PMID:30031708 PMID:35191607 More... NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
JBrowse link
G Nmu neuromedin U increases expression
decreases methylation
ISO Glucose results in increased expression of NMU mRNA
Glucose results in decreased methylation of NMU promoter
CTD PMID:31525975 NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
JBrowse link
G Nnt nicotinamide nucleotide transhydrogenase affects response to substance
decreases metabolic processing
ISO NNT protein affects the susceptibility to Glucose
NNT protein results in decreased metabolism of Glucose
CTD PMID:23504317 NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
JBrowse link
G Nobox NOBOX oogenesis homeobox multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NOBOX mRNA CTD PMID:37567420 NCBI chr 4:72,128,931...72,134,436
Ensembl chr 4:72,128,931...72,134,436
JBrowse link
G Nog noggin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of NOG mRNA CTD PMID:37567420 NCBI chr10:74,128,712...74,130,339
Ensembl chr10:74,128,712...74,130,339
JBrowse link
G Nol6 nucleolar protein 6 multiple interactions EXP NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 5:56,259,919...56,270,540
Ensembl chr 5:56,260,830...56,270,336
JBrowse link
G Nono non-POU domain containing, octamer-binding affects metabolic processing ISO NONO gene mutant form affects the metabolism of Glucose CTD PMID:29358041 NCBI chr  X:66,554,131...66,571,992
Ensembl chr  X:66,554,098...66,571,952
JBrowse link
G Nos1 nitric oxide synthase 1 decreases expression
multiple interactions
ISO Glucose deficiency results in decreased expression of NOS1 protein
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS1 protein]
CTD PMID:17855661 NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of NOS2 mRNA; Glucose results in increased expression of NOS2 protein
[Glucose co-treated with IGF2R protein modified form] results in decreased expression of NOS2 protein; [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of NOS2 protein]; [Oxygen co-treated with Glucose] promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of NOS2 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased expression of NOS2 protein]
SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 protein]
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; CDK9 protein affects the reaction [Glucose results in increased expression of NOS2 mRNA]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]
CTD PMID:19587355 PMID:21925195 PMID:22363694 PMID:22425406 PMID:22467055 More... NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nos3 nitric oxide synthase 3 decreases expression
increases expression
multiple interactions
increases O-linked glycosylation
decreases phosphorylation
ISO
EXP
Glucose deficiency results in decreased expression of NOS3 protein; Glucose results in decreased expression of NOS3 mRNA; Glucose results in decreased expression of NOS3 protein
Glucose results in increased expression of NOS3 mRNA; Glucose results in increased expression of NOS3 protein
Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein; pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]; [Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide; [salvianolic acid co-treated with Glucose] inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased phosphorylation of NOS3 protein]; acetovanillone inhibits the reaction [Glucose results in decreased expression of NOS3 protein]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of NOS3 protein]; Glucose inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased phosphorylation of NOS3 protein]; Glucose results in increased expression of and results in increased activity of NOS3 protein; Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]; Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]]; TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]; U 0126 inhibits the reaction [TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]]; Wortmannin inhibits the reaction [Rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; Wortmannin inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]
Glucose results in increased O-linked glycosylation of NOS3 protein
CTD PMID:10502298 PMID:11696579 PMID:15490108 PMID:17075048 PMID:17090780 More... NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions
increases expression
ISO Glucose results in increased expression of and results in increased activity of NOX1 protein; resveratrol inhibits the reaction [Glucose results in increased expression of and results in increased activity of NOX1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of NOX1 mRNA] CTD PMID:23731528 NCBI chr  X:97,279,058...97,332,291
Ensembl chr  X:97,279,056...97,302,236
JBrowse link
G Nox4 NADPH oxidase 4 multiple interactions
increases expression
EXP
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of NOX4 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOX4 mRNA; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOX4 mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of NOX4 protein]; farrerol inhibits the reaction [Glucose results in increased expression of NOX4 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of NOX4 protein]
Glucose results in increased expression of NOX4 mRNA; Glucose results in increased expression of NOX4 protein
[Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of NOX4 protein]
CTD PMID:29702141 PMID:31494106 PMID:31838053 PMID:35961541 NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
JBrowse link
G Npas3 neuronal PAS domain protein 3 decreases expression ISO Glucose results in decreased expression of NPAS3 mRNA CTD PMID:31525975 NCBI chr 6:70,702,773...71,527,928
Ensembl chr 6:70,703,170...71,524,884
JBrowse link
G Nppa natriuretic peptide A multiple interactions
increases expression
EXP cinnamic acid inhibits the reaction [Glucose results in increased expression of NPPA protein]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; Metformin inhibits the reaction [Glucose results in increased expression of NPPA protein]; NPPA protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose]; Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]
Glucose results in increased expression of NPPA mRNA; Glucose results in increased expression of NPPA protein
CTD PMID:15127950 PMID:24810525 PMID:30144576 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
JBrowse link
G Npr1 natriuretic peptide receptor 1 increases expression ISO Glucose results in increased expression of NPR1 mRNA CTD PMID:31655124 NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
JBrowse link
G Npy neuropeptide Y increases expression
multiple interactions
decreases expression
EXP
ISO
Glucose deficiency results in increased expression of NPY mRNA; Glucose results in increased expression of NPY protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NPY mRNA
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased expression of NPY protein]]; Dexamethasone inhibits the reaction [Glucose results in increased expression of NPY protein]
Glucose results in decreased expression of NPY mRNA; Glucose results in decreased expression of NPY protein
CTD PMID:11177238 PMID:16210367 PMID:18627777 PMID:31778773 PMID:37567420 NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
decreases expression
ISO
EXP
Glucose results in increased expression of NQO1 mRNA; Glucose results in increased expression of NQO1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [Glucose results in increased expression of NQO1 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; NQO1 gene mutant form promotes the reaction [Glucose results in increased chemical synthesis of Hydrogen Peroxide]; SMARCA4A protein promotes the reaction [Glucose results in increased expression of NQO1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein]; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [Glucose results in increased expression of NQO1 mRNA]
Glucose deficiency results in increased expression of NQO1 protein
Glucose results in decreased expression of NQO1 mRNA; Glucose results in decreased expression of NQO1 protein
solanesol inhibits the reaction [Glucose results in decreased expression of NQO1 mRNA]; solanesol inhibits the reaction [Glucose results in decreased expression of NQO1 protein]
CTD PMID:17178593 PMID:27558805 PMID:29211853 PMID:29457851 PMID:29649567 More... NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 multiple interactions ISO [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose CTD PMID:22062806 NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 decreases expression ISO Glucose results in decreased expression of NR1D2 mRNA CTD PMID:17178593 NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 decreases expression
multiple interactions
ISO Glucose results in decreased expression of NR1H2 mRNA; Glucose results in decreased expression of NR1H2 protein
morroniside inhibits the reaction [Glucose results in decreased expression of NR1H2 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of NR1H2 protein]
CTD PMID:34485530 NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions
increases expression
ISO
EXP
Allopurinol inhibits the reaction [Glucose results in increased expression of NR1H3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of NR1H3 protein] CTD PMID:23647015 NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 affects expression ISO Glucose affects the expression of NR1H4 mRNA CTD PMID:36156098 NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 decreases expression
increases expression
multiple interactions
decreases activity
ISO Glucose results in decreased expression of NR1I2 mRNA
Glucose results in increased expression of NR1I2 mRNA
[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose; Ketoconazole inhibits the reaction [NR1I2 protein results in decreased uptake of and results in decreased metabolism of Glucose]; NR1I2 protein results in decreased uptake of and results in decreased metabolism of Glucose; Polyphenols inhibits the reaction [Glucose results in decreased activity of NR1I2 protein]; resveratrol inhibits the reaction [NR1I2 protein results in decreased uptake of and results in decreased metabolism of Glucose]; SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose]
CTD PMID:21682256 PMID:22363694 PMID:24204015 PMID:26616219 PMID:36156098 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 decreases metabolic processing ISO NR1I3 mRNA results in decreased metabolism of Glucose CTD PMID:32428594 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 multiple interactions ISO Glucose affects the reaction [NR2F1 protein binds to SHBG promoter] CTD PMID:17992261 NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO NR3C1 protein affects the metabolism of and affects the abundance of Glucose CTD PMID:15919808 NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
JBrowse link
G Nrbp2 nuclear receptor binding protein 2 decreases expression
multiple interactions
ISO Glucose results in decreased expression of NRBP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of NRBP2 mRNA]
CTD PMID:33448797 NCBI chr 7:107,798,642...107,805,225
Ensembl chr 7:107,799,497...107,805,230
JBrowse link
G Nrg1 neuregulin 1 multiple interactions
increases transport
EXP
ISO
[NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose; MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; MAPK3 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; PDK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; PRKCZ protein promotes the reaction [NRG1 protein results in increased transport of Glucose]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NRG1 mRNA
CTD PMID:14711829 PMID:37567420 NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
JBrowse link
G Nrip2 nuclear receptor interacting protein 2 decreases expression ISO Glucose results in decreased expression of NRIP2 mRNA CTD PMID:17178593 NCBI chr 4:161,673,964...161,684,055
Ensembl chr 4:161,639,356...161,684,070
JBrowse link
G Nt5c1a 5'-nucleotidase, cytosolic IA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NT5C1A mRNA CTD PMID:37567420 NCBI chr 5:135,473,107...135,494,400
Ensembl chr 5:135,473,231...135,499,338
JBrowse link
G Nt5dc2 5'-nucleotidase domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA CTD PMID:37567420 NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
JBrowse link
G Ntm neurotrimin multiple interactions
increases expression
ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NTM mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NTM mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of NTM mRNA] CTD PMID:33448797 PMID:37567420 NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
JBrowse link
G Nts neurotensin increases transport EXP NTS protein results in increased transport of Glucose CTD PMID:11208724 NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
JBrowse link
G Nucb2 nucleobindin 2 decreases expression ISO Glucose results in decreased expression of NUCB2 mRNA CTD PMID:17178593 NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
JBrowse link
G Nudt8 nudix hydrolase 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NUDT8 mRNA CTD PMID:37567420 NCBI chr 1:201,293,660...201,295,233
Ensembl chr 1:201,292,619...201,295,224
JBrowse link
G Nuf2 NUF2 component of NDC80 kinetochore complex multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of NUF2 mRNA CTD PMID:37567420 NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator decreases abundance ISO NUPR1 results in decreased abundance of Glucose CTD PMID:16822955 NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
JBrowse link
G Nutm1 NUT midline carcinoma, family member 1 decreases expression ISO Glucose results in decreased expression of NUTM1 mRNA CTD PMID:31525975 NCBI chr 3:99,053,510...99,064,311
Ensembl chr 3:99,053,510...99,064,311
JBrowse link
G Nxnl1 nucleoredoxin-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NXNL1 mRNA CTD PMID:37567420 NCBI chr16:18,270,604...18,279,797
Ensembl chr16:18,262,688...18,279,987
JBrowse link
G Nxpe3 neurexophilin and PC-esterase domain family, member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NXPE3 mRNA CTD PMID:37567420 NCBI chr11:44,726,905...44,777,694
Ensembl chr11:44,727,069...44,777,694
JBrowse link
G Nxpe4 neurexophilin and PC-esterase domain family member 4 decreases expression
multiple interactions
ISO Glucose results in decreased expression of NXPE4 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of NXPE4 mRNA]
CTD PMID:33448797 NCBI chr 8:48,502,697...48,744,101
Ensembl chr 8:48,722,440...48,744,100
JBrowse link
G Nxph4 neurexophilin 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NXPH4 mRNA CTD PMID:37567420 NCBI chr 7:63,367,758...63,376,579
Ensembl chr 7:63,367,761...63,376,579
JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OAS1G mRNA CTD PMID:37567420 NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
JBrowse link
G Oas2 2'-5' oligoadenylate synthetase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OAS2 mRNA CTD PMID:37567420 NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371
JBrowse link
G Oas3 2'-5'-oligoadenylate synthetase 3 increases expression
multiple interactions
ISO Glucose results in increased expression of OAS3 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of OAS3 mRNA]
CTD PMID:33448797 NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
JBrowse link
G Oasl 2'-5'-oligoadenylate synthetase-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of OASL1 mRNA CTD PMID:37567420 NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
JBrowse link
G Oat ornithine aminotransferase multiple interactions EXP Glucose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] CTD PMID:2827574 NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
JBrowse link
G Obscn obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF increases expression
multiple interactions
ISO Glucose results in increased expression of OBSCN mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of OBSCN mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OBSCN mRNA
CTD PMID:31525975 PMID:37567420 NCBI chr10:43,774,113...43,919,718
Ensembl chr10:43,789,293...43,919,723
JBrowse link
G Ocln occludin decreases expression
multiple interactions
ISO Glucose results in decreased expression of OCLN mRNA; Glucose results in decreased expression of OCLN protein
MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN protein]
CTD PMID:21617913 PMID:31655124 PMID:34464088 NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase decreases expression ISO Glucose results in decreased expression of OGT mRNA CTD PMID:17178593 NCBI chr  X:66,771,278...66,816,148
Ensembl chr  X:66,771,349...66,816,146
JBrowse link
G Olfml1 olfactomedin-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of OLFML1 mRNA CTD PMID:37567420 NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:161,478,242...161,502,537
JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 multiple interactions
increases expression
ISO acetovanillone inhibits the reaction [Glucose results in increased expression of OLR1 mRNA] CTD PMID:19878672 NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase decreases expression
multiple interactions
increases expression
EXP
ISO
Glucose results in decreased expression of OPA1 protein
[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA]
Glucose results in increased expression of OPA1 mRNA
cinnamic acid inhibits the reaction [Glucose results in decreased expression of OPA1 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of OPA1 protein]
CTD PMID:27684054 PMID:30144576 PMID:33962019 NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
JBrowse link
G Orc4 origin recognition complex, subunit 4 decreases expression ISO Glucose results in decreased expression of ORC4 mRNA CTD PMID:17178593 NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
JBrowse link
G Otop1 otopetrin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OTOP1 mRNA CTD PMID:37567420 NCBI chr14:72,505,036...72,532,497
Ensembl chr14:72,503,592...72,532,497
JBrowse link
G Ovol3 ovo-like zinc finger 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of OVOL3 mRNA CTD PMID:37567420 NCBI chr 1:85,484,956...85,488,592
Ensembl chr 1:85,484,956...85,488,592
JBrowse link
G Oxr1 oxidation resistance 1 decreases expression ISO Glucose results in decreased expression of OXR1 mRNA CTD PMID:17178593 NCBI chr 7:72,528,750...72,965,666
Ensembl chr 7:72,528,786...72,965,666
JBrowse link
G P2rx2 purinergic receptor P2X 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of P2RX2 mRNA CTD PMID:37567420 NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
JBrowse link
G P2rx7 purinergic receptor P2X 7 increases expression EXP Glucose results in increased expression of P2RX7 mRNA CTD PMID:21832250 NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
JBrowse link
G P2ry10 P2Y receptor family member 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of P2RY10 mRNA CTD PMID:37567420 NCBI chr  X:72,121,558...72,207,174
Ensembl chr  X:72,111,264...72,212,265
JBrowse link
G P4ha1 prolyl 4-hydroxylase subunit alpha 1 increases expression ISO Glucose deficiency results in increased expression of P4HA1 protein CTD PMID:22314686 NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
JBrowse link
G P4hb prolyl 4-hydroxylase subunit beta increases expression
multiple interactions
EXP Glucose results in increased expression of P4HB protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of P4HB protein]; Metformin inhibits the reaction [Glucose results in increased expression of P4HB protein]
CTD PMID:34801538 NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
JBrowse link
G Pabpc1l poly(A) binding protein, cytoplasmic 1-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PABPC1L mRNA CTD PMID:37567420 NCBI chr 3:152,692,825...152,725,997
Ensembl chr 3:152,693,700...152,725,997
JBrowse link
G Pacsin1 protein kinase C and casein kinase substrate in neurons 1 increases expression
multiple interactions
ISO Glucose results in increased expression of PACSIN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of PACSIN1 mRNA]
CTD PMID:33448797 NCBI chr20:5,718,134...5,768,064
Ensembl chr20:5,719,857...5,765,313
JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 increases expression ISO Glucose results in increased expression of PAFAH1B1 protein CTD PMID:23776576 NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
JBrowse link
G Paip2 poly(A) binding protein interacting protein 2 multiple interactions ISO Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR] CTD PMID:12820898 NCBI chr18:27,199,762...27,218,359
Ensembl chr18:27,199,796...27,214,863
JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 decreases expression ISO Glucose results in decreased expression of PAK3 mRNA CTD PMID:17178593 NCBI chr  X:107,116,308...107,374,342
Ensembl chr  X:107,260,898...107,368,314
JBrowse link
G Pappa2 pappalysin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA CTD PMID:37567420 NCBI chr13:70,873,918...71,147,874
Ensembl chr13:70,876,794...71,147,779
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases expression
increases activity
multiple interactions
increases expression
increases cleavage
affects localization
increases acetylation
EXP
ISO
Glucose results in decreased expression of PARP1 mRNA
Glucose results in increased activity of PARP1 protein
[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; Quercetin inhibits the reaction [Glucose results in increased cleavage of PARP1 protein]; sesamin inhibits the reaction [Glucose results in increased cleavage of PARP1 protein]; Simvastatin inhibits the reaction [Glucose results in increased activity of PARP1 protein]; SOD1 protein inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein]
Glucose results in increased expression of PARP1 mRNA; Glucose results in increased expression of PARP1 protein modified form
[Glucose co-treated with Oxygen deficiency] results in increased activity of PARP1 protein; [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein; [Glucose deficiency co-treated with CAT] results in increased cleavage of PARP1 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [Glucose results in increased activity of PARP1 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased activity of PARP1 protein]; PARP1 protein affects the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of INSR protein]]; PARP1 protein affects the reaction [Glucose promotes the reaction [JUN protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; PARP1 protein affects the reaction [Glucose results in decreased expression of CYTB mRNA]; PARP1 protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; PARP1 protein affects the reaction [Glucose results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of PARP1 protein modified form]; SIRT1 protein inhibits the reaction [Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]]; SIRT1 protein inhibits the reaction [Glucose results in increased acetylation of PARP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased activity of PARP1 protein]
Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]; PARP1 protein affects the reaction [Glucose results in increased ADP-ribosylation of GAPDH protein]
Glucose affects the localization of PARP1 protein
CTD PMID:14523042 PMID:17309078 PMID:18004065 PMID:18545258 PMID:21031461 More... NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
JBrowse link
G Parp14 poly (ADP-ribose) polymerase family, member 14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
JBrowse link
G Pax3 paired box 3 multiple interactions
decreases expression
ISO
EXP
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA]; S-ethyl glutathione inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] CTD PMID:12739027 PMID:21818840 NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
JBrowse link
G Pax5 paired box 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAX5 mRNA CTD PMID:37567420 NCBI chr 5:58,763,334...58,945,719
Ensembl chr 5:58,765,036...58,944,326
JBrowse link
G Pax6 paired box 6 decreases expression
multiple interactions
EXP
ISO
Glucose results in decreased expression of PAX6 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of PAX6 mRNA
CTD PMID:21818840 PMID:37567420 NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
JBrowse link
G Pbk PDZ binding kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PBK mRNA CTD PMID:37567420 NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
JBrowse link
G Pbld1 phenazine biosynthesis-like protein domain containing 1 increases expression ISO Glucose results in increased expression of PBLD1 mRNA CTD PMID:31525975 NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
JBrowse link
G Pbx4 PBX homeobox 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA CTD PMID:37567420 NCBI chr16:19,555,089...19,590,054
Ensembl chr16:19,555,090...19,590,014
JBrowse link
G Pc pyruvate carboxylase increases oxidation
affects expression
ISO
EXP
PC protein results in increased oxidation of Glucose
Glucose affects the expression of PC mRNA
CTD PMID:23504317 PMID:24349266 NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
JBrowse link
G Pcdh10 protocadherin 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PCDH10 mRNA CTD PMID:37567420 NCBI chr 2:128,617,212...128,683,354
Ensembl chr 2:128,617,174...128,677,190
JBrowse link
G Pcdh17 protocadherin 17 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA] CTD PMID:33448797 NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999
JBrowse link
G Pcdhga8 protocadherin gamma subfamily A, 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PCDHGA8 mRNA CTD PMID:37567420 NCBI chr18:29,553,882...29,667,865
Ensembl chr18:29,493,954...29,667,868
JBrowse link
G Pcdhgb6 protocadherin gamma subfamily B, 6 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDHGB6 mRNA] CTD PMID:33448797
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions
increases expression
ISO [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA; [Glucose deficiency co-treated with alpha-Linolenic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Clofibrate] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Docosahexaenoic Acids] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Linoleic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with Oleic Acid] results in increased expression of PCK1 mRNA; [Glucose deficiency co-treated with palmitoleic acid] results in increased expression of PCK1 mRNA
Glucose results in increased expression of PCK1 mRNA
CTD PMID:8536680 PMID:36156098 NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) multiple interactions
increases expression
ISO Catechin inhibits the reaction [Glucose results in increased expression of PCK2 protein]; Plant Extracts inhibits the reaction [Glucose results in increased expression of PCK2 protein] CTD PMID:24262486 NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
JBrowse link
G Pcmtd1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 decreases expression ISO Glucose results in decreased expression of PCMTD1 mRNA CTD PMID:17178593 NCBI chr 5:12,284,711...12,355,680
Ensembl chr 5:12,284,711...12,354,899
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
increases expression
EXP
ISO
resveratrol inhibits the reaction [Glucose results in increased expression of PCNA protein]; rosiglitazone inhibits the reaction [Glucose results in increased expression of PCNA protein]
[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of PCNA protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA protein]
CTD PMID:18665442 PMID:24971582 PMID:25192544 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
JBrowse link
G Pcsk2 proprotein convertase subtilisin/kexin type 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PCSK2 mRNA CTD PMID:37567420 NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
JBrowse link
G Pcsk9 proprotein convertase subtilisin/kexin type 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
JBrowse link
G Pde11a phosphodiesterase 11A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PDE11A mRNA CTD PMID:37567420 NCBI chr 3:60,913,562...61,297,154
Ensembl chr 3:60,913,562...61,297,158
JBrowse link
G Pdha1 pyruvate dehydrogenase E1 subunit alpha 1 multiple interactions ISO Glucose inhibits the reaction [Dichloroacetic Acid results in decreased phosphorylation of PDHA1 protein] CTD PMID:31654802 NCBI chr  X:34,700,481...34,714,309
Ensembl chr  X:34,700,409...34,714,311
JBrowse link
G Pdhb pyruvate dehydrogenase E1 subunit beta affects expression EXP Glucose affects the expression of PDHB mRNA CTD PMID:24349266 NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 decreases expression ISO Glucose results in decreased expression of PDIA3 mRNA CTD PMID:17178593 NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 decreases expression ISO Glucose results in decreased expression of PDIA4 mRNA CTD PMID:17178593 NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
JBrowse link
G Pdia6 protein disulfide isomerase family A, member 6 decreases expression ISO Glucose results in decreased expression of PDIA6 mRNA CTD PMID:17178593 NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions
affects expression
EXP
ISO
PDK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose]
Glucose affects the reaction [Fusaric Acid results in increased expression of PDK1 mRNA]; Glucose affects the reaction [Fusaric Acid results in increased expression of PDK1 protein]
Glucose affects the expression of PDK1 mRNA
CTD PMID:14711829 PMID:24349266 PMID:31654802 NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
JBrowse link
G Pdk2 pyruvate dehydrogenase kinase 2 affects expression EXP Glucose affects the expression of PDK2 mRNA CTD PMID:24349266 NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase 4 increases expression
multiple interactions
ISO Glucose results in increased expression of PDK4 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PDK4 mRNA
CTD PMID:17178593 PMID:37567420 NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
JBrowse link
G Pdp1 pyruvate dehydrogenase phosphatase catalytic subunit 1 multiple interactions EXP [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein CTD PMID:20181797 NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
JBrowse link
G Pdx1 pancreatic and duodenal homeobox 1 multiple interactions
affects localization
decreases expression
affects expression
increases expression
increases activity
ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of PDX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein]; [Glucose co-treated with INS protein] affects the localization of PDX1 protein; [Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein; [SB 203580 co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; [wortmannin co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein]; calyculin A inhibits the reaction [Glucose affects the localization of PDX1 protein]; Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein; Okadaic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]; Palmitic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [[Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [Glucose affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein]; wortmannin inhibits the reaction [Glucose affects the localization of PDX1 protein]; wortmannin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein]
Glucose results in decreased expression of PDX1 protein
Glucose affects the expression of PDX1 mRNA
lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]
Glucose results in increased activity of PDX1 promoter
[copper bis(3,5-diisopropylsalicylate) co-treated with Glucose] results in increased expression of PDX1 protein; [ebselen co-treated with Glucose] results in increased expression of PDX1 protein; [Glucose co-treated with INS1 protein] affects the localization of PDX1 protein; [Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein; [Metformin co-treated with Glucose] affects the localization of PDX1 protein; calyculin A inhibits the reaction [Glucose affects the localization of PDX1 protein]; Glucose results in increased phosphorylation of and results in increased activity of PDX1 protein; IL1B protein inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; Okadaic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]; Palmitic Acid inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]; PDX1 protein affects the reaction [bisphenol A promotes the reaction [Glucose results in increased secretion of INS protein]]; rosiglitazone promotes the reaction [Glucose results in increased activity of PDX1 promoter]; SB 203580 inhibits the reaction [[Glucose co-treated with sodium arsenite] affects the localization of PDX1 protein]; SB 203580 inhibits the reaction [Glucose affects the localization of PDX1 protein]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]]; wortmannin inhibits the reaction [Glucose affects the localization of PDX1 protein]
CTD PMID:9873045 PMID:11574405 PMID:16489446 PMID:22558381 PMID:23795780 More... NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression
increases secretion
ISO Glucose deficiency results in increased expression of PEBP1 protein
Glucose deficiency results in increased secretion of PEBP1 protein
CTD PMID:22314686 PMID:24802182 NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 decreases expression ISO Glucose results in decreased expression of PECAM1 mRNA CTD PMID:31655124 NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
JBrowse link
G Peg10 paternally expressed 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PEG10 mRNA CTD PMID:37567420 NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
JBrowse link
G Penk proenkephalin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PENK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PENK mRNA CTD PMID:37567420 NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
JBrowse link
G Per3 period circadian regulator 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PER3 mRNA CTD PMID:37567420 NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
JBrowse link
G Pf4 platelet factor 4 increases expression ISO Glucose results in increased expression of PF4 mRNA CTD PMID:31655124 NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
JBrowse link
G Phb2 prohibitin 2 decreases expression
multiple interactions
EXP Glucose results in decreased expression of PHB2 protein
Inositol inhibits the reaction [Glucose results in decreased expression of PHB2 protein]
CTD PMID:35243728 NCBI chr 4:157,517,662...157,522,268
Ensembl chr 4:157,517,577...157,522,272
JBrowse link
G Phf11 PHD finger protein 11 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PHF11 mRNA CTD PMID:37567420 NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
JBrowse link
G Phf19 PHD finger protein 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PHF19 mRNA CTD PMID:37567420 NCBI chr 3:18,175,281...18,197,289
Ensembl chr 3:18,175,282...18,196,405
JBrowse link
G Phgdh phosphoglycerate dehydrogenase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PHGDH mRNA CTD PMID:37567420 NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression ISO Glucose results in increased expression of PHLDA1 mRNA CTD PMID:17178593 NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
JBrowse link
G Pi16 peptidase inhibitor 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA CTD PMID:37567420 NCBI chr20:7,376,073...7,385,386
Ensembl chr20:7,376,126...7,385,383
JBrowse link
G Pianp PILR alpha associated neural protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA CTD PMID:37567420 NCBI chr 4:157,796,425...157,804,842
Ensembl chr 4:157,798,808...157,804,842
JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A decreases expression ISO Glucose results in decreased expression of PIGA mRNA CTD PMID:17178593 NCBI chr  X:30,043,033...30,055,861
Ensembl chr  X:30,042,343...30,055,804
JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions ISO Glucose promotes the reaction [PIK3R1 protein binds to IRS1 protein] CTD PMID:10430617 NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase multiple interactions
decreases expression
ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of PIM1 protein]
Glucose results in decreased expression of PIM1 mRNA; Glucose results in decreased expression of PIM1 protein
CTD PMID:27049278 NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
JBrowse link
G Pimreg PICALM interacting mitotic regulator multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA CTD PMID:37567420 NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791
JBrowse link
G Pink1 PTEN induced kinase 1 increases expression
decreases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of PINK1 mRNA
Glucose results in decreased expression of PINK1 protein
Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]
[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]
CTD PMID:33962019 PMID:35243728 NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
JBrowse link
G Pip5k1b phosphatidylinositol-4-phosphate 5-kinase type 1 beta multiple interactions
decreases methylation
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased methylation of PIP5K1B gene]; fucoxanthin inhibits the reaction [Glucose results in increased expression of PIP5K1B mRNA] CTD PMID:33448797 NCBI chr 1:221,907,220...222,183,672
Ensembl chr 1:221,914,159...222,183,672
JBrowse link
G Pitpnm3 PITPNM family member 3 decreases expression
multiple interactions
ISO Glucose results in decreased expression of PITPNM3 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of PITPNM3 mRNA]
CTD PMID:33448797 NCBI chr10:56,674,697...56,766,552
Ensembl chr10:56,676,261...56,766,584
JBrowse link
G Pjvk pejvakin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PJVK mRNA CTD PMID:37567420 NCBI chr 3:61,594,644...61,605,051
Ensembl chr 3:61,596,641...61,605,045
JBrowse link
G Pklr pyruvate kinase L/R increases expression
increases activity
multiple interactions
ISO
EXP
Glucose results in increased expression of PKLR mRNA
Glucose results in increased activity of PKLR protein
4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile inhibits the reaction [Glucose results in increased expression of PKLR mRNA]; Fatty Acids affects the reaction [Glucose results in increased activity of PKLR protein]; Fatty Acids, Unsaturated inhibits the reaction [Glucose results in increased expression of PKLR mRNA]; Glucose promotes the reaction [H3F4 protein modified form binds to PKLR promoter]; Glucose promotes the reaction [H4C16 protein modified form binds to PKLR promoter]; Metformin inhibits the reaction [Glucose results in increased expression of PKLR mRNA]; pirinixic acid inhibits the reaction [Glucose results in increased activity of PKLR protein]; pirinixic acid inhibits the reaction [Glucose results in increased expression of PKLR mRNA]
CTD PMID:2824512 PMID:8144600 PMID:16644726 PMID:16790840 PMID:17786952 More... NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions
increases uptake
ISO Fulvestrant inhibits the reaction [Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]]; Glucose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA]; Glucose affects the reaction [Fusaric Acid results in increased expression of PKM protein]; Glucose deficiency promotes the reaction [SAICAR binds to and results in increased activity of PKM protein]; Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]
PKM protein results in increased uptake of Glucose
CTD PMID:22574221 PMID:23086999 PMID:31654802 PMID:32078667 NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
JBrowse link
G Pla2g12b phospholipase A2, group XIIB multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLA2G12B mRNA CTD PMID:37567420 NCBI chr20:27,369,196...27,389,517
Ensembl chr20:27,370,266...27,388,743
JBrowse link
G Plagl1 PLAG1 like zinc finger 1 decreases expression ISO Glucose results in decreased expression of PLAGL1 mRNA CTD PMID:17178593 NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
JBrowse link
G Plat plasminogen activator, tissue type increases expression ISO Glucose results in increased expression of PLAT mRNA CTD PMID:17178593 NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
JBrowse link
G Plau plasminogen activator, urokinase decreases expression ISO Glucose results in decreased expression of PLAU mRNA CTD PMID:31655124 NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
JBrowse link
G Plcb1 phospholipase C beta 1 multiple interactions
increases expression
EXP acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB1 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB1 protein] CTD PMID:20691780 NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
JBrowse link
G Plcb2 phospholipase C, beta 2 multiple interactions
increases expression
EXP acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB2 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein] CTD PMID:20691780 NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302
JBrowse link
G Plg plasminogen multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PLG mRNA CTD PMID:37567420 NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
JBrowse link
G Plin1 perilipin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLIN1 mRNA CTD PMID:37567420 NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
JBrowse link
G Plk1 polo-like kinase 1 increases expression ISO Glucose results in increased expression of PLK1 mRNA CTD PMID:17178593 NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 increases expression ISO Glucose results in increased expression of PLOD2 mRNA CTD PMID:17178593 NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
JBrowse link
G Pls3 plastin 3 increases expression ISO Glucose results in increased expression of PLS3 mRNA CTD PMID:10026205 NCBI chr  X:111,589,193...111,683,908
Ensembl chr  X:111,589,254...111,683,891
JBrowse link
G Plxdc1 plexin domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PLXDC1 mRNA CTD PMID:37567420 NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of PMAIP1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PMAIP1 mRNA] CTD PMID:33962019 NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
JBrowse link
G Pnkp polynucleotide kinase 3'-phosphatase decreases expression ISO Glucose results in decreased expression of PNKP mRNA CTD PMID:32942007 NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
JBrowse link
G Pnpla2 patatin-like phospholipase domain containing 2 decreases expression ISO Glucose deficiency results in decreased expression of PNPLA2 protein CTD PMID:24802182 NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
JBrowse link
G Pnpla3 patatin-like phospholipase domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PNPLA3 mRNA CTD PMID:37567420 NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
JBrowse link
G Pomc proopiomelanocortin multiple interactions
decreases expression
increases response to substance
ISO
EXP
POMC inhibits the reaction [INS1 results in increased uptake of Glucose]
Glucose results in decreased expression of POMC mRNA
Glucose results in increased susceptibility to POMC protein
CTD PMID:18310442 PMID:18627777 PMID:19489000 NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
JBrowse link
G Pon2 paraoxonase 2 affects abundance ISO PON2 gene polymorphism affects the abundance of Glucose CTD PMID:16185677 NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
JBrowse link
G Popdc3 popeye domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of POPDC3 mRNA CTD PMID:37567420 NCBI chr20:48,772,397...48,800,677
Ensembl chr20:48,772,462...48,800,593
JBrowse link
G Pou4f1 POU class 4 homeobox 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of POU4F1 mRNA CTD PMID:37567420 NCBI chr15:81,253,714...81,260,057
Ensembl chr15:81,257,781...81,259,728
JBrowse link
G Pou5f1 POU class 5 homeobox 1 affects localization ISO Glucose affects the localization of POU5F1 protein CTD PMID:33992720 NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases expression
multiple interactions
affects expression
affects metabolic processing
affects abundance
ISO
EXP
Glucose results in decreased expression of PPARA protein
[pirinixic acid binds to and results in increased activity of PPARA protein] which affects the metabolism of Glucose; [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased susceptibility to Glucose; Allopurinol inhibits the reaction [Glucose results in decreased expression of PPARA protein]; HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARA protein]]; naringenin inhibits the reaction [Glucose results in decreased expression of PPARA protein]; PPARA protein promotes the reaction [Glucose results in increased secretion of INS1 protein]; Quercetin inhibits the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]
Glucose results in decreased expression of PPARA mRNA; Glucose results in decreased expression of PPARA protein
[Bezafibrate binds to and results in increased activity of PPARA protein] which results in decreased abundance of Glucose; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; Allopurinol inhibits the reaction [Glucose results in decreased expression of PPARA protein]; Quercetin inhibits the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]
Glucose affects the expression of PPARA mRNA
[Acetylglucosamine co-treated with Glucose] binds to PPARA protein; [Atropine co-treated with Glucose] binds to PPARA protein; [Budesonide co-treated with Glucose] binds to PPARA protein; [Enalapril co-treated with Glucose] binds to PPARA protein; [gamma-Aminobutyric Acid co-treated with Glucose] binds to PPARA protein; [gedunin co-treated with Glucose] binds to PPARA protein; [GW 7647 binds to and results in increased activity of PPARA protein] affects the reaction [Glucose affects the abundance of Calcium]; [Oleylethanolamide binds to and results in increased activity of PPARA protein] affects the reaction [Glucose affects the abundance of Calcium]; [pirinixic acid binds to and results in increased activity of PPARA protein] affects the reaction [Glucose affects the abundance of Calcium]; [Pyrazinamide co-treated with Glucose] binds to PPARA protein; [Saccharin co-treated with Glucose] binds to PPARA protein; [salicylamide co-treated with Glucose] binds to PPARA protein; [Tolazoline co-treated with Glucose] binds to PPARA protein; [Tolmetin co-treated with Glucose] binds to PPARA protein; Acetylglucosamine inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Atorvastatin promotes the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Atropine inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Budesonide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Enalapril inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Fenofibrate promotes the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; gamma-Aminobutyric Acid inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; gedunin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]; PPARA protein promotes the reaction [pirinixic acid results in decreased abundance of Glucose]; Pravastatin promotes the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Pyrazinamide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of PPARA protein]; Saccharin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; salicylamide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Tolazoline inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]; Tolmetin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]
PPARA protein affects the metabolism of Glucose
PPARA protein affects the abundance of Glucose
CTD PMID:15878969 PMID:16600694 PMID:16777972 PMID:18469201 PMID:18812576 More... NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
JBrowse link
G Ppard peroxisome proliferator-activated receptor delta affects expression
multiple interactions
decreases expression
EXP
ISO
Glucose affects the expression of PPARD mRNA
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA
HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]]; naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]
CTD PMID:24349266 PMID:31063766 PMID:32613381 NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
decreases expression
ISO
EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]]; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]
Glucose results in decreased expression of PPARG mRNA; Glucose results in decreased expression of PPARG protein
[ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose; HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]]; naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]; PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]
CTD PMID:15878969 PMID:18063688 PMID:19609456 PMID:21333731 PMID:31063766 More... NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha decreases expression
multiple interactions
increases expression
affects expression
increases acetylation
ISO
EXP
Glucose deficiency results in decreased expression of PPARGC1A mRNA; Glucose results in decreased expression of PPARGC1A mRNA; Glucose results in decreased expression of PPARGC1A protein
Inositol inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]
Glucose deficiency results in increased expression of PPARGC1A mRNA; Glucose results in increased expression of PPARGC1A mRNA
Glucose affects the expression of PPARGC1A mRNA
4-phenylbutyric acid inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; [SIRT1 protein co-treated with Resveratrol] affects the reaction [Glucose affects the expression of PPARGC1A protein]; AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; DDIT3 affects the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; Glucose inhibits the reaction [DDIT3 protein binds to PPARGC1A promoter]; Metformin inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; morroniside inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]]; [Pyruvic Acid co-treated with Glucose] results in decreased acetylation of PPARGC1A protein; ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]; Glucose promotes the reaction [YY1 protein binds to PPARGC1A promoter]; Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA]; YY1 promotes the reaction [Glucose results in decreased expression of PPARGC1A protein]
Glucose results in increased acetylation of PPARGC1A protein
CTD PMID:17855661 PMID:19071085 PMID:23090186 PMID:24349266 PMID:26811028 More... NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
JBrowse link
G Ppp1r12a protein phosphatase 1, regulatory subunit 12A multiple interactions EXP 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein] CTD PMID:25305180 NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
JBrowse link
G Prdx1 peroxiredoxin 1 increases expression ISO Glucose results in increased expression of PRDX1 mRNA CTD PMID:32942007 NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
JBrowse link
G Prex1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 decreases expression ISO Glucose results in decreased expression of PREX1 mRNA CTD PMID:32942007 NCBI chr 3:155,306,950...155,456,688
Ensembl chr 3:155,306,950...155,456,688
JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO 6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; Apigenin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; Glucose inhibits the reaction [SGA 360 results in increased phosphorylation of PRKAA1 protein]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein; Metformin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; PRKAA1 protein affects the reaction [Metformin inhibits the reaction [Glucose deficiency results in increased chemical synthesis of Reactive Oxygen Species]]; PRKAA1 protein affects the reaction [Ribonucleosides inhibits the reaction [Glucose deficiency results in increased chemical synthesis of Reactive Oxygen Species]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of NCF1 protein]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of RAC1 protein]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]
[[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate; [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in increased abundance of Glucose-6-Phosphate; [PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein; PRKAA1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]
CTD PMID:16380484 PMID:16873680 PMID:17916771 PMID:18482975 PMID:19052259 More... NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
JBrowse link
G Prkaa2 protein kinase AMP-activated catalytic subunit alpha 2 multiple interactions
decreases expression
affects response to substance
ISO
EXP
[Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein; PRKAA2 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]; SIRT1 protein promotes the reaction [[Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides]
Glucose results in decreased expression of PRKAA2 mRNA; Glucose results in decreased expression of PRKAA2 protein
PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency
[[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate; [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in increased abundance of Glucose-6-Phosphate; [PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]; Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; PRKAA2 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]
CTD PMID:15806154 PMID:18482975 PMID:19052259 PMID:23090186 PMID:24349266 More... NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
JBrowse link
G Prkar2b protein kinase cAMP-dependent type II regulatory subunit beta increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of PRKAR2B mRNA
2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein]; [Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein; rhodioloside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein]
CTD PMID:17178593 PMID:24726522 NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
JBrowse link
G Prkca protein kinase C, alpha increases phosphorylation
multiple interactions
ISO
EXP
Glucose results in increased phosphorylation of PRKCA protein
[Glucose co-treated with Silymarin] results in increased phosphorylation of PRKCA protein; Glucose promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of PRKCA protein]
Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein]
CTD PMID:20800666 PMID:22162761 PMID:29753610 NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
JBrowse link
G Prkcb protein kinase C, beta increases phosphorylation
increases expression
multiple interactions
increases activity
ISO
EXP
Glucose results in increased phosphorylation of PRKCB protein
Glucose results in increased expression of PRKCB protein; Glucose results in increased expression of PRKCB protein alternative form
Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein; PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein]; PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein]
5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein]; Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein]; resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein]
CTD PMID:16285992 PMID:19587355 PMID:20578705 PMID:22162761 NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
JBrowse link
G Prkcd protein kinase C, delta multiple interactions
increases expression
EXP
ISO
diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of PRKCD protein]
5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCD protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCD protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCD protein]; Mannitol inhibits the reaction [Glucose results in increased expression of PRKCD protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCD protein]
CTD PMID:12821678 PMID:16285992 NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
JBrowse link
G Prkch protein kinase C, eta decreases expression ISO Glucose results in decreased expression of PRKCH mRNA CTD PMID:17178593 NCBI chr 6:92,292,000...92,490,663
Ensembl chr 6:92,292,000...92,490,654
JBrowse link
G Prkcz protein kinase C, zeta multiple interactions EXP PRKCZ protein promotes the reaction [NRG1 protein results in increased transport of Glucose] CTD PMID:14711829 NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 multiple interactions
decreases expression
EXP acetovanillone inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]; Glucose results in decreased expression of and results in decreased activity of PRKG1 protein; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]; Reactive Oxygen Species promotes the reaction [Glucose results in decreased expression of PRKG1 protein]; tempol inhibits the reaction [Glucose results in decreased expression of PRKG1 protein]
Glucose results in decreased expression of PRKG1 mRNA
CTD PMID:17320767 NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
JBrowse link
G Prkg2 protein kinase cGMP-dependent 2 increases expression ISO Glucose results in increased expression of PRKG2 mRNA CTD PMID:17178593 NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase decreases expression
multiple interactions
EXP Glucose results in decreased expression of PRKN protein
Inositol inhibits the reaction [Glucose results in decreased expression of PRKN protein]
CTD PMID:35243728 NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
JBrowse link
G Prlr prolactin receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRLR mRNA CTD PMID:37567420 NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
JBrowse link
G Prnp prion protein multiple interactions ISO [PRNP protein results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose CTD PMID:21265952 NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
JBrowse link
G Prok1 prokineticin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PROK1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PROK1 mRNA CTD PMID:37567420 NCBI chr 2:194,850,539...194,859,343
Ensembl chr 2:194,853,991...194,859,250
JBrowse link
G Prpf40a pre-mRNA processing factor 40 homolog A decreases expression ISO Glucose results in decreased expression of PRPF40A mRNA CTD PMID:17178593 NCBI chr 3:37,625,585...37,689,859
Ensembl chr 3:37,627,690...37,690,886
JBrowse link
G Prr11 proline rich 11 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PRR11 mRNA CTD PMID:37567420 NCBI chr10:71,898,858...71,943,325
Ensembl chr10:71,901,202...71,921,012
JBrowse link
G Prr32 proline rich 32 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PRR32 mRNA CTD PMID:37567420 NCBI chr  X:123,978,010...123,979,928
Ensembl chr  X:123,977,985...123,979,942
JBrowse link
G Prr33 proline rich 33 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PRR33 mRNA CTD PMID:37567420 NCBI chr 1:197,644,903...197,650,774
Ensembl chr 1:197,644,902...197,650,714
JBrowse link
G Prrg4 proline rich and Gla domain 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PRRG4 mRNA CTD PMID:37567420 NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
JBrowse link
G Prrt3 proline-rich transmembrane protein 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of PRRT3 mRNA CTD PMID:37567420 NCBI chr 4:146,641,173...146,650,487
Ensembl chr 4:146,641,173...146,650,317
JBrowse link
G Prtn3 proteinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA CTD PMID:37567420 NCBI chr 7:9,822,123...9,831,300
Ensembl chr 7:9,822,122...9,831,944
JBrowse link
G Psd2 pleckstrin and Sec7 domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PSD2 mRNA CTD PMID:37567420 NCBI chr18:27,564,912...27,616,674
Ensembl chr18:27,565,587...27,616,672
JBrowse link
G Psen2 presenilin 2 increases methylation
decreases expression
multiple interactions
ISO Glucose results in increased methylation of PSEN2 gene
Glucose results in decreased expression of PSEN2 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of PSEN2 mRNA]
CTD PMID:33448797 NCBI chr13:91,967,506...91,993,240
Ensembl chr13:91,967,983...91,993,174
JBrowse link
G Psma1 proteasome 20S subunit alpha 1 decreases expression ISO Glucose deficiency results in decreased expression of PSMA1 protein CTD PMID:22314686 NCBI chr 1:168,442,421...168,453,440
Ensembl chr 1:168,440,936...168,453,472
JBrowse link
G Psmb10 proteasome 20S subunit beta 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PSMB10 mRNA CTD PMID:37567420 NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
JBrowse link
G Psmb5 proteasome 20S subunit beta 5 increases secretion ISO Glucose deficiency results in increased secretion of PSMB5 protein CTD PMID:24802182 NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
JBrowse link
G Psmb8 proteasome 20S subunit beta 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PSMB8 mRNA CTD PMID:37567420 NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283
JBrowse link
G Psors1c2 psoriasis susceptibility 1 candidate 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PSORS1C2 mRNA CTD PMID:37567420 NCBI chr20:3,202,178...3,203,599
Ensembl chr20:3,202,174...3,203,599
JBrowse link
G Ptafr platelet-activating factor receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PTAFR mRNA CTD PMID:37567420 NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
JBrowse link
G Ptch1 patched 1 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein] CTD PMID:27481074 NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
JBrowse link
G Ptgds prostaglandin D2 synthase decreases secretion ISO Glucose deficiency results in decreased secretion of PTGDS protein CTD PMID:24802182 NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
JBrowse link
G Ptger1 prostaglandin E receptor 1 increases expression EXP Glucose results in increased expression of PTGER1 mRNA CTD PMID:12888618 NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
JBrowse link
G Ptger4 prostaglandin E receptor 4 increases expression EXP Glucose results in increased expression of PTGER4 mRNA; Glucose results in increased expression of PTGER4 protein CTD PMID:12888618 NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 increases expression EXP
ISO
Glucose results in increased expression of PTGS1 protein
Glucose results in increased expression of PTGS1 mRNA
CTD PMID:12888618 PMID:32942007 NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
decreases expression
ISO
EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PTGS2 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PTGS2 protein]; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]
Glucose results in increased expression of PTGS2 mRNA; Glucose results in increased expression of PTGS2 protein
[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]
Glucose results in decreased expression of PTGS2 mRNA; Glucose results in decreased expression of PTGS2 protein
CTD PMID:12888618 PMID:14514642 PMID:16395278 PMID:17178593 PMID:19225232 More... NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Ptgs2os prostaglandin-endoperoxide synthase 2, opposite strand increases expression
multiple interactions
ISO Glucose results in increased expression of PTGS2OS mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of PTGS2OS mRNA]
CTD PMID:33448797 NCBI chr13:62,160,002...62,163,710 JBrowse link
G Ptk2 protein tyrosine kinase 2 multiple interactions
decreases expression
ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of PTK2 protein]; Glucose inhibits the reaction [IL1B protein results in increased phosphorylation of PTK2 protein]
Glucose results in decreased expression of PTK2 mRNA
CTD PMID:30098273 PMID:31483951 PMID:31655124 NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
JBrowse link
G Ptpn7 protein tyrosine phosphatase, non-receptor type 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PTPN7 mRNA CTD PMID:37567420 NCBI chr13:46,570,904...46,584,048
Ensembl chr13:46,571,712...46,583,308
JBrowse link
G Ptprh protein tyrosine phosphatase, receptor type, H multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PTPRH mRNA CTD PMID:37567420 NCBI chr 1:69,243,704...69,276,294
Ensembl chr 1:69,242,321...69,285,077
JBrowse link
G Pvr PVR cell adhesion molecule increases expression ISO Glucose results in increased expression of PVR mRNA CTD PMID:17178593 NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
JBrowse link
G Pxn paxillin multiple interactions
decreases expression
increases expression
ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]] CTD PMID:31483951 NCBI chr12:41,060,791...41,107,952
Ensembl chr12:41,060,791...41,107,931
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions
increases expression
ISO
EXP
Allopurinol inhibits the reaction [Glucose results in increased expression of PYCARD protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PYCARD protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein; Allopurinol inhibits the reaction [Glucose results in increased expression of PYCARD protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein]; Quercetin inhibits the reaction [Glucose results in increased expression of PYCARD protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of PYCARD protein]
CTD PMID:23647015 PMID:29031534 PMID:35191607 NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
JBrowse link
G Pygl glycogen phosphorylase L multiple interactions EXP Glucose inhibits the reaction [[Phenylephrine co-treated with Calcium] results in increased activity of PYGL protein] CTD PMID:747652 NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
JBrowse link
G Pyy peptide YY affects expression EXP Glucose affects the expression of PYY protein CTD PMID:18627777 NCBI chr10:87,061,155...87,062,278
Ensembl chr10:87,061,161...87,061,815
JBrowse link
G R3hdml R3H domain containing-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA CTD PMID:37567420 NCBI chr 3:152,171,382...152,182,151
Ensembl chr 3:152,171,382...152,182,151
JBrowse link
G Rab40b Rab40b, member RAS oncogene family multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA] CTD PMID:33448797 NCBI chr10:106,631,514...106,659,090
Ensembl chr10:106,631,514...106,659,090
JBrowse link
G Rab42 RAB42, member RAS oncogene family multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of RAB42 mRNA CTD PMID:37567420 NCBI chr 5:144,497,159...144,498,829
Ensembl chr 5:144,496,215...144,498,848
JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions
increases expression
increases activity
affects localization
increases localization
ISO
EXP
Atorvastatin inhibits the reaction [Glucose results in increased localization of RAC1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose affects the localization of RAC1 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Atorvastatin inhibits the reaction [Glucose results in increased localization of RAC1 protein]]; PRKAA1 protein affects the reaction [Rosiglitazone inhibits the reaction [Glucose affects the localization of RAC1 protein]]; Rosiglitazone inhibits the reaction [Glucose affects the localization of RAC1 protein]
Glucose results in increased expression of RAC1 protein
Glucose results in increased activity of RAC1 protein
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased activity of RAC1 protein]]; Resveratrol inhibits the reaction [Glucose results in increased activity of RAC1 protein]
[Resveratrol co-treated with Glucose] results in decreased expression of RAC1 mRNA; Eucalyptol inhibits the reaction [Glucose results in increased expression of RAC1 protein]
CTD PMID:17279352 PMID:17916771 PMID:24659233 PMID:26054749 PMID:31483951 NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
JBrowse link
G Rad51b RAD51 paralog B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RAD51B mRNA CTD PMID:37567420 NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
JBrowse link
G Ramp2 receptor activity modifying protein 2 increases expression ISO Glucose results in increased expression of RAMP2 mRNA CTD PMID:17178593 NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
JBrowse link
G Ramp3 receptor activity modifying protein 3 increases expression ISO Glucose results in increased expression of RAMP3 mRNA CTD PMID:17178593 NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902
JBrowse link
G Ranbp17 RAN binding protein 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RANBP17 mRNA CTD PMID:37567420 NCBI chr10:17,800,406...18,102,947
Ensembl chr10:17,800,999...18,102,831
JBrowse link
G Rarres2 retinoic acid receptor responder 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RARRES2 mRNA CTD PMID:37567420 NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
JBrowse link
G Rasl12 RAS-like, family 12 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA CTD PMID:37567420 NCBI chr 8:65,917,840...65,931,885
Ensembl chr 8:65,917,840...65,932,741
JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions
increases expression
ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of RB1 protein] CTD PMID:35264022 NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
JBrowse link
G Rbm3 RNA binding motif protein 3 increases expression ISO Glucose results in increased expression of RBM3 mRNA CTD PMID:10026205 NCBI chr  X:14,348,909...14,352,387
Ensembl chr  X:14,348,910...14,353,580
JBrowse link
G Rbp4 retinol binding protein 4 increases abundance ISO RBP4 protein results in increased abundance of Glucose CTD PMID:31228551 NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
JBrowse link
G Rbpjl recombination signal binding protein for immunoglobulin kappa J region-like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA CTD PMID:37567420 NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
JBrowse link
G Rd3 RD3 regulator of GUCY2D multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RD3 mRNA CTD PMID:37567420 NCBI chr13:103,551,823...103,562,925
Ensembl chr13:103,552,857...103,562,622
JBrowse link
G Rdh10 retinol dehydrogenase 10 decreases expression ISO Glucose results in decreased expression of RDH10 mRNA CTD PMID:25627686 NCBI chr 5:3,186,671...3,215,572
Ensembl chr 5:3,188,445...3,215,572
JBrowse link
G Recql4 RecQ like helicase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RECQL4 mRNA CTD PMID:37567420 NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit affects localization
increases expression
multiple interactions
increases activity
increases phosphorylation
decreases phosphorylation
ISO
EXP
Glucose affects the localization of RELA protein
Glucose results in increased expression of RELA mRNA; Glucose results in increased expression of RELA protein; Glucose results in increased expression of RELA protein modified form
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF protein]; [Resveratrol affects the localization of RELA protein] which results in decreased susceptibility to Glucose; aspalathin inhibits the reaction [Glucose affects the localization of RELA protein]; Aspirin inhibits the reaction [Glucose results in increased expression of RELA protein]; Bosentan inhibits the reaction [Glucose results in increased activity of RELA protein]; Catechin inhibits the reaction [Glucose affects the localization of RELA protein]; chelerythrine inhibits the reaction [Glucose results in increased activity of RELA protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of RELA protein]; Curcumin inhibits the reaction [Glucose results in increased activity of RELA protein]; epigallocatechin gallate inhibits the reaction [Glucose affects the localization of RELA protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of RELA protein]; GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; Glucose promotes the reaction [RELA protein binds to AGER promoter]; Glucose promotes the reaction [RELA protein binds to MMP9 promoter]; Glucose promotes the reaction [RELA protein binds to SRI promoter]; isoangustone A inhibits the reaction [Glucose affects the localization of RELA protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of RELA protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of RELA protein]; Luteolin inhibits the reaction [Glucose affects the localization of RELA protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; nothofagin inhibits the reaction [Glucose affects the localization of RELA protein]; PARP1 protein affects the reaction [Glucose promotes the reaction [RELA protein binds to MMP9 promoter]]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Polyphenols inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose affects the localization of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased activity of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of RELA protein]; pyrrolidine dithiocarbamic acid promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of RELA protein]]; Quercetin inhibits the reaction [Glucose affects the localization of RELA protein]; RELA promotes the reaction [Glucose results in increased expression of AGER mRNA]; RELA protein affects the reaction [Glucose affects the localization of MLXIP protein]; RELA protein affects the reaction [Glucose results in decreased expression of SRI protein]; Rutin inhibits the reaction [Glucose affects the localization of RELA protein]; sitaxsentan inhibits the reaction [Glucose results in increased activity of RELA protein]; SN50 peptide inhibits the reaction [Glucose results in increased activity of RELA protein]; swietenine inhibits the reaction [Glucose results in increased expression of RELA protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of and affects the localization of RELA protein]; ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of RELA protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; Gallic Acid inhibits the reaction [Glucose results in increased expression of RELA protein]; Glucose results in increased expression of and affects the localization of RELA protein; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]]; PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein]; prolinedithiocarbamate inhibits the reaction [Glucose affects the localization of RELA protein]; Quercetin inhibits the reaction [Glucose affects the localization of RELA protein]; Quercetin inhibits the reaction [Glucose results in increased expression of RELA mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of RELA protein]; ruboxistaurin inhibits the reaction [Glucose results in increased activity of RELA protein]; Y 27632 inhibits the reaction [Glucose affects the localization of RELA protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of and affects the localization of RELA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of RELA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of RELA protein; [Ribose co-treated with Glucose] affects the localization of RELA protein; AGER protein affects the reaction [Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]]; Glucose results in increased phosphorylation of and affects the localization of RELA protein; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of RELA protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of RELA protein]; RELA protein modified form promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]; RELA protein promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]; Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]
Glucose results in decreased phosphorylation of RELA protein
CTD PMID:12388107 PMID:16395278 PMID:16600694 PMID:19557821 PMID:19587355 More... NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
JBrowse link
G Ren renin increases expression EXP Glucose results in increased expression of REN mRNA; Glucose results in increased expression of REN protein CTD PMID:19861503 NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
JBrowse link
G Ret ret proto-oncogene increases expression EXP Glucose results in increased expression of RET mRNA CTD PMID:21818840 NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
JBrowse link
G Retn resistin decreases uptake
multiple interactions
ISO RETN protein results in decreased uptake of Glucose
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of RETN mRNA
CTD PMID:14671216 PMID:37567420 NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
JBrowse link
G Retreg1 reticulophagy regulator 1 multiple interactions
decreases expression
EXP Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
JBrowse link
G Rhd Rh blood group, D antigen multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of RHD mRNA CTD PMID:37567420 NCBI chr 5:147,087,479...147,121,716
Ensembl chr 5:147,087,518...147,121,715
JBrowse link
G Rhoa ras homolog family member A increases activity
increases expression
multiple interactions
EXP
ISO
Glucose results in increased activity of RHOA protein
Glucose results in increased expression of RHOA protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of RHOA protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein inhibits the reaction [Glucose results in decreased expression of VCL protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]]; RHOA protein promotes the reaction [Glucose results in increased expression of GSK3B protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased activity of RHOA protein]
CTD PMID:22031849 PMID:23376009 PMID:31483951 NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
JBrowse link
G Rhob ras homolog family member B increases expression ISO Glucose results in increased expression of RHOB mRNA CTD PMID:17178593 NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
JBrowse link
G Rhoxf2b Rhox homeobox family member 2B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RHOX6 mRNA CTD PMID:37567420 NCBI chr  X:116,507,488...116,514,240
Ensembl chr  X:116,507,488...116,513,870
JBrowse link
G Ribc2 RIB43A domain with coiled-coils 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RIBC2 mRNA CTD PMID:37567420 NCBI chr 7:116,242,863...116,257,868
Ensembl chr 7:116,242,863...116,257,863
JBrowse link
G Rimbp3 RIMS binding protein 3 increases expression
multiple interactions
ISO Glucose results in increased expression of RIMBP3 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of RIMBP3 mRNA]
CTD PMID:33448797 NCBI chr11:83,783,816...83,789,391
Ensembl chr11:83,784,244...83,789,082
JBrowse link
G Rmi2 RecQ mediated genome instability 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RMI2 mRNA CTD PMID:37567420 NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
JBrowse link
G Rnasel ribonuclease L multiple interactions ISO [2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased uptake of Glucose CTD PMID:24651439 NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
JBrowse link
G Rnf180 ring finger protein 180 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RNF180 mRNA CTD PMID:37567420 NCBI chr 2:36,330,285...36,511,168
Ensembl chr 2:36,330,292...36,512,614
JBrowse link
G Rnf24 ring finger protein 24 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of RNF24 mRNA CTD PMID:37567420 NCBI chr 3:118,520,459...118,575,213
Ensembl chr 3:118,525,349...118,541,080
JBrowse link
G Rock1 Rho-associated coiled-coil containing protein kinase 1 multiple interactions
increases expression
EXP
ISO
[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of ROCK1 protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of ROCK1 protein]
Glucose results in increased expression of ROCK1 protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of ROCK1 protein]
CTD PMID:25305180 PMID:31483951 NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
JBrowse link
G Rpl13a ribosomal protein L13A multiple interactions EXP RPL13A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
JBrowse link
G Rps12 ribosomal protein S12 decreases expression ISO Glucose deficiency results in decreased expression of RPS12 protein CTD PMID:22314686 NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
JBrowse link
G Rps6 ribosomal protein S6 multiple interactions EXP resveratrol inhibits the reaction [Glucose results in increased phosphorylation of RPS6 protein] CTD PMID:20332614 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602
Ensembl chr 5:101,371,136...101,374,602
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 increases phosphorylation
multiple interactions
ISO Glucose results in increased phosphorylation of RPS6KB1 protein
HU 308 inhibits the reaction [Glucose results in increased phosphorylation of RPS6KB1 protein]; Sirolimus inhibits the reaction [Glucose results in increased phosphorylation of RPS6KB1 protein]
CTD PMID:30459625 PMID:35445903 NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
JBrowse link
G Rpsa ribosomal protein SA decreases expression
multiple interactions
ISO
EXP
Glucose deficiency results in decreased expression of RPSA protein
RPSA protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
CTD PMID:21124846 PMID:22314686 NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
JBrowse link
G Rptn repetin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RPTN mRNA CTD PMID:37567420 NCBI chr 2:179,061,768...179,066,056
Ensembl chr 2:179,060,017...179,065,910
JBrowse link
G RT1-Bb RT1 class II, locus Bb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-AB1 mRNA CTD PMID:37567420 NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
JBrowse link
G RT1-DMa RT1 class II, locus DMa multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-DMA mRNA CTD PMID:37567420 NCBI chr20:4,707,028...4,710,432
Ensembl chr20:4,707,028...4,710,432
JBrowse link
G RT1-DMb RT1 class II, locus DMb multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-DMB1 mRNA CTD PMID:37567420 NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
JBrowse link
G RT1-M3-1 RT1 class Ib, locus M3, gene 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of H2-M3 mRNA CTD PMID:37567420 NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
JBrowse link
G Rtn3 reticulon 3 multiple interactions
increases expression
EXP Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of RTN3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of RTN3 protein] CTD PMID:34801538 NCBI chr 1:204,612,675...204,669,212
Ensembl chr 1:204,612,675...204,669,275
JBrowse link
G Rtn4rl2 reticulon 4 receptor-like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RTN4RL2 mRNA CTD PMID:37567420 NCBI chr 3:69,954,557...69,971,108
Ensembl chr 3:69,955,169...69,971,488
JBrowse link
G Rtp4 receptor (chemosensory) transporter protein 4 increases expression
multiple interactions
ISO Glucose results in increased expression of RTP4 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RTP4 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of RTP4 mRNA]
CTD PMID:33448797 PMID:37567420 NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
JBrowse link
G Rubcnl rubicon like autophagy enhancer multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA CTD PMID:37567420 NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849
JBrowse link
G Runx2 RUNX family transcription factor 2 increases expression
multiple interactions
decreases expression
ISO
EXP
Glucose results in increased expression of RUNX2 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 protein; Melatonin inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]
Glucose results in decreased expression of RUNX2 mRNA; Glucose results in decreased expression of RUNX2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]
morroniside inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]
CTD PMID:17178593 PMID:30894315 PMID:32643284 PMID:33450223 PMID:38000455 NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
JBrowse link
G Runx3 RUNX family transcription factor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of RUNX3 mRNA CTD PMID:37567420 NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
JBrowse link
G S100a14 S100 calcium binding protein A14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of S100A14 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of S100A14 mRNA CTD PMID:37567420 NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:176,008,395...176,010,423
JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions
increases expression
ISO GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; Glucose promotes the reaction [JUN protein binds to S100A8 promoter]; JUN promotes the reaction [Glucose results in increased expression of S100A8 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]
Glucose results in increased expression of S100A8 mRNA; Glucose results in increased expression of S100A8 protein
CTD PMID:19833897 NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
JBrowse link
G S100a9 S100 calcium binding protein A9 increases secretion ISO Glucose deficiency results in increased secretion of S100A9 protein CTD PMID:24802182 NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
JBrowse link
G S100b S100 calcium binding protein B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of S100B mRNA CTD PMID:37567420 NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 decreases expression EXP Glucose results in decreased expression of S1PR1 mRNA CTD PMID:22406263 NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
JBrowse link
G S1pr2 sphingosine-1-phosphate receptor 2 multiple interactions
increases expression
EXP [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] results in decreased susceptibility to [sphingosine 1-phosphate co-treated with Glucose]
Glucose results in increased expression of S1PR2 mRNA
CTD PMID:22406263 NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
JBrowse link
G S1pr3 sphingosine-1-phosphate receptor 3 decreases expression EXP Glucose results in decreased expression of S1PR3 mRNA CTD PMID:22406263 NCBI chr17:13,781,050...13,794,408
Ensembl chr17:13,781,050...13,794,505
JBrowse link
G S1pr4 sphingosine-1-phosphate receptor 4 decreases expression EXP Glucose results in decreased expression of S1PR4 mRNA CTD PMID:22406263 NCBI chr 7:8,207,767...8,210,043
Ensembl chr 7:8,208,098...8,211,893
JBrowse link
G S1pr5 sphingosine-1-phosphate receptor 5 increases expression EXP Glucose results in increased expression of S1PR5 mRNA CTD PMID:22406263 NCBI chr 8:19,786,676...19,791,862
Ensembl chr 8:19,786,663...19,791,795
JBrowse link
G Saa4 serum amyloid A4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SAA4 mRNA CTD PMID:37567420 NCBI chr 1:97,247,580...97,251,882 JBrowse link
G Samd15 sterile alpha motif domain containing 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SAMD15 mRNA CTD PMID:37567420 NCBI chr 6:106,841,405...106,856,197
Ensembl chr 6:106,840,781...106,860,423
JBrowse link
G Sash3 SAM and SH3 domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SASH3 mRNA CTD PMID:37567420 NCBI chr  X:127,326,815...127,341,521
Ensembl chr  X:127,326,859...127,341,519
JBrowse link
G Sbsn suprabasin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SBSN mRNA CTD PMID:37567420 NCBI chr 1:85,978,970...86,006,034
Ensembl chr 1:86,001,567...86,006,034
JBrowse link
G Scamp4 secretory carrier membrane protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SCAMP4 mRNA CTD PMID:37567420 NCBI chr 7:9,101,504...9,113,929
Ensembl chr 7:9,101,489...9,113,967
JBrowse link
G Scarna17 small Cajal body-specific RNA 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SCARNA17 mRNA CTD PMID:37567420 NCBI chr18:68,344,475...68,344,553
Ensembl chr18:68,344,475...68,344,553
JBrowse link
G Scd stearoyl-CoA desaturase increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of SCD1 mRNA
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]
Glucose results in increased expression of SCD mRNA; Glucose results in increased expression of SCD1 mRNA
CTD PMID:15066988 PMID:16790840 PMID:22413010 PMID:32613381 NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
JBrowse link
G Scn1a sodium voltage-gated channel alpha subunit 1 increases expression ISO Glucose results in increased expression of SCN1A mRNA CTD PMID:31525975 NCBI chr 3:50,952,790...51,071,804
Ensembl chr 3:50,952,791...51,071,699
JBrowse link
G Scn4a sodium voltage-gated channel alpha subunit 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SCN4A mRNA CTD PMID:37567420 NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,246,936...91,296,545
JBrowse link
G Sec11c SEC11 homolog C, signal peptidase complex subunit decreases expression ISO Glucose results in decreased expression of SEC11C mRNA CTD PMID:17178593 NCBI chr18:59,320,932...59,337,272
Ensembl chr18:59,320,884...59,337,364
JBrowse link
G Sec13 SEC13 homolog, nuclear pore and COPII coat complex component decreases expression ISO Glucose deficiency results in decreased expression of SEC13 protein CTD PMID:22314686 NCBI chr 4:146,877,739...146,891,130
Ensembl chr 4:146,875,524...146,891,173
JBrowse link
G Sec14l3 SEC14-like lipid binding 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SEC14L3 mRNA CTD PMID:37567420 NCBI chr14:78,944,568...78,955,608
Ensembl chr14:78,912,750...78,956,099
JBrowse link
G Sec14l4 SEC14-like lipid binding 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SEC14L4 mRNA CTD PMID:37567420 NCBI chr14:78,912,750...78,928,799
Ensembl chr14:78,912,750...78,956,099
JBrowse link
G Sec62 SEC62 homolog, preprotein translocation factor multiple interactions
increases expression
EXP Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of SEC62 protein]; Metformin inhibits the reaction [Glucose results in increased expression of SEC62 protein] CTD PMID:34801538 NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
JBrowse link
G Sele selectin E multiple interactions
increases secretion
increases expression
ISO 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of SELE mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of SELE protein]; aspalathin inhibits the reaction [Glucose results in increased expression of SELE protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of SELE mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of SELE protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of SELE mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of SELE protein]; Mannitol inhibits the reaction [Glucose results in increased expression of SELE mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of SELE protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of SELE mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of SELE protein]; nothofagin inhibits the reaction [Glucose results in increased expression of SELE protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of SELE mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of SELE mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of SELE protein]
Glucose results in increased expression of SELE; Glucose results in increased expression of SELE mRNA; Glucose results in increased expression of SELE protein
CTD PMID:15304054 PMID:16285992 PMID:20960276 PMID:21682256 PMID:22074828 More... NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
JBrowse link
G Selenop selenoprotein P increases expression
multiple interactions
increases secretion
EXP Glucose results in increased expression of SELENOP mRNA
Metformin inhibits the reaction [Glucose results in increased expression of SELENOP mRNA]; Metformin inhibits the reaction [Glucose results in increased secretion of SELENOP protein]
CTD PMID:19576170 NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
JBrowse link
G Selenos selenoprotein S affects expression ISO Glucose affects the expression of SELENOS mRNA CTD PMID:18498015 NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
JBrowse link
G Selp selectin P multiple interactions ISO [Glucose results in increased susceptibility to sodium arsenite] which results in increased expression of SELP protein; Glucose inhibits the reaction [Aspirin inhibits the reaction [Arachidonic Acid results in increased expression of SELP protein]] CTD PMID:18413191 PMID:28264687 NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
JBrowse link
G Sema3a semaphorin 3A decreases expression ISO Glucose results in decreased expression of SEMA3A mRNA CTD PMID:17178593 NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:21,287,982...21,494,432
JBrowse link
G Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SERPINA3N mRNA CTD PMID:37567420 NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SERPINC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SERPINC1 mRNA CTD PMID:37567420 NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
JBrowse link
G Serpine1 serpin family E member 1 increases secretion
decreases expression
increases expression
multiple interactions
ISO
EXP
Glucose results in increased secretion of SERPINE1 protein
Glucose results in decreased expression of SERPINE1 mRNA
Glucose results in increased expression of SERPINE1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; [Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA; [Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein; [eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; [eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; UCP1 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]
Indomethacin inhibits the reaction [Glucose results in increased secretion of SERPINE1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]
CTD PMID:11050244 PMID:12409145 PMID:16320596 PMID:18682491 PMID:31655124 NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
JBrowse link
G Serpinf1 serpin family F member 1 decreases secretion
multiple interactions
ISO Glucose deficiency results in decreased secretion of SERPINF1 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SERPINF1 mRNA
CTD PMID:24802182 PMID:37567420 NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
JBrowse link
G Setd7 SET domain containing 7, histone lysine methyltransferase multiple interactions EXP Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]] CTD PMID:27652271 NCBI chr 2:135,562,683...135,605,468
Ensembl chr 2:135,562,683...135,605,468
JBrowse link
G Sfrp2 secreted frizzled-related protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SFRP2 mRNA CTD PMID:37567420 NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
JBrowse link
G Sftpd surfactant protein D decreases expression ISO Glucose results in decreased expression of SFTPD mRNA CTD PMID:32942007 NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
decreases expression
ISO
EXP
Glucose results in increased expression of SGK1 mRNA
Glucose results in decreased expression of SGK1 mRNA; Glucose results in decreased expression of SGK1 protein
CTD PMID:17178593 PMID:31729781 NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
JBrowse link
G Sgk2 serum/glucocorticoid regulated kinase 2 multiple interactions ISO SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
JBrowse link
G Sh3bgr SH3 domain binding glutamate-rich protein decreases expression ISO Glucose results in decreased expression of SH3BGR mRNA CTD PMID:31525975 NCBI chr11:35,503,663...35,527,853
Ensembl chr11:35,503,725...35,527,853
JBrowse link
G Sh3bp2 SH3-domain binding protein 2 increases expression ISO Glucose results in increased expression of SH3BP2 mRNA CTD PMID:17178593 NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
JBrowse link
G Shbg sex hormone binding globulin multiple interactions
decreases expression
ISO Cerulenin inhibits the reaction [Glucose results in decreased expression of SHBG protein]; Glucose affects the reaction [HNF4A protein binds to SHBG promoter]; Glucose affects the reaction [NR2F1 protein binds to SHBG promoter] CTD PMID:17992261 NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
JBrowse link
G Shc1 SHC adaptor protein 1 increases expression
multiple interactions
ISO Glucose results in increased expression of SHC1; Glucose results in increased expression of SHC1 mRNA; Glucose results in increased expression of SHC1 protein
SIRT1 inhibits the reaction [Glucose results in increased expression of SHC1]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 protein]
CTD PMID:21778425 PMID:23993977 NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
JBrowse link
G Shc3 SHC adaptor protein 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SHC3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SHC3 mRNA CTD PMID:37567420 NCBI chr17:13,652,247...13,772,710
Ensembl chr17:13,651,202...13,772,710
JBrowse link
G Shc4 SHC adaptor protein 4 multiple interactions
increases expression
ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of SHC4 mRNA] CTD PMID:33448797 NCBI chr 3:112,880,598...112,974,216
Ensembl chr 3:112,880,600...112,974,366
JBrowse link
G Shcbp1l SHC binding and spindle associated 1 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA CTD PMID:37567420 NCBI chr13:65,568,863...65,599,155
Ensembl chr13:65,568,863...65,599,154
JBrowse link
G Shfl shiftless antiviral inhibitor of ribosomal frameshifting decreases expression ISO Glucose results in decreased expression of SHFL mRNA CTD PMID:31525975 NCBI chr 8:19,408,298...19,414,084
Ensembl chr 8:19,408,333...19,413,971
JBrowse link
G Shh sonic hedgehog signaling molecule multiple interactions ISO cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased secretion of SHH protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SHH mRNA; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased secretion of SHH protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTCH1 protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein]
CTD PMID:27481074 NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
JBrowse link
G Shisal1 shisa like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHISAL1 mRNA CTD PMID:37567420 NCBI chr 7:115,506,947...115,611,518
Ensembl chr 7:115,509,035...115,575,449
JBrowse link
G Si sucrase-isomaltase increases expression ISO Glucose results in increased expression of SI mRNA CTD PMID:17786952 NCBI chr 2:157,505,893...157,586,228
Ensembl chr 2:157,506,342...157,585,260
JBrowse link
G Siglec1 sialic acid binding Ig like lectin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SIGLEC1 mRNA CTD PMID:37567420 NCBI chr 3:118,287,988...118,307,125
Ensembl chr 3:118,287,988...118,306,850
JBrowse link
G Sik1 salt-inducible kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SIK1 mRNA CTD PMID:37567420 NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
JBrowse link
G Sim2 SIM bHLH transcription factor 2 multiple interactions
increases response to substance
increases expression
EXP Curcumin inhibits the reaction [Glucose results in increased expression of SIM2 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of SIM2 protein]
SIM2 protein results in increased susceptibility to Glucose
Glucose results in increased expression of SIM2 mRNA; Glucose results in increased expression of SIM2 protein
CTD PMID:23333261 NCBI chr11:33,414,218...33,453,663
Ensembl chr11:33,414,218...33,453,663
JBrowse link
G Sirt1 sirtuin 1 multiple interactions
increases phosphorylation
decreases expression
increases expression
affects expression
increases response to substance
decreases response to substance
affects abundance
ISO
EXP
[6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] which results in increased susceptibility to Glucose; [[Resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]; [Resveratrol results in increased localization of and results in increased activity of SIRT1 protein] which results in decreased susceptibility to Glucose; [SIRT1 protein co-treated with Resveratrol] affects the reaction [Glucose affects the expression of PPARGC1A protein]; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Glucose; AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA]; icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; PRKAA1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]; PRKAA2 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; SB 203580 inhibits the reaction [icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA]]; SB 203580 inhibits the reaction [icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein]]
Glucose deficiency results in increased phosphorylation of SIRT1 protein
Glucose results in decreased expression of SIRT1 mRNA; Glucose results in decreased expression of SIRT1 protein
Glucose deficiency results in increased expression of SIRT1 mRNA; Glucose deficiency results in increased expression of SIRT1 protein
[6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] inhibits the reaction [Fructose results in increased abundance of Glucose]; [Niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [Fructose results in increased abundance of Glucose]; [SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; [SRT1720 results in increased activity of SIRT1 protein] which results in increased abundance of Glucose; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in decreased expression of SIRT1 protein]; NAD inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Sirolimus inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of HIF1A protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]]; SIRT1 protein promotes the reaction [[Glucose results in increased abundance of Adenosine Triphosphate] which results in increased expression of INS1 protein]; SIRT1 protein promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SRT1720 inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; UCP2 protein inhibits the reaction [SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[Glucose co-treated with Resveratrol] results in increased expression of SIRT1 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]]; [Glucose co-treated with Resveratrol] results in increased expression of SIRT1 protein; [Glucose deficiency co-treated with Galactose co-treated with Amino Acids co-treated with Pyruvic Acid] inhibits the reaction [Resveratrol results in increased expression of SIRT1 protein]; [Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]; [Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein; [Pyruvic Acid co-treated with Glucose] results in increased expression of and results in increased activity of SIRT1 protein; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] promotes the reaction [Glutathione binds to SIRT1 protein]]; GLRX protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased oxidation of and results in decreased activity of SIRT1 protein]; Glucose results in decreased expression of and results in decreased activity of SIRT1 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of SIRT1 protein]; PARP1 protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased abundance of Triglycerides]]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 mRNA]; salvianolic acid inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; SIRT1 inhibits the reaction [Glucose results in increased expression of SHC1]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 mutant form promotes the reaction [Glucose results in increased expression of SHC1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [Glucose promotes the reaction [PARP1 protein binds to MMP9 promoter]]; SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]; SIRT1 protein inhibits the reaction [Glucose results in increased abundance of Triglycerides]; SIRT1 protein inhibits the reaction [Glucose results in increased acetylation of PARP1 protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 mRNA]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of SHC1 protein]; SIRT1 protein inhibits the reaction [Resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; SIRT1 protein promotes the reaction [[Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]]
Glucose affects the expression of SIRT1 protein
SIRT1 protein results in increased susceptibility to Glucose
SIRT1 protein results in decreased susceptibility to Glucose
SIRT1 protein affects the abundance of Glucose
CTD PMID:16366736 PMID:18482975 PMID:18849969 PMID:19071085 PMID:19303870 More... NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
JBrowse link
G Sirt3 sirtuin 3 increases expression
decreases expression
multiple interactions
ISO Glucose deficiency results in increased expression of SIRT3 protein
Glucose results in decreased expression of SIRT3 protein
SIRT3 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]
polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of SIRT3 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased acetylation of FOXO1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CAT protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CDKN2A protein alternative form]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of SOD2 protein]
CTD PMID:23494737 PMID:25979314 PMID:37417536 NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
JBrowse link
G Sirt4 sirtuin 4 affects expression
decreases expression
EXP Glucose affects the expression of SIRT4 protein
Glucose results in decreased expression of SIRT4 mRNA
CTD PMID:24349266 NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439
JBrowse link
G Sirt7 sirtuin 7 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 protein; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein] CTD PMID:28675767 NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
JBrowse link
G Sit1 signaling threshold regulating transmembrane adaptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SIT1 mRNA CTD PMID:37567420 NCBI chr 5:57,740,212...57,741,838
Ensembl chr 5:57,740,218...57,741,838
JBrowse link
G Skil SKI-like proto-oncogene increases expression ISO Glucose results in increased expression of SKIL mRNA CTD PMID:17178593 NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
JBrowse link
G Slamf1 signaling lymphocytic activation molecule family member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLAMF1 mRNA CTD PMID:37567420 NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
JBrowse link
G Slamf8 SLAM family member 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA CTD PMID:37567420 NCBI chr13:85,047,729...85,057,571
Ensembl chr13:85,047,727...85,057,211
JBrowse link
G Slc11a2 solute carrier family 11 member 2 multiple interactions ISO [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 protein alternative form
RELA protein modified form promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]; RELA protein promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC11A2 mRNA alternative form]
CTD PMID:22666436 NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
JBrowse link
G Slc12a1 solute carrier family 12 member 1 increases activity
multiple interactions
EXP Glucose results in increased activity of SLC12A1 protein
[Glucose results in increased activity of SLC12A1 protein] which results in increased import of Water
CTD PMID:12433675 NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
JBrowse link
G Slc12a2 solute carrier family 12 member 2 multiple interactions ISO Bumetanide inhibits the reaction [SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein]]; SLC12A2 gene mutant form promotes the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:22872759 NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
JBrowse link
G Slc16a14 solute carrier family 16, member 14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA CTD PMID:37567420 NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
JBrowse link
G Slc16a5 solute carrier family 16 member 5 decreases expression
multiple interactions
increases methylation
ISO Glucose results in decreased expression of SLC16A5 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC16A5 mRNA]
Glucose results in increased methylation of SLC16A5 gene
CTD PMID:33448797 NCBI chr10:100,707,434...100,721,338
Ensembl chr10:100,707,434...100,721,338
JBrowse link
G Slc17a2 solute carrier family 17, member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC17A2 mRNA CTD PMID:37567420 NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
JBrowse link
G Slc17a8 solute carrier family 17 member 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SLC17A8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC17A8 mRNA CTD PMID:37567420 NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
JBrowse link
G Slc18a2 solute carrier family 18 member A2 multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC18A2 mRNA] CTD PMID:33448797 NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
JBrowse link
G Slc1a3 solute carrier family 1 member 3 decreases expression
multiple interactions
EXP Glucose results in decreased expression of SLC1A3 mRNA; Glucose results in decreased expression of SLC1A3 protein
resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein]
CTD PMID:26677078 NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
JBrowse link
G Slc22a25 solute carrier family 22, member 25 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC22A19 mRNA CTD PMID:37567420 NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SLC22A3 mRNA CTD PMID:37567420 NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
JBrowse link
G Slc22a7 solute carrier family 22 member 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC22A7 mRNA CTD PMID:37567420 NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
JBrowse link
G Slc25a1 solute carrier family 25 member 1 increases expression EXP Glucose results in increased expression of SLC25A1 protein CTD PMID:24349266 NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
JBrowse link
G Slc25a10 solute carrier family 25 member 10 increases expression EXP Glucose results in increased expression of SLC25A10 mRNA; Glucose results in increased expression of SLC25A10 protein CTD PMID:24349266 NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
JBrowse link
G Slc25a12 solute carrier family 25 member 12 decreases expression EXP Glucose results in decreased expression of SLC25A12 mRNA CTD PMID:24349266 NCBI chr 3:56,097,166...56,191,841
Ensembl chr 3:56,097,269...56,192,100
JBrowse link
G Slc25a14 solute carrier family 25 member 14 increases expression EXP Glucose results in increased expression of SLC25A14 mRNA CTD PMID:24349266 NCBI chr  X:127,807,630...127,845,823
Ensembl chr  X:127,807,449...127,845,823
JBrowse link
G Slc25a22 solute carrier family 25 member 22 affects expression EXP Glucose affects the expression of SLC25A22 protein CTD PMID:24349266 NCBI chr 1:196,528,471...196,536,398
Ensembl chr 1:196,528,472...196,536,331
JBrowse link
G Slc25a27 solute carrier family 25, member 27 increases expression EXP Glucose results in increased expression of SLC25A27 mRNA CTD PMID:24349266 NCBI chr 9:17,306,898...17,333,942
Ensembl chr 9:17,307,023...17,332,731
JBrowse link
G Slc26a3 solute carrier family 26 member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SLC26A3 mRNA CTD PMID:37567420 NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
JBrowse link
G Slc26a6 solute carrier family 26 member 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC26A6 mRNA CTD PMID:37567420 NCBI chr 8:109,558,968...109,569,778
Ensembl chr 8:109,559,642...109,569,778
JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions
increases uptake
decreases expression
increases activity
increases transport
increases stability
increases expression
ISO
EXP
7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; [bisphenol A results in increased activity of and affects the localization of SLC2A1 protein] which results in increased uptake of Glucose; [Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein; [PRNP protein results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose; [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein]; Barbiturates inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; Chloral Hydrate inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; Cyclofenil inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; daidzein inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Diazepam inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; Diethylstilbestrol inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Genistein inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; isoliquiritigenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; kaempferol inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; myricetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; naringenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Phloretin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Quercetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Resveratrol inhibits the reaction [SLC2A1 protein results in increased uptake of Glucose]; Tamoxifen inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; Valproic Acid inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]
[troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose
Glucose results in decreased expression of SLC2A1 mRNA
[2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [3-phenylpropanol-1 co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [bromopyruvate results in decreased expression of SLC2A1 protein] which results in decreased uptake of Glucose; [cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [Progesterone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose; [propionaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; [Troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose; [Troglitazone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose; Cysteine inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein]; Mercaptoethanol inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein]; oxophenylarsine inhibits the reaction [Glucose deficiency results in increased activity of SLC2A1 protein]
Glucose results in increased stability of SLC2A1 protein
Glucose results in increased expression of SLC2A1 mRNA
CTD PMID:1727734 PMID:8457197 PMID:8895337 PMID:10726906 PMID:11420438 More... NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions
increases expression
decreases expression
increases transport
ISO
EXP
Catechin inhibits the reaction [Glucose results in decreased expression of SLC2A2 protein]; Glucose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A2 protein results in increased transport of Fructose]; Plant Extracts inhibits the reaction [Glucose results in decreased expression of SLC2A2 protein]
Glucose results in increased expression of SLC2A2 mRNA
Dactinomycin inhibits the reaction [Glucose results in increased expression of SLC2A2 mRNA]; ML 7 inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose]; Phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose]
[copper bis(3,5-diisopropylsalicylate) co-treated with Glucose] results in increased expression of SLC2A2 protein; [ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein; [Sodium Selenite co-treated with Glucose] results in increased expression of SLC2A2 protein; Glucose inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA]; Glucose results in increased expression of and affects the localization of SLC2A2 protein
SLC2A2 protein results in increased transport of Glucose
CTD PMID:1727734 PMID:8457197 PMID:12137914 PMID:12787936 PMID:12937289 More... NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
JBrowse link
G Slc2a3 solute carrier family 2 member 3 multiple interactions EXP
ISO
[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein]
[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose]; Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein]
CTD PMID:8457197 PMID:24726522 PMID:28951307 NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
JBrowse link
G Slc2a4 solute carrier family 2 member 4 multiple interactions
increases uptake
increases expression
decreases expression
ISO
EXP
[3,3',4,5'-tetrahydroxystilbene results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose; [Glucose co-treated with picolinic acid] affects the localization of SLC2A4 protein; Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; Glucose inhibits the reaction [SLC2A4 protein results in increased uptake of Glucosamine]; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose]; MYH2 protein affects the reaction [SLC2A4 protein results in increased uptake of Glucose]; Plant Extracts promotes the reaction [SLC2A4 protein results in increased uptake of Glucose]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Chloroquine affects the localization of SLC2A4 protein] which results in increased uptake of Glucose]; [[Chloroquine results in increased abundance of Calcium] which affects the localization of SLC2A4 protein] which results in increased uptake of Glucose; [Chloroquine affects the localization of SLC2A4 protein] which results in increased uptake of Glucose; [Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose; ESR1 protein promotes the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; Fulvestrant inhibits the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]
Glucose results in increased expression of SLC2A4 mRNA
Glucose results in decreased expression of SLC2A4 mRNA
ACACB protein affects the reaction [Glucose results in decreased expression of SLC2A4 protein]
CTD PMID:1727734 PMID:15111496 PMID:16870493 PMID:18426865 PMID:18773891 More... NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
JBrowse link
G Slc2a5 solute carrier family 2 member 5 multiple interactions
increases expression
increases transport
ISO
EXP
Colforsin promotes the reaction [Glucose results in increased expression of SLC2A5 mRNA]; Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR]
Glucose results in increased expression of SLC2A5 protein
SLC2A5 protein results in increased transport of Glucose
Glucose results in increased expression of SLC2A5 mRNA; Glucose results in increased expression of SLC2A5 protein
CTD PMID:8048533 PMID:8554516 PMID:12820898 PMID:12937289 PMID:17710649 NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
JBrowse link
G Slc2a6 solute carrier family 2 member 6 decreases expression ISO Glucose results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 NCBI chr 3:10,348,395...10,355,208
Ensembl chr 3:10,348,395...10,355,208
JBrowse link
G Slc2a7 solute carrier family 2 member 7 increases transport ISO SLC2A7 protein results in increased transport of Glucose CTD PMID:15033637 PMID:17710649 NCBI chr 5:160,624,793...160,643,994
Ensembl chr 5:160,624,793...160,643,514
JBrowse link
G Slc2a9 solute carrier family 2 member 9 multiple interactions
increases transport
ISO Glucose promotes the reaction [SLC2A9 protein alternative form results in increased transport of Uric Acid]
SLC2A9 protein results in increased transport of Glucose
CTD PMID:17710649 PMID:18842065 NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981
JBrowse link
G Slc30a1 solute carrier family 30 member 1 increases expression
multiple interactions
EXP Glucose results in increased expression of SLC30A1 mRNA
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of SLC30A1 mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of SLC30A1 mRNA]
CTD PMID:23056475 NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
JBrowse link
G Slc30a3 solute carrier family 30 member 3 increases expression
affects expression
multiple interactions
ISO
EXP
Glucose results in increased expression of SLC30A3
Glucose affects the expression of SLC30A3
[Glucose co-treated with dihydroxyethyldithiocarbamate] results in increased expression of SLC30A3 mRNA
SLC30A3 results in increased susceptibility to [Glucose co-treated with INS1 protein]
CTD PMID:18545258 PMID:19492079 NCBI chr 6:25,264,310...25,284,720
Ensembl chr 6:25,275,528...25,284,720
JBrowse link
G Slc30a5 solute carrier family 30 member 5 affects expression EXP Glucose affects the expression of SLC30A5 CTD PMID:19492079 NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
JBrowse link
G Slc30a7 solute carrier family 30 member 7 multiple interactions ISO SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of GSDMD protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL18 protein]]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased secretion of IL1B protein]] CTD PMID:35607288 NCBI chr 2:203,855,484...203,922,155
Ensembl chr 2:203,859,175...203,922,132
JBrowse link
G Slc30a8 solute carrier family 30 member 8 multiple interactions
decreases expression
ISO
EXP
SLC30A8 protein promotes the reaction [Glucose results in increased secretion of INS protein]
[Glucose co-treated with dihydroxyethyldithiocarbamate] results in decreased expression of SLC30A8; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Glucose results in decreased expression of SLC30A8 mRNA]; SLC30A8 protein affects the reaction [Glucose results in increased secretion of INS1 protein]
Glucose results in decreased expression of SLC30A8; Glucose results in decreased expression of SLC30A8 mRNA
SLC30A8 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]
CTD PMID:16984975 PMID:19450229 PMID:19479076 PMID:19492079 PMID:23056475 NCBI chr 7:83,591,993...83,627,786
Ensembl chr 7:83,591,993...83,626,305
JBrowse link
G Slc38a11 solute carrier family 38, member 11 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SLC38A11 mRNA CTD PMID:37567420 NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
JBrowse link
G Slc38a4 solute carrier family 38, member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC38A4 mRNA CTD PMID:37567420 NCBI chr 7:128,142,866...128,203,000
Ensembl chr 7:128,144,807...128,202,995
JBrowse link
G Slc47a2 solute carrier family 47 member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA CTD PMID:37567420 NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
JBrowse link
G Slc4a1 solute carrier family 4 member 1 (Diego blood group) multiple interactions
increases expression
ISO Furans analog inhibits the reaction [Glucose results in increased expression of SLC4A1 protein] CTD PMID:28911973 NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
JBrowse link
G Slc4a5 solute carrier family 4 member 5 decreases expression ISO Glucose results in decreased expression of SLC4A5 mRNA CTD PMID:31525975 NCBI chr 4:115,710,101...115,810,330
Ensembl chr 4:115,725,592...115,810,323
JBrowse link
G Slc5a1 solute carrier family 5 member 1 multiple interactions
affects uptake
increases expression
affects transport
ISO
EXP
Glucose inhibits the reaction [[Sodium co-treated with SLC5A1 protein] results in increased uptake of methylglucoside]
SLC5A1 protein affects the uptake of Glucose
Glucose results in increased expression of SLC5A1 protein
[Cisplatin results in decreased expression of SLC5A1 mRNA] which affects the transport of Glucose; [Gentamicins results in decreased expression of SLC5A1 mRNA] which affects the transport of Glucose
Glucose results in increased expression of SLC5A1 mRNA
[gentamicin C results in decreased expression of SLC5A1 protein] which results in decreased uptake of Glucose; [Phlorhizin results in decreased activity of SLC5A1 protein] which results in decreased uptake of Glucose
SLC5A1 protein affects the transport of Glucose
CTD PMID:8048533 PMID:12927799 PMID:12937289 PMID:16300400 PMID:17288452 More... NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
JBrowse link
G Slc5a10 solute carrier family 5 member 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA CTD PMID:37567420 NCBI chr10:46,352,060...46,400,795
Ensembl chr10:46,352,061...46,399,811
JBrowse link
G Slc5a2 solute carrier family 5 member 2 multiple interactions EXP [Cisplatin results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose; [Gentamicins results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose; EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose]; NPPA protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] CTD PMID:15127950 PMID:18656965 NCBI chr 1:182,847,185...182,853,309
Ensembl chr 1:182,847,106...182,853,306
JBrowse link
G Slc5a4 solute carrier family 5 member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC5A4A mRNA CTD PMID:37567420 NCBI chr20:12,475,644...12,518,738
Ensembl chr20:12,475,644...12,518,738
JBrowse link
G Slc5a7 solute carrier family 5 member 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A7 mRNA CTD PMID:37567420 NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258
JBrowse link
G Slc6a18 solute carrier family 6 member 18 increases expression
multiple interactions
ISO Glucose results in increased expression of SLC6A18 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of SLC6A18 mRNA]
CTD PMID:33448797 NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925
JBrowse link
G Slc6a7 solute carrier family 6 member 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC6A7 mRNA CTD PMID:37567420 NCBI chr18:54,448,464...54,467,319
Ensembl chr18:54,448,464...54,467,319
JBrowse link
G Slc7a10 solute carrier family 7 member 10 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC7A10 mRNA CTD PMID:37567420 NCBI chr 1:87,829,084...87,845,073
Ensembl chr 1:87,829,175...87,845,071
JBrowse link
G Slc7a12 solute carrier family 7 (cationic amino acid transporter, y+ system), member 12 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC7A12 mRNA CTD PMID:37567420 NCBI chr 2:87,079,724...87,146,875
Ensembl chr 2:87,079,749...87,146,875
JBrowse link
G Slc8a1 solute carrier family 8 member A1 multiple interactions EXP [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] which results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of SLC8A1 protein CTD PMID:21293012 NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
JBrowse link
G Slfnl1 schlafen-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLFNL1 mRNA CTD PMID:37567420 NCBI chr 5:134,117,634...134,122,105
Ensembl chr 5:133,990,520...134,122,105
JBrowse link
G Slitrk6 SLIT and NTRK-like family, member 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA CTD PMID:37567420 NCBI chr15:87,563,506...87,570,125
Ensembl chr15:87,563,322...87,570,393
JBrowse link
G Smad2 SMAD family member 2 increases phosphorylation
multiple interactions
ISO
EXP
Glucose results in increased phosphorylation of SMAD2 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; farrerol inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; LY2109761 inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]
Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein; isoangustone A inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein]; protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein]
CTD PMID:17597607 PMID:21367880 PMID:31838053 NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
JBrowse link
G Smad3 SMAD family member 3 multiple interactions
increases phosphorylation
ISO 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased phosphorylation of SMAD3 protein]; Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein; protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein] CTD PMID:17597607 PMID:26045780 NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
JBrowse link
G Smad4 SMAD family member 4 increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of SMAD4 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of SMAD4 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of SMAD4 protein]; farrerol inhibits the reaction [Glucose results in increased expression of SMAD4 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of SMAD4 protein]
isoangustone A inhibits the reaction [Glucose results in increased expression of SMAD4 protein]
CTD PMID:21367880 PMID:31838053 NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 multiple interactions ISO [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein] CTD PMID:29457851 NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
JBrowse link
G Smc4 structural maintenance of chromosomes 4 increases expression ISO Glucose results in increased expression of SMC4 mRNA CTD PMID:17178593 NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
JBrowse link
G Smo smoothened, frizzled class receptor multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein]; SHH protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMO protein] CTD PMID:27481074 NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
JBrowse link
G Smox spermine oxidase increases expression ISO Glucose results in increased expression of SMOX mRNA CTD PMID:17178593 NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
JBrowse link
G Smyd1 SET and MYND domain containing 1 decreases expression ISO Glucose results in decreased expression of SMYD1 mRNA CTD PMID:31525975 NCBI chr 4:103,195,330...103,252,989
Ensembl chr 4:103,200,322...103,311,766
JBrowse link
G Snai1 snail family transcriptional repressor 1 increases expression
multiple interactions
ISO Glucose results in increased expression of SNAI1 mRNA; Glucose results in increased expression of SNAI1 protein
[Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein]; gingerol inhibits the reaction [Glucose results in increased expression of SNAI1 mRNA]; MAPK14 protein promotes the reaction [Glucose results in increased expression of SNAI1 mRNA]
CTD PMID:21829520 PMID:35445903 PMID:35961541 NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
JBrowse link
G Snai3 snail family transcriptional repressor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SNAI3 mRNA CTD PMID:37567420 NCBI chr19:50,516,771...50,529,295
Ensembl chr19:50,516,771...50,523,486
JBrowse link
G Snap25 synaptosome associated protein 25 decreases expression EXP Glucose results in decreased expression of SNAP25 protein CTD PMID:23776493 NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
JBrowse link
G Snora5c small nucleolar RNA, H/ACA box 5C increases expression ISO Glucose results in increased expression of SNORA5C mRNA CTD PMID:31525975 NCBI chr14:81,487,218...81,487,354
Ensembl chr14:81,487,218...81,487,354
JBrowse link
G Snord49a small nucleolar RNA, C/D box 49A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SNORD49A mRNA CTD PMID:37567420 NCBI chr10:47,297,488...47,297,559
Ensembl chr10:47,297,488...47,297,559
JBrowse link
G Socs2 suppressor of cytokine signaling 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SOCS2 mRNA CTD PMID:37567420 NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
JBrowse link
G Socs3 suppressor of cytokine signaling 3 increases expression ISO Glucose results in increased expression of SOCS3 mRNA CTD PMID:17178593 NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
JBrowse link
G Sod1 superoxide dismutase 1 affects binding
decreases metabolic processing
decreases expression
increases expression
multiple interactions
ISO
EXP
Glucose binds to SOD1 protein mutant form
SOD1 protein mutant form results in decreased metabolism of Glucose
Glucose results in decreased expression of SOD1 mRNA
Glucose results in increased expression of SOD1 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of SOD1 protein; [Oxygen co-treated with Glucose] promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SOD1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SOD1 protein; naringenin inhibits the reaction [Glucose results in increased expression of SOD1 mRNA]; SOD1 protein inhibits the reaction [[INS1 protein co-treated with Glucose] results in increased activity of PARP1 protein]
copper bis(3,5-diisopropylsalicylate) inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of SOD1 protein]; SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased activity of NFKB1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]; SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]; Sodium Selenite inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
Glucose results in increased expression of SOD1 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SOD1 protein; Acetylcysteine inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; Glucose deficiency results in decreased expression of and results in increased degradation of SOD1 protein; Glucose promotes the reaction [SOD1 protein mutant form results in increased chemical synthesis of Hydrogen Peroxide]; lactacystin inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 mRNA]; SOD1 protein inhibits the reaction [Glucose results in increased expression of NOS2 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Glucose deficiency results in decreased expression of and results in increased degradation of SOD1 protein]; U 0126 inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]
CTD PMID:12626432 PMID:16395278 PMID:17309078 PMID:18545258 PMID:19228841 More... NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
JBrowse link
G Sod2 superoxide dismutase 2 affects folding
affects expression
decreases secretion
decreases expression
multiple interactions
decreases activity
increases expression
decreases response to substance
ISO
EXP
Glucose deficiency affects the folding of SOD2 protein
Glucose affects the expression of SOD2 mRNA
Glucose deficiency results in decreased secretion of SOD2 protein
Glucose results in decreased expression of SOD2 mRNA; Glucose results in decreased expression of SOD2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; KU-32 compound inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; naringenin inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; SRT1720 inhibits the reaction [Glucose results in decreased expression of SOD2 protein]
[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein; [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein]; pimagedine inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; resveratrol inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; SOD2 protein inhibits the reaction [sodium arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]
2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of SOD2 protein]]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of SOD2 protein]; Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; CAT inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of SOD2 protein]]; Glucose results in decreased expression of and results in decreased activity of SOD2 protein; manganese chloride inhibits the reaction [Glucose results in decreased activity of SOD2 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of SOD2 protein]; SOD2 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER protein]; SOD2 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; SOD2 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased activity of PARP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Dinoprostone]; SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; SOD2 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; SOD2 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; SOD2 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
Glucose deficiency results in increased expression of SOD2 protein; Glucose results in increased expression of SOD2 protein
Glucose results in increased expression of SOD2 mRNA
SOD2 protein results in decreased susceptibility to Glucose
Glucose deficiency results in decreased expression of SOD2 protein
CTD PMID:11050244 PMID:14514642 PMID:14523042 PMID:17309078 PMID:18483403 More... NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
JBrowse link
G Sod3 superoxide dismutase 3 decreases expression EXP Glucose results in decreased expression of SOD3 mRNA CTD PMID:21818840 NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
JBrowse link
G Sorcs1 sortilin-related VPS10 domain containing receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA CTD PMID:37567420 NCBI chr 1:249,080,662...249,594,520
Ensembl chr 1:249,081,355...249,594,507
JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO Glucose results in increased expression of SORD mRNA CTD PMID:16805838 NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
JBrowse link
G Sox2 SRY-box transcription factor 2 decreases expression ISO Glucose results in decreased expression of SOX2 protein CTD PMID:33992720 NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
JBrowse link
G Sox6 SRY-box transcription factor 6 increases expression ISO Glucose results in increased expression of SOX6 mRNA; Glucose results in increased expression of SOX6 protein CTD PMID:36073553 NCBI chr 1:169,723,306...170,334,846
Ensembl chr 1:169,729,194...170,277,386
JBrowse link
G Sox9 SRY-box transcription factor 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SOX9 mRNA CTD PMID:37567420 NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
JBrowse link
G Sp1 Sp1 transcription factor multiple interactions ISO
EXP
SOD2 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
UCP1 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; UCP1 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
CTD PMID:11050244 NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
JBrowse link
G Sp7 Sp7 transcription factor multiple interactions ISO [EPO protein co-treated with Glucose] results in increased expression of SP7 mRNA; [EPO protein co-treated with Glucose] results in increased expression of SP7 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SP7 mRNA
CTD PMID:30894315 PMID:37567420 NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
JBrowse link
G Spaca9 sperm acrosome associated 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SPACA9 mRNA CTD PMID:37567420 NCBI chr 3:12,019,376...12,028,801
Ensembl chr 3:12,019,363...12,029,119
JBrowse link
G Sparc secreted protein acidic and cysteine rich multiple interactions
decreases expression
ISO cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
JBrowse link
G Spata20 spermatogenesis associated 20 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SPATA20 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPATA20 mRNA CTD PMID:37567420 NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
JBrowse link
G Sphk1 sphingosine kinase 1 multiple interactions
increases expression
EXP Acetylcysteine inhibits the reaction [Glucose results in increased expression of and results in increased activity of SPHK1 protein]; Glucose results in increased expression of and results in increased activity of SPHK1 protein; N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased activity of SPHK1 protein]; Pyridoxamine inhibits the reaction [Glucose results in increased expression of and results in increased activity of SPHK1 protein]; SPHK1 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; SPHK1 protein inhibits the reaction [Glucose results in increased expression of FN1 protein]
Glucose results in increased expression of SPHK1 mRNA
CTD PMID:21998146 NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
JBrowse link
G Spib Spi-B transcription factor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPIB mRNA CTD PMID:37567420 NCBI chr 1:95,018,939...95,024,804
Ensembl chr 1:95,018,947...95,024,780
JBrowse link
G Spmip7 sperm microtubule inner protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SPMIP7 mRNA CTD PMID:37567420 NCBI chr14:86,030,427...86,085,644
Ensembl chr14:86,030,655...86,085,644
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression
decreases expression
multiple interactions
increases secretion
ISO
EXP
Glucose results in increased expression of SPP1 mRNA
Glucose results in decreased expression of SPP1 mRNA; Glucose results in decreased expression of SPP1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 protein]]; Melatonin inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of SPP1 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SPP1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPP1 mRNA
Glucose results in increased secretion of SPP1 protein
Glucose results in increased expression of SPP1; Glucose results in increased expression of SPP1 mRNA
1-Methyl-3-isobutylxanthine inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; 8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; Dinitrochlorobenzene inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; Dinitrochlorobenzene inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; Dinitrochlorobenzene inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; Dipyridamole inhibits the reaction [Glucose results in increased expression of SPP1 mRNA]; Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; KT 5823 inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; morroniside inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]
CTD PMID:12505755 PMID:17178593 PMID:20453393 PMID:32643284 PMID:37567420 More... NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
JBrowse link
G Spry2 sprouty RTK signaling antagonist 2 increases expression ISO Glucose results in increased expression of SPRY2 mRNA CTD PMID:17178593 NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
JBrowse link
G Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 increases expression ISO Glucose results in increased expression of SPSB1 mRNA CTD PMID:17178593 NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
JBrowse link
G Spta1 spectrin, alpha, erythrocytic 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA CTD PMID:37567420 NCBI chr13:86,203,504...86,279,371
Ensembl chr13:86,203,504...86,279,371
JBrowse link
G Sptlc3 serine palmitoyltransferase, long chain base subunit 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of SPTLC3 mRNA CTD PMID:37567420 NCBI chr 3:126,847,878...126,978,010
Ensembl chr 3:126,847,878...126,978,010
JBrowse link
G Sqstm1 sequestosome 1 increases expression
multiple interactions
decreases expression
EXP
ISO
Glucose results in increased expression of SQSTM1 protein
Glucose deficiency results in increased expression of SQSTM1 protein
HU 308 inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]
Glucose deficiency results in decreased expression of SQSTM1 protein
3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [Resveratrol promotes the reaction [Glucose results in increased expression of SQSTM1 protein]]; Inositol inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]; Resveratrol promotes the reaction [Glucose results in increased expression of SQSTM1 protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]; ULK1 protein affects the reaction [Glucose results in increased expression of SQSTM1 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]
CTD PMID:28713934 PMID:29128638 PMID:29649567 PMID:30459625 PMID:34580807 More... NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions
decreases expression
ISO
EXP
[Resveratrol co-treated with Glucose] results in decreased expression of SRC mRNA; [Resveratrol co-treated with Glucose] results in decreased expression of SRC protein; [Resveratrol co-treated with Glucose] results in decreased expression of SRC protein modified form; Eucalyptol inhibits the reaction [Glucose results in decreased expression of SRC protein]; SRC protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein]; Chlorpromazine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein]
CTD PMID:11990355 PMID:24659233 PMID:29702141 PMID:31483951 NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of SREBF1 mRNA; Glucose results in increased expression of SREBF1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; Allopurinol inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; fatostatin inhibits the reaction [Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; fatostatin inhibits the reaction [Glucose results in increased activity of and results in increased cleavage of SREBF1 protein]; Glucose promotes the reaction [SREBF1 protein binds to FASN promoter]; Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]; Glucose results in increased activity of and results in increased cleavage of SREBF1 protein; L 709049 analog inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; PD168393 inhibits the reaction [Glucose results in increased activity of and results in increased cleavage of SREBF1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; RTKI cpd inhibits the reaction [Glucose results in increased activity of and results in increased cleavage of SREBF1 protein]; SREBF1 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; Wortmannin inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]; Y 27632 inhibits the reaction [Glucose results in increased cleavage of SREBF1 protein]
[INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA; Allopurinol inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 mRNA]]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]]; L 709049 analog inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; Niacinamide inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]]; platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 mRNA]; platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of SREBF1 protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of SREBF1 mRNA]; STO 609 inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 mRNA]]
resveratrol inhibits the reaction [Glucose results in increased expression of SREBF1 protein]
CTD PMID:10913129 PMID:15066988 PMID:19724016 PMID:22031849 PMID:23090186 More... NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
JBrowse link
G Srebf2 sterol regulatory element binding transcription factor 2 multiple interactions
increases expression
ISO
EXP
Allopurinol inhibits the reaction [Glucose results in increased expression of SREBF2 protein]; L 709049 analog inhibits the reaction [Glucose results in increased expression of SREBF2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of SREBF2 protein] CTD PMID:23647015 NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
JBrowse link
G Sri sorcin decreases expression
multiple interactions
ISO Glucose results in decreased expression of SRI protein
Glucose promotes the reaction [NCOR1 protein binds to SRI promoter]; Glucose promotes the reaction [RELA protein binds to SRI promoter]; NCOR1 protein affects the reaction [Glucose results in decreased expression of SRI protein]; RELA protein affects the reaction [Glucose results in decreased expression of SRI protein]; SRI protein inhibits the reaction [Glucose affects the localization of MLXIP protein]
CTD PMID:33930463 NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
JBrowse link
G Sstr3 somatostatin receptor 3 increases expression
multiple interactions
EXP Glucose results in increased expression of SSTR3 protein
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased expression of SSTR3 protein]]; Dexamethasone inhibits the reaction [Glucose results in increased expression of SSTR3 protein]
CTD PMID:31778773 NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
JBrowse link
G St18 ST18 C2H2C-type zinc finger transcription factor increases expression ISO Glucose results in increased expression of ST18 mRNA CTD PMID:23236509 NCBI chr 5:12,582,493...12,914,221
Ensembl chr 5:12,584,110...12,671,790
JBrowse link
G Stac2 SH3 and cysteine rich domain 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA CTD PMID:37567420 NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260
JBrowse link
G Stag2 STAG2 cohesin complex component decreases expression ISO Glucose results in decreased expression of STAG2 mRNA CTD PMID:17178593 NCBI chr  X:120,974,687...121,105,677
Ensembl chr  X:120,974,857...121,105,677
JBrowse link
G Stat1 signal transducer and activator of transcription 1 increases phosphorylation
multiple interactions
EXP
ISO
Glucose results in increased phosphorylation of STAT1 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of STAT1 mRNA
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Glucose results in increased phosphorylation of STAT1 protein]
CTD PMID:20060012 PMID:37567420 NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
decreases phosphorylation
increases expression
EXP
ISO
[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 protein; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of STAT3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]
[[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein]; STAT3 gene mutant form inhibits the reaction [IL22 protein results in decreased abundance of Glucose]
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of STAT3 protein modified form]]; resveratrol inhibits the reaction [Glucose results in increased expression of STAT3 protein modified form]
Glucose results in increased expression of STAT3 protein; Glucose results in increased expression of STAT3 protein modified form
CTD PMID:21940958 PMID:23421680 PMID:24064760 PMID:24810525 PMID:26064446 NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
JBrowse link
G Stim1 stromal interaction molecule 1 increases expression
multiple interactions
EXP Glucose results in increased expression of STIM1 mRNA; Glucose results in increased expression of STIM1 protein
STIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]; STIM1 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; STIM1 protein affects the reaction [Glucose results in increased expression of BAX protein]
CTD PMID:27234048 NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
JBrowse link
G Stk11 serine/threonine kinase 11 multiple interactions ISO Glucose results in increased acetylation of and results in decreased activity of STK11 protein; resveratrol inhibits the reaction [Glucose results in increased acetylation of and results in decreased activity of STK11 protein] CTD PMID:19765649 NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
JBrowse link
G Stmnd1 stathmin domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of STMND1 mRNA CTD PMID:37567420 NCBI chr17:18,393,312...18,420,655
Ensembl chr17:18,394,346...18,437,412
JBrowse link
G Stra6 signaling receptor and transporter of retinol STRA6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STRA6 mRNA CTD PMID:37567420 NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
JBrowse link
G Strbp spermatid perinuclear RNA binding protein decreases expression ISO Glucose results in decreased expression of STRBP mRNA CTD PMID:17178593 NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
JBrowse link
G Strip2 striatin interacting protein 2 increases expression
multiple interactions
ISO Glucose results in increased expression of STRIP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of STRIP2 mRNA]
CTD PMID:33448797 NCBI chr 4:58,536,034...58,578,279
Ensembl chr 4:58,536,055...58,578,291
JBrowse link
G Stum stum, mechanosensory transduction mediator homolog multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of STUM mRNA CTD PMID:37567420 NCBI chr13:92,172,175...92,227,205
Ensembl chr13:92,173,544...92,227,213
JBrowse link
G Stx19 syntaxin 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of STX19 mRNA CTD PMID:37567420 NCBI chr11:172,855...178,053
Ensembl chr11:171,395...179,191
JBrowse link
G Sult4a1 sulfotransferase family 4A, member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SULT4A1 mRNA CTD PMID:37567420 NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
JBrowse link
G Syn1 synapsin I decreases expression
multiple interactions
ISO Glucose results in decreased expression of SYN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of SYN1 mRNA]
CTD PMID:33448797 NCBI chr  X:1,172,208...1,227,400
Ensembl chr  X:1,172,208...1,227,396
JBrowse link
G Syndig1 synapse differentiation inducing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of SYNDIG1 mRNA CTD PMID:37567420 NCBI chr 3:138,030,995...138,234,646
Ensembl chr 3:138,031,769...138,198,122
JBrowse link
G Synpo2l synaptopodin 2-like multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of SYNPO2L mRNA] CTD PMID:33448797 NCBI chr15:3,631,974...3,641,429
Ensembl chr15:3,631,834...3,641,429
JBrowse link
G Syp synaptophysin decreases expression EXP Glucose results in decreased expression of SYP protein CTD PMID:23776493 NCBI chr  X:14,849,444...14,864,553
Ensembl chr  X:14,849,444...14,864,745
JBrowse link
G Syt1 synaptotagmin 1 increases expression EXP Glucose results in increased expression of SYT1 protein CTD PMID:23776493 NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
JBrowse link
G Syvn1 synoviolin 1 decreases expression ISO Glucose results in decreased expression of SYVN1 mRNA CTD PMID:17178593 NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
JBrowse link
G Tagln transgelin increases secretion ISO Glucose deficiency results in increased secretion of TAGLN protein CTD PMID:24802182 NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
JBrowse link
G Tap1 transporter 1, ATP binding cassette subfamily B member multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TAP1 mRNA CTD PMID:37567420 NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
JBrowse link
G Tas1r1 taste 1 receptor member 1 multiple interactions ISO Glucose promotes the reaction [TAS1R3 protein binds to TAS1R1 protein]; TAS1R1 protein affects the reaction [Glucose results in decreased expression of CDKN1A protein] CTD PMID:33992720 NCBI chr 5:162,533,838...162,546,408
Ensembl chr 5:162,533,841...162,545,562
JBrowse link
G Tas1r2 taste 1 receptor member 2 multiple interactions ISO Glucose promotes the reaction [TAS1R3 protein binds to TAS1R2 protein] CTD PMID:33992720 NCBI chr 5:151,909,617...151,925,760
Ensembl chr 5:151,830,701...151,925,345
JBrowse link
G Tas1r3 taste 1 receptor member 3 multiple interactions ISO Glucose promotes the reaction [TAS1R3 protein binds to TAS1R1 protein]; Glucose promotes the reaction [TAS1R3 protein binds to TAS1R2 protein] CTD PMID:33992720 NCBI chr 5:166,468,703...166,472,759
Ensembl chr 5:166,469,589...166,472,742
JBrowse link
G Tbc1d4 TBC1 domain family, member 4 multiple interactions
increases phosphorylation
ISO GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein] CTD PMID:21559284 NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
JBrowse link
G Tbx15 T-box transcription factor 15 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TBX15 mRNA CTD PMID:37567420 NCBI chr 2:186,576,650...186,687,748
Ensembl chr 2:186,576,676...186,687,663
JBrowse link
G Tbx2 T-box transcription factor 2 increases expression EXP Glucose results in increased expression of TBX2 mRNA CTD PMID:21818840 NCBI chr10:70,679,670...70,688,868
Ensembl chr10:70,679,518...70,688,529
JBrowse link
G Tbx4 T-box transcription factor 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TBX4 mRNA CTD PMID:37567420 NCBI chr10:70,730,686...70,760,829
Ensembl chr10:70,731,163...70,760,825
JBrowse link
G Tc2n tandem C2 domains, nuclear multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of TC2N mRNA CTD PMID:37567420 NCBI chr 6:120,761,112...120,856,835
Ensembl chr 6:120,761,119...120,849,326
JBrowse link
G Tcf19 transcription factor 19 affects response to substance
multiple interactions
affects activity
ISO TCF19 protein affects the susceptibility to Glucose
Glucose promotes the reaction [TCF19 protein binds to CHD2 protein]
Glucose affects the activity of TCF19 protein
CTD PMID:29042441 NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
JBrowse link
G Tdrd9 tudor domain containing 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TDRD9 mRNA CTD PMID:37567420 NCBI chr 6:131,029,644...131,145,076
Ensembl chr 6:131,029,652...131,144,651
JBrowse link
G Tek TEK receptor tyrosine kinase decreases expression ISO Glucose results in decreased expression of TEK mRNA CTD PMID:31655124 NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
JBrowse link
G Tert telomerase reverse transcriptase multiple interactions
decreases activity
ISO Fluorometholone inhibits the reaction [Glucose results in decreased activity of TERT protein] CTD PMID:35264022 NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
JBrowse link
G Tex51 testis expressed 51 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA CTD PMID:37567420 NCBI chr18:24,093,015...24,097,223
Ensembl chr18:24,093,115...24,097,007
JBrowse link
G Tfam transcription factor A, mitochondrial multiple interactions
decreases expression
increases expression
EXP
ISO
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of TFAM protein; Inositol inhibits the reaction [Glucose results in decreased expression of TFAM protein]
Glucose deficiency results in increased expression of TFAM mRNA
CTD PMID:25997894 PMID:26811028 PMID:35243728 NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
JBrowse link
G Tfpi tissue factor pathway inhibitor decreases expression ISO Glucose results in decreased expression of TFPI mRNA CTD PMID:31655124 NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
JBrowse link
G Tgfa transforming growth factor alpha multiple interactions
increases expression
ISO
EXP
Diazooxonorleucine inhibits the reaction [Glucose results in increased expression of TGFA mRNA]; EGF protein promotes the reaction [Glucose results in increased expression of TGFA mRNA]; Glucose promotes the reaction [EGF protein results in increased expression of TGFA mRNA]
[Glucose co-treated with Glucosamine] results in increased expression of TGFA protein; Glucosamine promotes the reaction [Glucose results in increased expression of TGFA mRNA]
CTD PMID:1518840 PMID:8638660 NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
increases acetylation
increases secretion
ISO
EXP
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; [Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein; [Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein; [Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein; [Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein; [Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein; [Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of HSPA5 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NLRP3 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of NOX4 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of SNAI1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein]; isoangustone A inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of KRT20 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; SOD2 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased secretion of TGFB1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; CEBPB protein inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Valsartan inhibits the reaction [Glucose results in increased expression of TGFB1 protein]
Glucose results in increased expression of TGFB1 mRNA; Glucose results in increased expression of TGFB1 protein
Glucose results in increased acetylation of TGFB1 promoter
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; [Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; [Eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; [Lipopolysaccharides co-treated with Glucose] results in increased secretion of TGFB1 protein; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in increased secretion of TGFB1 protein]; Curcumin analog inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Dinoprostone inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; farrerol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; fatostatin inhibits the reaction [Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]]; fatostatin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Glucose promotes the reaction [SREBF1 protein binds to TGFB1 promoter]; Glycyrrhizic Acid inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of TGFB1 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; manumycin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of TGFB1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein]]; SREBF1 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; Superoxides affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]]; TGFB1 protein promotes the reaction [Glucose results in increased expression of CDKN1A mRNA]; UCP1 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Y 27632 inhibits the reaction [Glucose results in increased expression of TGFB1 protein]
CTD PMID:8877289 PMID:11050244 PMID:16572112 PMID:17199790 PMID:17597607 More... NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
JBrowse link
G Tgfb1i1 transforming growth factor beta 1 induced transcript 1 increases methylation
decreases expression
multiple interactions
ISO Glucose results in increased methylation of TGFB1I1 gene
Glucose results in decreased expression of TGFB1I1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TGFB1I1 mRNA]
CTD PMID:33448797 NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor 1 increases expression
multiple interactions
ISO Glucose results in increased expression of TGFBR1 protein
isoangustone A inhibits the reaction [Glucose results in increased expression of TGFBR1 protein]
CTD PMID:21367880 NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 increases expression
multiple interactions
ISO Glucose results in increased expression of TGFBR2 protein
isoangustone A inhibits the reaction [Glucose results in increased expression of TGFBR2 protein]
CTD PMID:21367880 NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
JBrowse link
G Tgm4 transglutaminase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TGM4 mRNA CTD PMID:37567420 NCBI chr 8:122,689,429...122,726,463
Ensembl chr 8:122,689,429...122,726,463
JBrowse link
G Tgm5 transglutaminase 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of TGM5 mRNA CTD PMID:37567420 NCBI chr 3:108,008,087...108,044,013
Ensembl chr 3:108,008,143...108,043,976
JBrowse link
G Thbd thrombomodulin decreases expression ISO Glucose results in decreased expression of THBD mRNA CTD PMID:31655124 NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
JBrowse link
G Thbs1 thrombospondin 1 multiple interactions
decreases expression
EXP
ISO
Glucose inhibits the reaction [Dietary Fats results in increased expression of THBS1 protein]
Glucose results in decreased expression of THBS1 mRNA
CTD PMID:21394550 PMID:31655124 NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
JBrowse link
G Thbs2 thrombospondin 2 increases expression ISO Glucose results in increased expression of THBS2 protein CTD PMID:23723366 NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
JBrowse link
G Them5 thioesterase superfamily member 5 increases expression ISO Glucose results in increased expression of THEM5 mRNA CTD PMID:31525975 NCBI chr 2:181,980,783...181,986,002
Ensembl chr 2:181,980,783...181,986,002
JBrowse link
G Themis thymocyte selection associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of THEMIS mRNA CTD PMID:37567420 NCBI chr 1:16,433,906...16,623,889
Ensembl chr 1:16,432,631...16,664,329
JBrowse link
G Themis2 thymocyte selection associated family member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of THEMIS2 mRNA CTD PMID:37567420 NCBI chr 5:144,991,110...145,006,362
Ensembl chr 5:144,991,112...145,006,400
JBrowse link
G Thg1l tRNA-histidine guanylyltransferase 1-like increases expression ISO Glucose results in increased expression of THG1L mRNA CTD PMID:10026205 NCBI chr10:30,387,929...30,396,579
Ensembl chr10:30,387,940...30,396,687
JBrowse link
G Thsd7a thrombospondin type 1 domain containing 7A increases expression
multiple interactions
ISO Glucose results in increased expression of THSD7A mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of THSD7A mRNA]
CTD PMID:33448797 NCBI chr 4:40,461,124...40,899,345
Ensembl chr 4:40,460,814...40,899,583
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases secretion
multiple interactions
ISO Glucose deficiency results in increased secretion of TIMP1 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TIMP1 mRNA
CTD PMID:24802182 PMID:37567420 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:1,212,972...1,217,664
JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 increases expression
multiple interactions
ISO Glucose results in increased expression of TIMP2 protein
[Glucose co-treated with Air Pollutants] results in decreased expression of TIMP2 mRNA; [Glucose co-treated with Particulate Matter] results in decreased expression of TIMP2 mRNA; isoangustone A inhibits the reaction [Glucose results in increased expression of TIMP2 protein]
CTD PMID:21367880 PMID:26179980 NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
JBrowse link
G Tjp1 tight junction protein 1 multiple interactions
decreases expression
ISO 2-methoxyestradiol inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in decreased expression of TJP1 protein]
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]
CTD PMID:21617913 PMID:27783111 PMID:35445903 NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
JBrowse link
G Tjp2 tight junction protein 2 decreases expression
multiple interactions
ISO Glucose results in decreased expression of TJP2 protein
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP2 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP2 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP2 protein]
CTD PMID:27783111 NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
JBrowse link
G Tlcd2 TLC domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TLCD2 mRNA CTD PMID:37567420 NCBI chr10:60,310,577...60,314,263
Ensembl chr10:60,311,099...60,313,622
JBrowse link
G Tlk1 tousled-like kinase 1 decreases expression ISO Glucose results in decreased expression of TLK1 mRNA CTD PMID:17178593 NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
JBrowse link
G Tln1 talin 1 decreases expression
multiple interactions
ISO Glucose results in decreased expression of TLN1 protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]
CTD PMID:31483951 NCBI chr 5:57,787,670...57,817,900
Ensembl chr 5:57,787,943...57,817,900
JBrowse link
G Tlr2 toll-like receptor 2 decreases expression
multiple interactions
ISO Glucose results in decreased expression of TLR2 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TLR2 mRNA
CTD PMID:20200188 PMID:37567420 NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
JBrowse link
G Tlr4 toll-like receptor 4 decreases expression
increases expression
multiple interactions
ISO
EXP
Glucose results in decreased expression of TLR4 protein
Glucose results in increased expression of TLR4 protein
Phytic Acid inhibits the reaction [Glucose results in increased expression of TLR4 protein]
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein]
TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of INS2 mRNA alternative form]]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of MAFA mRNA]]; TLR4 affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Glucose results in increased expression of PDX1 mRNA]]
CTD PMID:20200188 PMID:22558381 PMID:30031708 PMID:38000455 NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
JBrowse link
G Tlr8 toll-like receptor 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TLR8 mRNA CTD PMID:37567420 NCBI chr  X:27,091,780...27,116,092
Ensembl chr  X:27,091,778...27,116,549
JBrowse link
G Tlr9 toll-like receptor 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TLR9 mRNA CTD PMID:37567420 NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
JBrowse link
G Tmed3 transmembrane p24 trafficking protein 3 decreases expression ISO Glucose results in decreased expression of TMED3 mRNA CTD PMID:17178593 NCBI chr 8:90,241,516...90,249,429
Ensembl chr 8:90,241,516...90,249,346
JBrowse link
G Tmeff1 transmembrane protein with EGF-like and two follistatin-like domains 1 decreases expression
increases methylation
multiple interactions
ISO Glucose results in decreased expression of TMEFF1 mRNA
Glucose results in increased methylation of TMEFF1 gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TMEFF1 mRNA]; fucoxanthin inhibits the reaction [Glucose results in increased methylation of TMEFF1 gene]
CTD PMID:33448797 NCBI chr 5:62,910,740...62,996,494
Ensembl chr 5:62,910,740...62,996,493
JBrowse link
G Tmem123 transmembrane protein 123 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of TMEM123 mRNA CTD PMID:23637816 NCBI chr 8:4,922,077...4,952,228
Ensembl chr 8:4,922,098...4,952,224
JBrowse link
G Tmem145 transmembrane protein 145 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TMEM145 mRNA CTD PMID:37567420 NCBI chr 1:80,891,888...80,901,615
Ensembl chr 1:80,891,927...80,901,611
JBrowse link
G Tmem229b transmembrane protein 229B multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of TMEM229B mRNA] CTD PMID:33448797 NCBI chr 6:97,771,645...97,819,582
Ensembl chr 6:97,775,332...97,819,489
JBrowse link
G Tmem232 transmembrane protein 232 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TMEM232 mRNA CTD PMID:37567420 NCBI chr 9:104,887,669...105,115,737
Ensembl chr 9:104,887,669...105,143,027
JBrowse link
G Tmem45a2 transmembrane protein 45A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TMEM45A2 mRNA CTD PMID:37567420 NCBI chr11:43,483,509...43,527,025
Ensembl chr11:43,483,519...43,526,916
JBrowse link
G Tmem52 transmembrane protein 52 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TMEM52 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TMEM52 mRNA CTD PMID:37567420 NCBI chr 5:166,048,669...166,050,423
Ensembl chr 5:166,046,565...166,050,433
JBrowse link
G Tmsb4x thymosin beta 4, X-linked increases expression ISO Glucose results in increased expression of TMSB4X mRNA CTD PMID:17178593 NCBI chr  X:27,144,666...27,146,667
Ensembl chr  X:27,128,610...27,146,667
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases secretion
decreases uptake
increases expression
increases oxidation
ISO
EXP
2-chloro-4'-methoxychalcone inhibits the reaction [Glucose results in increased expression of TNF mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of TNF mRNA]; 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased secretion of TNF protein]; [Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of TNF protein; CDK9 protein affects the reaction [Glucose results in increased expression of TNF mRNA]; CDK9 protein affects the reaction [Glucose results in increased secretion of TNF protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [TNF protein results in decreased uptake of Glucose]; Silymarin inhibits the reaction [[Glucose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased secretion of TNF protein]; SNHG1 affects the reaction [Glucose results in increased expression of TNF mRNA]; SNHG1 affects the reaction [Glucose results in increased expression of TNF protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of TNF protein]]
Glucose results in increased expression of TNF mRNA; Glucose results in increased expression of TNF protein
TNF protein results in increased oxidation of Glucose
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; [Glucose co-treated with Lipopolysaccharides] results in decreased expression of TNF protein; [Glucose co-treated with Pam(3)CSK(4) peptide] results in decreased expression of TNF protein; [Glucose co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of PPARA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CXCL5 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NFKB1 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of RELA mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of TNF protein]; [TNF protein co-treated with IFNG protein co-treated with IL1B protein] inhibits the reaction [Glucose results in increased secretion of INS protein alternative form]; Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein]]; asiatic acid inhibits the reaction [Glucose results in increased secretion of TNF protein]; asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in increased secretion of TNF protein]]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Carnosine inhibits the reaction [Glucose results in increased secretion of TNF protein]; Carnosine promotes the reaction [asiatic acid inhibits the reaction [Glucose results in increased secretion of TNF protein]]; Catechin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Catechin inhibits the reaction [Glucose results in increased expression of TNF protein]; chromic acid inhibits the reaction [[Glucose co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of TNF protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased secretion of TNF protein]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Luteolin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Luteolin inhibits the reaction [Glucose results in increased expression of TNF protein]; MIR217 mRNA inhibits the reaction [Glucose results in increased secretion of TNF protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TNF protein]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of TNF protein]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; rutecarpine inhibits the reaction [Glucose results in increased expression of TNF mRNA]; rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein]; Rutin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of TNF protein]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of TNF mRNA]; [Glucose co-treated with IGF2R protein modified form] results in increased expression of TNF protein; [Lipopolysaccharides co-treated with Glucose] results in increased secretion of TNF protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein; [TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein]; Atorvastatin inhibits the reaction [TNF protein results in increased oxidation of Glucose]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in increased secretion of TNF protein]; Curcumin analog inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of TNF protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Glucose results in increased secretion of TNF protein]; farrerol inhibits the reaction [Glucose results in increased expression of TNF mRNA]; farrerol inhibits the reaction [Glucose results in increased secretion of TNF protein]; Gallic Acid inhibits the reaction [Glucose results in increased secretion of TNF protein]; morroniside inhibits the reaction [Glucose results in increased secretion of TNF protein]; prolinedithiocarbamate inhibits the reaction [Glucose results in increased secretion of TNF protein]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of TNF protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; S-4-bromobenzylglutathione cyclopentyl diester inhibits the reaction [morroniside inhibits the reaction [Glucose results in increased secretion of TNF protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]
CTD PMID:7956951 PMID:11726202 PMID:19557821 PMID:20200188 PMID:21788014 More... NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link
G Tnfaip6 TNF alpha induced protein 6 increases expression ISO Glucose results in increased expression of TNFAIP6 mRNA CTD PMID:17178593 NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
JBrowse link
G Tnfaip8l3 TNF alpha induced protein 8 like 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TNFAIP8L3 mRNA CTD PMID:37567420 NCBI chr 8:54,413,503...54,455,512
Ensembl chr 8:54,414,457...54,500,079
JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B decreases secretion
multiple interactions
ISO Glucose results in decreased secretion of TNFRSF11B protein
cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of TNFRSF11B protein]
CTD PMID:19924377 NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
JBrowse link
G Tnfrsf25 TNF receptor superfamily member 25 decreases expression ISO Glucose results in decreased expression of TNFRSF25 mRNA CTD PMID:31525975 NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
JBrowse link
G Tnfrsf9 TNF receptor superfamily member 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA CTD PMID:37567420 NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
JBrowse link
G Tnfsf10 TNF superfamily member 10 decreases expression ISO Glucose results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
JBrowse link
G Tnfsf13 TNF superfamily member 13 decreases expression
multiple interactions
ISO Glucose results in decreased expression of TNFSF13 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]
CTD PMID:33448797 NCBI chr10:54,400,054...54,403,723
Ensembl chr10:54,400,065...54,403,042
JBrowse link
G Tnfsf14 TNF superfamily member 14 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TNFSF14 mRNA CTD PMID:37567420 NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
JBrowse link
G Tnfsf8 TNF superfamily member 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFSF8 mRNA CTD PMID:37567420 NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
JBrowse link
G Tnnt2 troponin T2, cardiac type increases expression ISO Glucose results in increased expression of TNNT2 mRNA CTD PMID:17178593 NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
JBrowse link
G Tomm20l translocase of outer mitochondrial membrane 20 like multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of TOMM20L mRNA CTD PMID:37567420 NCBI chr 6:89,594,016...89,612,070
Ensembl chr 6:89,599,873...89,610,147
JBrowse link
G Top2a DNA topoisomerase II alpha multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TOP2A mRNA CTD PMID:37567420 NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
JBrowse link
G Tp53 tumor protein p53 increases acetylation
multiple interactions
increases expression
affects localization
ISO
EXP
Glucose results in increased acetylation of TP53 protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein]
Glucose results in increased expression of TP53 mRNA; Glucose results in increased expression of TP53 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of TP53 mRNA; [Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein; [Resveratrol co-treated with AICA ribonucleotide] inhibits the reaction [Glucose results in increased expression of TP53 protein]; [Tretinoin results in increased uptake of Glucose] inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]; Glucose inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased expression of TP53 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of TP53 mRNA]; Melatonin inhibits the reaction [Glucose results in increased expression of TP53 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 protein]; Resveratrol inhibits the reaction [Glucose affects the localization of TP53 protein]; Resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of TP53 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of TP53 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]]
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TP53 protein; TP53 protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2]; TP53 protein affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
CTD PMID:20068143 PMID:21548882 PMID:23451161 PMID:24218232 PMID:24451382 More... NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
JBrowse link
G Tp63 tumor protein p63 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of TRP63 mRNA CTD PMID:37567420 NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
JBrowse link
G Tp73 tumor protein p73 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TRP73 mRNA CTD PMID:37567420 NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
JBrowse link
G Tph1 tryptophan hydroxylase 1 multiple interactions ISO TPH1 protein affects the reaction [Glucose results in increased secretion of INS protein]; TPH1 protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]; TPH1 protein affects the reaction [UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]] CTD PMID:30562058 NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
JBrowse link
G Tph2 tryptophan hydroxylase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TPH2 mRNA CTD PMID:37567420 NCBI chr 7:50,685,694...50,789,424
Ensembl chr 7:50,685,694...50,789,424
JBrowse link
G Tpsb2 tryptase beta 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TPSB2 mRNA CTD PMID:37567420 NCBI chr10:14,381,779...14,383,571
Ensembl chr10:14,382,013...14,383,569
JBrowse link
G Traf2 Tnf receptor-associated factor 2 multiple interactions
increases expression
EXP Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of TRAF2 protein] CTD PMID:34801538 NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
JBrowse link
G Traf3 Tnf receptor-associated factor 3 multiple interactions
increases expression
ISO tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein] CTD PMID:25516495 NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:130,206,484...130,305,481
JBrowse link
G Trcg1 taste receptor cell gene 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRCG1 mRNA CTD PMID:37567420 NCBI chr 8:57,633,748...57,643,007
Ensembl chr 8:57,633,840...57,642,860
JBrowse link
G Trem2 triggering receptor expressed on myeloid cells 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TREM2 mRNA CTD PMID:37567420 NCBI chr 9:12,647,605...12,654,190
Ensembl chr 9:12,647,259...12,654,170
JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions EXP TRIB3 protein affects the reaction [INS1 protein results in increased uptake of Glucose] CTD PMID:21190014 NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
JBrowse link
G Trim66 tripartite motif-containing 66 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of TRIM66 mRNA CTD PMID:37567420 NCBI chr 1:163,468,944...163,539,633
Ensembl chr 1:163,470,350...163,537,185
JBrowse link
G Trim69 tripartite motif-containing 69 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA CTD PMID:37567420 NCBI chr 3:109,111,468...109,135,255
Ensembl chr 3:109,111,468...109,132,037
JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of TRPM2 mRNA CTD PMID:37567420 NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
JBrowse link
G Trpm7 transient receptor potential cation channel, subfamily M, member 7 multiple interactions
increases expression
ISO Glucose results in increased expression of and results in increased activity of TRPM7 protein; TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]; U 0126 inhibits the reaction [TRPM7 affects the reaction [Glucose results in decreased expression of NOS3 protein]]
Glucose results in increased expression of TRPM7 mRNA
Glucose results in increased expression of and results in increased activity of TRPM7 protein; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP12 protein]; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TRPM7 protein affects the reaction [Glucose results in increased expression of DDIT3 protein]
CTD PMID:24223965 PMID:30076216 NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
JBrowse link
G Tsbp1 testis expressed basic protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TSBP1 mRNA CTD PMID:37567420 NCBI chr20:4,410,002...4,467,284
Ensembl chr20:4,410,004...4,457,053
JBrowse link
G Tsc22d1 TSC22 domain family, member 1 increases expression ISO Glucose results in increased expression of TSC22D1 mRNA CTD PMID:17178593 NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
JBrowse link
G Tshb thyroid stimulating hormone subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of TSHB mRNA CTD PMID:37567420 NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
JBrowse link
G Tshr thyroid stimulating hormone receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TSHR mRNA CTD PMID:37567420 NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
JBrowse link
G Tsku tsukushi, small leucine rich proteoglycan multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TSKU mRNA CTD PMID:37567420 NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
JBrowse link
G Tspan7 tetraspanin 7 multiple interactions EXP TSPAN7 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr  X:12,208,783...12,306,092
Ensembl chr  X:12,208,783...12,306,131
JBrowse link
G Tssk2 testis-specific serine kinase 2 decreases expression ISO Glucose results in decreased expression of TSSK2 mRNA CTD PMID:31525975 NCBI chr11:83,086,578...83,087,933 JBrowse link
G Ttc21a tetratricopeptide repeat domain 21A increases methylation
decreases expression
multiple interactions
ISO Glucose results in increased methylation of TTC21A gene
Glucose results in decreased expression of TTC21A mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of TTC21A mRNA]
CTD PMID:33448797 NCBI chr 8:119,667,044...119,702,028
Ensembl chr 8:119,666,933...119,702,456
JBrowse link
G Ttc6 tetratricopeptide repeat domain 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of TTC6 mRNA CTD PMID:37567420 NCBI chr 6:75,136,827...75,368,176
Ensembl chr 6:75,136,792...75,368,178
JBrowse link
G Ttk Ttk protein kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA CTD PMID:37567420 NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
JBrowse link
G Tuba1a tubulin, alpha 1A multiple interactions EXP TUBA1A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
JBrowse link
G Tubb2a tubulin, beta 2A class IIa increases expression ISO Glucose results in increased expression of TUBB2A mRNA CTD PMID:17178593 NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
JBrowse link
G Tubb6 tubulin, beta 6 class V increases expression ISO Glucose results in increased expression of TUBB6 mRNA CTD PMID:17178593 NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
JBrowse link
G Tug1 taurine up-regulated 1 multiple interactions
decreases expression
ISO Glucose promotes the reaction [HDAC1 protein binds to TUG1 promoter]; Glucose promotes the reaction [MLX protein binds to TUG1 promoter]; Glucose promotes the reaction [MLXIP protein binds to TUG1 promoter]; Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter]; Glucose promotes the reaction [MXD1 protein binds to TUG1 promoter]
Glucose results in decreased expression of TUG1 mRNA
CTD PMID:32467232 NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
JBrowse link
G Tvp23a trans-golgi network vesicle protein 23 homolog A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of TVP23A mRNA CTD PMID:37567420 NCBI chr10:5,227,198...5,263,185
Ensembl chr10:5,227,220...5,263,180
JBrowse link
G Twist1 twist family bHLH transcription factor 1 decreases expression
increases expression
ISO Glucose deficiency results in decreased expression of TWIST1 mRNA
Glucose results in increased expression of TWIST1 protein
CTD PMID:35427737 PMID:35445903 NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
JBrowse link
G Txn1 thioredoxin 1 multiple interactions
increases secretion
decreases expression
EXP
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; 8-bromocyclic GMP inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]; KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]]
Glucose deficiency results in increased secretion of TXN protein
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]
CTD PMID:17178593 PMID:20453393 PMID:24802182 PMID:26660634 NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
JBrowse link
G Txnip thioredoxin interacting protein decreases expression
increases response to substance
increases expression
multiple interactions
increases activity
ISO
EXP
Glucose deficiency results in decreased expression of TXNIP mRNA; Glucose deficiency results in decreased expression of TXNIP protein
TXNIP mRNA results in increased susceptibility to Glucose
Glucose results in increased expression of TXNIP protein
Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein]; Quercetin inhibits the reaction [Glucose results in increased expression of TXNIP protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of TXNIP protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of TXNIP protein]; TXNIP protein affects the reaction [Glucose results in increased expression of CERT1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 protein]
[Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein; Allopurinol inhibits the reaction [Glucose results in increased expression of TXNIP protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of TXNIP protein]; Quercetin inhibits the reaction [Glucose results in increased expression of TXNIP protein]; TXNIP mRNA promotes the reaction [Glucose results in decreased expression of PPARA protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of TXNIP protein]
[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA; [Glucose results in decreased expression of MIR17 mRNA] which results in increased stability of TXNIP protein; [NFE2L2 protein binds to TXNIP promoter] inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]; Glucose promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species]; GPD2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; NFE2L2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMB2 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMB3 mRNA]; TXNIP promotes the reaction [Glucose results in increased expression of LAMC1 mRNA]
Glucose results in increased expression of TXNIP mRNA; Glucose results in increased expression of TXNIP protein
Glucose results in increased activity of TXNIP mRNA
CTD PMID:17178593 PMID:20195491 PMID:21832250 PMID:22869588 PMID:23647015 More... NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO Glucose results in increased expression of TXNRD1 mRNA CTD PMID:32942007 NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
JBrowse link
G Ubd ubiquitin D multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UBD mRNA CTD PMID:37567420 NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639
Ensembl chr20:1,385,864...1,408,639
JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA CTD PMID:37567420 NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
JBrowse link
G Ube2l6 ubiquitin-conjugating enzyme E2L 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2L6 mRNA CTD PMID:37567420 NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
JBrowse link
G Uchl3 ubiquitin C-terminal hydrolase L3 increases secretion ISO Glucose deficiency results in increased secretion of UCHL3 protein CTD PMID:24802182 NCBI chr15:78,485,304...78,527,355
Ensembl chr15:78,485,315...78,527,355
Ensembl chr 3:78,485,315...78,527,355
JBrowse link
G Ucp1 uncoupling protein 1 multiple interactions
decreases response to substance
EXP
ISO
UCP1 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; UCP1 protein inhibits the reaction [Glucose results in increased chemical synthesis of Dinoprostone]; UCP1 protein inhibits the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; UCP1 protein inhibits the reaction [Glucose results in increased expression of SERPINE1 mRNA]; UCP1 protein inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; UCP1 protein inhibits the reaction [Glucose results in increased O-linked glycosylation of SP1 protein]
UCP1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER protein]; UCP1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; UCP1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]
UCP1 protein results in decreased susceptibility to Glucose
CTD PMID:11050244 PMID:14514642 PMID:14523042 PMID:19833897 NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
JBrowse link
G Ucp2 uncoupling protein 2 increases expression
multiple interactions
ISO
EXP
Glucose results in increased expression of UCP2 protein
Glucose results in increased expression of UCP2 mRNA
[copper bis(3,5-diisopropylsalicylate) co-treated with Glucose] results in increased expression of UCP2 protein; [ebselen co-treated with Glucose] results in decreased expression of UCP2 protein; [Sodium Selenite co-treated with Glucose] results in decreased expression of UCP2 protein
[SIRT1 protein results in decreased expression of UCP2 mRNA] promotes the reaction [Glucose results in increased abundance of Adenosine Triphosphate]; UCP2 protein inhibits the reaction [SIRT1 protein promotes the reaction [Glucose results in increased expression of INS1 protein]]
CTD PMID:16366736 PMID:18167556 PMID:23795780 PMID:28027979 NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
JBrowse link
G Ucp3 uncoupling protein 3 decreases expression
multiple interactions
ISO Glucose results in decreased expression of UCP3 protein
UCP3 protein promotes the reaction [Glucose results in increased secretion of INS protein]
CTD PMID:18167556 NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of UGT1A1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A1 mRNA CTD PMID:37567420 NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of UGT1A2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A2 mRNA CTD PMID:37567420 NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 multiple interactions ISO TPH1 protein affects the reaction [UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]]]; UGT1A6A protein affects the reaction [sodium arsenite inhibits the reaction [Glucose results in increased secretion of INS protein]] CTD PMID:30562058 NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UGT1A9 mRNA CTD PMID:37567420 NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UHRF1 mRNA CTD PMID:37567420 NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 affects phosphorylation
multiple interactions
EXP Glucose affects the phosphorylation of ULK1 protein
3-methyladenine affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; bafilomycin A1 affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]; Sirolimus affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; ULK1 protein affects the reaction [Glucose affects the phosphorylation of ULK1 protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [Glucose results in decreased expression of MAP1LC3B protein]; ULK1 protein affects the reaction [Glucose results in increased expression of SQSTM1 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]]
CTD PMID:29128638 NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
JBrowse link
G Unc13c unc-13 homolog C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of UNC13C mRNA CTD PMID:37567420 NCBI chr 8:74,247,026...74,697,629
Ensembl chr 8:74,247,899...74,673,223
JBrowse link
G Unc79 unc-79 homolog, NALCN channel complex subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of UNC79 mRNA CTD PMID:37567420 NCBI chr 6:122,082,369...122,327,641
Ensembl chr 6:122,080,308...122,327,591
JBrowse link
G Unc80 unc-80 homolog, NALCN channel complex subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of UNC80 mRNA CTD PMID:37567420 NCBI chr 9:68,011,940...68,190,135
Ensembl chr 9:68,011,728...68,187,659
JBrowse link
G Upp2 uridine phosphorylase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of UPP2 mRNA CTD PMID:37567420 NCBI chr 3:43,273,048...43,317,417
Ensembl chr 3:43,273,048...43,317,417
JBrowse link
G Usf2 upstream transcription factor 2, c-fos interacting increases activity ISO Glucose results in increased activity of USF2 protein CTD PMID:15767253 NCBI chr 1:86,174,703...86,185,942
Ensembl chr 1:86,174,703...86,185,617
JBrowse link
G Vash2 vasohibin 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of VASH2 mRNA CTD PMID:37567420 NCBI chr13:102,529,718...102,561,204
Ensembl chr13:102,529,719...102,560,391
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions
increases secretion
increases expression
ISO
EXP
5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; [Glucose co-treated with Serotonin] results in increased expression of VCAM1 protein; aspalathin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; Mannitol inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Mannitol inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased secretion of VCAM1 protein]; nothofagin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; Polyphenols inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Rimonabant inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; sarpogrelate inhibits the reaction [[Glucose co-treated with Serotonin] results in increased expression of VCAM1 protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of VCAM1 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of VCAM1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of VCAM1 mRNA
Curcumin analog inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of VCAM1 mRNA]
Glucose results in increased expression of VCAM1 mRNA; Glucose results in increased expression of VCAM1 protein
CTD PMID:15304054 PMID:16285992 PMID:21373835 PMID:21682256 PMID:22785018 More... NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
JBrowse link
G Vcl vinculin multiple interactions
decreases expression
increases expression
ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of VCL protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of VCL protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]] CTD PMID:31483951 NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606
JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VDAC1 protein]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; VDAC1 protein results in increased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:25488258 NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
JBrowse link
G Vdr vitamin D receptor multiple interactions EXP [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA; [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR protein; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA]; Calcitriol inhibits the reaction [[Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR protein] CTD PMID:21788014 NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
JBrowse link
G Vegfa vascular endothelial growth factor A increases secretion
decreases expression
multiple interactions
increases expression
ISO
EXP
Glucose deficiency results in increased secretion of VEGFA protein
Glucose results in decreased expression of VEGFA mRNA
[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA protein; [Glucose co-treated with Deferoxamine] results in increased expression of VEGFA mRNA; [Glucose co-treated with Resveratrol] results in decreased expression of VEGFA mRNA; Fluorometholone inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of VEGFA protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of VEGFA mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA protein]
[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of VEGFA protein]; HIF1A protein affects the reaction [Glucose results in increased expression of VEGFA protein]; manumycin inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of VEGFA protein]; resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]; rosiglitazone inhibits the reaction [Glucose results in decreased expression of VEGFA mRNA]; Simvastatin inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of VEGFA protein]]
Glucose results in increased expression of VEGFA mRNA; Glucose results in increased expression of VEGFA protein
2-methoxyestradiol inhibits the reaction [Glucose results in increased expression of VEGFA protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in increased expression of VEGFA protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of VEGFA protein
Glucose deficiency results in increased expression of VEGFA mRNA; Glucose results in increased expression of VEGFA mRNA; Glucose results in increased expression of VEGFA protein
CTD PMID:12147617 PMID:18569938 PMID:19228841 PMID:19609456 PMID:19759273 More... NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
JBrowse link
G Vegfd vascular endothelial growth factor D increases expression ISO Glucose results in increased expression of VEGFD mRNA CTD PMID:17178593 NCBI chr  X:30,073,122...30,108,413
Ensembl chr  X:30,074,163...30,108,295
JBrowse link
G Vim vimentin multiple interactions
increases secretion
increases expression
ISO [Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of VIM protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of VIM mRNA]
Glucose deficiency results in increased secretion of VIM protein
Glucose results in increased expression of VIM mRNA; Glucose results in increased expression of VIM protein
CTD PMID:21829520 PMID:24802182 PMID:33992720 PMID:35445903 NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
JBrowse link
G Vpreb3 V-set pre-B cell surrogate light chain 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of VPREB3 mRNA CTD PMID:37567420 NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
JBrowse link
G Vwa1 von Willebrand factor A domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of VWA1 mRNA CTD PMID:37567420 NCBI chr 5:166,377,451...166,382,784
Ensembl chr 5:166,377,455...166,382,637
JBrowse link
G Vwf von Willebrand factor decreases expression ISO Glucose results in decreased expression of VWF mRNA CTD PMID:31655124 NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
JBrowse link
G Wdr17 WD repeat domain 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of WDR17 mRNA CTD PMID:37567420 NCBI chr16:37,059,923...37,191,125
Ensembl chr16:37,059,895...37,191,122
JBrowse link
G Wdr35 WD repeat domain 35 multiple interactions
increases expression
EXP WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]
Glucose results in increased expression of WDR35 mRNA
CTD PMID:20224876 NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
JBrowse link
G Wfikkn2 WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA CTD PMID:37567420 NCBI chr10:79,185,563...79,191,657
Ensembl chr10:79,186,647...79,191,657
JBrowse link
G Wnk2 WNK lysine deficient protein kinase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of WNK2 mRNA CTD PMID:37567420 NCBI chr17:15,503,672...15,612,479
Ensembl chr17:15,504,261...15,612,479
JBrowse link
G Wnt1 Wnt family member 1 increases expression ISO Glucose results in increased expression of WNT1 mRNA CTD PMID:29163160 NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
JBrowse link
G Wnt3a Wnt family member 3A decreases expression EXP Glucose results in decreased expression of WNT3A mRNA CTD PMID:21818840 NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
JBrowse link
G Wnt4 Wnt family member 4 multiple interactions
decreases expression
EXP Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT4 mRNA] CTD PMID:18004065 NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
JBrowse link
G Wnt5a Wnt family member 5A multiple interactions
increases expression
decreases expression
EXP
ISO
Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA]
Glucose results in increased expression of WNT5A mRNA
CTD PMID:18004065 PMID:29163160 NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
JBrowse link
G Wnt7a Wnt family member 7A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of WNT7A mRNA CTD PMID:37567420 NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
JBrowse link
G Wnt7b Wnt family member 7B multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of WNT7B mRNA] CTD PMID:33448797 NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
JBrowse link
G Wwp1 WW domain containing E3 ubiquitin protein ligase 1 decreases expression ISO Glucose results in decreased expression of WWP1 mRNA CTD PMID:17178593 NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
JBrowse link
G Xaf1 XIAP associated factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of XAF1 mRNA CTD PMID:37567420 NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
JBrowse link
G Xbp1 X-box binding protein 1 decreases expression
multiple interactions
increases splicing
increases expression
ISO
EXP
Glucose results in decreased expression of XBP1 mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]
Glucose deficiency results in increased splicing of XBP1 mRNA
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased splicing of XBP1 mRNA]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]
Glucose deficiency results in increased expression of XBP1 protein; Glucose results in increased expression of XBP1 mRNA
CTD PMID:17178593 PMID:21337367 PMID:24349266 PMID:31022492 PMID:34801538 NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
JBrowse link
G Xcr1 X-C motif chemokine receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of XCR1 mRNA CTD PMID:37567420 NCBI chr 8:123,479,454...123,516,168
Ensembl chr 8:123,479,590...123,487,226
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased abundance of Proteoglycans]; [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA] CTD PMID:11801247 NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
JBrowse link
G Xkr5 XK related 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of XKR5 mRNA CTD PMID:37567420 NCBI chr16:70,874,983...70,892,972
Ensembl chr16:70,875,093...70,892,967
JBrowse link
G Xrcc5 X-ray repair cross complementing 5 multiple interactions ISO [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
JBrowse link
G Xrcc6 X-ray repair cross complementing 6 multiple interactions ISO [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein]
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [[Glucose co-treated with Bupivacaine] results in increased expression of XRCC6 protein]; [Glucose co-treated with Bupivacaine] results in increased expression of XRCC6 protein; Glucose inhibits the reaction [Bupivacaine results in increased expression of XRCC6 protein]
CTD PMID:22926048 PMID:31672611 NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
JBrowse link
G Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta multiple interactions ISO YWHAZ protein affects the reaction [G3BP1 protein results in increased uptake of Glucose] CTD PMID:35945655 NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
JBrowse link
G Yy1 YY1 transcription factor multiple interactions ISO [Glucose promotes the reaction [MTOR protein binds to YY1 protein]] which results in increased expression of YY1 protein; Glucose promotes the reaction [YY1 protein binds to PPARGC1A promoter]; Glucose results in increased expression of and affects the localization of YY1 protein; YY1 promotes the reaction [Glucose results in decreased expression of PPARGC1A protein]
Sirolimus inhibits the reaction [Glucose results in increased phosphorylation of YY1 protein]
CTD PMID:35445903 NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
JBrowse link
G Zap70 zeta chain of T cell receptor associated protein kinase 70 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ZAP70 mRNA CTD PMID:37567420 NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ZBTB16 mRNA CTD PMID:37567420 NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
JBrowse link
G Zdhhc19 zinc finger DHHC-type palmitoyltransferase 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ZDHHC19 mRNA CTD PMID:37567420 NCBI chr11:68,277,847...68,289,110
Ensembl chr11:68,277,848...68,288,954
JBrowse link
G Zfand4 zinc finger AN1-type containing 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ZFAND4 mRNA CTD PMID:37567420 NCBI chr 4:149,327,339...149,399,495
Ensembl chr 4:149,327,412...149,399,487
JBrowse link
G Zfp386 zinc finger protein 386 (Kruppel-like) decreases expression ISO Glucose results in decreased expression of ZFP386 mRNA CTD PMID:17178593 NCBI chr 6:136,966,547...136,984,013
Ensembl chr 6:136,966,586...136,983,441
JBrowse link
G Zfp521 zinc finger protein 521 increases expression
multiple interactions
decreases expression
ISO Glucose results in increased expression of ZFP521 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ZFP521 mRNA]
CTD PMID:16805838 PMID:33448797 NCBI chr18:4,775,952...5,068,592
Ensembl chr18:4,787,295...5,068,458
JBrowse link
G Zfp566 zinc finger protein 566 increases expression
multiple interactions
ISO Glucose results in increased expression of ZFP566 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ZFP566 mRNA]
CTD PMID:33448797 NCBI chr 1:85,318,449...85,342,186
Ensembl chr 1:85,318,452...85,333,161
JBrowse link
G Zfp647 zinc finger protein 647 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ZFP647 mRNA CTD PMID:37567420 NCBI chr 7:108,632,248...108,649,264
Ensembl chr 7:108,632,250...108,637,433
JBrowse link
G Zfp68 zinc finger protein 68 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ZFP300 mRNA CTD PMID:37567420 NCBI chr12:16,026,058...16,040,995
Ensembl chr12:16,026,079...16,040,995
JBrowse link
G Zfp683 zinc finger protein 683 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ZFP683 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ZFP683 mRNA CTD PMID:37567420 NCBI chr 5:146,277,972...146,285,856
Ensembl chr 5:146,278,978...146,285,000
JBrowse link
G Zic2 Zic family member 2 decreases expression ISO Glucose results in decreased expression of ZIC2 mRNA CTD PMID:31525975 NCBI chr15:99,576,697...99,581,522
Ensembl chr15:99,576,697...99,581,522
JBrowse link
G Zkscan2 zinc finger with KRAB and SCAN domains 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of ZKSCAN2 mRNA CTD PMID:37567420 NCBI chr 1:178,006,003...178,028,239
Ensembl chr 1:178,009,238...178,028,131
JBrowse link
G Zwint ZW10 interacting kinetochore protein multiple interactions EXP ZWINT protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
JBrowse link
G Zxdb zinc finger, X-linked, duplicated B multiple interactions
decreases expression
ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of ZXDA mRNA] CTD PMID:33448797 NCBI chr  X:59,700,765...59,706,737
Ensembl chr  X:59,701,178...59,703,871
Ensembl chr  X:59,701,178...59,703,871
JBrowse link
3-O-methyl-D-glucose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ins1 insulin 1 multiple interactions
increases transport
increases uptake
EXP Manganese deficiency inhibits the reaction [INS1 protein results in increased uptake of 3-O-Methylglucose]; oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of 3-O-Methylglucose]; pervanadate promotes the reaction [INS1 protein results in increased uptake of 3-O-Methylglucose]; Quercetin inhibits the reaction [pervanadate promotes the reaction [INS1 protein results in increased uptake of 3-O-Methylglucose]] CTD PMID:2185640 PMID:2204694 PMID:8404595 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions
increases uptake
decreases transport
ISO Pentobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose]; Pentobarbital promotes the reaction [SLC2A1 gene polymorphism results in decreased uptake of 3-O-Methylglucose]; Phenobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose]; Phenobarbital promotes the reaction [SLC2A1 gene polymorphism results in decreased uptake of 3-O-Methylglucose]
SLC2A1 protein mutant form results in decreased transport of 3-O-Methylglucose
CTD PMID:10590023 PMID:11603379 NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions
increases uptake
ISO
EXP
Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]; Phloretin inhibits the reaction [Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]]; Phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]
Cytochalasin B inhibits the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]; Mercuric Chloride inhibits the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]
CTD PMID:10825458 PMID:15986457 NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
JBrowse link
aldehydo-D-glucosamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aacs acetoacetyl-CoA synthetase increases expression ISO Glucosamine results in increased expression of AACS mRNA CTD PMID:17178593 NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 increases expression EXP Glucosamine results in increased expression of ABCG1 mRNA CTD PMID:17109745 NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases expression ISO Glucosamine results in increased expression of ACACA mRNA CTD PMID:22096489 NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
JBrowse link
G Acan aggrecan multiple interactions
increases expression
decreases expression
affects expression
ISO
EXP
Glucosamine analog affects the reaction [IL1B results in decreased expression of ACAN mRNA]; Glucosamine inhibits the reaction [IL1B protein results in decreased expression of ACAN mRNA]; Glucosamine results in decreased cleavage of and results in decreased secretion of ACAN protein
Glucosamine results in increased expression of ACAN mRNA
Glucosamine inhibits the reaction [IL1B results in decreased expression of ACAN mRNA]
Glucosamine analog results in increased expression of ACAN protein; Glucosamine results in increased expression of ACAN mRNA; Glucosamine results in increased expression of ACAN protein
Glucosamine analog results in decreased expression of ACAN mRNA
Glucosamine analog affects the expression of ACAN mRNA
CTD PMID:12801482 PMID:16300972 PMID:16872674 PMID:17109745 PMID:17337215 More... NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression ISO Glucosamine results in increased expression of ACOT1 mRNA CTD PMID:17178593 NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression ISO Glucosamine results in decreased expression of ACOX2 mRNA CTD PMID:17178593 NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Glucosamine results in increased expression of ACSS2 mRNA CTD PMID:17178593 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
JBrowse link
G Adam15 ADAM metallopeptidase domain 15 multiple interactions
decreases expression
EXP Glucosamine affects the reaction [IL1B results in decreased expression of ADAM15 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of ADAM15 mRNA] CTD PMID:17109745 NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
JBrowse link
G Adam17 ADAM metallopeptidase domain 17 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of ADAM17 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of ADAM17 mRNA] CTD PMID:17109745 NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 decreases expression
multiple interactions
ISO
EXP
Glucosamine analog results in decreased expression of ADAMTS1 mRNA
Glucosamine results in decreased expression of ADAMTS1 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of ADAMTS1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of ADAMTS1 mRNA]
CTD PMID:16300972 PMID:17109745 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
JBrowse link
G Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 decreases cleavage ISO Glucosamine results in decreased cleavage of ADAMTS20 protein alternative form CTD PMID:19909832 NCBI chr 7:125,396,227...125,528,020
Ensembl chr 7:125,397,734...125,527,777
JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 increases expression EXP Glucosamine results in increased expression of ADAMTS4 mRNA CTD PMID:17109745 NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif, 5 decreases expression
multiple interactions
ISO Glucosamine analog results in decreased expression of ADAMTS5 mRNA
Glucosamine results in decreased cleavage of and results in decreased activity of ADAMTS5 protein alternative form
CTD PMID:16300972 PMID:19909832 NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 decreases cleavage ISO Glucosamine results in decreased cleavage of ADAMTS9 protein alternative form CTD PMID:19909832 NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing increases expression ISO
EXP
Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
JBrowse link
G Afp alpha-fetoprotein increases expression ISO Glucosamine results in increased expression of AFP mRNA CTD PMID:17178593 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
JBrowse link
G Agt angiotensinogen increases expression ISO Glucosamine results in increased expression of AGT mRNA CTD PMID:17178593 NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
JBrowse link
G Ahi1 Abelson helper integration site 1 decreases expression ISO Glucosamine results in decreased expression of AHI1 mRNA CTD PMID:17178593 NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
JBrowse link
G Akt1 AKT serine/threonine kinase 1 affects phosphorylation
multiple interactions
ISO Glucosamine analog affects the phosphorylation of AKT1 protein
Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]
Glucosamine analog affects the reaction [IL1B results in increased phosphorylation of AKT1 protein]; Glucosamine promotes the reaction [IL1B results in increased phosphorylation of AKT1 protein]
CTD PMID:18080321 PMID:18340449 PMID:30602124 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Alb albumin multiple interactions EXP [LEPR protein affects the susceptibility to Glucosamine] which affects the expression of ALB protein CTD PMID:33345901 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase decreases expression ISO Glucosamine results in decreased expression of ALG12 mRNA CTD PMID:17178593 NCBI chr 7:119,895,112...119,909,488
Ensembl chr 7:119,895,120...119,909,458
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
increases expression
increases activity
ISO 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein]
Glucosamine analog results in increased expression of ALPL mRNA
CTD PMID:20458730 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
JBrowse link
G Apoa1 apolipoprotein A1 increases secretion
increases stability
ISO Glucosamine results in increased secretion of APOA1 protein
Glucosamine results in increased stability of APOA1 mRNA
CTD PMID:15164326 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
JBrowse link
G Apob apolipoprotein B multiple interactions
increases degradation
increases ubiquitination
decreases secretion
decreases localization
decreases expression
ISO
EXP
acetylleucyl-leucyl-norleucinal inhibits the reaction [Glucosamine results in decreased expression of and results in decreased secretion of APOB protein]; Glucosamine results in decreased expression of and results in decreased secretion of APOB protein; Oleic Acid inhibits the reaction [Glucosamine results in decreased secretion of APOB protein]
Oleic Acid inhibits the reaction [Glucosamine results in increased degradation of APOB protein]
Glucosamine results in increased ubiquitination of APOB protein
Glucosamine results in decreased localization of APOB protein
Glucosamine results in decreased expression of APOB protein
CTD PMID:15618547 PMID:19383982 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
JBrowse link
G Apoe apolipoprotein E multiple interactions ISO [Streptozocin co-treated with APOE mutant form] results in increased abundance of Glucosamine; INS1 inhibits the reaction [[Streptozocin co-treated with APOE mutant form] results in increased abundance of Glucosamine] CTD PMID:16380481 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
JBrowse link
G Ass1 argininosuccinate synthase 1 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of ASS1 mRNA] CTD PMID:17109745 NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
JBrowse link
G Atf3 activating transcription factor 3 decreases expression ISO Glucosamine results in decreased expression of ATF3 mRNA CTD PMID:17178593 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
JBrowse link
G Atf4 activating transcription factor 4 increases expression
multiple interactions
ISO Glucosamine results in increased expression of ATF4 mRNA; Glucosamine results in increased expression of ATF4 protein
NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF4 mRNA]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF4 protein]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of ATF4 mRNA]; GSK2656157 inhibits the reaction [Glucosamine results in increased expression of ATF4 mRNA]
CTD PMID:30602124 PMID:33812996 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
JBrowse link
G Atf6 activating transcription factor 6 multiple interactions
increases expression
decreases expression
ISO
EXP
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]
Glucosamine results in increased expression of ATF6 protein
ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]
Glucosamine results in decreased expression of ATF6 mRNA
CTD PMID:17178593 PMID:19383982 PMID:20165829 PMID:30602124 PMID:33812996 NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
JBrowse link
G Atf7ip activating transcription factor 7 interacting protein increases expression ISO Glucosamine results in increased expression of ATF7IP mRNA CTD PMID:17178593 NCBI chr 4:169,385,872...169,471,652
Ensembl chr 4:169,385,872...169,471,650
JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 decreases expression ISO Glucosamine results in decreased expression of ATP2A2 mRNA CTD PMID:17178593 NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
JBrowse link
G Azin1 antizyme inhibitor 1 decreases expression
multiple interactions
EXP Glucosamine results in decreased expression of AZIN1 mRNA
IL1B promotes the reaction [Glucosamine results in increased expression of AZIN1 mRNA]
CTD PMID:17109745 NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
JBrowse link
G B3gat3 beta-1,3-glucuronyltransferase 3 multiple interactions
increases expression
EXP [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucosamine results in increased expression of B3GAT3 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in decreased activity of B3GAT3 protein]; Glucosamine inhibits the reaction [IL1B protein results in decreased expression of B3GAT3 mRNA] CTD PMID:11229466 PMID:11801247 NCBI chr 1:205,817,374...205,823,928
Ensembl chr 1:205,817,378...205,837,807
JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression
multiple interactions
ISO Glucosamine results in decreased expression of BCL2L1 protein
pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein]
CTD PMID:15972124 PMID:16850161 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression ISO Glucosamine results in decreased expression of BDNF mRNA CTD PMID:17178593 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
JBrowse link
G Bglap bone gamma-carboxyglutamate protein increases expression ISO Glucosamine analog results in increased expression of BGLAP mRNA CTD PMID:20458730 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
JBrowse link
G Bgn biglycan multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of BGN mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of BGN mRNA] CTD PMID:17109745 NCBI chr  X:151,197,296...151,209,458
Ensembl chr  X:151,197,273...151,209,461
JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression ISO Glucosamine results in decreased expression of BMAL1 mRNA; Glucosamine results in decreased expression of BMAL1 protein CTD PMID:24442997 NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of BMP2 mRNA] CTD PMID:17109745 NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
JBrowse link
G Bmp4 bone morphogenetic protein 4 decreases expression
multiple interactions
EXP Glucosamine results in decreased expression of BMP4 mRNA
Glucosamine promotes the reaction [IL1B results in decreased expression of BMP4 mRNA]
CTD PMID:17109745 NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of BMP6 mRNA]
Glucosamine results in decreased expression of BMP6 mRNA
CTD PMID:17109745 NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of BMP7 mRNA]
Glucosamine results in increased expression of BMP7 mRNA
CTD PMID:17109745 NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
JBrowse link
G Calr calreticulin decreases expression ISO Glucosamine results in decreased expression of CALR mRNA CTD PMID:17178593 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Car3 carbonic anhydrase 3 decreases expression EXP Glucosamine results in decreased expression of CAR3 mRNA CTD PMID:17109745 NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
ISO Glucosamine results in increased cleavage of CASP3 protein
Glucosamine results in increased activity of and results in increased cleavage of CASP3 protein
CTD PMID:16850161 PMID:22020377 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp4 caspase 4 decreases expression ISO Glucosamine results in decreased expression of CASP4 mRNA CTD PMID:17178593 NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
JBrowse link
G Cbr2 carbonyl reductase 2 increases expression ISO Glucosamine results in increased expression of CBR2 mRNA CTD PMID:17178593 NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO Glucosamine results in increased expression of CBR3 mRNA CTD PMID:17178593 NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
ISO
EXP
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of CCL2 protein]]; Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL2 protein]; Glucosamine inhibits the reaction [Cathelicidins results in increased expression of CCL2 mRNA]; Glucosamine inhibits the reaction [Cathelicidins results in increased expression of CCL2 protein]; Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 protein]
Glucosamine results in increased expression of CCL2 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of CCL2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CCL2 mRNA]
CTD PMID:17109745 PMID:18080321 PMID:18949387 PMID:19020780 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CCL20 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CCL20 mRNA] CTD PMID:17109745 NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
JBrowse link
G Ccl22 C-C motif chemokine ligand 22 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CCL22 mRNA] CTD PMID:17109745 NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CCL3 mRNA] CTD PMID:17109745 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO
EXP
Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein]
Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA]
CTD PMID:17109745 PMID:18080321 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CCL7 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CCL7 mRNA] CTD PMID:17109745 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
JBrowse link
G Ccn2 cellular communication network factor 2 increases expression EXP Glucosamine analog results in increased expression of CCN2 mRNA CTD PMID:21466783 NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
JBrowse link
G Ccnb1 cyclin B1 decreases expression EXP Glucosamine results in decreased expression of CCNB1 mRNA CTD PMID:17109745 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
JBrowse link
G Cd24 CD24 molecule increases expression ISO Glucosamine results in increased expression of CD24A mRNA CTD PMID:17178593 NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
JBrowse link
G Cd28 Cd28 molecule increases expression EXP Glucosamine results in increased expression of CD28 mRNA CTD PMID:17109745 NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
JBrowse link
G Cdc20 cell division cycle 20 decreases expression EXP Glucosamine results in decreased expression of CDC20 mRNA CTD PMID:17109745 NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
JBrowse link
G Cdc23 cell division cycle 23 decreases expression EXP Glucosamine results in decreased expression of CDC23 mRNA CTD PMID:17109745 NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression EXP Glucosamine results in decreased expression of CDK1 mRNA CTD PMID:17109745 NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression EXP
ISO
Glucosamine results in increased expression of CDKN1A protein
Glucosamine results in increased expression of CDKN1A mRNA
CTD PMID:15654767 PMID:17178593 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression EXP Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression EXP Glucosamine results in decreased expression of CDKN3 mRNA CTD PMID:17109745 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
JBrowse link
G Cenpf centromere protein F decreases expression EXP Glucosamine results in decreased expression of CENPF mRNA CTD PMID:17109745 NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
JBrowse link
G Chi3l1 chitinase 3 like 1 decreases expression ISO Glucosamine analog results in decreased expression of CHI3L1 mRNA CTD PMID:16142878 NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex multiple interactions
decreases activity
ISO Glucosamine analog results in decreased activity of and results in decreased localization of CHUK protein
Glucosamine analog results in decreased activity of CHUK protein
CTD PMID:20113495 NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
JBrowse link
G Ckap2 cytoskeleton associated protein 2 decreases expression EXP Glucosamine results in decreased expression of CKAP2 mRNA CTD PMID:17109745 NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
JBrowse link
G Clock clock circadian regulator decreases expression ISO Glucosamine results in decreased expression of CLOCK mRNA; Glucosamine results in decreased expression of CLOCK protein CTD PMID:24442997 NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
JBrowse link
G Clta clathrin, light chain A decreases expression EXP Glucosamine results in decreased expression of CLTA mRNA CTD PMID:17109745 NCBI chr 5:58,244,253...58,263,480
Ensembl chr 5:58,245,442...58,263,472
JBrowse link
G Col11a1 collagen type XI alpha 1 chain multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of COL11A1 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of COL11A1 mRNA] CTD PMID:17109745 NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions
decreases expression
ISO Glucosamine inhibits the reaction [IL1B protein results in increased expression of COL1A1 mRNA]
Glucosamine results in decreased expression of COL1A1 mRNA
CTD PMID:18321735 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
JBrowse link
G Col2a1 collagen type II alpha 1 chain multiple interactions
affects expression
increases expression
ISO
EXP
Glucosamine analog affects the reaction [IL1B results in decreased expression of COL2A1 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in decreased expression of COL2A1 mRNA]
Glucosamine inhibits the reaction [IL1B results in decreased expression of COL2A1 mRNA]
Glucosamine analog affects the expression of COL2A1 mRNA
Glucosamine analog results in increased expression of COL2A1 mRNA; Glucosamine results in increased expression of COL2A1 mRNA
CTD PMID:16300972 PMID:17109745 PMID:17337215 PMID:18321735 NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of COL3A1 mRNA] CTD PMID:17109745 NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
JBrowse link
G Col8a1 collagen type VIII alpha 1 chain multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of COL8A1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of COL8A1 mRNA] CTD PMID:17109745 NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CSF1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of CSF1 mRNA] CTD PMID:17109745 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CSF2 mRNA]
Glucosamine results in increased expression of CSF2 mRNA
CTD PMID:17109745 NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
JBrowse link
G Csf3 colony stimulating factor 3 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CSF3 mRNA]
Glucosamine results in increased expression of CSF3 mRNA
CTD PMID:17109745 NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
JBrowse link
G Ctsd cathepsin D affects localization
multiple interactions
increases activity
decreases expression
ISO Glucosamine affects the localization of CTSD protein
pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form]
Glucosamine results in increased activity of CTSD protein
CTD PMID:15972124 PMID:16850161 NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
JBrowse link
G Cul2 cullin 2 multiple interactions ISO Glucosamine analog inhibits the reaction [TNF results in increased expression of CUL2 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of CUL2 mRNA] CTD PMID:18173918 NCBI chr17:54,169,093...54,210,197
Ensembl chr17:54,169,086...54,209,968
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of CXCL1 mRNA] CTD PMID:17109745 NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO
EXP
Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]
Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA]
CTD PMID:17109745 PMID:20737476 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL11 mRNA] CTD PMID:17109745 NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
decreases expression
EXP Glucosamine promotes the reaction [IL1B results in decreased expression of CXCL12 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of CXCL12 mRNA] CTD PMID:17109745 NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CXCL2 mRNA] CTD PMID:17109745 NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL3 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CXCL3 mRNA] CTD PMID:17109745 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL5 mRNA] CTD PMID:17109745 NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
JBrowse link
G Cyba cytochrome b-245 alpha chain decreases expression ISO Glucosamine results in decreased expression of CYBA mRNA CTD PMID:18077487 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
JBrowse link
G Cycs cytochrome c, somatic affects localization ISO Glucosamine affects the localization of CYCS protein CTD PMID:15972124 PMID:22020377 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
Ensembl chr18:79,651,378...79,654,054
JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression ISO Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
JBrowse link
G Dbi diazepam binding inhibitor increases expression ISO Glucosamine results in increased expression of DBI mRNA CTD PMID:17178593 NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions
decreases expression
ISO Glucosamine results in increased expression of DDIT3 mRNA; Glucosamine results in increased expression of DDIT3 protein
NUS1 protein inhibits the reaction [Glucosamine results in increased expression of DDIT3 mRNA]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of DDIT3 protein]
Glucosamine results in decreased expression of DDIT3 mRNA
CTD PMID:16380481 PMID:17178593 PMID:30602124 PMID:33812996 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression EXP Glucosamine results in increased expression of DDIT4L mRNA CTD PMID:17109745 NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase increases expression ISO Glucosamine results in increased expression of DHCR7 mRNA CTD PMID:17178593 NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 decreases expression ISO Glucosamine results in decreased expression of DNAJB11 mRNA CTD PMID:17178593 NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 decreases expression ISO Glucosamine results in decreased expression of DNAJB9 mRNA CTD PMID:17178593 NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 decreases expression ISO Glucosamine results in decreased expression of DNAJC3 mRNA CTD PMID:17178593 NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
JBrowse link
G Dspp dentin sialophosphoprotein decreases expression ISO Glucosamine analog results in decreased expression of DSPP mRNA CTD PMID:20458730 NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA]
Glucosamine results in increased expression of DUSP5 mRNA
CTD PMID:17109745 NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
JBrowse link
G Dusp7 dual specificity phosphatase 7 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP7 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of DUSP7 mRNA] CTD PMID:17109745 NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
JBrowse link
G Dync1i1 dynein cytoplasmic 1 intermediate chain 1 decreases expression EXP Glucosamine results in decreased expression of DYNC1I1 mRNA CTD PMID:17109745 NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149
JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 decreases expression ISO Glucosamine results in decreased expression of EDEM1 mRNA CTD PMID:17178593 NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases expression
increases phosphorylation
EXP
ISO
EIF2AK3 gene mutant form inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]
Glucosamine results in increased expression of EIF2AK3 protein
NUS1 protein inhibits the reaction [Glucosamine results in increased expression of EIF2AK3 protein]
EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of ATF4 mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]
Glucosamine results in increased phosphorylation of EIF2AK3 protein
CTD PMID:16324875 PMID:19383982 PMID:30602124 PMID:33812996 NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases phosphorylation
multiple interactions
ISO
EXP
Glucosamine results in increased phosphorylation of EIF2S1 protein
NUS1 protein inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]; EIF2AK3 protein affects the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]; GSK2656157 inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]
EIF2AK3 gene mutant form inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]
CTD PMID:16324875 PMID:19383982 PMID:30602124 PMID:33812996 NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression ISO Glucosamine results in increased expression of ELOVL6 mRNA CTD PMID:17178593 NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
JBrowse link
G Epas1 endothelial PAS domain protein 1 decreases expression
multiple interactions
EXP Glucosamine results in decreased expression of EPAS1 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of EPAS1 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of EPAS1 mRNA]
CTD PMID:17109745 NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 decreases expression ISO Glucosamine results in decreased expression of EPRS1 mRNA CTD PMID:17178593 NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 multiple interactions
increases expression
ISO ERN1 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased splicing of XBP1 mRNA]
Glucosamine results in increased expression of ERN1 mRNA
NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ERN1 mRNA]
CTD PMID:30602124 PMID:33812996 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression ISO
EXP
Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
JBrowse link
G Fasn fatty acid synthase increases expression ISO Glucosamine results in increased expression of FASN mRNA CTD PMID:22096489 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
JBrowse link
G Fbp2 fructose-bisphosphatase 2 increases expression ISO Glucosamine results in increased expression of FBP2 mRNA CTD PMID:17178593 NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions EXP Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
JBrowse link
G Fgf7 fibroblast growth factor 7 decreases expression
multiple interactions
EXP Glucosamine results in decreased expression of FGF7 mRNA
IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA]
CTD PMID:17109745 NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
JBrowse link
G Fgf9 fibroblast growth factor 9 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of FGF9 mRNA]
Glucosamine results in increased expression of FGF9 mRNA
CTD PMID:17109745 NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of FGFR1 mRNA]
Glucosamine results in increased expression of FGFR1 mRNA
CTD PMID:17109745 NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 decreases expression ISO Glucosamine results in decreased expression of FKBP11 mRNA CTD PMID:17178593 NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
JBrowse link
G Fn1 fibronectin 1 decreases expression ISO
EXP
Glucosamine results in decreased expression of FN1 protein CTD PMID:17178593 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Glucosamine analog inhibits the reaction [Buthionine Sulfoximine results in increased expression of FOS mRNA]
Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS protein]
CTD PMID:19375915 PMID:21825963 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
JBrowse link
G Furin furin (paired basic amino acid cleaving enzyme) decreases cleavage
multiple interactions
ISO Glucosamine results in decreased cleavage of FURIN protein alternative form
Glucosamine results in decreased glycosylation of and results in decreased activity of FURIN protein
CTD PMID:19909832 NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
JBrowse link
G Fxyd2 FXYD domain-containing ion transport regulator 2 increases expression EXP Glucosamine results in increased expression of FXYD2 mRNA CTD PMID:17109745 NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
JBrowse link
G Gatm glycine amidinotransferase decreases expression EXP Glucosamine results in decreased expression of GATM mRNA CTD PMID:17109745 NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
JBrowse link
G Gck glucokinase decreases expression EXP Glucosamine results in decreased expression of GCK mRNA CTD PMID:11893929 NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression ISO Glucosamine analog results in increased expression of GCLC mRNA CTD PMID:21825963 NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
JBrowse link
G Gfpt1 glutamine fructose-6-phosphate transaminase 1 multiple interactions EXP [Glucosamine co-treated with INS1 protein] affects the localization of GFPT1 protein CTD PMID:9453242 NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
JBrowse link
G Glrx glutaredoxin increases expression ISO Glucosamine results in increased expression of GLRX mRNA CTD PMID:17178593 NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
JBrowse link
G Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 decreases expression ISO Glucosamine results in decreased expression of GNPNAT1 mRNA CTD PMID:17178593 NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
JBrowse link
G Gnptab N-acetylglucosamine-1-phosphate transferase subunits alpha and beta increases expression ISO Glucosamine results in increased expression of GNPTAB mRNA CTD PMID:17178593 NCBI chr 7:22,800,502...22,866,336
Ensembl chr 7:22,800,485...22,866,933
JBrowse link
G Gpd1l1 glycerol-3-phosphate dehydrogenase 1 like 1 increases expression ISO Glucosamine results in increased expression of GPD1L mRNA CTD PMID:17178593 NCBI chr 8:114,591,103...114,620,771
Ensembl chr 8:114,588,487...114,620,723
JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of GREM1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of GREM1 mRNA] CTD PMID:17109745 NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta decreases phosphorylation
multiple interactions
ISO Glucosamine results in decreased phosphorylation of GSK3B protein
Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; PRKAA1 protein promotes the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; PRKAA1 protein promotes the reaction [NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]]
CTD PMID:33812996 NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
JBrowse link
G Gspt1 G1 to S phase transition 1 multiple interactions ISO Glucosamine analog inhibits the reaction [TNF results in increased expression of GSPT1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of GSPT1 mRNA] CTD PMID:18173918 NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression ISO Glucosamine results in increased expression of GSTT1 mRNA CTD PMID:17178593 NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 decreases expression
multiple interactions
EXP Glucosamine results in decreased expression of HAPLN1 mRNA
Glucosamine inhibits the reaction [IL1B results in decreased expression of HAPLN1 mRNA]; IL1B promotes the reaction [Glucosamine results in decreased expression of HAPLN1 mRNA]
CTD PMID:17109745 NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 decreases expression ISO Glucosamine results in decreased expression of HERPUD1 mRNA CTD PMID:17178593 NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions
decreases expression
ISO Glucosamine affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of HIF1A protein]; Glucosamine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]
Glucosamine results in decreased expression of HIF1A mRNA; Glucosamine results in decreased expression of HIF1A protein
CTD PMID:19254699 PMID:22020377 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
JBrowse link
G Hk1 hexokinase 1 increases expression ISO
EXP
Glucosamine results in increased expression of HK1 mRNA CTD PMID:11893929 PMID:17178593 NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
JBrowse link
G Hmga1 high mobility group AT-hook 1 increases expression EXP Glucosamine results in increased expression of HMGA1 mRNA CTD PMID:17109745 NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression ISO Glucosamine results in increased expression of HMGCS1 mRNA CTD PMID:17178593 NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
JBrowse link
G Hmmr hyaluronan-mediated motility receptor decreases expression EXP Glucosamine results in decreased expression of HMMR mRNA CTD PMID:17109745 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO Glucosamine inhibits the reaction [IL1B results in decreased expression of HMOX1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of HMOX1 protein]
Glucosamine results in increased expression of HMOX1 mRNA; Glucosamine results in increased expression of HMOX1 protein
CTD PMID:18077487 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G Hoxa1 homeobox A1 decreases expression ISO Glucosamine results in decreased expression of HOXA1 mRNA CTD PMID:17178593 NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase decreases expression EXP Glucosamine results in decreased expression of HPGD mRNA CTD PMID:17109745 NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 decreases expression
increases expression
ISO
EXP
Glucosamine results in decreased expression of HSP90B1 mRNA
Glucosamine results in increased expression of HSP90B1 protein
CTD PMID:15618547 PMID:17109745 PMID:17178593 NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
decreases expression
ISO
EXP
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein]
Glucosamine results in increased expression of HSPA5 mRNA; Glucosamine results in increased expression of HSPA5 protein
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]
Glucosamine results in decreased expression of HSPA5 mRNA
CTD PMID:15618547 PMID:16380481 PMID:17178593 PMID:19383982 PMID:20165829 More... NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G Hyou1 hypoxia up-regulated 1 decreases expression ISO Glucosamine results in decreased expression of HYOU1 mRNA CTD PMID:17178593 NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
decreases activity
ISO
EXP
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [[IL6 co-treated with TNF] results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [Cathelicidins results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [Cathelicidins results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IFNG promotes the reaction [TNF results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [IFNG results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [IFNG results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IL1B promotes the reaction [TNF results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [IL1B results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IL6 results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [TNF promotes the reaction [IFNG results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [TNF promotes the reaction [IL1B results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [TNF results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of ICAM1 protein]
Glucosamine results in decreased activity of ICAM1 protein
Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]
CTD PMID:16431966 PMID:16822504 PMID:17238806 PMID:18949387 PMID:19020780 More... NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression ISO Glucosamine results in increased expression of ID1 mRNA CTD PMID:17178593 NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
JBrowse link
G Id2 inhibitor of DNA binding 2 increases expression ISO Glucosamine results in increased expression of ID2 mRNA CTD PMID:17178593 NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Glucosamine results in increased expression of ID3 mRNA CTD PMID:17178593 NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 increases expression ISO Glucosamine results in increased expression of IDH1 mRNA CTD PMID:17178593 NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 increases expression ISO Glucosamine results in increased expression of IFIT3 mRNA CTD PMID:17178593 NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
JBrowse link
G Ifng interferon gamma decreases secretion
multiple interactions
ISO Glucosamine results in decreased secretion of IFNG protein
Glucosamine inhibits the reaction [IFNG promotes the reaction [TNF results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [IFNG results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [IFNG results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IFNG results in increased localization of STAT1 protein modified form]; Glucosamine inhibits the reaction [IFNG results in increased phosphorylation of and results in increased localization of STAT1 protein]; Glucosamine inhibits the reaction [TNF promotes the reaction [IFNG results in increased expression of ICAM1 protein]]
CTD PMID:14507305 PMID:16431966 PMID:16822504 PMID:17238806 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP3 mRNA]; IL1B inhibits the reaction [Glucosamine results in increased expression of IGFBP3 mRNA]
Glucosamine results in decreased expression of IGFBP3 mRNA
CTD PMID:17109745 NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 decreases expression ISO Glucosamine results in decreased expression of IGFBP4 mRNA CTD PMID:17178593 NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA]
Glucosamine results in increased expression of IGFBP5 mRNA
CTD PMID:17109745 NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions ISO Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of IKBKB protein] CTD PMID:18786831 NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
JBrowse link
G Ikbkg inhibitor of nuclear factor kappa B kinase regulatory subunit gamma multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IKBKG mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of IKBKG mRNA] CTD PMID:17109745 NCBI chr  X:152,216,485...152,241,476
Ensembl chr  X:152,216,596...152,239,499
JBrowse link
G Il11 interleukin 11 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IL11 mRNA] CTD PMID:17109745 NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IL13RA1 mRNA]
Glucosamine results in decreased expression of IL13RA1 mRNA
CTD PMID:17109745 NCBI chr  X:115,348,822...115,408,682
Ensembl chr  X:115,348,860...115,408,681
Ensembl chr11:115,348,860...115,408,681
JBrowse link
G Il1a interleukin 1 alpha multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IL1A mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of IL1A mRNA] CTD PMID:17109745 NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
decreases expression
ISO
EXP
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGES protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in increased expression of TIMP3 mRNA; [Glucosamine co-treated with Chondroitin Sulfates] inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]; [Glucosamine co-treated with Chondroitin Sulfates] inhibits the reaction [IL1B protein results in increased secretion of Nitrites]; Glucosamine analog affects the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Glucosamine analog affects the reaction [IL1B results in decreased expression of ACAN mRNA]; Glucosamine analog affects the reaction [IL1B results in decreased expression of COL2A1 mRNA]; Glucosamine analog affects the reaction [IL1B results in increased phosphorylation of AKT1 protein]; Glucosamine analog inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; Glucosamine analog inhibits the reaction [IL1B protein results in increased expression of MMP13]; Glucosamine analog inhibits the reaction [IL1B protein results in increased expression of MMP1]; Glucosamine analog inhibits the reaction [IL1B protein results in increased expression of MMP3]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of and results in increased secretion of MMP1 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of and results in increased secretion of MMP13 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of and results in increased secretion of MMP3 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of CXCL8 mRNA]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of MMP1 mRNA]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of MMP13 mRNA]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of MMP3 mRNA]; Glucosamine analog inhibits the reaction [IL1B results in increased localization of RELA protein]; Glucosamine analog inhibits the reaction [IL1B results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL2 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CXCL8 protein]; Glucosamine analog promotes the reaction [IL1B results in increased phosphorylation of MAPK1 protein]; Glucosamine analog promotes the reaction [IL1B results in increased phosphorylation of MAPK3 protein]; Glucosamine analog promotes the reaction [IL1B results in increased phosphorylation of MAPK8 protein]; Glucosamine inhibits the reaction [[OSM protein co-treated with IL1B protein] results in decreased methylation of IL1B promoter]; Glucosamine inhibits the reaction [[OSM protein co-treated with IL1B protein] results in increased expression of IL1B mRNA]; Glucosamine inhibits the reaction [IL1B promotes the reaction [TNF results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [IL1B protein results in decreased expression of ACAN mRNA]; Glucosamine inhibits the reaction [IL1B protein results in decreased expression of COL2A1 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased activity of JUN protein]; Glucosamine inhibits the reaction [IL1B protein results in increased activity of JUND protein]; Glucosamine inhibits the reaction [IL1B protein results in increased degradation of NFKBIA protein]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of COL1A1 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]; Glucosamine inhibits the reaction [IL1B protein results in increased localization of NFKB1 protein]; Glucosamine inhibits the reaction [IL1B protein results in increased localization of RELA protein]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of MMP1 protein]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of MMP13 protein]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of MMP3 protein]; Glucosamine inhibits the reaction [IL1B results in decreased expression of HMOX1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of HMOX1 protein]; Glucosamine inhibits the reaction [IL1B results in increased abundance of Dinoprostone]; Glucosamine inhibits the reaction [IL1B results in increased abundance of Nitric Oxide]; Glucosamine inhibits the reaction [IL1B results in increased abundance of Nitrites]; Glucosamine inhibits the reaction [IL1B results in increased degradation of NFKB1 protein]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL8 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL8 protein]; Glucosamine inhibits the reaction [IL1B results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP3 protein]; Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of PTGES mRNA]; Glucosamine inhibits the reaction [IL1B results in increased localization of RELA protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK1 protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK14 protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK3 protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK8 protein]; Glucosamine inhibits the reaction [IL1B results in increased secretion of CXCL8 protein]; Glucosamine inhibits the reaction [TNF promotes the reaction [IL1B results in increased expression of ICAM1 protein]]; Glucosamine promotes the reaction [IL1B results in increased expression of PPARG]; Glucosamine promotes the reaction [IL1B results in increased phosphorylation of AKT1 protein]
Glucosamine results in increased expression of IL1B mRNA
Glucosamine results in decreased expression of IL1B mRNA
[IL1B protein co-treated with Glucosamine] results in increased expression of IL1R2 mRNA; Glucosamine affects the reaction [IL1B results in decreased expression of ADAM15 mRNA]; Glucosamine affects the reaction [IL1B results in decreased expression of OAT mRNA]; Glucosamine inhibits the reaction [IL1B protein results in decreased activity of B3GAT3 protein]; Glucosamine inhibits the reaction [IL1B protein results in decreased expression of B3GAT3 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; Glucosamine inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of ACAN mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of COL11A1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of COL2A1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of COL3A1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of FGFR1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of HAPLN1 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of LAMA4 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of SDC2 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of SOX4 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of THBS4 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of TIMP2 mRNA]; Glucosamine inhibits the reaction [IL1B results in decreased expression of TIMP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of ADAM17 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of ADAMTS1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of ASS1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of BGN mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of BMP2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of BMP6 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of BMP7 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CCL2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CCL20 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CCL22 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CCL3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CCL7 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of COL8A1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CSF1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CSF2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CSF3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL11 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL5 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP7 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of EPAS1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of FGF9 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of GREM1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IKBKG mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IL11 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IL13RA1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IL1A mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IL1B mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IL23R mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of IL6 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of JAK2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of JUNB mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP10 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP12 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP13 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of NFKBIA mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of NFKBIB mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of NGF mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of PDGFA mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G4A mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of RELB mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of SDC4 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of SLC7A8 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of TIMP1 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of TNFAIP6 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of TNK2 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of VCAN mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Glucosamine promotes the reaction [IL1B results in decreased expression of BMP4 mRNA]; Glucosamine promotes the reaction [IL1B results in decreased expression of CXCL12 mRNA]; IL1B affects the reaction [Glucosamine affects the expression of PDGFA mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of ADAM15 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of BGN mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of COL11A1 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of CXCL12 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of DUSP7 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of EPAS1 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of IKBKG mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of JUNB mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of TNFAIP6 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of VCAN mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of ADAM17 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of IL1A mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of JAK2 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of LAMA4 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of MMP9 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of NFKBIB mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of TIMP3 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of ADAMTS1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of COL8A1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of CSF1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of CXCL1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of GREM1 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of NFKBIA mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G5 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of SDC4 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of SLC7A8 mRNA]; IL1B inhibits the reaction [Glucosamine results in increased expression of IGFBP3 mRNA]; IL1B promotes the reaction [Glucosamine results in decreased expression of HAPLN1 mRNA]; IL1B promotes the reaction [Glucosamine results in decreased expression of SDC2 mRNA]; IL1B promotes the reaction [Glucosamine results in decreased expression of THBS4 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of AZIN1 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CCL2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CCL20 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CCL7 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CXCL2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of CXCL3 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP10 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP12 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP13 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP3 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of NOS2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of TIMP1 mRNA]
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]
CTD PMID:11229466 PMID:11801247 PMID:12681956 PMID:15144122 PMID:16822504 More... NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il1r2 interleukin 1 receptor type 2 multiple interactions EXP [IL1B protein co-treated with Glucosamine] results in increased expression of IL1R2 mRNA CTD PMID:11801247 NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
JBrowse link
G Il2 interleukin 2 decreases secretion ISO Glucosamine results in decreased secretion of IL2 protein CTD PMID:14507305 NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
JBrowse link
G Il23r interleukin 23 receptor multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of IL23R mRNA] CTD PMID:17109745 NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
JBrowse link
G Il33 interleukin 33 decreases expression EXP Glucosamine results in decreased expression of IL33 mRNA CTD PMID:17109745 NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
JBrowse link
G Il4 interleukin 4 decreases secretion
decreases expression
ISO Glucosamine results in decreased secretion of IL4 protein
Glucosamine results in decreased expression of IL4
CTD PMID:14507305 PMID:21284687 NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
JBrowse link
G Il5 interleukin 5 decreases secretion
decreases expression
ISO Glucosamine results in decreased secretion of IL5 protein
Glucosamine results in decreased expression of IL5
CTD PMID:14507305 PMID:21284687 NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression
ISO
EXP
Glucosamine analog inhibits the reaction [TNF results in increased expression of IL6 mRNA]; Glucosamine inhibits the reaction [[IL6 co-treated with TNF] results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IL6 results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of IL6 mRNA]
Glucosamine inhibits the reaction [IL1B results in increased expression of IL6 mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
Glucosamine analog results in decreased expression of IL6 mRNA; Glucosamine results in decreased expression of IL6 mRNA
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
CTD PMID:16822504 PMID:17109745 PMID:18786831 PMID:19098112 PMID:20093129 More... NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Inpp5k inositol polyphosphate-5-phosphatase K increases expression
multiple interactions
ISO Glucosamine results in increased expression of INPP5K mRNA
NUS1 protein inhibits the reaction [Glucosamine results in increased expression of INPP5K mRNA]
CTD PMID:33812996 NCBI chr10:60,474,262...60,495,813
Ensembl chr10:60,475,897...60,496,773
JBrowse link
G Ins1 insulin 1 multiple interactions EXP
ISO
4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]]; [Glucosamine co-treated with INS1 protein] affects the localization of GFPT1 protein; Glucosamine inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Glucosamine inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]; Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]; ursodoxicoltaurine inhibits the reaction [Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]]
[INS1 protein co-treated with Glucosamine] results in increased expression of OSTN mRNA; Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]; INS1 inhibits the reaction [[Streptozocin co-treated with APOE mutant form] results in increased abundance of Glucosamine]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]
CTD PMID:9453242 PMID:11893929 PMID:16380481 PMID:20165829 PMID:30602124 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
JBrowse link
G Ins2 insulin 2 multiple interactions ISO 4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]]; Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]; NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; PRKAA1 protein promotes the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; PRKAA1 protein promotes the reaction [NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]]; ursodoxicoltaurine inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]] CTD PMID:20165829 PMID:33812996 NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions ISO Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] CTD PMID:20737476 NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
JBrowse link
G Isyna1 inositol-3-phosphate synthase 1 increases expression EXP Glucosamine results in increased expression of ISYNA1 mRNA CTD PMID:17109745 NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
JBrowse link
G Jak2 Janus kinase 2 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of JAK2 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of JAK2 mRNA] CTD PMID:17109745 NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Glucosamine inhibits the reaction [IL1B protein results in increased activity of JUN protein]
Glucosamine analog inhibits the reaction [Buthionine Sulfoximine results in increased expression of JUN mRNA]
CTD PMID:17925024 PMID:21825963 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of JUNB mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of JUNB mRNA] CTD PMID:17109745 NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Glucosamine inhibits the reaction [IL1B protein results in increased activity of JUND protein] CTD PMID:17925024 NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
JBrowse link
G Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 increases expression ISO Glucosamine results in increased expression of KCNJ16 mRNA CTD PMID:17178593 NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
JBrowse link
G Kif11 kinesin family member 11 decreases expression EXP Glucosamine results in decreased expression of KIF11 mRNA CTD PMID:17109745 NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
JBrowse link
G Kif4a kinesin family member 4A decreases expression EXP Glucosamine results in decreased expression of KIF4A mRNA CTD PMID:17109745 NCBI chr  X:65,721,746...65,824,277
Ensembl chr  X:65,721,779...65,824,139
JBrowse link
G Klf10 KLF transcription factor 10 increases expression ISO Glucosamine results in increased expression of KLF10 mRNA CTD PMID:17178593 NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
JBrowse link
G Lama4 laminin subunit alpha 4 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of LAMA4 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of LAMA4 mRNA] CTD PMID:17109745 NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
JBrowse link
G Lamb1 laminin subunit beta 1 multiple interactions ISO TXNIP promotes the reaction [Glucosamine results in increased expression of LAMB1 mRNA] CTD PMID:17178593 NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
JBrowse link
G Lamc1 laminin subunit gamma 1 multiple interactions ISO TXNIP promotes the reaction [Glucosamine results in increased expression of LAMC1 mRNA] CTD PMID:17178593 NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
JBrowse link
G Lcn2 lipocalin 2 decreases expression ISO Glucosamine results in decreased expression of LCN2 mRNA CTD PMID:17178593 NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
JBrowse link
G Lepr leptin receptor multiple interactions
affects response to substance
EXP [LEPR protein affects the susceptibility to Glucosamine] which affects the expression of ALB protein CTD PMID:33345901 NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
JBrowse link
G Lpin1 lipin 1 increases expression ISO Glucosamine results in increased expression of LPIN1 mRNA CTD PMID:17178593 NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
JBrowse link
G Ly6a lymphocyte antigen 6 family member A increases expression ISO Glucosamine results in increased expression of LY6A mRNA CTD PMID:17178593 NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
JBrowse link
G Mafb MAF bZIP transcription factor B increases expression EXP Glucosamine results in increased expression of MAFB mRNA CTD PMID:17109745 NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
ISO Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAPK1 protein]; Glucosamine analog promotes the reaction [IL1B results in increased phosphorylation of MAPK1 protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK1 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
Glucosamine analog results in increased phosphorylation of MAPK1 protein
CTD PMID:18080321 PMID:18340449 PMID:19375915 PMID:19626664 PMID:20307528 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions ISO Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK14 protein] CTD PMID:19626664 NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
ISO Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAPK3 protein]; Glucosamine analog promotes the reaction [IL1B results in increased phosphorylation of MAPK3 protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK3 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
Glucosamine analog results in increased phosphorylation of MAPK3 protein
CTD PMID:18080321 PMID:18340449 PMID:19375915 PMID:19626664 PMID:20307528 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
ISO Glucosamine analog promotes the reaction [IL1B results in increased phosphorylation of MAPK8 protein]; Glucosamine inhibits the reaction [IL1B results in increased phosphorylation of MAPK8 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]
Glucosamine analog results in increased phosphorylation of MAPK8 protein
CTD PMID:18080321 PMID:19626664 PMID:20307528 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member decreases expression ISO Glucosamine results in decreased expression of MCL1 mRNA; Glucosamine results in decreased expression of MCL1 protein CTD PMID:22020377 NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
JBrowse link
G Mef2a myocyte enhancer factor 2a multiple interactions
decreases expression
ISO
EXP
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]
Glucosamine results in decreased expression of MEF2A mRNA; Glucosamine results in decreased expression of MEF2A protein
CTD PMID:20165829 NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
JBrowse link
G Mettl1 methyltransferase 1, tRNA methylguanosine decreases expression ISO Glucosamine results in decreased expression of METTL1 mRNA CTD PMID:17178593 NCBI chr 7:62,864,860...62,869,202
Ensembl chr 7:62,864,853...62,869,202
JBrowse link
G Mfap3l microfibril associated protein 3 like increases expression ISO Glucosamine results in increased expression of MFAP3L mRNA CTD PMID:17178593 NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863
JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression EXP Glucosamine results in decreased expression of MKI67 mRNA CTD PMID:17109745 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions ISO Glucosamine analog inhibits the reaction [IL1B protein results in increased expression of MMP1]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of and results in increased secretion of MMP1 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of MMP1 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of MMP1 protein] CTD PMID:15144122 PMID:17925024 PMID:18080321 NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
JBrowse link
G Mmp10 matrix metallopeptidase 10 increases expression
multiple interactions
EXP Glucosamine results in increased expression of MMP10 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of MMP10 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP10 mRNA]
CTD PMID:17109745 NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of MMP12 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP12 mRNA] CTD PMID:17109745 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
JBrowse link
G Mmp13 matrix metallopeptidase 13 affects expression
multiple interactions
increases expression
ISO
EXP
Glucosamine analog affects the expression of MMP13 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of MMP13 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP13 mRNA]
Glucosamine analog inhibits the reaction [IL1B protein results in increased expression of MMP13]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of and results in increased secretion of MMP13 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of MMP13 mRNA]; Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of MMP13 protein]
CTD PMID:15144122 PMID:17109745 PMID:17337215 PMID:17925024 PMID:18080321 More... NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
increases expression
ISO
EXP
Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP2 protein]; Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA]; Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA]; Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein]
IL1B promotes the reaction [Glucosamine results in increased expression of MMP2 mRNA]
CTD PMID:17109745 PMID:17498959 PMID:19375915 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions
increases expression
decreases expression
ISO
EXP
[Glucosamine co-treated with Chondroitin Sulfates] results in decreased expression of MMP3 mRNA; [Glucosamine co-treated with Chondroitin Sulfates] results in decreased secretion of MMP3 protein; Glucosamine analog inhibits the reaction [IL1B protein results in increased expression of MMP3]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of and results in increased secretion of MMP3 protein]; Glucosamine analog inhibits the reaction [IL1B results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased secretion of MMP3 protein]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP3 protein]; Glucosamine results in decreased expression of and results in decreased activity of MMP3 protein
Glucosamine results in increased expression of MMP3 mRNA
Glucosamine inhibits the reaction [IL1B protein results in increased expression of MMP3 mRNA]; Glucosamine inhibits the reaction [IL1B results in increased expression of MMP3 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of MMP3 mRNA]
Glucosamine analog results in decreased expression of MMP3 mRNA
CTD PMID:11229466 PMID:12801482 PMID:15144122 PMID:16300972 PMID:17109745 More... NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
increases expression
ISO
EXP
Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]
Glucosamine results in increased expression of MMP9 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of MMP9 mRNA]
CTD PMID:17109745 PMID:17498959 PMID:19375915 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mnda myeloid cell nuclear differentiation antigen increases expression ISO Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
JBrowse link
G Mpo myeloperoxidase decreases activity EXP Glucosamine results in decreased activity of MPO protein CTD PMID:19098112 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Mvd mevalonate diphosphate decarboxylase increases expression ISO Glucosamine results in increased expression of MVD mRNA CTD PMID:17178593 NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
JBrowse link
G Ndufa4 Ndufa4, mitochondrial complex associated increases expression EXP Glucosamine results in increased expression of NDUFA4 mRNA CTD PMID:17109745 NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,002,216...40,023,920
JBrowse link
G Nedd4 NEDD4 E3 ubiquitin protein ligase decreases expression EXP Glucosamine results in decreased expression of NEDD4 mRNA CTD PMID:17109745 NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions
decreases activity
ISO
EXP
Glucosamine inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased localization of NFKB1 protein]; Glucosamine inhibits the reaction [IL1B protein results in increased localization of NFKB1 protein]; Glucosamine inhibits the reaction [IL1B results in increased degradation of NFKB1 protein]; Glucosamine inhibits the reaction [NFKB1 results in increased degradation of RELA protein]; Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFKB1 protein]
Glucosamine results in decreased activity of NFKB1 protein
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NFKB1 protein]
CTD PMID:12681956 PMID:16431966 PMID:16822504 PMID:17498959 PMID:18036590 More... NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
decreases phosphorylation
decreases expression
ISO
EXP
Glucosamine analog inhibits the reaction [IL1B results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Glucosamine inhibits the reaction [IL1B protein results in increased degradation of NFKBIA protein]
Glucosamine results in decreased phosphorylation of NFKBIA protein
Glucosamine results in decreased expression of NFKBIA mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of NFKBIA mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; IL1B inhibits the reaction [Glucosamine results in decreased expression of NFKBIA mRNA]
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA protein modified form]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]
CTD PMID:12681956 PMID:17109745 PMID:18080321 PMID:18205790 PMID:19098112 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
JBrowse link
G Nfkbib NFKB inhibitor beta multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of NFKBIB mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of NFKBIB mRNA] CTD PMID:17109745 NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
JBrowse link
G Ngef neuronal guanine nucleotide exchange factor increases expression ISO Glucosamine results in increased expression of NGEF mRNA CTD PMID:17178593 NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914
JBrowse link
G Ngf nerve growth factor multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of NGF mRNA] CTD PMID:17109745 NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression
decreases expression
ISO
EXP
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein; Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]
Glucosamine results in increased expression of NOS2 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of NOS2 mRNA]
Glucosamine results in decreased expression of NOS2 mRNA
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD PMID:17109745 PMID:17440993 PMID:17605605 PMID:18077487 PMID:18205790 More... NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 affects expression EXP Glucosamine affects the expression of NR1H4 CTD PMID:19373748 NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
JBrowse link
G Nsdhl NAD(P) dependent steroid dehydrogenase-like increases expression ISO Glucosamine results in increased expression of NSDHL mRNA CTD PMID:17178593 NCBI chr  X:150,775,034...150,807,161
Ensembl chr  X:150,775,080...150,807,142
JBrowse link
G Nucb2 nucleobindin 2 decreases expression ISO Glucosamine results in decreased expression of NUCB2 mRNA CTD PMID:17178593 NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
JBrowse link
G Nuf2 NUF2 component of NDC80 kinetochore complex decreases expression EXP Glucosamine results in decreased expression of NUF2 mRNA CTD PMID:17109745 NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
JBrowse link
G Nus1 NUS1 dehydrodolichyl diphosphate synthase subunit multiple interactions ISO NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF4 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of DDIT3 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of EIF2AK3 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ERN1 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of INPP5K mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; PRKAA1 protein promotes the reaction [NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]] CTD PMID:33812996 NCBI chr20:31,811,817...31,838,562
Ensembl chr20:31,811,817...31,838,561
JBrowse link
G Oat ornithine aminotransferase multiple interactions EXP Glucosamine affects the reaction [IL1B results in decreased expression of OAT mRNA] CTD PMID:17109745 NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase decreases expression ISO Glucosamine results in decreased expression of OGT mRNA CTD PMID:17178593 NCBI chr  X:66,771,278...66,816,148
Ensembl chr  X:66,771,349...66,816,146
JBrowse link
G Orc2 origin recognition complex, subunit 2 decreases expression ISO Glucosamine results in decreased expression of ORC2 mRNA CTD PMID:17178593 NCBI chr 9:60,001,631...60,038,301
Ensembl chr 9:60,001,910...60,038,195
JBrowse link
G Osm oncostatin M multiple interactions ISO Glucosamine inhibits the reaction [[OSM protein co-treated with IL1B protein] results in decreased methylation of IL1B promoter]; Glucosamine inhibits the reaction [[OSM protein co-treated with IL1B protein] results in increased expression of IL1B mRNA] CTD PMID:21219853 NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
JBrowse link
G Ostn osteocrin multiple interactions
increases expression
ISO 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; [INS1 protein co-treated with Glucosamine] results in increased expression of OSTN mRNA; ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; GSK2656157 inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]] CTD PMID:30602124 NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603
JBrowse link
G Oxr1 oxidation resistance 1 decreases expression ISO Glucosamine results in decreased expression of OXR1 mRNA CTD PMID:17178593 NCBI chr 7:72,528,750...72,965,666
Ensembl chr 7:72,528,786...72,965,666
JBrowse link
G Pank1 pantothenate kinase 1 increases expression ISO Glucosamine results in increased expression of PANK1 mRNA CTD PMID:17178593 NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage
multiple interactions
ISO Glucosamine results in increased cleavage of PARP1 protein
pepstatin inhibits the reaction [Glucosamine results in increased cleavage of PARP1 protein]
CTD PMID:16850161 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
JBrowse link
G Pdgfa platelet derived growth factor subunit A affects expression
multiple interactions
EXP Glucosamine affects the expression of PDGFA mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of PDGFA mRNA]; IL1B affects the reaction [Glucosamine affects the expression of PDGFA mRNA]
CTD PMID:17109745 NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 decreases expression ISO Glucosamine results in decreased expression of PDIA4 mRNA CTD PMID:17178593 NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
JBrowse link
G Pdia6 protein disulfide isomerase family A, member 6 decreases expression ISO Glucosamine results in decreased expression of PDIA6 mRNA CTD PMID:17178593 NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase 4 increases expression ISO Glucosamine results in increased expression of PDK4 mRNA CTD PMID:17178593 NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
JBrowse link
G Pfkp phosphofructokinase, platelet increases expression ISO Glucosamine results in increased expression of PFKP mRNA CTD PMID:17178593 NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A decreases expression ISO Glucosamine results in decreased expression of PIGA mRNA CTD PMID:17178593 NCBI chr  X:30,043,033...30,055,861
Ensembl chr  X:30,042,343...30,055,804
JBrowse link
G Pla2g2a phospholipase A2 group IIA multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
JBrowse link
G Pla2g4a phospholipase A2 group IVA affects expression
multiple interactions
EXP Glucosamine affects the expression of PLA2G4A mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G4A mRNA]
CTD PMID:17109745 NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
JBrowse link
G Pla2g5 phospholipase A2, group V multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G5 mRNA] CTD PMID:17109745 NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
JBrowse link
G Plat plasminogen activator, tissue type increases expression ISO Glucosamine results in increased expression of PLAT mRNA CTD PMID:17178593 NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
JBrowse link
G Plk1 polo-like kinase 1 increases expression
decreases expression
ISO
EXP
Glucosamine results in increased expression of PLK1 mRNA
Glucosamine results in decreased expression of PLK1 mRNA
CTD PMID:17109745 PMID:17178593 NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
JBrowse link
G Plpp3 phospholipid phosphatase 3 decreases expression EXP Glucosamine results in decreased expression of PLPP3 mRNA CTD PMID:17109745 NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
increases expression
ISO
EXP
Glucosamine promotes the reaction [IL1B results in increased expression of PPARG]
Glucosamine results in increased expression of PPARG mRNA
CTD PMID:15694357 PMID:22089456 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions
decreases expression
ISO
EXP
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]
Glucosamine results in decreased expression of PPARGC1A mRNA; Glucosamine results in decreased expression of PPARGC1A protein
CTD PMID:20165829 NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
JBrowse link
G Ppm1a protein phosphatase, Mg2+/Mn2+ dependent, 1A decreases expression ISO Glucosamine results in decreased expression of PPM1A mRNA CTD PMID:17178593 NCBI chr 6:91,439,094...91,486,139
Ensembl chr 6:91,438,834...91,480,697
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A decreases expression ISO Glucosamine results in decreased expression of PPP1R15A mRNA CTD PMID:17178593 NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression EXP Glucosamine results in decreased expression of PRC1 mRNA CTD PMID:17109745 NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO PRKAA1 protein promotes the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; PRKAA1 protein promotes the reaction [NUS1 protein inhibits the reaction [Glucosamine inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]] CTD PMID:33812996 NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
JBrowse link
G Psme3 proteasome activator subunit 3 decreases expression ISO Glucosamine results in decreased expression of PSME3 CTD PMID:21697645 NCBI chr10:86,257,672...86,265,458
Ensembl chr10:86,257,668...86,333,804
JBrowse link
G Ptges prostaglandin E synthase multiple interactions ISO [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGES protein; Glucosamine inhibits the reaction [IL1B results in increased expression of PTGES mRNA] CTD PMID:17605605 PMID:22089456 NCBI chr 3:14,177,892...14,189,236 JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression
decreases expression
multiple interactions
decreases glycosylation
ISO
EXP
Glucosamine analog results in increased expression of PTGS2 protein alternative form
Glucosamine results in decreased expression of PTGS2 mRNA
Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Glucosamine inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased secretion of Dinoprostone]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
Glucosamine results in decreased glycosylation of PTGS2 protein
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein; Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]
CTD PMID:12681956 PMID:17440993 PMID:17605605 PMID:18205790 PMID:19656660 More... NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin decreases expression EXP Glucosamine results in decreased expression of PTTG1 mRNA CTD PMID:17109745 NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
JBrowse link
G Rab32 RAB32, member RAS oncogene family increases expression ISO Glucosamine results in increased expression of RAB32 mRNA CTD PMID:17178593 NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
JBrowse link
G Racgap1 Rac GTPase-activating protein 1 decreases expression EXP Glucosamine results in decreased expression of RACGAP1 mRNA CTD PMID:17109745 NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
JBrowse link
G Rbm39 RNA binding motif protein 39 decreases expression ISO Glucosamine results in decreased expression of RBM39 mRNA CTD PMID:17178593 NCBI chr 3:144,662,998...144,696,222
Ensembl chr 3:144,663,001...144,696,213
JBrowse link
G Recql4 RecQ like helicase 4 increases expression ISO Glucosamine results in increased expression of RECQL4 mRNA CTD PMID:17178593 NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
decreases activity
increases localization
ISO
EXP
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]]; Glucosamine analog inhibits the reaction [IL1B results in increased localization of RELA protein]; Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RELA protein]; Glucosamine inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased localization of RELA protein]; Glucosamine inhibits the reaction [IL1B protein results in increased localization of RELA protein]; Glucosamine inhibits the reaction [IL1B results in increased localization of RELA protein]; Glucosamine inhibits the reaction [NFKB1 results in increased degradation of RELA protein]; Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RELA protein]; Glucosamine inhibits the reaction [TNF results in increased localization of RELA protein]; Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]
Glucosamine results in decreased activity of RELA protein
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]; Glucosamine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of RELA mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]
Glucosamine results in increased localization of RELA protein
CTD PMID:12681956 PMID:16431966 PMID:16822504 PMID:17238806 PMID:17498959 More... NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
JBrowse link
G Relb RELB proto-oncogene, NF-kB subunit multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of RELB mRNA] CTD PMID:17109745 NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
JBrowse link
G Rhob ras homolog family member B increases expression ISO Glucosamine results in increased expression of RHOB mRNA CTD PMID:17178593 NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
JBrowse link
G Rhoc ras homolog family member C decreases expression ISO Glucosamine analog results in decreased expression of RHOC mRNA CTD PMID:16142878 NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
JBrowse link
G Rnd1 Rho family GTPase 1 multiple interactions
decreases expression
ISO Glucosamine analog inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of RND1 mRNA]
Glucosamine results in decreased expression of RND1 mRNA
CTD PMID:17178593 PMID:18173918 NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
JBrowse link
G Rps6 ribosomal protein S6 decreases phosphorylation ISO Glucosamine results in decreased phosphorylation of RPS6 protein CTD PMID:19254699 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602
Ensembl chr 5:101,371,136...101,374,602
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 decreases phosphorylation ISO Glucosamine results in decreased phosphorylation of RPS6KB1 protein CTD PMID:19254699 NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
JBrowse link
G Runx2 RUNX family transcription factor 2 increases phosphorylation
increases expression
multiple interactions
ISO Glucosamine analog results in increased phosphorylation of RUNX2 protein
Glucosamine analog results in increased expression of RUNX2 mRNA
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased phosphorylation of RUNX2 protein]
CTD PMID:20458730 NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 increases expression ISO Glucosamine results in increased expression of SCD2 mRNA CTD PMID:17178593 NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
JBrowse link
G Sdc2 syndecan 2 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of SDC2 mRNA]; IL1B promotes the reaction [Glucosamine results in decreased expression of SDC2 mRNA] CTD PMID:17109745 NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
JBrowse link
G Sdc4 syndecan 4 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of SDC4 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of SDC4 mRNA] CTD PMID:17109745 NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
JBrowse link
G Selenbp1 selenium binding protein 1 decreases expression EXP Glucosamine results in decreased expression of SELENBP1 mRNA CTD PMID:17109745 NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
JBrowse link
G Serpinb2 serpin family B member 2 increases expression EXP Glucosamine results in increased expression of SERPINB2 mRNA CTD PMID:17109745 NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
JBrowse link
G Serpinh1 serpin family H member 1 increases expression ISO Glucosamine results in increased expression of SERPINH1 protein CTD PMID:16380481 NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
JBrowse link
G Sfrp2 secreted frizzled-related protein 2 decreases expression EXP Glucosamine results in decreased expression of SFRP2 mRNA CTD PMID:17109745 NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 decreases expression ISO Glucosamine results in decreased expression of SGK1 mRNA CTD PMID:17178593 NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
JBrowse link
G Shcbp1 SHC binding and spindle associated 1 decreases expression EXP Glucosamine results in decreased expression of SHCBP1 mRNA CTD PMID:17109745 NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844
JBrowse link
G Slc17a1 solute carrier family 17 member 1 increases expression ISO Glucosamine results in increased expression of SLC17A1 mRNA CTD PMID:17178593 NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
JBrowse link
G Slc23a2 solute carrier family 23 member 2 increases expression EXP Glucosamine results in increased expression of SLC23A2 mRNA CTD PMID:17109745 NCBI chr 3:119,302,651...119,395,289
Ensembl chr 3:119,302,666...119,460,343
JBrowse link
G Slc2a2 solute carrier family 2 member 2 decreases expression EXP Glucosamine results in decreased expression of SLC2A2 mRNA CTD PMID:11893929 NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
JBrowse link
G Slc2a4 solute carrier family 2 member 4 multiple interactions
decreases expression
increases uptake
ISO
EXP
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]
Glucosamine results in decreased expression of SLC2A4 mRNA; Glucosamine results in decreased expression of SLC2A4 protein
SLC2A4 protein results in increased uptake of Glucosamine
Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; Glucose inhibits the reaction [SLC2A4 protein results in increased uptake of Glucosamine]
CTD PMID:19373748 PMID:20165829 NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
JBrowse link
G Slc2a6 solute carrier family 2 member 6 decreases expression ISO Glucosamine results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 NCBI chr 3:10,348,395...10,355,208
Ensembl chr 3:10,348,395...10,355,208
JBrowse link
G Slc37a4 solute carrier family 37 member 4 increases expression ISO Glucosamine results in increased expression of SLC37A4 mRNA CTD PMID:17178593 NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
JBrowse link
G Slc4a4 solute carrier family 4 member 4 decreases expression EXP Glucosamine results in decreased expression of SLC4A4 mRNA CTD PMID:17109745 NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
JBrowse link
G Slc7a8 solute carrier family 7 member 8 increases expression
multiple interactions
EXP Glucosamine results in increased expression of SLC7A8 mRNA
Glucosamine inhibits the reaction [IL1B results in increased expression of SLC7A8 mRNA]; IL1B inhibits the reaction [Glucosamine results in decreased expression of SLC7A8 mRNA]
CTD PMID:17109745 NCBI chr15:28,183,013...28,242,717
Ensembl chr15:28,183,015...28,242,717
JBrowse link
G Smad2 SMAD family member 2 multiple interactions
increases phosphorylation
ISO 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased phosphorylation of SMAD2 protein] CTD PMID:20458730 NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
JBrowse link
G Smpd3 sphingomyelin phosphodiesterase 3 decreases expression EXP Glucosamine results in decreased expression of SMPD3 mRNA CTD PMID:17109745 NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
JBrowse link
G Sox4 SRY-box transcription factor 4 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of SOX4 mRNA]
Glucosamine results in decreased expression of SOX4 mRNA
CTD PMID:17109745 NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
JBrowse link
G Srsf3 serine and arginine rich splicing factor 3 decreases expression ISO Glucosamine results in decreased expression of SRSF3 mRNA CTD PMID:17178593 NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
JBrowse link
G St6gal1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 increases expression ISO Glucosamine results in increased expression of ST6GAL1 mRNA CTD PMID:17178593 NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO Glucosamine inhibits the reaction [IFNG results in increased localization of STAT1 protein modified form]; Glucosamine inhibits the reaction [IFNG results in increased phosphorylation of and results in increased localization of STAT1 protein] CTD PMID:16431966 PMID:17238806 NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
JBrowse link
G Tacc3 transforming, acidic coiled-coil containing protein 3 decreases expression EXP Glucosamine results in decreased expression of TACC3 mRNA CTD PMID:17109745 NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
JBrowse link
G Testin testin gene decreases expression EXP Glucosamine results in decreased expression of TESTIN mRNA CTD PMID:17109745 NCBI chr17:3,824,222...3,859,385
Ensembl chr17:3,846,899...3,859,385
JBrowse link
G Tgfa transforming growth factor alpha multiple interactions EXP [Glucose co-treated with Glucosamine] results in increased expression of TGFA protein; Glucosamine promotes the reaction [Glucose results in increased expression of TGFA mRNA] CTD PMID:1518840 NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression EXP Glucosamine analog results in increased expression of TGFB1 mRNA CTD PMID:21466783 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor 1 increases expression
multiple interactions
ISO Glucosamine analog results in increased expression of TGFBR1 protein
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased expression of TGFBR1 protein]
CTD PMID:20458730 NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
JBrowse link
G Thbs4 thrombospondin 4 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in decreased expression of THBS4 mRNA]; IL1B promotes the reaction [Glucosamine results in decreased expression of THBS4 mRNA] CTD PMID:17109745 NCBI chr 2:23,983,158...24,025,289
Ensembl chr 2:23,983,158...24,026,313
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions
increases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of TIMP1 mRNA]; IL1B promotes the reaction [Glucosamine results in increased expression of TIMP1 mRNA] CTD PMID:17109745 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:1,212,972...1,217,664
JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 affects expression
multiple interactions
EXP Glucosamine affects the expression of TIMP2 mRNA
Glucosamine inhibits the reaction [IL1B results in decreased expression of TIMP2 mRNA]
CTD PMID:17109745 NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
JBrowse link
G Timp3 TIMP metallopeptidase inhibitor 3 multiple interactions
increases expression
ISO
EXP
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in increased expression of TIMP3 mRNA
Glucosamine results in increased expression of TIMP3 mRNA
Glucosamine inhibits the reaction [IL1B results in decreased expression of TIMP3 mRNA]; IL1B affects the reaction [Glucosamine results in increased expression of TIMP3 mRNA]
CTD PMID:17109745 PMID:17605605 NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
JBrowse link
G Tinag tubulointerstitial nephritis antigen increases expression ISO Glucosamine results in increased expression of TINAG mRNA CTD PMID:17178593 NCBI chr 8:77,800,031...77,885,077
Ensembl chr 8:77,800,032...77,885,077
JBrowse link
G Tk1 thymidine kinase 1 decreases expression EXP Glucosamine results in decreased expression of TK1 mRNA CTD PMID:17109745 NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
JBrowse link
G Tlr1 toll-like receptor 1 increases expression ISO Glucosamine results in increased expression of TLR1 mRNA CTD PMID:17178593 NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
JBrowse link
G Tnf tumor necrosis factor decreases secretion
multiple interactions
decreases expression
ISO
EXP
Glucosamine results in decreased secretion of TNF protein
Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
Glucosamine analog results in decreased expression of TNF mRNA; Glucosamine results in decreased expression of TNF mRNA
Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]
[Glucosamine co-treated with Chondroitin Sulfates] results in decreased expression of TNF; Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]]; Glucosamine analog inhibits the reaction [TNF results in increased expression of CUL2 mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of CXCL8 mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of GSPT1 mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of IL6 mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1A mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine analog inhibits the reaction [TNF results in increased expression of TRAF6 mRNA]; Glucosamine inhibits the reaction [[IL6 co-treated with TNF] results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [IFNG promotes the reaction [TNF results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [IL1B promotes the reaction [TNF results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [TNF promotes the reaction [IFNG results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [TNF promotes the reaction [IL1B results in increased expression of ICAM1 protein]]; Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 protein]; Glucosamine inhibits the reaction [TNF results in increased expression of CUL2 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of CXCL8 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of GSPT1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of ICAM1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of ICAM1 protein]; Glucosamine inhibits the reaction [TNF results in increased expression of IL6 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1A mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TRAF6 mRNA]; Glucosamine inhibits the reaction [TNF results in increased localization of RELA protein]; Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]
CTD PMID:14507305 PMID:16431966 PMID:16445576 PMID:16822504 PMID:17238806 More... NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link
G Tnfaip6 TNF alpha induced protein 6 multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of TNFAIP6 mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of TNFAIP6 mRNA] CTD PMID:17109745 NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B multiple interactions ISO [Chondroitin Sulfates co-treated with Glucosamine co-treated with Cholecalciferol] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Glucosamine co-treated with Cholecalciferol] results in increased expression of TNFRSF11B protein; [Chondroitin Sulfates co-treated with Glucosamine] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Glucosamine] results in increased expression of TNFRSF11B protein CTD PMID:17996099 NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
JBrowse link
G Tnfrsf1a TNF receptor superfamily member 1A multiple interactions ISO Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1A mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1A mRNA] CTD PMID:18173918 NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
JBrowse link
G Tnfrsf1b TNF receptor superfamily member 1B multiple interactions ISO Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA] CTD PMID:18173918 NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
JBrowse link
G Tnfsf11 TNF superfamily member 11 multiple interactions
increases expression
ISO [Chondroitin Sulfates co-treated with Glucosamine] inhibits the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA]; Chondroitin Sulfates inhibits the reaction [Glucosamine results in increased expression of TNFSF11 mRNA] CTD PMID:17996099 NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
JBrowse link
G Tnk2 tyrosine kinase, non-receptor, 2 multiple interactions EXP Glucosamine inhibits the reaction [IL1B results in increased expression of TNK2 mRNA] CTD PMID:17109745 NCBI chr11:68,114,725...68,154,254
Ensembl chr11:68,114,726...68,154,009
JBrowse link
G Top2a DNA topoisomerase II alpha decreases expression EXP Glucosamine results in decreased expression of TOP2A mRNA CTD PMID:17109745 NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
JBrowse link
G Traf6 TNF receptor associated factor 6 multiple interactions ISO Glucosamine analog inhibits the reaction [TNF results in increased expression of TRAF6 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TRAF6 mRNA] CTD PMID:18173918 NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
JBrowse link
G Trpv4 transient receptor potential cation channel, subfamily V, member 4 increases expression ISO Glucosamine results in increased expression of TRPV4 mRNA CTD PMID:17178593 NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
JBrowse link
G Txn1 thioredoxin 1 decreases expression EXP
ISO
Glucosamine results in decreased expression of TXN1 protein CTD PMID:17178593 NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
JBrowse link
G Txnip thioredoxin interacting protein increases expression
multiple interactions
EXP
ISO
Glucosamine results in increased expression of TXNIP protein
Glucosamine results in increased expression of TXNIP mRNA; Glucosamine results in increased expression of TXNIP protein
Glucosamine promotes the reaction [TXNIP results in increased abundance of Reactive Oxygen Species]; TXNIP promotes the reaction [Glucosamine results in increased expression of LAMB1 mRNA]; TXNIP promotes the reaction [Glucosamine results in increased expression of LAMC1 mRNA]
CTD PMID:17178593 NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
JBrowse link
G Ucp2 uncoupling protein 2 decreases expression EXP Glucosamine results in decreased expression of UCP2 mRNA CTD PMID:11893929 NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
JBrowse link
G Uqcrh ubiquinol-cytochrome c reductase hinge protein increases expression ISO Glucosamine results in increased expression of UQCRH mRNA CTD PMID:17178593 NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
JBrowse link
G Vamp1 vesicle-associated membrane protein 1 increases expression EXP Glucosamine results in increased expression of VAMP1 mRNA CTD PMID:17109745 NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349
JBrowse link
G Vcan versican multiple interactions
decreases expression
EXP Glucosamine inhibits the reaction [IL1B results in increased expression of VCAN mRNA]; IL1B affects the reaction [Glucosamine results in decreased expression of VCAN mRNA] CTD PMID:17109745 NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
increases expression
decreases expression
ISO
EXP
Glucosamine inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA protein]
Glucosamine results in increased expression of VEGFA protein
Glucosamine results in decreased expression of VEGFA protein
CTD PMID:16324875 PMID:19254699 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
JBrowse link
G Vegfd vascular endothelial growth factor D increases expression
decreases expression
ISO
EXP
Glucosamine results in increased expression of VEGFD mRNA
Glucosamine results in decreased expression of VEGFD mRNA
CTD PMID:17109745 PMID:17178593 NCBI chr  X:30,073,122...30,108,413
Ensembl chr  X:30,074,163...30,108,295
JBrowse link
G Vnn1 vanin 1 increases expression ISO Glucosamine results in increased expression of VNN1 mRNA CTD PMID:17178593 NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions
increases splicing
increases expression
decreases splicing
ISO
EXP
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]
Glucosamine results in increased expression of XBP1 protein alternative form
4-methylumbelliferone 8-carbaldehyde affects the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased splicing of XBP1 mRNA]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]
Glucosamine results in decreased splicing of XBP1 mRNA
CTD PMID:19383982 PMID:20165829 PMID:30602124 PMID:33812996 NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucosamine results in increased abundance of Proteoglycans]; [XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucosamine results in increased expression of B3GAT3 mRNA] CTD PMID:11801247 NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
JBrowse link
G Zfp467 zinc finger protein 467 increases expression ISO Glucosamine results in increased expression of ZFP467 mRNA CTD PMID:17178593 NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
JBrowse link
aldehydo-D-glucosamine 6-phosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cebpa CCAAT/enhancer binding protein alpha decreases expression ISO glucosamine 6-phosphate results in decreased expression of CEBPA protein CTD PMID:19427183 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 decreases expression ISO glucosamine 6-phosphate results in decreased expression of DLK1 mRNA CTD PMID:19427183 NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
JBrowse link
G Fabp4 fatty acid binding protein 4 decreases expression ISO glucosamine 6-phosphate results in decreased expression of FABP4 mRNA CTD PMID:19427183 NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
JBrowse link
G Fas Fas cell surface death receptor decreases expression ISO glucosamine 6-phosphate results in decreased expression of FAS mRNA CTD PMID:19427183 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 multiple interactions
increases abundance
ISO Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glucosamine 6-phosphate] CTD PMID:27469509 NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
JBrowse link
G Lep leptin decreases expression ISO glucosamine 6-phosphate results in decreased expression of LEP mRNA CTD PMID:19427183 NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
JBrowse link
G Lipe lipase E, hormone sensitive type increases expression ISO glucosamine 6-phosphate results in increased expression of LIPE mRNA CTD PMID:19427183 NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
JBrowse link
G Lpl lipoprotein lipase decreases expression ISO glucosamine 6-phosphate results in decreased expression of LPL mRNA CTD PMID:19427183 NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma decreases expression ISO glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 decreases expression ISO glucosamine 6-phosphate results in decreased expression of SREBF1 protein CTD PMID:19427183 NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
JBrowse link
G Tnf tumor necrosis factor decreases expression ISO glucosamine 6-phosphate results in decreased expression of TNF mRNA CTD PMID:19427183 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19918
    role 19894
      biological role 19892
        biochemical role 19588
          metabolite 19574
            fundamental metabolite 14450
              glucose 2828
                D-glucose 2826
                  aldehydo-D-glucose 1659
                    2-deoxy-2-fluoro-aldehydo-D-glucose + 0
                    2-galloyl-D-glucose 0
                    3-O-methyl-D-glucose 3
                    6-O-methyl-D-glucose 0
                    aldehydo-D-glucosamine + 328
                    aldehydo-D-glucuronic acid + 0
                    aldehydo-D-kanosamine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19918
    subatomic particle 19916
      composite particle 19916
        hadron 19916
          baryon 19916
            nucleon 19916
              atomic nucleus 19916
                atom 19916
                  main group element atom 19866
                    p-block element atom 19866
                      carbon group element atom 19811
                        carbon atom 19806
                          organic molecular entity 19806
                            heteroorganic entity 19548
                              organochalcogen compound 19303
                                organooxygen compound 19217
                                  carbohydrates and carbohydrate derivatives 15307
                                    carbohydrate 15307
                                      monosaccharide 4809
                                        aldose 3223
                                          aldohexose 2872
                                            glucose 2828
                                              D-glucose 2826
                                                aldehydo-D-glucose 1659
                                                  2-deoxy-2-fluoro-aldehydo-D-glucose + 0
                                                  2-galloyl-D-glucose 0
                                                  3-O-methyl-D-glucose 3
                                                  6-O-methyl-D-glucose 0
                                                  aldehydo-D-glucosamine + 328
                                                  aldehydo-D-glucuronic acid + 0
                                                  aldehydo-D-kanosamine 0
paths to the root